- Trials with a EudraCT protocol (50)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (6,736)
Query did not match any clinical trials.
| These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006). | |
| Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records. | |
| Study title: OPEN, NONCOMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF SULTAMICILLIN PO IN CHILDREN WITH MILD TO MODERATE UPPER RESPIRATORY INFECTIONS |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42968 |
| Study title: ORAL SULTAMICILLIN IN THE TREATMENT OF UPPER RESPIRATORY TRACT PEDIATRIC INFECTIONS |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42980 |
| Study title: SAFETY AND EFFICACY OF ORAL SULTAMICILLIN IN PEDIATRIC PATIENTS WITH URTI. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43036 |
| Study title: Aldress K et al. Candida meningitis in children: Report of two cases. J Chemother. September 5, 2000, 339-44 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27321 |
| Study title: Ancotil (Flucytosin) als Kombinationspartner in der antimykotischen Therapie tiefsitzender Mykosen - Anwndngsbeobachtung nach §§49, 67 AMG, Statistischer Bericht Teilkolektiv Hämatol-onkol. Pat., 2001 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27333 |
| Study title: Baley J, Meyers C, Kliegman R, Jacobs M, Blumer J. Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates. J Pediatrics 1990; 116 (no. 5): 791-97 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27332 |
| Study title: Bennett JE et al. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis. N Engl J Med. 1979 Jul 19;301(3):126-31 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27309 |
| Study title: Berg RA, Stein JM. Medical management of fungal suppurative thrombosis of great central veins in a child. Pediatr Infect Dis J. August 15, 1989, 469-70 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27330 |
| Study title: Brady MT. Management of children with human immunodeficiency virus infection. Comp Ther. May 4, 1995, 139-147 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27328 |
| Study title: Cherrick I, Kveselis DA, Baesl TJ. Medical management of Candida-infected thrombosis in a pediatric oncology patient. Pediatr Infect Dis J. May 30, 1995, 398-400 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27327 |
| Study title: Chotmongkol V, Sukeepaisarncharoen W, Thavornpitak Y. Comparison of amphotericin B, flucytosine and itraconazole with amphotericin B and flucytosine in the treatment of cryptococcal meningitis in AIDS. J Med Assoc Thai. 1997 Jul;80(7):416-25 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27301 |
| Study title: Dismukes WE et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N Engl J Med. 1987 Aug 6;317(6):334-41 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27305 |
| Study title: Filioti J.; Spiroglou K.; Roilides E. Invasive candidiasis in pediatric intensive care patients: Epidemiology, risk factors, management, and outcome. Intensive Care Med. July 1, 2007, 1272-83 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27312 |
| Study title: VIII national congress of SIUP (Italian Society of Pediatric Urology) Messina -Taormina 8-10 June 1992 (in English) |
| Active substance: CEFTIBUTEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23590 |
| Study title: A Comparative Study of Single-Dose Intramuscular (IM) Ceftriaxone and a 10-day Oral (PO) Course of Amoxicillin for the Treatment of Acute Otitis Media in Infants and Children |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23623 |
| Study title: A Comparative Study of Single-Dose Intramuscular (IM) Ceftriaxone and a 10-day Oral (PO) Course of Cefaclor for the Treatment of Uncomplicated Acute Otitis Media in Infants and Children |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23624 |
| Study title: A Comparative Study of Single-Dose Intramuscular (IM) Ceftriaxone and a 10-Day Oral (PO) Course of Trimethorprim-sulfamethoxazole for the Treatment of Acute Otitis Media in Infants and Children |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23622 |
| Study title: A Randomised Open Study to Compare ROCEPHIN with a Combination of Azlocillin plus Netilmicin in Neutropenic Children wth Episodes of Infection (ISN 10401). |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23620 |
| Study title: An Open Study of ROCEPHIN in the Treatment of Neutropenic Children with Episodes of Infection. |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23621 |
| Study title: Bronchial provocation tests with dermatophagoides in sensitized, school-aged children : a double-blind, placebo-controlled study of the protector effect of cetirizine and determination of the optimal dose. |
| Active substance: CETIRIZINE |
| Study summary document link (including results): A106 - Cetirizine - RRCE92K2901.pdf |
| View full study record |
| Document reference: 23736 |
| Study title: Central nervous system side effects of first- and second-generation antihistamines in school children with perennial allergic rhinitis |
| Active substance: CETIRIZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23711 |
| Study title: Cetirizin effects on children with atopic dermatitis. correlation among the eosinophil cationic protein (ecp), il2r soluble (cd25), cd23 (b cells) and clinical score. |
| Active substance: CETIRIZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23689 |
| Study title: Neuroimage. 2003 Jul;19(3):777-83. Developmental hemispheric asymmetry of interregional metabolic correlation of the auditory cortex in deaf subjects. Kang E, Lee DS, Lee JS, Kang H, Hwang CH, Oh SH, Kim CS, Chung JK, Lee MC, Jang MJ, Lee YJ, Morosan P, Zilles K. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28145 |
| Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27823 |
| Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27997 |
| Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28002 |
| Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28007 |
| Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE TOLERANCE AND EFFICACY OF A WEEKLY SINGLE 150MG DOSE OF ORAL FLUCONAZOLE IN THE TREATMENT OF PATIENTS WITH TINEA PEDIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27582 |
| Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE TOLERANCE AND EFFICACY OF A WEEKLY SINGLE 150MG DOSE OF ORAL FLUCONAZOLE IN THE TREATMENT OF PATIENTS WITH TINEA PEDIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27945 |
| Study title: AN OPEN NON-COMPARATIVE PILOT STUDY OF THE SAFETY AND EFFICACY OF ONE OR TWO ORAL DOSES (150 MG) OF FCA IN ORAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27390 |
| Study title: AN OPEN NON-COMPARATIVE PILOT STUDY OF THE SAFETY AND EFFICACY OF ONE OR TWO ORAL DOSES (150 MG) OF FCA IN ORAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27755 |
| Study title: AN OPEN NON-COMPARATIVE STUDY FOR THE EVALUATION OF FLUCONAZOLE IN EMPIRIC FUNGAL TREATMENT IN FEBRILE GRANULOCYTOPENIC CANCER PATIENT. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27448 |
| Study title: AN OPEN NON-COMPARATIVE STUDY FOR THE EVALUATION OF FLUCONAZOLE IN EMPIRIC FUNGAL TREATMENT IN FEBRILE GRANULOCYTOPENIC CANCER PATIENT. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27812 |
| Study title: AN OPEN NON-COMPARATIVE STUDY IN THE EFFICACY AND SAFETY OF ORAL FLUCONAZOLE IN THE TREATMENT OF TINEA CORPORIS, CRURIS OR PEDIS OR CUTANEOUS CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27626 |
| Study title: AN OPEN NON-COMPARATIVE STUDY IN THE EFFICACY AND SAFETY OF ORAL FLUCONAZOLE IN THE TREATMENT OF TINEA CORPORIS, CRURIS OR PEDIS OR CUTANEOUS CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27988 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF EFFICACY AND SAFETY OF ORAL FLUCONAZOLE 150MG IN THE TREATMENT OF TINEA CORPORIS CRURIS OR CUTANEOUS CANDIDIASIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27625 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF EFFICACY AND SAFETY OF ORAL FLUCONAZOLE 150MG IN THE TREATMENT OF TINEA CORPORIS CRURIS OR CUTANEOUS CANDIDIASIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27987 |
|
Study title: CEFTRIAXONE (CRO) VERSUS STANDARD TREATMENT |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23608 |
| Study title: Ceftriaxone versus Penicillin+Chloramphenicol in the treatment of Bacterial Meningitis in Children. Results from Dr. E. Rosen, Baragwanath Hospital, South Africa. 22.04.1986 |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23604 |
| Study title: Ceftriaxone versus standard treatment (ampicillin in combination with chloramphenicol) in pediatric patients suffering from purulent meningitis. An open prospective randomized comparative study. Results of Prof. J. L. Ngu, Dr. T. J. Youmbissi, Centre Universitaire des Sciences de la Sante, Yaounde, Cameroun. 07.04.1986 |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23603 |
| Study title: Ceftriaxone vs Ampicillin (AMP) + Chloramphenicol (CAP) in the Treatment of Purulent Meningitis of Children (Ro 13-9904). 30.11.1993 |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23609 |
| Study title: Comparative study of Rocephin versus cefotaxime in the treatment of purulent meningitis in children. Results from Dr. J. B. de Bary, Hopital Protestant Dabou, Cote d'Ivoire. 03.04.1987 |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23607 |
| Study title: Final Study Report: A Comparative Study of Single-Dose Intramuscular (IM) Ceftriaxone Versus Single-Dose IM Bicillin CR plus Oral Trimethoprim-Sulfamethoxazole for the Treatment of Uncomplicated Acute Otitis Media in Infants and Children (Howie Protocol) |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23613 |
| Study title: Final Study Report: A Single-Blind Randomized Comparative Study of Single Dose (IM) Ceftriaxone and a Ten-Day Course (PO) of Amoxicillin/Clavulanate Potassium for the Treatment of Acute Otitis Media in Infants and Children [Ident No: NR14545] 14.10.1996 |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23614 |
| Study title: Final Study Report: An Open-Label, Non-Comparative Study Describing the Efficacy and Safety of Rocephin (Ro 13-9904) Administered Once Intramuscularly (50 mg/kg/day: maximum of 1 g/day) in the Treatment of Acute Otitis Media Caused by Streptococcus pneumoniae, Haemophilus influenzae, and/or Moraxella catarrhalis in Infants and Children [Ident No: NR15168] 22.10.1996 |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23612 |
| Study title: The safety and efficacy of topical norfloxacin compared with chloramphenicol for the treatment of external ocular bacterial infections. The Norfloxacin-Chloramphenicol Ophthalmic Study Group. Miller IM, Wittreich JM, Cook T, Vogel R. Eye. 1992;6 ( Pt 1):111-4. The safety and efficacy of topical norfloxacin compared with chloramphenicol for the treatment of external ocular bacterial infections. The Norfloxacin-Chloramphenicol Ophthalmic Study Group. Miller IM, Wittreich JM, Cook T, Vogel R. Eye. 1992;6 ( Pt 1):111-4. |
| Active substance: CHLORAMPHENICOL_ CHLORAMPHENICOL +CORTISONE ACETATE +ETHACRIDINE LACTATE +ZINC OXIDE / CHLORAMPHENICOL AND MEDROXYPROGESTERONE AND TETRYZOLINE |
| Study summary document link (including results): The safety and efficacy of topical norfloxacin compared with.pdf |
| View full study record |
| Document reference: 23867 |
| Study title: A Twelve Month Safety/Tolerance Study of 240mg MDL 16,455A QD and Placebo QD in Normal Healthy Subjects |
| Active substance: FEXOFENADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27227 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF EFFICACY AND SAFETY OF SINGLE DOSE OF ORAL FLUCONAZOLE 150MG CAP IN THE TREATMENT OF VAGINAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27627 |
| Study title: Gillman−Sherwin−A, Blatter−Mark, Condemi−John−J, Collins−Millicent, Olufade−Abayomi−O, Leidy−Nancy−Kline, Chapman−Douglass, Kramer− Benjamin. The health−related quality of life effects of once−daily cetirizine HCl syrup in children with seasonal allergic rhinitis.Clinical pediatrics, Nov−Dec 2002, vol. 41, no. 9, p. 687−96.Gillman−Sherwin−A, Blatter−Mark, Condemi−John−J, Collins−Millicent, Olufade−Abayomi−O, Leidy−Nancy−Kline, Chapman−Douglass, Kramer− Benjamin. The health−related quality of life effects of once−daily cetirizine HCl syrup in children with seasonal allergic rhinitis.Clinical pediatrics, Nov−Dec 2002, vol. 41, no. 9, p. 687−96. |
| Active substance: CETIRIZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23662 |
| Study title: H1 receptor antagonist and histamine induced skin wheal in children: double-blind vs placebo controlled study on inhibitory effects |
| Active substance: CETIRIZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23708 |
| Study title: In vitro effects of loratadine versus cetirizine on the ciliary beat frequency of children: a comparative study. |
| Active substance: CETIRIZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23687 |
| Study title: Inhibition of histamine-induced wheal and flare reactions by cetirizine dihydrochloride and mequitazine both in healthy and atopic subjects: a comparative double-blind placebo controlled study. |
| Active substance: CETIRIZINE |
| Study summary document link (including results): DE89J111P - Cetirizine.pdf |
| View full study record |
| Document reference: 23717 |
| Study title: Investigation of the immediate effect of cetirizine on nocturnal cough in asthmatic children. |
| Active substance: CETIRIZINE |
| Study summary document link (including results): 9128 - Cetirizine - MRCF92F2201.pdf |
| View full study record |
| Document reference: 23772 |
| Study title: The benefit of using ceterizine (Zyrtec) with stimulant in children with comorbid allergy and ADHD. |
| Active substance: CETIRIZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23707 |
| Study title: Pharmacokinetics of Fentanyl in neotal humans and lambs : effects of age. Gauntlett et al., anaesthesiology, 1988, 69, 683-687 |
| Active substance: FENTANYL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27164 |
| Study title: Postoperative analgesia with intravenous fentanyl PCA vs epidural block after thoracoscopic pectus excavatum repair in children. Butkovic, D., et al., Br J Anaesth, 2007. 98(5): p. 677-81. |
| Active substance: FENTANYL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27136 |
| Study title: A RANDOMIZED COMPARATIVE MULTICENTER TRIAL OF FLUCONAZOLE AND KETOCONAZOLE IN THE TREATMENT OF ESOPHAGEAL CANDIDIASIS IN IMMUNOCOMPROMISED PATIENTS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27709 |
| Study title: A RANDOMIZED COMPARATIVE MULTICENTER TRIAL OF FLUCONAZOLE AND AMPHOTERICIN B IN THE TREATMENT OF ESOPHAGEAL CANDIDIASIS IN PATIENTS WITH MALIGNANCIES |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27350 |
| Study title: A RANDOMIZED COMPARATIVE MULTICENTER TRIAL OF FLUCONAZOLE AND AMPHOTERICIN B IN THE TREATMENT OF ESOPHAGEAL CANDIDIASIS IN PATIENTS WITH MALIGNANCIES |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27716 |
| Study title: A Twelve-Month Safety/Tolerance Study of 240 mg MDL 16,455A QD and Placebo QD in Normal Healthy Subjects |
| Active substance: FEXOFENADINE |
| Study summary document link (including results): Fexofenadine - Study 30.pdf |
| View full study record |
| Document reference: 27263 |
| Study title: An abbreviated report on the adverse event data after recoding of data from protocols PJPR0066 & PJPR0077 comparing fexofenadine HCL ( 15, 30 & 60 mg b.i.b) and placebo in paediatric seasonal allergic rhinitis subjects aged 6 through 11 years. 15 February 2002 |
| Active substance: FEXOFENADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27260 |
| Study title: An open label, bioavailability study of fexofenadine HCl 60 mg capsules administered orally in food delivery vehicles in fasting healthy adult male subjects-( 27-Dec-2001) |
| Active substance: FEXOFENADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27235 |
| Study title: Comparative study evaluating the effects of fexofenadine HCI 180 mg with orange juice versus placebo with orange juice in a skin wheal and flare challenge model |
| Active substance: FEXOFENADINE |
| Study summary document link (including results): Fexofenadine - Study 8.pdf |
| View full study record |
| Document reference: 45686 |
| Study title: AN OPEN NON COMPARATIVE STUDY ON THE EFFICACY AND SAFETY OF FLUCONAZOLE 150 MG (1 CAPSULE) SINGLE DOSE IN THE VAGINAL CANDIDIASIS TREATMENT. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27947 |
| Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27387 |
| Study title: EFFICACY AND SECURITY OF SULTAMICILLIN IN PEDIATRIC PATIENTS WITH SKIN AND SOFT TISSUE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42965 |
| Study title: EFFICACY OF SULTAMICILLIN IN PATIENTS WITH MODERATE GENERAL INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42962 |
| Study title: therapeutic effect of vitamin C. A co-twin control study. |
| Active substance: CHLORPHENAMINE AND FERROUS AND PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24033 |
| Study title: A randomized, placebo-controlled trial of the effect of antihistamine or corticosteroid treatment in acute otitis media |
| Active substance: CHLORPHENAMINE AND PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24035 |
| Study title: analgesic efficacy of rectal acetaminophen and ibuprofen alone or in combination for paediatric day-case adenoidectomy |
| Active substance: CHLORPHENAMINE AND PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24053 |
| Study title: bronchodilator effect of two inhaled H1-receptor antagonists, clemastine and chlorpheniramine, in wheezy school-children. |
| Active substance: CHLORPHENAMINE AND PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24042 |
| Study title: Central nervous system side effects of first- and second- generation antihistamines in school children with perennial allergic rhinitis: A randomized, double blind, placebo. Controlled comparative study |
| Active substance: CHLORPHENAMINE AND PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24044 |
| Study title: Chlorpheniramine is no more effective than placebo in relieving the symptoms of childhood atopic dermatitis with a nocturnal itching and scratching component. |
| Active substance: CHLORPHENAMINE AND PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24037 |
| Study title: Comparison of CNS adverse effects between astemizole and chlorpheniramine in children: a randomized, double-blind study |
| Active substance: CHLORPHENAMINE AND PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24039 |
| Study title: Effect of allergy medication on children's reading comprehension. |
| Active substance: CHLORPHENAMINE AND PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24040 |
| Study title: Equal anipyretic effectiveness for oral and rectal acetaminophen; a randomized controlled trial (ISRCTN11886401) |
| Active substance: CHLORPHENAMINE AND PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24050 |
| Study title: Middle ear fluid histamine and leukotriene B4 in acute otitis media: effect of antihistamine or corticosteroid treatment. |
| Active substance: CHLORPHENAMINE AND PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24036 |
| Study title: Premedication of pediatric tonsillectomy patients with oral transmucosal fentanyl citrate; Anesthesia and Analgesia 1998, 86(1): 66-70 |
| Active substance: FENTANYL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27171 |
| Study title: Prevention of withdrawal movement associated with injection of rocuronium in children: comparison of remifentanil, alfentanil and fentanyl. Oh, A.Y., et al., Acta Anaesthesiol Scand, 2007. 51(9): p. 1190-3. |
| Active substance: FENTANYL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27172 |
| Study title: Protection of fentanyl against cardiac disrythmias during induction of anaesthesia; Lindgren et al., European Journal of Anaesthesiology, 1987, 4, 229-233. |
| Active substance: FENTANYL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27176 |
| Study title: Protection of fentanyl against cardiac disrythmias during induction of anaesthesia. Lindgren et al., European Journal of Anaesthesiology, 1987, 4, 229-233. |
| Active substance: FENTANYL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27175 |
| Study title: Randomised trial of Fentanyl anaesthesia in preterm babies undergoing surgery : effects on the stress respons. Anand et al., The Lancet, 1987, January, 10, 62-65 |
| Active substance: FENTANYL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27177 |
| Study title: Safety of intravenous midazolam and fentanyl for pediatric GI endoscopy: prospective study of 1578 endoscopies. Mamula, P., et al., Gastrointest Endosc, 2007. 65(2): p. 203-10. |
| Active substance: FENTANYL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27180 |
| Study title: Fukushima T et al. Successful treatment of invasive thoracopulmonary mucormycosis in a patient with acute lymphoblastic leukaemia. Cancer. September 8, 1995, 895-9 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27326 |
| Study title: Gaber KA et al. Fungal septicaemia in patients with cystic fibrosis associated with totally implantable venous access device system. Journal of Cystic Fibrosis. September 1, 2007, 317-9 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27310 |
| Study title: Groll AH, Muller F-MC. Advances in prevention and treatment of infectious complications in children and adoloscents with cancer. Klinische Padiatrie. May 28, 1998, 106-14 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27323 |
| Study title: Hofmann H et al. Invasive chromoblastomycosis and sinusitis due to Phialophora verrucosa in a child from northern Africa. Mycoses. November 1, 2005, 456-61 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27313 |
| Study title: Kulkarni S. Infective endocarditis in children. Indian Journal of Practical Pediatrics. Indian J Pract Pediatr. October 1, 2004, 309-15 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27316 |
| Study title: Kurrle E et al. Antimicrobial prophylaxis in acute leukaemia: prospective randomized study comparing two methods of selective decontamination. Klin Wochenschr. 1983 Jul 15;61(14):691-8 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27307 |
| Study title: A RANDOMIZED MULTICENTER STUDY OF THE EFFICACY, SAFETY AND TOLERATION OF FLUCONAZOLE OR CLOTRIMAZOLE TROCHES IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL THRUSH IN ASSOCIATION WITH MALIGNANCY |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27344 |
| Study title: A RANDOMIZED MULTICENTER STUDY OF THE EFFICACY, SAFETY AND TOLERATION OF FLUCONAZOLE OR CLOTRIMAZOLE TROCHES IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS IN ASSOCIATION WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27352 |
| Study title: A RANDOMIZED MULTICENTER STUDY OF THE EFFICACY, SAFETY AND TOLERATION OF FLUCONAZOLE OR CLOTRIMAZOLE TROCHES IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL THRUSH IN ASSOCIATION WITH MALIGNANCY |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27710 |
| Study title: A RANDOMIZED MULTICENTER STUDY OF THE EFFICACY, SAFETY AND TOLERATION OF FLUCONAZOLE OR CLOTRIMAZOLE TROCHES IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS IN ASSOCIATION WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27718 |
| Study title: A RANDOMIZED, DOUBLE-BLIND COMPARATIVE MULTICENTER STUDY OF FLUCONAZOLE PLUS AMPHOTERICIN B VERSUS FLUCONAZOLE PLUS PLACEBO IN THE TREATMENT OF CANDIDEMIA AND ITS CONSEQUENCES IN NON-NEUTROPENIC PATIENTS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27702 |
| Study title: A RANDOMIZED, DOUBLE-BLIND MULTICENTER STUDY OF THE ASSESSMENT OF CLINICAL EFFICACY AND SYSTEMIC SAFETY OF FCA 50MG AND 100MG CAP VS. ITRACONAZOLE 100MG CAP IN TREATMENT OF DERMATOMYCOSIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27468 |
| Study title: A RANDOMIZED, DOUBLE-BLIND MULTICENTER STUDY OF THE ASSESSMENT OF CLINICAL EFFICACY AND SYSTEMIC SAFETY OF FCA 50MG AND 100MG CAP VS. ITRACONAZOLE 100MG CAP IN TREATMENT OF DERMATOMYCOSIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27832 |
| Study title: A RANDOMIZED, THIRD PARTY BLIND, MULTICENTER TRIAL COMPARING THE EFFICACY AND SAFETY OF DIFLUCAN (FLUCONAZOLE) FOR 3 WEEKS VERSUS DIFLUCAN FOR 6 WEEKS VERSUS GRIFULVIN V (GRISEOFULVIN) FOR 6 WEEKS GIVEN ONCE DAILY TO PEDIATRIC PATIENTS WITH TINEA CAPITIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27727 |
| Study title: A RANDOMIZED, THIRD PARTY BLIND, MULTICENTER TRIAL COMPARING THE EFFICACY AND SAFETY OF DIFLUCAN (FLUCONAZOLE) FOR 3 WEEKS VERSUS DIFLUCAN FOR 6 WEEKS VERSUS GRIFULVIN V (GRISEOFULVIN) FOR 6 WEEKS GIVEN ONCE DAILY TO PEDIATRIC PATIENTS WITH TINEA CAPITIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27728 |
| Study title: A THREE ARM RANDOMIZED STUDY COMPARING INTRAVENOUS LIPOSOMAL AMPHOTERICIN, ORAL FLUCONAZOLE AND FLUCONAZOLE PLACEBO AS PROPHYLACTIC ANTIFUNGAL AGENTS AFTER BONE MARROW TRANSPLANTATION. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27670 |
| Study title: A comparative study of ebastine and cetirizine effect on in -vivo test- on children who are sensitive to olea pollen. |
| Active substance: CETIRIZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23676 |
| Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27411 |
| Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27413 |
| Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27414 |
| Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27415 |
| Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27459 |
| Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27635 |
| Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27640 |
| Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27645 |
| Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27752 |
| Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27776 |
| Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27778 |
| Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27779 |
| Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27780 |
| Study title: SAFETY AND EFFICACY OF S/A, STM IN MODERATE TO SEVERE OSTEOMYELITIS EITHER ACUTE OR PERSISTENT. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42956 |
| Study title: SAFETY AND EFFICACY OF SULBACTAM/AMPICILLIN FOLLOWED BY SULTAMICILLIN IN CHILDREN WITH MODERATE TO SEVERE INFECTIONS |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42953 |
| Study title: STM IN THE TREATMENT OF PEDIATRIC INFECTIONS OF THE UPPER RESPIRATORY TRACT. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42978 |
| Study title: STM IN URINARY TRACT INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42979 |
| Study title: SULTAMICILLIN (UNASYN) IN MILD AND MODERATE RESPIRATORY TRACT INFECTIONS |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42977 |
| Study title: Lehrnbecher T et al. Antifungal usage in children undergoing intensive treatment for acute myeloid leukemia: analysis of the multicenter clinical trial AML-BFM 93. Eur J Clin Microbiol Infect Dis. 2007 Oct;26(10):735-8 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27297 |
| Study title: Lehrnbecher T, Groll AH, Chanock SJ. Treatment of fungal infections in neutropenic children. Curr Opin Pediatr. March 2, 1999, 47-55 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27322 |
| Study title: Link H et al. Interventional antimicrobial therapy in febrile neutropenic patients. Study Group of the Paul Ehrlich Society for Chemotherapy. Ann Hematol. 1994 Nov;69(5):231-43 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27302 |
| Study title: Mavinkurve-Groothuis AMC et al. Cryptococcal meningitis in a child with acute lymphoblastic leukaemia. Pediatr Infect Dis J. June 1, 2003, 576 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27319 |
| Study title: Mirdha BR, Sarkar T. Concurrent cryptococcal meningitis and falciparum malaria in a child with nephrotic syndrome. Indian Pediatr. April 1, 1998, 360-3 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27324 |
| Study title: Mobacken H et al. Transfer factor in the treatment of chronic mucocutaneous candidiasis: a controlled study. Acta Derm Venereol. 1980;60(1):51-5 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27308 |
| Study title: Pasqualotto AC et al. Flucytosine therapeutic monitoring: 15 years experience from the UK J Antimicrob Chemother. April 1, 2007, 791-3 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27311 |
| Study title: Pediatric AIDS and HIV Infection. Treatment trials open to pregnant women, children, and adolescents: Part III: Opportunistic infections and other HIV-related symptomatology. May 31, 1994, 126-54 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27329 |
| Study title: Ridola V et al. Candida Infections in Children Treated with Conventional Chemotherapy for Solid Tumors (Transplant Recipients Excluded): The Institut Gustave Roussy Pediatrics Department Experience. Pediatr Blood Cancer. April 1, 2004, 332-7 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27317 |
| Study title: Schaefer F et al. Management of peritonitis in children receiving chronic peritoneal dialysis. Paediatr Drugs. June 11, 2003, 315-25 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27320 |
| Study title: Schwartz S et al. Poor efficacy of amphotericin B-based therapy in CNS aspergillosis.Mycoses. 2007 May;50(3):196-200 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27298 |
| Study title: Schwarze R, Seebacher C, Blaschke-Hellmessen R. Candida infections in infants and children. Z Arztl Fortbild Qual Sich. April 1, 1998, 163-8 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27325 |
| Study title: Serra G, Mezzano P, Bonacci W. Therapeutic treatment of systemic candidiasis in newborns. J Chemother. 1991 Jan;3 Suppl 1:240-4 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27304 |
| Study title: Silling G et al. Early empiric antifungal therapy of infections in neutropenic patients comparing fluconazole with amphotericin B/flucytosine. Mycoses. 1999;42 Suppl 2:101-4 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27300 |
| Study title: Final Study Report: Clinical and Statistical: Ro 13-9904/ /Once daily ceftriaxone plus amikacin compared to three times daily ceftazidime plus amikacin in the treatment of febrile neutropenic children with cancer. 22.11.1994 |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23611 |
| Study title: Germano G*,Bergamini N: ROCEPHIN versus ampicillin + chloramphenicol in the treatment of bacterial meningitis in children. Prof. D. Stamboulian, Argentina, Centre No. 18.1569. 24.06.1986 |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23605 |
| Study title: Kissling M: Rocephin tretment of severe pediatric infections including meningitis. An open, non comparative multicentre trial in 232 patients including neonates, infants and young children. 24.08.1983 |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23626 |
| Study title: Kurzzeitbehandlung der eitrigen Meningitis - Vergleich zwischen Ceftriaxon und Cefotaxim |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23625 |
| Study title: Once-A-Day Administration of Ceftriaxone in Pediatric Meningitis16.11.1994 |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23610 |
| Study title: A double blind, parallel, randomized study: cetirizine versus loratadine in the management of perennial allergic rhinitis in children (6-12 years old). Study of the effect on the inhibition of histamine-induced wheals. Assessment of the safety of both drugs. |
| Active substance: CETIRIZINE |
| Study summary document link (including results): 9153 - Cetirizine - MRCE98G0201 (1V).pdf |
| View full study record |
| Document reference: 47903 |
| Study title: A Double-blind parallel study of cetirizine vs Loratadine and Placebo to determine clinical onset of action and efficacy in reducing symptoms of seasonal allergic rhinitis in ragweed sensitive subjects exposed to pollen challenge in an environmental exposure unit. |
| Active substance: CETIRIZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23840 |
| Study title: A double-blind, parallel, randomized study : cetirizine versus loratadine in the management of perennial allergic rhinitis in children (6-12 years old). study of the effect on the inhibition of histamine-induced wheals. assessment of the safety of both drugs. |
| Active substance: CETIRIZINE |
| Study summary document link (including results): 9153 - Cetirizine - MRCE98G0201 (1V).pdf |
| View full study record |
| Document reference: 23762 |
| Study title: Comparison of efficacy of loratadine and cetirizine in children with urticaria. |
| Active substance: CETIRIZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23700 |
| Study title: Comparison of efficacy, onset and duration of action of Cetirizine vs Loratadine and Placebo in controlling seasonal allergic rhinitis symptoms occurring in subjects exposed to ragweed pollen in Environmental Exposure Unit |
| Active substance: CETIRIZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23825 |
| Study title: Corren−Jonathan, Storms−William, Bernstein−Jonathan, Berger−William, Nayak−Anjuli, Sacks−Harry. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis. Clinical therapeutics, {Clin−Ther}, May 2005, vol. 27, no. 5, p. 543−53,Corren−Jonathan, Storms−William, Bernstein−Jonathan, Berger−William, Nayak−Anjuli, Sacks−Harry. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis. Clinical therapeutics, {Clin−Ther}, May 2005, vol. 27, no. 5, p. 543−53, |
| Active substance: CETIRIZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23660 |
| Study title: Double blind cross-over study comparing the effects of two dose regimens of cetirizine (1 tablet of 10 mg od and 1 tablet of 5 mg bid during 3 days) on the histamine-induced wheal and flare reaction in 6 to 12 years old children |
| Active substance: CETIRIZINE |
| Study summary document link (including results): A168 - Cetirizine - RRCE92E2507.pdf |
| View full study record |
| Document reference: 23807 |
| Study title: A PILOT STUDY OF FLUCONAZOLE PLUS FLUCYTOSINE FOR THE TREATMENT OF AIDS PATIENTS WITH ACUTE CRYPTOCOCCAL MENINGITIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27697 |
| Study title: A PILOT STUDY OF FLUCONAZOLE PLUS FLUCYTOSINE FOR THE TREATMENT OF AIDS PATIENTS WITH ACUTE CRYPTOCOCCAL MENINGITIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28059 |
| Study title: A PROSPECTIVE COMPARATIVE MULTICENTER TRIAL COMPARING FLUCONAZOLE WITH AMPHOTERICIN B FOR ANTIFUNGAL PROPHYLAXIS IN LIVER TRANSPLANT RECIPIENTS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27671 |
| Study title: A PROSPECTIVE COMPARATIVE MULTICENTER TRIAL COMPARING FLUCONAZOLE WITH AMPHOTERICIN B FOR ANTIFUNGAL PROPHYLAXIS IN LIVER TRANSPLANT RECIPIENTS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28033 |
| Study title: A PROSPECTIVE RANDOMIZED TRIAL OF FCA VS. AMPHOTERICIN B FOR EMPERIC ANTI-FUNGAL THERAPY OF THE NEUTROPENIC FEBRILE PATIENTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27624 |
| Study title: A PROSPECTIVE SURVEY OF OPPORTUNISTIC INFECTIONS IN PATIENTS RECEIVING CHEMOTHERAPY FOR ACUTE LEUKEMIAS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27479 |
| Study title: A PROSPECTIVE SURVEY OF OPPORTUNISTIC INFECTIONS IN PATIENTS RECEIVING CHEMOTHERAPY FOR ACUTE LEUKEMIAS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27480 |
| Study title: SULTAMICILLIN IN MILD AND MODERATE INFECTIONS IN ADULTS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43047 |
| Study title: A PROSPECTIVE SURVEY OF OPPORTUNISTIC INFECTIONS IN PATIENTS RECEIVING CHEMOTHERAPY FOR ACUTE LEUKEMIAS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27482 |
| Study title: A PROSPECTIVE SURVEY OF OPPORTUNISTIC INFECTIONS IN PATIENTS RECEIVING CHEMOTHERAPY FOR ACUTE LEUKEMIAS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27843 |
| Study title: A PROSPECTIVE SURVEY OF OPPORTUNISTIC INFECTIONS IN PATIENTS RECEIVING CHEMOTHERAPY FOR ACUTE LEUKEMIAS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27844 |
| Study title: A PROSPECTIVE SURVEY OF OPPORTUNISTIC INFECTIONS IN PATIENTS RECEIVING CHEMOTHERAPY FOR ACUTE LEUKEMIAS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27845 |
| Study title: SULTAMICILLIN IN MILD TO MODERATE INFECTIONS IN PEDIATRICS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43046 |
| Study title: SULTAMICILLIN PHARMOKINETIC AND THERAPEUTIC TRIAL IN ACUTE SINUSITIS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42916 |
| Study title: SULTAMICILLIN VERSUS AMOXICILLIN IN THE TREATMENT OF ACUTE OTITIS MEDIA IN CHILDREN. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42921 |
| Study title: SULTAMICILLIN VS AMOXICILLIN IN THE TREATMENT OF ACUTE OTITIS MEDIA IN CHILDREN. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42922 |
| Study title: Penetration of Ceftriaxone into the Middle Ear Fluid of Children with Access Established Through Insertion of Tympanostomy Tubes [Ident No: MK102/OE] 25.10.1996 |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23615 |
| Study title: Prospective, randomized, open, comparative study of a five day treatment with ROCEPHIN versus a 3 week course with chloramphenicol in children with acute enteric fever. |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23602 |
| Study title: Prospective, randomized, open, comparative study of a six day treatment with ROCEPHIN versus a 14 day course with chloramphenicol in children with acute enteric fever. Dr. E. Welch, M. D., Santiago/ Chile, Centre RCH 1717. 13.09.1985 |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23601 |
| Study title: Rocephin (ceftriaxone) in the parenteral therapy of bacterial meningitis in infants and children. 31.01.1984 |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23596 |
| Study title: Rocephin (ceftriaxone) in the parenteral therapy of bacterial meningitis in infants and children. 31.01.1984 |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23598 |
| Study title: Rocephin (ceftriaxone) in the parenteral therapy of serious miscellaneous infections in children. 31.01.1984 |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23599 |
| Study title: Rocephin tretment of severe pediatric infections including meningitis. An open, non comparative multicentre trial in 232 patients including neonates, infants and young children. 24.08.1983 |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23593 |
| Study title: Rocephin versus chloramphenicol in children suffering from typhoid fever. Dr. Eduardo Welch, M.D., Santiago, Chile, centre No. 21.1717, cases Nos. 201-222. 25.05.1984 |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23600 |
| Study title: Rocephin versus chloramphenicol in children suffering from typhoid fever. Dr. Eduardo Welch, Santiago, Chile, centre No. 21.1717. Cases Nos. 1-21, 101-102, 111. 10.01.1984 |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23595 |
| Study title: ROCEPHIN versus chloramphenicol in the treatment of typhoid and paratyphoid fever in paediatric patients. Results from Dr. E. Welch, Hospital P. Jaraquemada, Santiago (Chile). 30.10.1986 |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23606 |
| Study title: Single dose pharmacokinetics and penetration into the CSF of ceftriaxone in pediatric patients. 31.01.1983 |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23592 |
| Study title: Single-blind, Randomized Study Assessing the Efficacy and Safety of a Single Intramuscular Dose of 500 mg of Ceftriaxone, Compared With a Ten Day Oral Course of 750 mg of Penicillin V, in the Treatment of Streptococcal Pharyngitis in Children [Ident No: NR14544B./A] 28.01.1997 |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23616 |
| Study title: Single-blind, Randomized Study Assessing the Efficacy and Safety of a Single Intramuscular Dose of 500 mg of Ceftriaxone, Compared With a Single Intramuscular Dose of Benzathine Penicillin G, in the Treatment of Streptococcal Pharyngitis in Children [Ident No: NR14690B./A] 28.01.1997 |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23617 |
| Study title: The effect of cetirizine on IFN-gamma and IL-10 production in children with allergic rhinitis. |
| Active substance: CETIRIZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23724 |
| Study title: The effect of cetirizine on sulfidoleukotriene production by blood leukocytes in children with allergic rhinitis. |
| Active substance: CETIRIZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23694 |
| Study title: absorption of chlorhexidine from the intact skin of newborn infantsCowen 1979 |
| Active substance: CHLORHEXIDINE |
| Study summary document link (including results): 1979-cowen-absorption of chlorhexidine from the intact skin of newborn infants.pdf |
| View full study record |
| Document reference: 48171 |
| Study title: BENQUE E. Report of Expert clinical trial. April 1977. |
| Active substance: CHLORHEXIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23884 |
| Study title: BENQUE E.P.;CADENAT H.;FABERT G.;CLOUET M. Rapport d'expertise clinique. Octobre 1976. |
| Active substance: CHLORHEXIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23886 |
| Study title: CADENAT P.; FABIE D.; BARTHELEMY D. Utilisation d'un bain de bouche à actions antiseptique et antalgique. Inf. dent., 1970, 46, 4333-4337. |
| Active substance: CHLORHEXIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23881 |
| Study title: COMMISSIONAT Y.Clinical Appraisal. October 1976 |
| Active substance: CHLORHEXIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23889 |
| Study title: DHOBLE V., PHADKE M.A. Role du Chl. De buclizine pour favoriser le gain de poids chez les enfants INDIAN PRACTITIONER MAR-1981. 34(3):147-149. |
| Active substance: CHLORHEXIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23887 |
| Study title: Effect of chlorexidine on dental plaque and gingivitis in mentally retarded childrenBay LM, Russel BG, 1975 |
| Active substance: CHLORHEXIDINE |
| Study summary document link (including results): 1975-bay-effect of chlorhexidine on dentalplaque and gingivitis in mentally retarded children.pdf |
| View full study record |
| Document reference: 48170 |
| Study title: Effects on supervised chlorhexidine mouth rinses in childrenLang 1982 |
| Active substance: CHLORHEXIDINE |
| Study summary document link (including results): 1982-lang-effects on supervised chlorhexidine mouthrinses in children .pdf |
| View full study record |
| Document reference: 48172 |
| Study title: FABIE M.;BARTHELEMY R. Clinical Study of a locally active solution. Rev. Odonto-stomatol. Midi Fr., 1969, 4, 267-273. |
| Active substance: CHLORHEXIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23882 |
| Study title: FIERE P.;BRYON P.A.;GUYON J.M. Study and tests for protection of the buccal mucosa during chemotherapy of hemopathies by a mouthwash containing chlorhexidine. Lyon Méditerrannée Medical, 1971, 18, 3-7. |
| Active substance: CHLORHEXIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23883 |
| Study title: FRANCHEBOIS P., SOUYRIS A. Clinical expert report. March 1970 |
| Active substance: CHLORHEXIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23894 |
| Study title: LAUDENBACH L. Report of expert clinical trial. November 1976. |
| Active substance: CHLORHEXIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23892 |
| Study title: LESTRADET H.;DANON J. Clinical Apraisal Report. October 1978. |
| Active substance: CHLORHEXIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23890 |
| Study title: Factors affecting the compliance of malaria chemusuppression with chloroquine at some maternal and child health clinics in Tanga region, Tanzania. Y.G. Matola, L.N. Malle. E. Afr. Med. J. (1985) 62, 720-4Factors affecting the compliance of malaria chemusuppression with chloroquine at some maternal and child health clinics in Tanga region, Tanzania. Y.G. Matola, L.N. Malle. E. Afr. Med. J. (1985) 62, 720-4 |
| Active substance: CHLOROQUINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23949 |
| Study title: A PROSPECTIVE SURVEY OF OPPORTUNISTIC INFECTIONS IN PATIENTS RECEIVING CHEMOTHERAPY FOR ACUTE LEUKEMIAS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27846 |
| Study title: A RANDOMIZED COMPARATIVE MULTICENTER TRIAL OF FLUCONAZOLE AND KETOCONAZOLE IN THE TREATMENT OF ESOPHAGEAL CANDIDIASIS IN IMMUNOCOMPROMISED PATIENTS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27343 |
| Study title: Multicenter comparative study of the efficacy and safety of cetirizine vs hydroxyzine and placebo in the treatment of chronic idiopathic urticaria |
| Active substance: CETIRIZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23835 |
| Study title: Multicenter double blind study in parallel groups, comparing to placebo 5 and 10 mg cetirizine administered in two daily doses for a week, to children aged 3-6 years suffering from atopic dermatitis - determination of the antipruritic effect. |
| Active substance: CETIRIZINE |
| Study summary document link (including results): A103 - Cetirizine - CE89G241.pdf |
| View full study record |
| Document reference: 23764 |
| Study title: The effects of a single dose of cetirizine (0.25 mg/kg b.w.) on polygraphic recording during the night in healthy and allergic infants : two pilot, crossover, double-blind, placebo-controlled studies. |
| Active substance: CETIRIZINE |
| Study summary document link (including results): 9241-9244 - Cetirizine - MRCE99H1701.pdf |
| View full study record |
| Document reference: 23812 |
| Study title: The health-related quality of life effects of once-daily cetirizine hcl syrup in children with seasonal allergic rhinitis. |
| Active substance: CETIRIZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23690 |
| Study title: The protective effect of cetirizine on exercise induced asthma. |
| Active substance: CETIRIZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23699 |
| Study title: Therapeutic effects of zyrtec preparation of children atopic bronchial asthma |
| Active substance: CETIRIZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23710 |
| Study title: VIRLIX efficacy in cases of pediatric allergic diseases |
| Active substance: CETIRIZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23801 |
| Study title: A randomized, double-blind, parallel-group, placebo-controlled, multi-centre study of the efficacy and safety of Cetirizine-Pseudoephidrine vs Loratadine-pseudoephidrine (Claritin-D 12 hour) vs Placebo in the treatment of subjects twelve years and older with seasonal allergic rhinitis. |
| Active substance: CETIRIZINE AND PSEUDOEPHEDRINE |
| Study summary document link (including results): cetirizine_pseudoephedrine A3771001-R.pdf |
| View full study record |
| Document reference: 23844 |
| Study title: Haustete: Report on a clinical trial (1963) |
| Active substance: CETRIMIDE AND LIDOCAINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23849 |
| Study title: |
| Active substance: CETYLPYRIDINIUM AND LIDOCAINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23855 |
| Study title: Side effects with use of oral transmucosal fentanyl; Pediatrics, 1995, 96(3 Pt 1): 544 |
| Active substance: FENTANYL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27181 |
| Study title: The effect of premedication with OTFC, with or without ondansetron, on postoperative agitation, and nausea and vomiting in pediatric ambulatory patients; Paediatric Anaesthesia 2004, 14(9): 759-67 |
| Active substance: FENTANYL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27183 |
| Study title: The effects of oral transmucosal fentanyl citrate premedication on preoperative behavioral responses and gastric volume and acidity in children; Anesthesia and Analgesia 1989, 69(3): 328-35 |
| Active substance: FENTANYL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27184 |
| Study title: A multicenter study to assess the safety and pharmacokinetics of open-label 30mg single dose fexofenadine hydrochloride oral suspension (6 mg/mL) in pediatric subjects 2 to 5 years of age (19-Sep-2005) |
| Active substance: FEXOFENADINE |
| Study summary document link (including results): Fexofenadine - Study 19.pdf |
| View full study record |
| Document reference: 27230 |
| Study title: A multicenter, double-blind, randomized, placebo-controlled, parallel study comparing the efficacy and safety of four dosage strengths of fexofenadine HCl (20, 60, 120, & 240 mg BID) in the treatment of chronic idiopathic urticaria |
| Active substance: FEXOFENADINE |
| Study summary document link (including results): Fexofenadine - Study 37.pdf |
| View full study record |
| Document reference: 45703 |
| Study title: A multicenter, double-blind, randomized, placebo-controlled, parallel study comparing the efficacy and safety of four dosage strengths of fexofenadine HCl (20, 60, 120, & 240 mg BID) in the treatment of chronic idiopathic urticaria |
| Active substance: FEXOFENADINE |
| Study summary document link (including results): Fexofenadine - Study 39.pdf |
| View full study record |
| Document reference: 45705 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL FLUCONAZOLE IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27443 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL FLUCONAZOLE IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27444 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL FLUCONAZOLE IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27806 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL FLUCONAZOLE IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27807 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL FLUCONAZOLE IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27808 |
| Study title: Cavallieri S.. Int Congress of Italian Soc. for study of Infect. & Parasit. Dis.1979. Clinical application of Isoprinosine in the treatment of varicella and herpes zoster infectionsCavallieri S.. Int Congress of Italian Soc. for study of Infect. & Parasit. Dis.1979. Clinical application of Isoprinosine in the treatment of varicella and herpes zoster infections |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30085 |
| Study title: Double-blind dose-finding study of MDL16,455A in chronic urticaria |
| Active substance: FEXOFENADINE |
| Study summary document link (including results): Fexofenadine - Study 23.pdf |
| View full study record |
| Document reference: 45695 |
| Study title: Evaluation of the efficacy and safety of fexofenadine hydrochloride (MDL16,455A) administered once daily at 120 mg and 180 mg for the treatment of chronic idiopathic urticaria (Double-blind, randomized, placebo- and bid administration-controlled trial) |
| Active substance: FEXOFENADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45682 |
| Study title: Suspected fatal diphenhydramine toxicity by application to the skin of an infant with varicella, Maswoswe, J.J., Hosp. Pharm. 1994 January; 29: 26, 28-30, 53 |
| Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25864 |
| Study title: EFFICACY OF SULTAMICILLIN IN UTI. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43011 |
| Study title: MULTICENTER TRIAL WITH UNASYN (R) POWDER FOR ORAL SUSPENSION IN CHILDREN WITH OTITIS MEDIA. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42961 |
| Study title: NON-COMPARATIVE MULTICENTER STUDY OF THE EFFICACY OF ORAL SULTAMICILLIN FOR THE TREATMENT OF MILD-MODERATE PEDIATRIC INFECTIONS |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42963 |
| Study title: Multicentre double blind study in parallel groups, comparing to placebo 10 and 15 mg cetirizine administered in two daily doses for a week, to children aged 6 - 12 years suffering from atopic dermatitis determination of the antipruritic effect. |
| Active substance: CETIRIZINE |
| Study summary document link (including results): A095 - Cetirizine - CE89G242.pdf |
| View full study record |
| Document reference: 23763 |
| Study title: Systematic review on analgesics gicven for pain following tonsillectomy in children |
| Active substance: CHLORPHENAMINE AND PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24049 |
| Study title: A randomized, placebo-controlled trial of the effect of antihistamine or corticosteroid treatment in acute otitis media |
| Active substance: CHLORPHENAMINE AND TRAMAZOLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24056 |
| Study title: bronchodilator effect of two inhaled H1-receptor antagonists, clemastine and chlorpheniramine, in wheezy school-children. |
| Active substance: CHLORPHENAMINE AND TRAMAZOLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24059 |
| Study title: Central nervous system side effects of first- and second- generation antihistamines in school children with perennial allergic rhinitis: A randomized, double blind, placebo. Controlled comparative study |
| Active substance: CHLORPHENAMINE AND TRAMAZOLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24060 |
| Study title: Chlorpheniramine is no more effective than placebo in relieving the symptoms of childhood atopic dermatitis with a nocturnal itching and scratching component. |
| Active substance: CHLORPHENAMINE AND TRAMAZOLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24061 |
| Study title: Comparison of CNS adverse effects between astemizole and chlorpheniramine in children: a randomized, double-blind study |
| Active substance: CHLORPHENAMINE AND TRAMAZOLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24065 |
| Study title: Effect of allergy medication on children's reading comprehension. |
| Active substance: CHLORPHENAMINE AND TRAMAZOLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24066 |
| Study title: Middle ear fluid histamine and leukotriene B4 in acute otitis media: effect of antihistamine or corticosteroid treatment. |
| Active substance: CHLORPHENAMINE AND TRAMAZOLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24070 |
| Study title: Smith H, Congdon P. Neonatal systemic candidiasis. Arch Dis Child. 1985; 60: 365-369.36. Johnson D, Thompson T, Green T, Ferrieri P. Systemic candidiasis in very low birthweight infants. Pediatrics 1984: 73; 138-143 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27331 |
| Study title: Stamm AM et al. Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis. Am J Med. 1987 Aug;83(2):236-42 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27306 |
| Study title: Steinbach WJ et al. A meta-analysis of medical versus surgical therapy for Candida endocarditis. J Infect. October 1, 2005, 230-47 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27314 |
| Study title: Veltri MA. Drug Dosing during Intermittent Hemodialysis and Continuous Renal Replacement Therapy: Special Considerations in Pediatric Patients. Paediatr Drugs. March 24, 2004, 45-65 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27318 |
| Study title: Yao Z, Liao W, Wen H. Antifungal therapy for treatment of cryptococcal meningitis.Chin Med J (Engl). 2000 Feb;113(2):178-80 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27299 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL AND IV FCA IN THE TREATMENT OF PATIENTS WITH SYSTEMIC CANDIDIASIS OR CRYPTOCOCCAL MENINGITIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27579 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL AND IV FCA IN THE TREATMENT OF PATIENTS WITH SYSTEMIC CANDIDIASIS OR CRYPTOCOCCAL MENINGITIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27942 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL AND IV FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL AND SYSTEMIC CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27573 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL AND IV FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL AND SYSTEMIC CANDIDIASIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27574 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL AND IV FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL AND SYSTEMIC CANDIDIASIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27575 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL AND IV FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL AND SYSTEMIC CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27937 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL AND IV FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL AND SYSTEMIC CANDIDIASIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27938 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL AND IV FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL AND SYSTEMIC CANDIDIASIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27939 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL AND IV FLUCONAZOLE IN THE TREATMENT OF PATIENTS WITH DEEP CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27388 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL AND IV FLUCONAZOLE IN THE TREATMENT OF PATIENTS WITH DEEP CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27753 |
| Study title: A multi-center, randomized, double blind, placebo controlled parallel group study of the safety of Zyrtec (Cetirizine Hydrochloride) syrup in pediatric subjects 6 months to 11 months of age |
| Active substance: CETIRIZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23842 |
| Study title: Ann Oncol. 2002 Jan;13(1):157-60. FDG-PET for detection of recurrences from malignant primary bone tumors: comparison with conventional imaging. Franzius C, Daldrup-Link HE, Wagner-Bohn A, Sciuk J, Heindel WL, Jürgens H, Schober O. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28161 |
| Study title: Yoder KE et al. Child assessment of dextromethorphan, diphenhydramine, and placebo for nocturnal cough due to upper respiratory infection. Clin Pediatr 2006; 45(7):633-640 |
| Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25881 |
| Study title: A MULTICENTER, OPEN, NON-COMPARATIVE STUDY ON THE EFFICACY AND TOLERABILITY OF FCA 150 MG ONCE WEEKLY, IN THE TREATMENT OF PATIENTS WITH TINEA CORPORIS, CRURIS AND PEDIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27984 |
| Study title: A MULTICENTRE STUDY OF THE EFFICACY AND LOCAL AND SYSTEMIC SAFETY WITH COMBINATION TCN 28% NAIL SOL. PLUS ORAL FCN 50MG CAP VS ORAL FLUCONAZOLE 50 MG IN TREATMENT OF ONYCHOMYCOSIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27465 |
| Study title: A MULTICENTRE STUDY OF THE EFFICACY AND LOCAL AND SYSTEMIC SAFETY WITH COMBINATION TCN 28% NAIL SOL. PLUS ORAL FCN 50MG CAP VS ORAL FLUCONAZOLE 50 MG IN TREATMENT OF ONYCHOMYCOSIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27829 |
| Study title: A NON-COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF FCA IN THE TREATMENT OF PATIENTS WITH ONYCHOMYCOSIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27644 |
| Study title: A NON-COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF FCA IN THE TREATMENT OF PATIENTS WITH ONYCHOMYCOSIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28006 |
| Study title: A NONCOMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FCA IN THE TREATMENT OF PATIENTS WITH SYSTEMIC CANDIDIASIS OR CRYPTOCOCCAL INFECTIONS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27641 |
| Study title: A NONCOMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FCA IN THE TREATMENT OF PATIENTS WITH SYSTEMIC CANDIDIASIS OR CRYPTOCOCCAL INFECTIONS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28003 |
| Study title: A PHASE IV RANDOMIZED STUDY OF THE USE OF FLUCONAZOLE AS CHRONIC SUPPRESSIVE THERAPY VERSUS EPISODIC THERAPY IN HIV POSITIVE SUBJECTS WITH RECURRENT OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27703 |
| Study title: EFFECT OF TREATMENT WITH PROSTAGLANDIN E1 AND N-ACETYLCYSTEINE ON THE FREQUENCY OF REJECTION IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS (DRUG ONLY STUDY) |
| Active substance: CABERGOLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23099 |
| Study title: Suwanchinda V, Tanphaichitr V, Pirayavaraporn S, Somprakit P, Laohapensang M. Hemodynamic responses to captopril during splenectomy in thalassemic children. J Med Assoc Thai. 1999 Jul;82(7):666-71. PMID: 10511768 [PubMed - indexed for MEDLINE]Suwanchinda V, Tanphaichitr V, Pirayavaraporn S, Somprakit P, Laohapensang M. Hemodynamic responses to captopril during splenectomy in thalassemic children. J Med Assoc Thai. 1999 Jul;82(7):666-71. PMID: 10511768 [PubMed - indexed for MEDLINE] |
| Active substance: CAPTOPRIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23230 |
| Study title: Yao Z.-R et al. Management of cryptococcosis in non-HIV-related patients. Medical Mycology. May 1, 2005, 245-51 |
| Active substance: FLUCOCYTOSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27315 |
| Study title: A COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF FCA CAPS VS. AMPHOTERICIN B SUSPENSION IN THE PREVENTION OF FUNGAL INFECTIONS IN LEUKAEMIC PATIENTS UNDERGOING REMISSION INDUCTION CHEMOTHERAPY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27586 |
| Study title: A COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF FCA CAPS VS. AMPHOTERICIN B SUSPENSION IN THE PREVENTION OF FUNGAL INFECTIONS IN LEUKAEMIC PATIENTS UNDERGOING REMISSION INDUCTION CHEMOTHERAPY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27949 |
| Study title: A COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF FLUCONAZOLE VS. TOPICAL AMPHOTERICIN IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS IN PATIENTS UNDERGOING RADIOTHERAPY FOR HEAD AND NECK TUMORS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27669 |
| Study title: A COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF FLUCONAZOLE VS. TOPICAL AMPHOTERICIN IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS IN PATIENTS UNDERGOING RADIOTHERAPY FOR HEAD AND NECK TUMORS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28031 |
| Study title: A COMPARISON OF PROPHYLACTIC EFFICACY OF FLUCONAZOLE AND AMPHOTERICIN B ON FUNGAL INFECTION IN NEUTROPENIC CHILDREN WITH MALIGNANT DISEASE IN COMBINATION WITH SULBACTAM/CEFOPERAZONE. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27487 |
| Study title: A COMPARISON OF PROPHYLACTIC EFFICACY OF FLUCONAZOLE AND AMPHOTERICIN B ON FUNGAL INFECTION IN NEUTROPENIC CHILDREN WITH MALIGNANT DISEASE IN COMBINATION WITH SULBACTAM/CEFOPERAZONE. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27851 |
| Study title: A DOUBLE BLIND COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF GRISEOFULVIN OR FLUCONAZOLE IN THE TREATMENT OF PATIENTS WITH ONYCHOMYCOSIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27606 |
| Study title: A DOUBLE BLIND COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF GRISEOFULVIN OR FLUCONAZOLE IN THE TREATMENT OF PATIENTS WITH ONYCHOMYCOSIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27968 |
| Study title: A DOUBLE BLIND PLACEBO AND DIFFERENT DOSAGES CONTROLLED STUDY OF FCA IN THE PREVENTION OF FUNGAL INFECTIONS IN THE HEAD AND NECK CANCER PATIENTS RECEIVING RADIATION THERAPY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27602 |
| Study title: A DOUBLE BLIND PLACEBO AND DIFFERENT DOSAGES CONTROLLED STUDY OF FCA IN THE PREVENTION OF FUNGAL INFECTIONS IN THE HEAD AND NECK CANCER PATIENTS RECEIVING RADIATION THERAPY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27965 |
| Study title: Single-dose pharmacokinetics of ceftriaxone in infants and young children. (For publication in Antimicrobial Agents and Chemotherapy) 09.07.1981 |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23618 |
| Study title: Stoeckel K,Schaad B: Single-dose pharmacokinetics of ceftriaxone in infants and young children. (For publication in Antimicrobial Agents and Chemotherapy) 09.07.1981 |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23627 |
| Study title: Treatment of acute gastroenteritis, shigellosis and cholera in adults, children and infants with Rocephin. Open, non-comparative trial. Final study report. 22.09.1981 |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23619 |
| Study title: Treatment of bacterial meningitis with Rocephin in pediatric patients. Results from Dr. V. Prado, Santiago, Chile, centre No. 21.1723, cases 1-24. 16.04.1984 |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23597 |
| Study title: A multicenter study of the safety and efficacy of cetirizine in the treatment of seasonal allergic rhinitis in children 6 to 11 years of age : comparison with chlorpheniramine. |
| Active substance: CETIRIZINE |
| Study summary document link (including results): 87CE16-0262 - Cetirizine - RRCE93B0401.pdf |
| View full study record |
| Document reference: 23757 |
| Study title: A multicenter, randomized, double-blind, placebo-controlled, parallel group study of the safety of zyrtec (cetirizine hydrochloride) syrup in pediatric subjects 6 months to 11 months of age. |
| Active substance: CETIRIZINE |
| Study summary document link (including results): A143-1010 - Cetirizine - ARCE02B0405.pdf |
| View full study record |
| Document reference: 23785 |
| Study title: MICHEL G., MOUCHARD J. Study of the safety and efficacy of the proposed formula. International Report. May 1988. |
| Active substance: CHLORHEXIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23893 |
| Study title: MUGNIER A. Etude de la tolérance d'Eludril chez l'enfant. Février 1977. |
| Active substance: CHLORHEXIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23885 |
| Study title: Oral complications of acute leukemia. prophylactic impact of chlorhexidine mouth rinse regimenMac Gaw 1985 |
| Active substance: CHLORHEXIDINE |
| Study summary document link (including results): 1985-MacGaw-oral complications of acute leukemia. prophylactic impact of chlorhexidine mouth rinse regimen.pdf |
| View full study record |
| Document reference: 48173 |
| Study title: PAQUELIN F. Clinical Appraisal Report. October 1978. |
| Active substance: CHLORHEXIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23891 |
| Study title: Double-blind, parallel study of cetirizine vs fexofenadine and placebo to determine clinical onset of action and efficacy in reducing symptoms of seasonal allergic rhinitis in ragweed sensitive subjects exposed to pollen challenge in an environmental exposure unit |
| Active substance: CETIRIZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23826 |
| Study title: early treatment of the atopic child (e.t.a.c.). evaluation of the efficacy and safety of cetirizine in preventing the onset of asthma in children who suffer from atopic dermatitis : a multi-country, double-blind, randomised, placebo-controlled trial. 18-month post-treatment follow-up (study periods III&IV). |
| Active substance: CETIRIZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23754 |
| Study title: early treatment of the atopic child (e.t.a.c.). evaluation of the efficacy and safety of cetirizine in preventing the onset of asthma in children who suffer from atopic dermatitis : a multi-country, double-blind, randomised, placebo-controlled trial. 6-month post-treatment follow-up (study period iii). |
| Active substance: CETIRIZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23755 |
| Study title: Effect of age and gender on qtc value in infants aged 12-24 months. analysis based on etac r study baseline data. |
| Active substance: CETIRIZINE |
| Study summary document link (including results): ARCE00E2401 - Cetirizine.pdf |
| View full study record |
| Document reference: 23767 |
| Study title: Correlation between carbamazepine plasma and saliva concentrations in epileptic children or young patients chronically treated (Project 599) |
| Active substance: CARBAMAZEPINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23247 |
| Study title: Prospective comparative randomised trial on Timonil 150 retard tablets versus Timonil Saft. Efficacy and tolerability in children". Report 1997 |
| Active substance: CARBAMAZEPINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23231 |
| Study title: Expertise clinique Claforan 0,50 g préparation injectable : étudier l'efficacité et la tolérance d'une nouvelle céphalosporine, le RU 756* en milieu pédiatrique - Pr H. Mathieu - 1979Expertise clinique Claforan 0,50 g préparation injectable : étudier l'efficacité et la tolérance d'une nouvelle céphalosporine, le RU 756* en milieu pédiatrique - Pr H. Mathieu - 1979 |
| Active substance: CEFOTAXIME |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23477 |
| Study title: Expertise clinique Claforan 1 g : préparation injectable - Pr. M. Goulon - 1979Expertise clinique Claforan 1 g : préparation injectable - Pr. M. Goulon - 1979 |
| Active substance: CEFOTAXIME |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23478 |
| Study title: Expertise clinique Claforan 1g I.M. préparation injectable solvant: Lidocaine - Pr J. Kermarec - 1979 Expertise clinique Claforan 1g I.M. préparation injectable solvant: Lidocaine - Pr J. Kermarec - 1979 |
| Active substance: CEFOTAXIME |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23480 |
| Study title: Expertise clinique Claforan 1g préparation injectable - Pr Armengaud, Pr Rey, Pr Aubertin, Pr Bertrand - No dateExpertise clinique Claforan 1g préparation injectable - Pr Armengaud, Pr Rey, Pr Aubertin, Pr Bertrand - No date |
| Active substance: CEFOTAXIME |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23481 |
| Study title: Expertise clinique Claforan 1g: préparation injectable - Pr J. Mottin - 1979Expertise clinique Claforan 1g: préparation injectable - Pr J. Mottin - 1979 |
| Active substance: CEFOTAXIME |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23482 |
| Study title: Failure of cefotaxime treatment in two children with meningitis caused by highly penicillin-resistant Streptococcus pneumoniae, M.Guibert at al., Acta Pediatr, 84:831-3, 1995Failure of cefotaxime treatment in two children with meningitis caused by highly penicillin-resistant Streptococcus pneumoniae, M.Guibert at al., Acta Pediatr, 84:831-3, 1995 |
| Active substance: CEFOTAXIME |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23483 |
| Study title: Friedland IR, Klugman KP. Cerebrospinal fluid bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in children with meningitis treated with high-dosage cefotaxime. Antimicrob Agents Chemother. 1997 Sep;41(9):1888-91.Friedland IR, Klugman KP. Cerebrospinal fluid bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in children with meningitis treated with high-dosage cefotaxime. Antimicrob Agents Chemother. 1997 Sep;41(9):1888-91. |
| Active substance: CEFOTAXIME |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23484 |
| Study title: Goldwater PN. Effect of cefotaxime or ceftriaxone treatment on nasopharyngeal Haemophilus influenzae type b colonization in children. Antimicrob Agents Chemother. 1995 Sep;39(9):2150-2.Goldwater PN. Effect of cefotaxime or ceftriaxone treatment on nasopharyngeal Haemophilus influenzae type b colonization in children. Antimicrob Agents Chemother. 1995 Sep;39(9):2150-2. |
| Active substance: CEFOTAXIME |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23485 |
|
Study title: Treatment of severe lower respiratory tract infections with Ro 13-9904 |
| Active substance: CEFTRIAXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23594 |
| Study title: |
| Active substance: CEFUROXIME |
| Study summary document link (including results): Study CAEH13 Cefuroxime Axetil-Zinnat suspension.xls |
| View full study record |
| Document reference: 47723 |
| Study title: |
| Active substance: CEFUROXIME |
| Study summary document link (including results): Study CAET95 Cefuroxime Axetil (Suspension).xls |
| View full study record |
| Document reference: 47732 |
| Study title: A multicentre, randomized, evaluation of taste acceptability and compliance with a ten day course of cefuroxime axetil suspension compared with cefaclor and amoxicillin/clavulanate suspensions in the treatment of otitis media in paediatric patients |
| Active substance: CEFUROXIME |
| Study summary document link (including results): Study CAE-221 Cefuroxime Axetil (Suspension).xls |
| View full study record |
| Document reference: 23629 |
| Study title: A single blind randomised multicentre study of the comparative efficacy of cefuroxime axetil suspension and penicillin V syrup in the treatment of children with recurrent tonsillitis due to Group A streptococcal infection. |
| Active substance: CEFUROXIME |
| Study summary document link (including results): Study CAEM03 Cefuroxime Axetil (Suspension).xls |
| View full study record |
| Document reference: 47724 |
| Study title: A study of intravenous cefuroxime followed by cefuroxime axetil suspension in the treatment of paediatric bacterial pneumonia |
| Active substance: CEFUROXIME |
| Study summary document link (including results): Study CAEM05 Cefuroxime Axetil (Suspension).xls |
| View full study record |
| Document reference: 47725 |
| Study title: An open multicentre study to investigate the efficacy, safety and pharmacokinetics of cefuroxime axetil suspension in children with urinary tract infection. |
| Active substance: CEFUROXIME |
| Study summary document link (including results): Study CAEM09 Cefuroxime Axetil (Suspension).xls |
| View full study record |
| Document reference: 47726 |
| Study title: CEFUROXIME AXETIL VS AMOXICILLINA - ACIDO CLAVULANICO NEL TRATTAMENTO DELLE INFEZIONI DELLE BASSE VIE RESPIRATORIE IN PAZIENTI PEDIATRICI. |
| Active substance: CEFUROXIME |
| Study summary document link (including results): Study CAET26 Cefuroxime Axetil.xls |
| View full study record |
| Document reference: 47730 |
| Study title: CEFUROXIME AXETIL VS AMOXICILLINA NEL TRATTAMENTO DELLE INFEZIONI DELLE BASSE VIE RESPIRATORIE IN PAZIENTI PEDIATRICI. |
| Active substance: CEFUROXIME |
| Study summary document link (including results): Study CAET25 Cefuroxime Axetil.xls |
| View full study record |
| Document reference: 47729 |
| Study title: CEFUROXIME AXETIL VS COTRIMOXAZOLO NEL TRATTAMENTO DELLE INFEZIONI ORL IN PAZIENTI PEDIATRICI. |
| Active substance: CEFUROXIME |
| Study summary document link (including results): Study CAET22 Cefuroxime Axetil.xls |
| View full study record |
| Document reference: 47727 |
| Study title: Seward MH. The effectiveness of a teething solution in infants. A clinical study. Br Dent J 1969; 127(10): 457−61Seward MH. The effectiveness of a teething solution in infants. A clinical study. Br Dent J 1969; 127(10): 457−61 |
| Active substance: CETYLPYRIDINIUM AND LIDOCAINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23852 |
| Study title: A DOUBLE-BLIND, DOUBLE-DUMMY, MULTICENTER STUDY TO COMPARE THE EFFICACY, SAFETY AND TOLERABILITY OF CIPROFLOXACIN AS A SUSPENSION VS.CEFTRIAXONE I.M.AS A TREATMENT OF INVASIV DIARRHEA IN EARLY CHILDHOOD. (AMENDMENT NO.1/03.SEPT.96) (AMENDMENT NO.2/29.OCT.97) |
| Active substance: CIPROFLOXACIN |
| Study summary document link (including results): Bayer Pharma_Ciprofloxacin_0573_study_synopsis.pdf |
| View full study record |
| Document reference: 24207 |
| Study title: A Prospective, Comparative, Randomised Clinical Trial to Evaluate the Use of a Single Dose Ciprofloxacin vs. Rifampicin in the Eradication of Neisseria Meningitidis from Close Contacts of Meningococcal Meningitis Cases |
| Active substance: CIPROFLOXACIN |
| Study summary document link (including results): Bayer Pharma_Ciprofloxacin_1258_study_synopsis.pdf |
| View full study record |
| Document reference: 24217 |
| Study title: A prospective, controlled, randomized, double-blind, multicentre study comparing the efficacy and safety of ciprofloxacin oral suspension administered for 3 days (short course) versus ciprofloxacin oral suspension administered for 5 days (standard course) in children and juveniles for the treatment of Shigella dysenteriae type one dysentery. |
| Active substance: CIPROFLOXACIN |
| Study summary document link (including results): 570.pdf |
| View full study record |
| Document reference: 24225 |
| Study title: A PROSPECTIVE, OPEN, SINGLE-CENTER STUDY TO DETERMINE THE SAFETY OF I.V.AND ORAL CIPROFLOXACIN IN THE TREATMENT OF SELECTED PAEDIATRIC INFECTION.(AMENDMENT NO.2/30.JUN.97) |
| Active substance: CIPROFLOXACIN |
| Study summary document link (including results): Bayer Pharma_Ciprofloxacin_0575_study_synopsis.pdf |
| View full study record |
| Document reference: 24200 |
| Study title: Katz A et al A prospective randomized evaluation of three schedules of mesna administration in patients receiving an ifosfamide-containing chemotherapy regimen: sustained efficiency and simplified administration J Cancer Res Clin Oncol. 1995;121(2):128-31Katz A et al A prospective randomized evaluation of three schedules of mesna administration in patients receiving an ifosfamide-containing chemotherapy regimen: sustained efficiency and simplified administration J Cancer Res Clin Oncol. 1995;121(2):128-31 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24950 |
| Study title: Katzenstein HM Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study J Clin Oncol 2002 Aug 15;20(16):3438-44Katzenstein HM Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study J Clin Oncol 2002 Aug 15;20(16):3438-44 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24951 |
| Study title: Am.J.Med.Sci. 1990;299:79-86. Bachmann, H. Propranolol versus chlorthalidone--a prospective therapeutic trial in children with chronic hypertension Helv.Paediatr.Acta 1984;39:55-61.Am.J.Med.Sci. 1990;299:79-86. Bachmann, H. Propranolol versus chlorthalidone--a prospective therapeutic trial in children with chronic hypertension Helv.Paediatr.Acta 1984;39:55-61. |
| Active substance: CHLORTHALIDONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24082 |
| Study title: Comparison of plasma creatinine determined with the Greiner Selective Analyser GSA II and the glomerular filtration rate.Colombo JP, Peheim E, Flury W.Clin Biochem. 1980 Feb;13(1):6-11. |
| Active substance: CHROMIUM 51 |
| Study summary document link (including results): Columbo JP et al 1980.pdf |
| View full study record |
| Document reference: 24098 |
| Study title: Müller L et al Recurrent atrial ectopic tachycardia following chemotherapy with ifosfamide Pediatr Hematol Oncol. 2004 Jun;21(4):307-11Müller L et al Recurrent atrial ectopic tachycardia following chemotherapy with ifosfamide Pediatr Hematol Oncol. 2004 Jun;21(4):307-11 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25030 |
| Study title: A prospective, randomized study to compare ciprofloxacin (either as oral suspension or as IV or sequential IV oral suspension therapy) versus control regimens (either trimethoprim/ sulfamethoxazole oral suspension, cefixime oral suspension, IV ceftazidime, sequential IV ceftazidime trimethoprim/ sulfamethoxazole oral suspension therapy or sequential IV ceftazidime PO cefixime) in the treatment of pediatric patients with complicated urinary tract infections or pyelonephritis. |
| Active substance: CIPROFLOXACIN |
| Study summary document link (including results): Bayer Pharma_Ciprofloxacin_100169_study_synopsis.pdf |
| View full study record |
| Document reference: 24204 |
| Study title: An open, non-comparative, pilot study using magnetic resonance imaging (MRI) scans to investigate any arthropathic effects of a 14 day course of ciprofloxacin bd oral tablets on the joints of children with Pseudomonas aeruginosa exacerbations of cystic fibrosis. |
| Active substance: CIPROFLOXACIN |
| Study summary document link (including results): Bayer Pharma_Ciprofloxacin_1427_study_synopsis.pdf |
| View full study record |
| Document reference: 24208 |
| Study title: AN OPEN, NON-COMPARATIVE, PILOT STUDY USING MAGNETIC RESONANCE IMAGING (MRI) SCANS TO INVESTIGATE ANY ARTHROPATIC EFFECTS OF A 14 DAY COURSE OF CIPROFLOXACIN BD ORAL TABLETS ON THE JOINTS OF CHILDREN WITH PSEUDOMONAS AERUGINOSA EXACERBATION OF CYSTIC FIBROSIS. |
| Active substance: CIPROFLOXACIN |
| Study summary document link (including results): Bayer Pharma_Ciprofloxacin_1427_study_synopsis.pdf |
| View full study record |
| Document reference: 24216 |
| Study title: Botulinum Toxin and Short-Term Electrical Stimulation in the Treatment of Equinus in Cerebral Palsy; Detrembleur et al |
| Active substance: CLOSTRIDIUM BOTULINUM TOXIN TYPE A |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24425 |
| Study title: Effect of Botulinum Toxin in the Treatment of Drooling: A Controlled Clinical Trial; Jongeriu et al, |
| Active substance: CLOSTRIDIUM BOTULINUM TOXIN TYPE A |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24423 |
| Study title: Evaluation by gait analysis of injection into the rectus femoris - semitendinosus muscle pair |
| Active substance: CLOSTRIDIUM BOTULINUM TOXIN TYPE A |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24418 |
| Study title: Fusi−G et al. A double blind clinical trial of the effectiveness and safety of an association of paracetamol−sobrerol vs paracetamol in pediatrics. {G−ITAL−RIC− CLIN−TER}, 1991, Vol/Iss/Pg. 12/1 (17−23) |
| Active substance: CODEINE_AND_PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24535 |
| Study title: WIRKSAMKEIT UND VERTRAEGLICHKEIT VON CIPROFLOXACIN BEI DER BEHANDLUNG VON JUGENDLICHEN PATIENTEN MIT CYSTISCHER FIBROSE, VERURSACHT DURCH GRAMPOSITIVE UND GRAMNEGATIVE BAKTERIEN. |
| Active substance: CIPROFLOXACIN |
| Study summary document link (including results): Bayer Pharma_Ciprofloxacin_1131_study_synopsis.pdf |
| View full study record |
| Document reference: 24215 |
| Study title: A prospective study of infection following tympanostomy and tube insertion. Balkany TJ, Barkin RM, Suzuki BH, Watson WJ. Am J Otol. 1983 Apr;4(4):288-91. A prospective study of infection following tympanostomy and tube insertion. Balkany TJ, Barkin RM, Suzuki BH, Watson WJ. Am J Otol. 1983 Apr;4(4):288-91. |
| Active substance: CIPROFLOXACIN HYDROCORTIZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24291 |
| Study title: Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL et al. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin-2 and Interferon Alfa-2b. Journal of Clinical Oncology 1999;17(3):968-975 1999;(3):968-975.Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL et al. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin-2 and Interferon Alfa-2b. Journal of Clinical Oncology 1999;17(3):968-975 1999;(3):968-975. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43188 |
| Study title: Comparison of treatment satisfaction and treatment adherence of a novel application form “Dose Sipping Technology” (DST) of oral clarithromycin vs. clarithromycin syrup in children suffering from acute otitis media, tonsillitis, pharyngitis, or acute bacterial bronchitis (DoSe iT) |
| Active substance: CLARITHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24303 |
| Study title: Efficacy and Safety of Clarithromycin Suspension in the Treatment of Pediatric Acute Otitis Media |
| Active substance: CLARITHROMYCIN |
| Study summary document link (including results): clarithromycin-cl4P01.pdf |
| View full study record |
| Document reference: 48062 |
| Study title: Multizentrische Anwendungsbeobachtung mit einer neuen Darreichungsform für Kinder |
| Active substance: CLARITHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24302 |
| Study title: PostMarketing Study of NeoClaroSip. Observational Study on a New Pharmaceutical form of Administration in Pediatrics |
| Active substance: CLARITHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24301 |
| Study title: “Seeding Neo-Clarosip“ (Survey on the use of Neoclarosip) |
| Active substance: CLARITHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24300 |
| Study title: AN 05281062 Medline 20070101. TI (On the clinical use of cyproheptadine as an anti-anorexic agent and its effects on the nutritional state). TT Sull'impiego clinico della ciproeptadina quale antianoressico e dei suoi effetti sullo stato di nutrizione. SO Minerva medica, {Minerva-Med}, 12 May 1971, vol. 62, no. 38, p. 1941-6, ISSN: 0026-4806. YR 1971.AN 05281062 Medline 20070101. TI (On the clinical use of cyproheptadine as an anti-anorexic agent and its effects on the nutritional state). TT Sull'impiego clinico della ciproeptadina quale antianoressico e dei suoi effetti sullo stato di nutrizione. SO Minerva medica, {Minerva-Med}, 12 May 1971, vol. 62, no. 38, p. 1941-6, ISSN: 0026-4806. YR 1971. |
| Active substance: CYPROHEPTADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25209 |
| Study title: AN 05287036 Medline 20070101. TI Treatment of cold urticaria with cyproheptadine. SO The Journal of allergy and clinical immunology, {J-Allergy-Clin- Immunol}, Dec 1971, vol. 48, no. 6, p. 366-71, ISSN: 0091-6749. AU Wanderer-A-A, Ellis-E-F. YR 1971.AN 05287036 Medline 20070101. TI Treatment of cold urticaria with cyproheptadine. SO The Journal of allergy and clinical immunology, {J-Allergy-Clin- Immunol}, Dec 1971, vol. 48, no. 6, p. 366-71, ISSN: 0091-6749. AU Wanderer-A-A, Ellis-E-F. YR 1971. |
| Active substance: CYPROHEPTADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25211 |
| Study title: AN 05503297 Medline 20070101. TI (Effect of cyproheptadine on appetite and body weight). TT Effetti della ciproeptadina sull'appetito e sul peso corporeo. SO Minerva pediatrica, {Minerva-Pediatr}, 1 Dec 1970, vol. 22, no. 48, p. 2404-8, ISSN: 0026-4946. AU Cantarini-A. YR 1970.AN 05503297 Medline 20070101. TI (Effect of cyproheptadine on appetite and body weight). TT Effetti della ciproeptadina sull'appetito e sul peso corporeo. SO Minerva pediatrica, {Minerva-Pediatr}, 1 Dec 1970, vol. 22, no. 48, p. 2404-8, ISSN: 0026-4946. AU Cantarini-A. YR 1970. |
| Active substance: CYPROHEPTADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25213 |
| Study title: Götte−R, Liedtke−R. (On the antipyretic effect of paracetamol. Clinical investigation with two different forms of application (author's transl)). {Med−Klin}, 6 Jan 1978, vol. 73, no. 1, p. 28−33 |
| Active substance: CODEINE_AND_PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24502 |
| Study title: Ipp, Gld, Greenberg, Goldbach, kupfert, Lloyd et al.; Pediatr Infect Dis J. 1987; |
| Active substance: CODEINE_AND_PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24579 |
| Study title: Kapoor−S−K et al. Comparison of antipyretic effect of nimesulide and paracetamol in children attending a secondary level hospital. {INDIAN−PEDIATR}, 2002, Vol/Iss/Pg. 39/5 (473−477) |
| Active substance: CODEINE_AND_PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24513 |
| Study title: Lal−A et al. Antipyretic effects of nimesulide, paracetamol and ibuprofen− paracetamol. {INDIAN−J−PEDIATR}, 2000, Vol/Iss/Pg. 67 /12 (865−870) |
| Active substance: CODEINE_AND_PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24520 |
| Study title: Leary−P−M et al. Antipyretic effect of oral v. rectal paracetamol. {S−Afr−Med−J}, Dec 1997, vol. 87, no. 12, p. 1708 |
| Active substance: CODEINE_AND_PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24518 |
| Study title: A comparison of the pupillary and cardiovascular effects of various mydriatic agents in preterm infants.Sindel BD, Baker MD, Maisels MJ, Weinstein J. J Pediatr Ophthalmol Strabismus. 1986 Nov-Dec;23(6):273-6. A comparison of the pupillary and cardiovascular effects of various mydriatic agents in preterm infants.Sindel BD, Baker MD, Maisels MJ, Weinstein J. J Pediatr Ophthalmol Strabismus. 1986 Nov-Dec;23(6):273-6. |
| Active substance: CYCLOPENTOLATE |
| Study summary document link (including results): A comparison of the pupillary and cardiovascular effects of .pdf |
| View full study record |
| Document reference: 24709 |
| Study title: A cross-over study of the cycloplegic effects of a single topical application of cyclopentolate-phenylephrine and routine atropinization for 3.5 days.Zetterström C. Acta Ophthalmol (Copenh). 1985 Oct;63(5):525-9. A cross-over study of the cycloplegic effects of a single topical application of cyclopentolate-phenylephrine and routine atropinization for 3.5 days.Zetterström C. Acta Ophthalmol (Copenh). 1985 Oct;63(5):525-9. |
| Active substance: CYCLOPENTOLATE |
| Study summary document link (including results): A cross-over study of the cycloplegic effects of a single to.pdf |
| View full study record |
| Document reference: 24710 |
| Study title: A mydriatic eye-drop combination without systemic effects for premature infants: a prospective double-blind study.Bolt B, Benz B, Koerner F, Bossi E. J Pediatr Ophthalmol Strabismus. 1992 May-Jun;29(3):157-62. A mydriatic eye-drop combination without systemic effects for premature infants: a prospective double-blind study.Bolt B, Benz B, Koerner F, Bossi E. J Pediatr Ophthalmol Strabismus. 1992 May-Jun;29(3):157-62. |
| Active substance: CYCLOPENTOLATE |
| Study summary document link (including results): A mydriatic eye-drop combination without systemc effects for.pdf |
| View full study record |
| Document reference: 24702 |
| Study title: Leiba M, Ehrenfeld M. Behcet’s Disease: Current Therapeutic Perspectives. Current Treatment Options in Cardiovascular Medecine 2005; 7:139-148Leiba M, Ehrenfeld M. Behcet’s Disease: Current Therapeutic Perspectives. Current Treatment Options in Cardiovascular Medecine 2005; 7:139-148 |
| Active substance: COLCHICINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24593 |
| Study title: Livneh A, Zemer D, Langevitz P, Laor A, Sohar E, Pras M. Colchicine treatment of AA amyloidosis of Familial Mediterranean Fever: an analysis of factors affecting outcome. Arthritsis Rheum 1994; 37:1804-1811Livneh A, Zemer D, Langevitz P, Laor A, Sohar E, Pras M. Colchicine treatment of AA amyloidosis of Familial Mediterranean Fever: an analysis of factors affecting outcome. Arthritsis Rheum 1994; 37:1804-1811 |
| Active substance: COLCHICINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24595 |
| Study title: Radu H, Keresztes L, Stenzel K. Effects of administration of phosphocreatine on the clinical, biochemical and electromyographic evolution of Duchenne's progressive muscular dystrophy. Minerva Med. 1968; 59 (99): 5524-29 Radu H, Keresztes L, Stenzel K. Effects of administration of phosphocreatine on the clinical, biochemical and electromyographic evolution of Duchenne's progressive muscular dystrophy. Minerva Med. 1968; 59 (99): 5524-29 |
| Active substance: CREATINE PHOSPHATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46922 |
| Study title: A randomised, double blind, 3-way crossover study to compare the protective effect of single doses of an alternative propellant (HFA-227) formulation of sodium cromoglycate 2x5 mg witn intal (Lomudal) MDI 2x5 mg and HFA- 227 placebo in asthmatic volunteers with exercise induced |
| Active substance: CROMOGLICIC ACID |
| Study summary document link (including results): CR 2710.pdf |
| View full study record |
| Document reference: 24657 |
| Study title: Results of treatment of primary metastatic Ewing sarcoma. A retrospective analysis of 48 patients |
| Active substance: DACTINOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25451 |
| Study title: The effect of a 7-day delay in chemotherapy cycles on complete response and event-free survival in good-risk disseminated germ cell tumor patients. |
| Active substance: DACTINOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25468 |
| Study title: Benesch M et al Outcome and long-term side effects after synchronous radiochemotherapy forchildhood brain stem gliomas Pediatr Neurosurg. 2001 Oct;35(4):173-80Benesch M et al Outcome and long-term side effects after synchronous radiochemotherapy forchildhood brain stem gliomas Pediatr Neurosurg. 2001 Oct;35(4):173-80 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24766 |
| Study title: Report/protocol/study N°: NF 113Comparison of oxatomide and clemastine in the treatment of chronic urticaria. A double blind study.Dermatologica 1985; 171:49-51 |
| Active substance: CLEMASTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24328 |
| Study title: Bacteriological, pharmacokinetic and clinical evaluations of cefpirome sulfate in the pediatric field - R. Fujii - 1990 (IV B1.10. Infections in pediatry IV B1.10.1.)Bacteriological, pharmacokinetic and clinical evaluations of cefpirome sulfate in the pediatric field - R. Fujii - 1990 (IV B1.10. Infections in pediatry IV B1.10.1.) |
| Active substance: CEFPIROME |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23507 |
| Study title: Urticaria in Thai children. Asian Pac J Allergy Immunol 1986; 4:41-45 Urticaria in Thai children. Asian Pac J Allergy Immunol 1986; 4:41-45 |
| Active substance: CLEMASTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24307 |
| Study title: Urticaria in Thai children. Asian Pac J Allergy Immunol 1986; 4:41-45 Urticaria in Thai children. Asian Pac J Allergy Immunol 1986; 4:41-45 |
| Active substance: CLEMASTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24327 |
| Study title: The effect of methylperon (Eunerpan) on aggressive and auto-aggressive behaviour in mentally retarded patients--a double blind study (author's transl)a |
| Active substance: DACTINOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25469 |
| Study title: Children's school performance is not impaired by short-term administration of diphenhydramine or loratadine, Bender, B.G., J. Pediatr. 2001; 138: 656-660Children's school performance is not impaired by short-term administration of diphenhydramine or loratadine, Bender, B.G., J. Pediatr. 2001; 138: 656-660 |
| Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25693 |
| Study title: Clinical Expert Statement of Framycetin sulfate containing formulations. - Dr R. Boyer - 21 Feb. 2002Clinical Expert Statement of Framycetin sulfate containing formulations. - Dr R. Boyer - 21 Feb. 2002 |
| Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25725 |
| Study title: BayQ3939 compared to erythromysin in pediatric cholera |
| Active substance: CIPROFLOXACIN |
| Study summary document link (including results): Bayer Pharma_Ciprofloxacin_10110_study_synopsis.pdf |
| View full study record |
| Document reference: 24203 |
| Study title: Cipro pediatric observational study.interim analysis/ A prospective, open-label, non-randomized, naturalistic, long-term safety surveillance, observational study of either ciprofloxacin (either as oral suspension, oral tablets or sequential IV oral therapy or purely IV therapy) or a non-quinolone antibiotic (either as oral suspension, oral tablets or sequential IV oral therapy or purely IV therapy) in the treatment of pediatric patients with infectious diagnoses. |
| Active substance: CIPROFLOXACIN |
| Study summary document link (including results): Bayer Pharma_Ciprofloxacin_100225_study_synopsis.pdf |
| View full study record |
| Document reference: 24205 |
| Study title: CIPROFLOXACIN IN THE TREATMENT OF GRAM-NEGATIVE INFECTIONS INCLUDING PSEUDOMONAS AERUGINOSA. STUDY NO. BAY-O9867/0368 |
| Active substance: CIPROFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24221 |
| Study title: Ciprofloxacin in the treatment of Pseudomonas infections in children with cystic fibrosis. Diagn Microbiol Infect Dis 1990; 13:153-155Ciprofloxacin in the treatment of Pseudomonas infections in children with cystic fibrosis. Diagn Microbiol Infect Dis 1990; 13:153-155 |
| Active substance: CIPROFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24210 |
| Study title: CIPROFLOXACIN PROPHYLAXIS FOR PREVENTION OF BACTERIAL INFECTIONS IN PEDIATRIC BONE MARROW TRANSPLANT PATIENTS; COMPARISON OF THE COMBINATION CIPROFLOXACIN/VANCOMYCIN TO PLACEBO (AMENDMENT NO.2 AND NO.3) |
| Active substance: CIPROFLOXACIN |
| Study summary document link (including results): Bayer Pharma_Ciprofloxacin_1350_study_synopsis.pdf |
| View full study record |
| Document reference: 24213 |
| Study title: CIPROFLOXACIN SINGLE DOSE AND STEADY STATE PHARMACOKINETICS IN CHILDREN. (IDENT. WITH BAYQ3939/0536) Study Design: NOT RANDOMIZED, NOT BLIND NO CONTROL GROUPS |
| Active substance: CIPROFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24206 |
| Study title: Kung FH et alI Ifosfamide/carboplatin/etoposide (ICE), an effective salvaging therapy forrecurrent malignant non-Hodgkin lymphoma of childhood: a Pediatric Oncology Group phase II study Med Pediatr Oncol. 1999 Mar;32(3):225-6. No abstract availableKung FH et alI Ifosfamide/carboplatin/etoposide (ICE), an effective salvaging therapy forrecurrent malignant non-Hodgkin lymphoma of childhood: a Pediatric Oncology Group phase II study Med Pediatr Oncol. 1999 Mar;32(3):225-6. No abstract available |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24973 |
| Study title: Kushner BH et al How effective is dose-intensive/myeloablative therapy against Ewing'ssarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review J Clin Oncol. 2001 Feb 1;19(3):870-80. ReviewKushner BH et al How effective is dose-intensive/myeloablative therapy against Ewing'ssarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review J Clin Oncol. 2001 Feb 1;19(3):870-80. Review |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24976 |
| Study title: Kushner BH et al Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults.J Clin Oncol 1995 Nov;13(11):2796-804Kushner BH et al Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults.J Clin Oncol 1995 Nov;13(11):2796-804 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24977 |
| Study title: Laithier V et al Progression-free survival in children with optic pathway tumors: dependence on age and the quality of the response to chemotherapy - results of the first French prospective study for the French Society of Pediatric Oncology J Clin Oncol 2003 Dec 15;21(24):4572-8Laithier V et al Progression-free survival in children with optic pathway tumors: dependence on age and the quality of the response to chemotherapy - results of the first French prospective study for the French Society of Pediatric Oncology J Clin Oncol 2003 Dec 15;21(24):4572-8 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24978 |
| Study title: 1. A randomised, double-blind, single centre, parallel group clinical trial to evaluate the comparative therapeutic efficacy of ciclopirox olamine 1.5% salicylic acid 3% scalp treatment, ciclopiroxolamine 1.5% scalp treatment and salicylic acid 3% scalp treatment against placebo, in patients with scalp psoriasis. 2. Two week home use test to assess the skin tolerance and acceptability of 1.5% CPO Body and Hair Shampoo. 3. 48 hour human patch test for primary irritation of ciclopirox olamine shampoos. 4. A double-blind, placebo-controlled trial of a ciclopirox olamine 1% shampoo for the treatment of scalp seborrhoeic dermatitis. 5. 48 hour human patch test for skin irritation of Physiogel Shampoo with Conditioner and Sarnol Lotion |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24128 |
| Study title: Tolerance study of Mollipect mixtur |
| Active substance: BROMHEXINE AND EPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22880 |
| Study title: Comparative clinical Study of Ciprofloxacin (BAY O 9867) and Norfloxacin in the Treatment of Complicated Urinary Tract Infections |
| Active substance: CIPROFLOXACIN |
| Study summary document link (including results): 717.pdf |
| View full study record |
| Document reference: 24201 |
| Study title: COMPARATIVE STUDY TO ASSESS THE EFFICACY, TOLERABILITY AND SAFETY OF CIPROFLOXACIN ORAL SUSPENSION VS TRIMETH OPRIM/SULFAMETHOXAZOLE IN THE TREATMENT OF ACUTE BLOODY DIARRHEA IN CHILDREN UNDER 5 YEARS OF AGE. |
| Active substance: CIPROFLOXACIN |
| Study summary document link (including results): Bayer Pharma_Ciprofloxacin_0551_study_synopsis.pdf |
| View full study record |
| Document reference: 24199 |
| Study title: Effectiveness of ototopical antibiotics for chronic suppurative otitis media in Aboriginal children: a community-based, multicentre, double-blind randomised controlled trial. Couzos S, Lea T, Mueller R, Murray R, Culbong M. Med J Aust. 2003 Aug 18;179(4):185-90. Effectiveness of ototopical antibiotics for chronic suppurative otitis media in Aboriginal children: a community-based, multicentre, double-blind randomised controlled trial. Couzos S, Lea T, Mueller R, Murray R, Culbong M. Med J Aust. 2003 Aug 18;179(4):185-90. |
| Active substance: CIPROFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24243 |
| Study title: Effects of topical otic preparations on hearing in chronic otitis media. Ozagar A, Koç A, Ciprut A, Tutkun A, Akdaş F, Sehitoğlu MA. Otolaryngol Head Neck Surg. 1997 Oct;117(4):405-8. Effects of topical otic preparations on hearing in chronic otitis media. Ozagar A, Koç A, Ciprut A, Tutkun A, Akdaş F, Sehitoğlu MA. Otolaryngol Head Neck Surg. 1997 Oct;117(4):405-8. |
| Active substance: CIPROFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24230 |
| Study title: Nabulsi−M et al. Equal antipyretic effectiveness of oral and rectal acetaminophen: A randomized controlled trial (ISRCTNI 1886401). {BMC−PEDIATR}, 06 SEP 2005, Vol/Iss/Pg. 5/− (7p) |
| Active substance: CODEINE_AND_PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24510 |
| Study title: Nabulsi−Mona et al. Equal antipyretic effectiveness of oral and rectal acetaminophen: a randomized controlled trial (ISRCTN11886401). {BMC−Pediatr}, 2005 (epub), vol. 5, p. 35 |
| Active substance: CODEINE_AND_PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24507 |
| Study title: Effectiveness of ototopical antibiotics for chronic suppurative otitis media in Aboriginal children: a community-based, multicentre, double-blind randomised controlled trial. Couzos S, Lea T, Mueller R, Murray R, Culbong M. Med J Aust. 2003 Aug 18;179(4):185-90. Effectiveness of ototopical antibiotics for chronic suppurative otitis media in Aboriginal children: a community-based, multicentre, double-blind randomised controlled trial. Couzos S, Lea T, Mueller R, Murray R, Culbong M. Med J Aust. 2003 Aug 18;179(4):185-90. |
| Active substance: CIPROFLOXACIN HYDROCORTIZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24270 |
| Study title: Effectiveness of budenoside nebulising suspension compared to disodium cromoglycate in early childhood asthma - Zielen S, Rose MA, Bez C, Jarish A, Reichbenbach J, Hofmann D - 2006 (Curr Med Res Opin 2006;22:367-73) Publication in CES clinical expert statement - Bruno Verdoncq - 28/08/07Effectiveness of budenoside nebulising suspension compared to disodium cromoglycate in early childhood asthma - Zielen S, Rose MA, Bez C, Jarish A, Reichbenbach J, Hofmann D - 2006 (Curr Med Res Opin 2006;22:367-73) Publication in CES clinical expert statement - Bruno Verdoncq - 28/08/07 |
| Active substance: CROMOGLICIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24670 |
| Study title: Effectiveness of budenoside nebulising suspension compared to disodium cromoglycate in early childhood asthma - Zielen S, Rose MA, Bez C, Jarish A, Reichbenbach J, Hofmann D - 2006 (Curr Med Res Opin 2006;22:367-73) Publication in CES clinical expert statement - Bruno Verdoncq - 28/08/07 |
| Active substance: CROMOGLICIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24684 |
| Study title: Effects of budenoside solution on health status and caregiver quality of life in childhood asthma - Murphy KR, Fitzpatrick S, Cruz-Rivera M, Miller CJ, Parasuraman B - 2003 (Pediatrics 2003;112-212-9) Publication in CES clinical expert statement - Bruno Verdoncq - 28/08/07Effects of budenoside solution on health status and caregiver quality of life in childhood asthma - Murphy KR, Fitzpatrick S, Cruz-Rivera M, Miller CJ, Parasuraman B - 2003 (Pediatrics 2003;112-212-9) Publication in CES clinical expert statement - Bruno Verdoncq - 28/08/07 |
| Active substance: CROMOGLICIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24671 |
| Study title: Effects of budenoside solution on health status and caregiver quality of life in childhood asthma - Murphy KR, Fitzpatrick S, Cruz-Rivera M, Miller CJ, Parasuraman B - 2003 (Pediatrics 2003;112-212-9) Publication in CES clinical expert statement - Bruno Verdoncq - 28/08/07 |
| Active substance: CROMOGLICIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24685 |
| Study title: Pappo AS et al A phase II trial of ifosfamide in previously untreated children and adolescents with unresectable rhabdomyosarcoma Cancer. 1993 Mar 15;71(6):2119-25Pappo AS et al A phase II trial of ifosfamide in previously untreated children and adolescents with unresectable rhabdomyosarcoma Cancer. 1993 Mar 15;71(6):2119-25 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25053 |
| Study title: A double-blind multiple dose study of the comparative antipyretic effectiveness and safety of standard and double standard doses of acetaminophen in febrile children. Jun 1986. |
| Active substance: CODEINE_AND_PARACETAMOL |
| Study summary document link (including results): paracetamol 0-220.pdf |
| View full study record |
| Document reference: 24570 |
| Study title: A phase III combined study of efficacy and side effects profile of extended release acetaminophen pediatric chewable tablets compared to acetaminophen eight-hour extended release pediatric suspension in the treatment of febrile children. Aug 1998. |
| Active substance: CODEINE_AND_PARACETAMOL |
| Study summary document link (including results): paracetamol 93-329.pdf |
| View full study record |
| Document reference: 24564 |
| Study title: A phase III double-blind, single dose study of the comparative antipyretic effectiveness and safety of standard and double standard (C-47) doses of acetaminophen in febrile children. Jan 1984. |
| Active substance: CODEINE_AND_PARACETAMOL |
| Study summary document link (including results): paracetamol 2-222.pdf |
| View full study record |
| Document reference: 24571 |
| Study title: A phase IV double-blind multicenter study comparing the antipyretic effectiveness of aspirin, acetaminophen, and placebo in febrile children. Aug 1992. |
| Active substance: CODEINE_AND_PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24573 |
| Study title: A phase IV double-blind multicenter study comparing the antipyretic effectiveness of aspirin, acetaminophen, choline salicylate and placebo in febrile children. Jun 1991. |
| Active substance: CODEINE_AND_PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24574 |
| Study title: A randomized, investigator-blinded, parallel, single dose, multicenter study to compare for eight hours the efficacy and side effects profile of sustained release acetaminophen pediatric chewable tablets (20-30 mg/kg) compared to regular strength, conventional release acetaminophen pediatric chewable tablets (10-25 mg/kg) in the treatment of febrile children. Jan 1990. |
| Active substance: CODEINE_AND_PARACETAMOL |
| Study summary document link (including results): paracetamol 88-813.pdf |
| View full study record |
| Document reference: 24569 |
| Study title: Scolnik−D et al. Comparison of oral versus normal and high−dose rectal acetaminophen in the treatment of febrile children. {PEDIATRICS}, 2002, Vol/Iss/Pg. 110/3 (553−556) |
| Active substance: CODEINE_AND_PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24512 |
| Study title: Similä−S, Kylmämaa−T. Antipyretic effect of tenoxicam and paracetamol in febrile children. {Drugs−Exp−Clin−Res}, 1985, vol. 11, no. 10, p. 731−4 |
| Active substance: CODEINE_AND_PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24543 |
| Study title: Tarlin−L et al. A comparison of the antipyretic effect of acetaminophen and aspirin. Another approach to poison prevention. {Am−J−Dis−Child}, Dec 1972, vol. 124, no. 6, p. 880−2 |
| Active substance: CODEINE_AND_PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24547 |
| Study title: Ulukol−B et al. Assessment of the efficacy and safety of paracetamol, ibuprofen and nimesulide in children with upper respiratory tract infections. {EUR−J−CLIN−PHARMACOL}, 1999, Vol/Iss/Pg. 55/9 (615−618 |
| Active substance: CODEINE_AND_PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24524 |
| Study title: Wahba−H. The Antipyretic Effect of Ibuprofen and Acetaminophen in Children. {PHARMACOTHERAPY}, 2004, Vol/Iss/Pg. 24/2 I (280−284) |
| Active substance: CODEINE_AND_PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24505 |
| Study title: Cost-effectiveness of cycloplegic agents: results of a randomized controlled trial in nigerian children.Ebri A, Kuper H, Wedner S. Invest Ophthalmol Vis Sci. 2007 Mar;48(3):1025-31. Cost-effectiveness of cycloplegic agents: results of a randomized controlled trial in nigerian children.Ebri A, Kuper H, Wedner S. Invest Ophthalmol Vis Sci. 2007 Mar;48(3):1025-31. |
| Active substance: CYCLOPENTOLATE |
| Study summary document link (including results): Cost-effectiveness of cycloplegic agents.pdf |
| View full study record |
| Document reference: 24696 |
| Study title: Effects of cyclopentolate eyedrops on gastric secretory function in pre-term infants.Isenberg SJ, Abrams C, Hyman PE. Ophthalmology. 1985 May;92(5):698-700. Effects of cyclopentolate eyedrops on gastric secretory function in pre-term infants.Isenberg SJ, Abrams C, Hyman PE. Ophthalmology. 1985 May;92(5):698-700. |
| Active substance: CYCLOPENTOLATE |
| Study summary document link (including results): Effects of cyclopentolate eyedrops.pdf |
| View full study record |
| Document reference: 24711 |
| Study title: A double -blind comparative study ciclopirox (HOE 296 b) gel 0,77% versus ciclopirox (HOE 296 b) gel 0,77% vehicle base in patients with tinea pedis - Ronald C. Savin et al. - 14/09/1994 - Publication in -Part IV volume 29-Clinical study synopsis Ciclopirox (HOE 296 b) gel 0,77% protocol 390 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24129 |
| Study title: Acute Intraperitoneal tolerance of compound HOE 296 for neonatal rats - F.R Springman et al. - 5/02/1976 (Hoescht AG) - Publication in Part III - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24133 |
| Study title: A COMPARISON OF CLEOCIN T TOPICAL GEL VS PLACEBO IN THE TREATMENT OF ACNE VULGARIS |
| Active substance: CLINDAMYCIN |
| Study summary document link (including results): M11120001 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 24369 |
| Study title: A COMPARISON OF CLEOCIN T TOPICAL SOLUTION VS CLEOCIN T TOPICAL GEL IN THE TREATMENT OF ACNE VULGARIS |
| Active substance: CLINDAMYCIN |
| Study summary document link (including results): M11120002 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 24370 |
| Study title: A COMPARISON OF CLEOCIN T TOPICAL SOLUTION, CLEOCIN T GEL AND PLACEBO IN THE TREATMENT OF ACNE VULGARIS |
| Active substance: CLINDAMYCIN |
| Study summary document link (including results): M11120004 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 24371 |
| Study title: A DOUBLE BLIND COMPARATIVE STUDY OF ORAL CLINDAMYCIN HYDROCHLORIDE 300 MG BID COMPARED AGAINST ORAL CLARITHROMYCIN 250 MG BID IN THE TREATMENT OF ACUTE RECURRENT TONSILLITIS/PHARYNGITIS DUE TO GROUP A-B HEMOLYTIC STREPTOCOCCI. A MULTINATIONAL MULTICENTRI |
| Active substance: CLINDAMYCIN |
| Study summary document link (including results): 251F-INF-9052-0279 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 24362 |
| Study title: A DOUBLE-BLIND MULTICENTER COMPARATIVE STUDY OF TWO ADMINISTRATION REGIMENS OF CLINDAMYCIN HYDROCHLORIDE IN THE TREATMENT OF ACUTE STREPTOCOCCAL TONSILITIS/PHARYNGITIS (PROTOCOL M/1120/0178) |
| Active substance: CLINDAMYCIN |
| Study summary document link (including results): M11200178 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 24374 |
| Study title: Eilber F et al, Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial, J Clin Oncol. 1987 Jan;5(1):21-6Eilber F et al, Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial, J Clin Oncol. 1987 Jan;5(1):21-6 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24858 |
| Study title: Bernstein ML et al Ifosfamide with mesna uroprotection and etoposide in recurrent, refractory acute leukemia in childhood. A Pediatric Oncology Group Study Cancer. 1993 Sep 1;72(5):1790-4Bernstein ML et al Ifosfamide with mesna uroprotection and etoposide in recurrent, refractory acute leukemia in childhood. A Pediatric Oncology Group Study Cancer. 1993 Sep 1;72(5):1790-4 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24768 |
| Study title: Berrak SG et al High-dose ifosfamide in relapsed pediatric osteosarcoma: therapeutic effects and renal toxicity Pediatr Blood Cancer. 2005 Mar;44(3):215-9Berrak SG et al High-dose ifosfamide in relapsed pediatric osteosarcoma: therapeutic effects and renal toxicity Pediatr Blood Cancer. 2005 Mar;44(3):215-9 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24770 |
| Study title: Bhatia S et al Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma andprimitive neuroectodermal tumor of bone: A report from the Children's Oncology Group Blood. 2007 Jan 1;109(1):46-51. Epub 2006 Sep 19Bhatia S et al Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma andprimitive neuroectodermal tumor of bone: A report from the Children's Oncology Group Blood. 2007 Jan 1;109(1):46-51. Epub 2006 Sep 19 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24775 |
| Study title: Bhatia S et al. Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group. Blood. 2007 Jan 1;109(1):46-51. Epub 2006 Sep 19. Bhatia S et al. Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group. Blood. 2007 Jan 1;109(1):46-51. Epub 2006 Sep 19. |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24776 |
| Study title: Hübner G et al. Intensive post-remission therapy in acute myeloid leukemia. Results of a prospective comparative study by the South Germany Hemoblastosis Group Med Klin (Munich). 1996 Apr 12;91 Suppl 3:26-32Hübner G et al. Intensive post-remission therapy in acute myeloid leukemia. Results of a prospective comparative study by the South Germany Hemoblastosis Group Med Klin (Munich). 1996 Apr 12;91 Suppl 3:26-32 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24930 |
| Study title: Cairo MS et al Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent or refractory solid tumors: a children's cancer group report J Pediatr Hematol Oncol 2001 Jan;23(1):30-8Cairo MS et al Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent or refractory solid tumors: a children's cancer group report J Pediatr Hematol Oncol 2001 Jan;23(1):30-8 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24806 |
| Study title: Resultados clinicos e micologico obtidos com o uso do ciclopirox (HOE 296) em micoses superficiais-clinical and mycological results obtained with the use of ciclopirox (HOE 296) in superficial mycoses - Manoel luis Moraes - 1974 ( Rev Bras Clin Ter vol 3, n°10, suppl 7) - Publication in Part Clinical documentation Batrafen Losung -No author - 11/1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24167 |
| Study title: Study on acute toxicity of 1-hydroxy-4 - methyl-6- cyclohexyl - 2- pyridone ethalonamine salt (HOE 296) in rats - Teruo Kitatani et al. - 08/06/1973 (Hoescht AG) - Publication in Part III - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24127 |
| Study title: Study on acute toxicity of 1-hydroxy-4 - methyl-6- cyclohexyl - 2- pyridone ethalonamine salt (HOE 296) in mice - Teruo Kitatani et al. - 08/06/1973 (Hoescht AG) - Publication in Part III - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24168 |
| Study title: Terapia delel onicomicosi con ciclopioxolamina per uso topico - G. Lo Scocco et al. - 1986 (Derm Clin vol 3) - Publication in Part clinical documentation-Batrafen Losung Study CIOMS-No author-11/ 1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24170 |
| Study title: Tratamento topico das micoses superficiais pelo HOE 296, um novo piridonico - Topical treatment of superficial mycoses with HOE 296, a new pyridonic antimycotic drug - Lorivaldo Minelli et al. - 1974 ( Rev Bras Clin Ter vol 3) -Publication in Part Clinical documentation Batrafen Losung - No author - 11/1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24171 |
| Study title: Tratamiento corto ciclopirox olamina 1% (Ciclochem) en pitriasis versicolor - A. Del Palacio Hernandez et al. - 1988 (Acta Dermos Sil vol 79) - Publication in Part clinical documentation- Batrafen Losung Study CIOMS- No author-11/ 1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24172 |
| Study title: Treatment of bacterially superinfected dermatomycoses - K. Jablonski - 1987 (Kassenartz vol 27) - Publication in clinical studies (volume 6) - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24173 |
| Study title: Tropical diseases : tropical fungal infections- RJ Hay- 1985 (Pharmacy international vol 6/4) - Publication in Part Clinical documentation Batrafen Losung - No author - 11/1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24174 |
| Study title: A Multiclinic Study of the Efficacy, Safety Tolerance and Pharmacology of a Range of Doses of Intravenous PRIMAXIN (MK-787/MK-791) in the Treatment of Hospitalized Neonates and Infants with Infections Caused by Susceptible Bacteria. |
| Active substance: CILASTATIN AND IMIPENEM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24177 |
| Study title: A Study of the Efficacy, Pharmaco-kinetics, Safety and Tolerability of Intravenously Administered Multiple doses of MK-787/MK-791 in Neonates, including Premature Infants. |
| Active substance: CILASTATIN AND IMIPENEM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24179 |
| Study title: A Study of the Pharmacology Profile, Safety and Tolerability of Intravenously Administered Single Doses of MK0787/MK0791 in Neonates. |
| Active substance: CILASTATIN AND IMIPENEM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24175 |
| Study title: A study of the Pharmacology Profile, Safety and Tolerability of Intravenously Administered Doses of PRIMAXIN (MK0787/MK0791) or Imipenem/Cilastatin in low Birth weight (LBW) Infants. |
| Active substance: CILASTATIN AND IMIPENEM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24178 |
| Study title: Grier HE et al Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone N Engl J Med. 2003 Feb 20;348(8):694-701Grier HE et al Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone N Engl J Med. 2003 Feb 20;348(8):694-701 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24914 |
| Study title: EFFICACY AND SAFETY OF BAY-O9867 / CIPROFLOXACIN IN THE TREATMENT OF PATIENTS WITH RESPIRATORY TRACT INFECTIONS (SEQUENTIAL THERAPY- PARENTERAL-ORAL). STUDY NO. 338 |
| Active substance: CIPROFLOXACIN |
| Study summary document link (including results): Bayer Pharma_Ciprofloxacin_0338_study_synopsis.pdf |
| View full study record |
| Document reference: 24220 |
| Study title: EFFICACY AND SAFETY OF CIPROFLOXACIN IN THE TREATMENT OF CHILDREN WITH INFECTIONS REFRACTORY TO CURRENTLY MARKETED ANTIBIOTICS (COMPASSIONATE USE).(IDENT.MIT BAYQ3939/0441) |
| Active substance: CIPROFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24218 |
| Study title: EFFICACY AND SAFETY OF CIPROFLOXACIN IN THE TREATMENT OF SYSTEMIC SALMONELLOSIS IN CHILDREN (IDENT.MIT BAYQ3939/0472) |
| Active substance: CIPROFLOXACIN |
| Study summary document link (including results): Bayer Pharma_Ciprofloxacin_1251_study_synopsis.pdf |
| View full study record |
| Document reference: 24214 |
| Study title: EFFICACY AND SAFETY OF CIPROFLOXACIN VERSUS CONTINUED PARENTERAL CEFTAZIDIME IN NEUTROPENIC PEDIATRIC CANCER PATIENTS WHO HAVE RESPONDED TO INITIAL PARENTERAL THERAPY. |
| Active substance: CIPROFLOXACIN |
| Study summary document link (including results): Bayer Pharma_Ciprofloxacin_1310_study_synopsis.pdf |
| View full study record |
| Document reference: 24212 |
| Study title: Humpl T et al Clinical aspects and prognosis of ependymoma in infants and children. A single institution experience Childs Nerv Syst. 2001 Apr;17(4-5):246-51Humpl T et al Clinical aspects and prognosis of ependymoma in infants and children. A single institution experience Childs Nerv Syst. 2001 Apr;17(4-5):246-51 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24932 |
| Study title: Ishii T et al The effects of high-dose ifosfamide in the treatment of bone and soft tissue sarcomas Gan To Kagaku Ryoho. 1997 Nov;24(14):2123-30. JapaneseIshii T et al The effects of high-dose ifosfamide in the treatment of bone and soft tissue sarcomas Gan To Kagaku Ryoho. 1997 Nov;24(14):2123-30. Japanese |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24938 |
| Study title: Chantada G et al Results of a prospective study for the treatment of retinoblastoma Cancer 2004 Feb 15;100(4):834-42Chantada G et al Results of a prospective study for the treatment of retinoblastoma Cancer 2004 Feb 15;100(4):834-42 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24823 |
| Study title: A Study of the Pharmacology Profile, Safety and Tolerability of Intravenously Administered Single and Multiple Doses of MK0787/MK0791 in Neonates. |
| Active substance: CILASTATIN AND IMIPENEM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24176 |
| Study title: Humanitarian Use of Imipenem/Cilastatin Sodium in Neonates. |
| Active substance: CILASTATIN AND IMIPENEM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24180 |
| Study title: Comparison of Pharmacokinetic and Pharmacodynamic Effects of Three Continuous IV Doses of Cimetidine in Children. |
| Active substance: CIMETIDINE |
| Study summary document link (including results): Study 923341-221-TA-S09-Cimetidine_DR Approved.xls |
| View full study record |
| Document reference: 24185 |
| Study title: K30- Absorption of clonazepam after rectal administration to children with febrile convulsions |
| Active substance: CLONAZEPAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24405 |
| Study title: A controlled trial investigating the effects of clonidine in children with Attention-deficit Hyperactivity Disorder. |
| Active substance: CLONIDINE |
| Study summary document link (including results): clonidine hydrochloride_U91-0711_synopsis.pdf |
| View full study record |
| Document reference: 47131 |
| Study title: USPDI Parenteral Dosage Forms, Antihistamines (Systemic) Diphenhydramine Hydrochloride Injection USP, United States Pharmacopoeia Dispensing InformationUSPDI Parenteral Dosage Forms, Antihistamines (Systemic) Diphenhydramine Hydrochloride Injection USP, United States Pharmacopoeia Dispensing Information |
| Active substance: CAFFEINE AND DIMENHYDRINATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23128 |
| Study title: ¿Es segura la administración de quinolonas en la edad pediátrica?Med Clin 2001; 117:676-677¿Es segura la administración de quinolonas en la edad pediátrica?Med Clin 2001; 117:676-677 |
| Active substance: CIPROFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24209 |
| Study title: ORAL CIPROFLOXACIN IN URINARY TRACT, RESPIRATORY AND OTHER BACTERIAL INFECTIONS DUE TO PSEUDOMONAS AERUGINOSA AND OTHER GERMS (STUDIES NO. 268 AND 277) |
| Active substance: CIPROFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24222 |
| Study title: Weisse−M−E et al. Fever response to acetaminophen in viral vs. bacterial infections. {Pediatr−Infect−Dis−J}, Dec 1987, vol. 6, no. 12, p. 1091−4 |
| Active substance: CODEINE_AND_PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24542 |
| Study title: The effect of topical ciprofloxacin on postoperative otorrhea after tympanostomy tube insertion. Zipfel TE, Wood WE, Street DF, Wulffman J, Tipirneni A, Frey C, Gibson WS. Am J Otol. 1999 Jul;20(4):416-20. The effect of topical ciprofloxacin on postoperative otorrhea after tympanostomy tube insertion. Zipfel TE, Wood WE, Street DF, Wulffman J, Tipirneni A, Frey C, Gibson WS. Am J Otol. 1999 Jul;20(4):416-20. |
| Active substance: CIPROFLOXACIN HYDROCORTIZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24273 |
| Study title: The effectiveness of topical treatment in discharging ears with in-dwelling ventilation tubes. Strachan D, Clarke SE, England RJ. Rev Laryngol Otol Rhinol (Bord). 2000;121(1):27-9.The effectiveness of topical treatment in discharging ears with in-dwelling ventilation tubes. Strachan D, Clarke SE, England RJ. Rev Laryngol Otol Rhinol (Bord). 2000;121(1):27-9. |
| Active substance: CIPROFLOXACIN HYDROCORTIZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24285 |
| Study title: Injections of Botulinum Toxin A in salivary glands in persons with cerebral palsy and a drooling problem. |
| Active substance: CLOSTRIDIUM BOTULINUM TOXIN TYPE A |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24420 |
| Study title: A double-blind, prospective, randomised, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of Dysport with placebo in lower limb spasticity in children with cerebral palsy |
| Active substance: CLOSTRIDIUM BOTULINUM TOXIN TYPE A - HAEMAGGLUTININ COMPLEX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24433 |
| Study title: A phase IV, monocentre, open, non-comparative, prospective study to evaluate the efficacy and tolerability of Dysport in the treatment of Dynamic Equinus Foot Deformity in young children with Cerebral Palsy |
| Active substance: CLOSTRIDIUM BOTULINUM TOXIN TYPE A - HAEMAGGLUTININ COMPLEX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24436 |
| Study title: An assessor-blind, prospective, randomised, chronic dosing study to compare the long-term efficacy and safety of two differing Dysport dosage regimens in the treatment of lower limb spasticity in children with cerebral palsy. |
| Active substance: CLOSTRIDIUM BOTULINUM TOXIN TYPE A - HAEMAGGLUTININ COMPLEX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24435 |
| Study title: |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24466 |
| Study title: 500 mg BAY b 5097 Vaginal Tablets. Effectiveness and Tolerance of 500 mg BAY b 5097 Vaginal Tablets After a Single Administration in Comparison with 3-Day Therapy with 150 mg Econazole Ovula |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0475_study_synopsis.pdf |
| View full study record |
| Document reference: 24463 |
| Study title: Activity and tolerability of Bay B 5097, 10%vaginal cream in patients with vaginal candida infections (open, mycologically controlled study) |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0263_study_synopsis.pdf |
| View full study record |
| Document reference: 24446 |
| Study title: Activity and tolerability of clotrimazole 10% vaginal cream in patients with vaginal yeast infections (bimetrically planned study with no control group) |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): 504.pdf |
| View full study record |
| Document reference: 24449 |
| Study title: Activity and tolerability of clotrimazole 10% vaginal cream in patients with vaginal yeast infections (biometrically planned study with no control group). |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0511_study_synopsis.pdf |
| View full study record |
| Document reference: 24452 |
| Study title: BAY b 5097 - 500-mg Vaginal Tablet. Effectiveness and Tolerance of BAY b 5097 500-mg Vaginal Tablets in Single-Dose or One-Day Therapy for Vaginal Yeast Infections |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0410_study_synopsis.pdf |
| View full study record |
| Document reference: 24456 |
| Study title: Bay b 5097 - 500-mg Vaginal Tablet. Activity and Tolerability of Bay b 5097 500-mg Vaginal Tablets After a Single Application in Patients with Vaginal Yeast Infections (Open, Mycologically Controlled Study) |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24459 |
| Study title: Fluticasone for the treatment of symptomatic bronchial asthma in children treated with sodium cromoglycate - a prospective, randomised trial - Von Berg A, Gappa M, Steinkamp G - 2002 (Eur J Med Res 2002;28:257-64) Publication in CES clinical expert statement - Bruno Verdoncq - 28/08/07Fluticasone for the treatment of symptomatic bronchial asthma in children treated with sodium cromoglycate - a prospective, randomised trial - Von Berg A, Gappa M, Steinkamp G - 2002 (Eur J Med Res 2002;28:257-64) Publication in CES clinical expert statement - Bruno Verdoncq - 28/08/07 |
| Active substance: CROMOGLICIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24674 |
| Study title: Induced sputum in children with newly diagnoses mild asthma: the effect of 6 months of treatment with budenoside or disodum cromoglycate - 2004 - Rytila P, Pelkonen AS, Metso T, Nikander K, Haahtela T, Turpeinen M (Allergy 2004;59:839-44) - Publication in CES clinical expert statement - Bruno Verdoncq - 28/08/07Induced sputum in children with newly diagnoses mild asthma: the effect of 6 months of treatment with budenoside or disodum cromoglycate - 2004 - Rytila P, Pelkonen AS, Metso T, Nikander K, Haahtela T, Turpeinen M (Allergy 2004;59:839-44) - Publication in CES clinical expert statement - Bruno Verdoncq - 28/08/07 |
| Active substance: CROMOGLICIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24675 |
| Study title: Wong−A et al. Antipyretic effects of dipyrone versus ibuprofen versus acetaminophen in children: Results of a multinational, randomized, modified double− blind study. {CLIN−PEDIATR}, 2001, Vol/Iss/Pg. 40/6 (313−324) |
| Active substance: CODEINE_AND_PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24519 |
| Study title: Comparative efficacy and tolerance of ibuprofen syrup or acetaminophen in children with pyrexia associated with infectious diseases and treated with antibioticsE.Autret et al. - 1994 (Eur.J.Clin.Pharmacol., 46, 197-201) - Publication in the Clinical expert report on the fixed combination of paracetamol+codeine phosphate-drotaverine hydrochloride(NO-SPALGIN |
| Active substance: CODEINE_DOTRAVERINE_PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24488 |
| Study title: Infants and young children metabolise codeine to morphine,A study after single and repeated rectal administration - H.Quiding et al. - 1992 (Br.J.Clin.Pharmac., 33, 45-49) - Publication in the Clinical expert report on the fixed combination of paracetamol+codeine phosphate-drotaverine hydrochloride(NO-SPALGIN) - |
| Active substance: CODEINE_DOTRAVERINE_PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24491 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Coenzyme compositum (injection solution) [AWB-020] |
| Active substance: Coenzyme compositum |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39831 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Coenzyme compositum (injection solution) [AWB-020] |
| Active substance: Coenzyme compositum-Heel - Ampullen |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39835 |
| Study title: Aasenden R, Peebles TC. Effects of fluoride supplementation from birth on human deciduous and permanent teeth. Arch Oral Biol 1974; 19: 321-326. |
| Active substance: COLECALCIFEROL AND SODIUM FLUORIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24626 |
| Study title: Andersson R, Grahnen H. Fluoride tablets in pre-school age – effect on primary and permanet teeth. Swed Dent J 1976; 69: 137-143. |
| Active substance: COLECALCIFEROL AND SODIUM FLUORIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24627 |
| Study title: De Liefde B, Herbison GP. Prevalence of developmental defects of enamel and denatl caries in New Zealand children receiving differing fluoride supplementation. Community Dent Oral Epidemiol 1985; 13: 164-167 |
| Active substance: COLECALCIFEROL AND SODIUM FLUORIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24628 |
| Study title: Fábián K, Velkey L, Fodor E. [Preventive value of vitamin D in various doses based on a prospective study of healthy infants. [Article in Hungarian] Orv Hetil. 1990 Mar 4;131(9):447-50. |
| Active substance: COLECALCIFEROL AND SODIUM FLUORIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24635 |
| Study title: Effect of caries-prophylaxis with Fluor-Vigantoletten 1000 on fluoride concentration in plasma of infants - Einfluß der Kariesprophylaxe mit Fluor-Vigantoletten 1000 auf die Plasma-Fluoridkonzentrationen beim Säugling.Monatsschr Kinderheilk 1979; 127: 192-195. Fuchs C. |
| Active substance: COLECALCIFEROL AND SODIUM FLUORIDE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 24623 |
| Study title: Lehtonen-Veroma M, Mottonen T, Nuotio I et al. Vitamin D and attainment of peak bone mass among peripubertal Finish girls: a 3-year prospective study. Am J Clin Nutr 2002; 76: 1446-53. |
| Active substance: COLECALCIFEROL AND SODIUM FLUORIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24636 |
| Study title: Leverett DH, Adair SM, Vaughan BW et al. Randomized clinical trail of the effect of prenatal fluoride supplements in preventing dental caries. Caries res 1997; 31: 174-179. |
| Active substance: COLECALCIFEROL AND SODIUM FLUORIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24632 |
| Study title: Bisogno G et al Intensive chemotherapy for children and young adults with metastatic primitive neuroectodermal tumors of the soft tissue.Bone Marrow Transplant 2002 Sep;30(5):297-302Bisogno G et al Intensive chemotherapy for children and young adults with metastatic primitive neuroectodermal tumors of the soft tissue.Bone Marrow Transplant 2002 Sep;30(5):297-302 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24778 |
| Study title: Determination of glomerular filtration rate with radionuclide renography and direct urinary activity quantitation.Otto AC, Pretorius PH, Dunn M, Nel MG, van Aswegen A, Marais J, Lötter MG.S Afr Med J. 1995 Aug;85(8):770-2. |
| Active substance: CHROMIUM 51 |
| Study summary document link (including results): 2011-09 GE Chromium EDTA response List of published articles.doc |
| View full study record |
| Document reference: 24093 |
| Study title: Primary vesicoureteral reflux detected in neonates with a history of fetal renal pelvis dilatation: a prospective clinical and imaging study.Ismaili K, Hall M, Piepsz A, Wissing KM, Collier F, Schulman C, Avni FE. |
| Active substance: CHROMIUM 51 |
| Study summary document link (including results): Ismaili K et al 2006.pdf |
| View full study record |
| Document reference: 24087 |
| Study title: Cefixime therapy for paediatric urinary tract infections - Farinati A.E et col.- 1993 (J. Drug. Dev., 6 (Supp. 1) : 45 - 47)Cefixime therapy for paediatric urinary tract infections - Farinati A.E et col.- 1993 (J. Drug. Dev., 6 (Supp. 1) : 45 - 47) |
| Active substance: CEFIXIME |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23443 |
| Study title: A double -blind comparative study ciclopirox (HOE 296 b) gel 0,77% versus ciclopirox (HOE 296 b) gel 0,77% vehicle base in patients with tinea pedis - Ronald C. Savin et al. - 14/09/1994 - Publication in -Part IV volume 29-Clinical study synopsis Ciclopirox (HOE 296 b) gel 0,77% protocol 390 - |
| Active substance: CICLOPIROX |
| Study summary document link (including results): CICLOPIROX STUDY HOE296B-8-USA-390-AF.xls |
| View full study record |
| Document reference: 24130 |
| Study title: A double blind multicente rparallel group study comparing ciclopirox olamine cream 1% and LOTRIMIN (clotrimazole cream 1%) in the subjects with tinea corporis or tinea cruris - Richard L. Dobson et al. - 08/ 1988 - Publication in clinical studies ( volume |
| Active substance: CICLOPIROX |
| Study summary document link (including results): Ciclopirox STUDY 305.xls |
| View full study record |
| Document reference: 24131 |
| Study title: lntraindividual, double-blind (double-dummy, crossover) trial on the antiinflammatory efficacy and protective effect in exercise-induced asthma of the fixed-dose combination of cromoglycate, disodium salt and reproterol hydrochloride compared to montelukast in children and adolescents six to fourteen years of age with mild to moderate asthma |
| Active substance: CROMOGLICIC ACID |
| Study summary document link (including results): Cromoglycate STUDY PAG 99019.xls |
| View full study record |
| Document reference: 47978 |
| Study title: Ferrari S et al Prospective evaluation of renal function in pediatric and adult patients treated with high-dose ifosfamide, cisplatin and high-dose methotrexate Anticancer Drugs. 2005 Aug;16(7):733-8Ferrari S et al Prospective evaluation of renal function in pediatric and adult patients treated with high-dose ifosfamide, cisplatin and high-dose methotrexate Anticancer Drugs. 2005 Aug;16(7):733-8 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24874 |
| Study title: Allen JC et al Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors Int J Radiat Oncol Biol Phys 1996 Dec 1;36(5):1155-61Allen JC et al Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors Int J Radiat Oncol Biol Phys 1996 Dec 1;36(5):1155-61 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24720 |
| Study title: Andriole GL et al The efficacy of mesna (2-mercaptoethane sodium sulfonate) as a uroprotectant in patients with hemorrhagic cystitis receiving further oxazaphosphorinechemotherapy J Clin Oncol. 1987 May;5(5):799-803Andriole GL et al The efficacy of mesna (2-mercaptoethane sodium sulfonate) as a uroprotectant in patients with hemorrhagic cystitis receiving further oxazaphosphorinechemotherapy J Clin Oncol. 1987 May;5(5):799-803 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24723 |
| Study title: Antman KH et al Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma J Clin Oncol. 1989 Jan;7(1):126-31. Erratum in: J Clin Oncol 1989 Sep;7(9):1369Antman KH et al Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma J Clin Oncol. 1989 Jan;7(1):126-31. Erratum in: J Clin Oncol 1989 Sep;7(9):1369 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24727 |
| Study title: Gururangan S et al Treatment of children with peripheral primitive neuroectodermal tumor or extraosseous Ewing's tumor with Ewing's-directed therapy J Pediatr Hematol Oncol. 1998 Jan-Feb;20(1):55-61Gururangan S et al Treatment of children with peripheral primitive neuroectodermal tumor or extraosseous Ewing's tumor with Ewing's-directed therapy J Pediatr Hematol Oncol. 1998 Jan-Feb;20(1):55-61 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24917 |
| Study title: A double blind multicentre parallel study group comparing ciclopirox olamine 1% cream and vehicle, cream base in the subjects with Tinea corporis or Tinea cruris - No author - august 1988 : Clinical/statistical report for ciclopirox olamine ( Loprox, HOE296) protocole 303 - Phillip Frost et al. - No date -Publication in clinical studies ( volume 4)- |
| Active substance: CICLOPIROX |
| Study summary document link (including results): Ciclopirox STUDY 301.xls |
| View full study record |
| Document reference: 24132 |
| Study title: Clinical/statistical report for ciclopirox olamine ( Loprox, HOE296) protocole 306- a double-bling multicenter parallel group study comparing ciclopirox olamine cream 1% and lotirimin (clotrimazole) cream 1% subjects with tinea pedis- W. christopher Duncan et al.- No date - Publication in clinical studies ( volume 4) - a double blind multicentre parallel study group comparing ciclopirox olamine 1% cream and vehicle, cream base in the subjects with Tinea corporis or Tinea cruris - No author - 08/1988 -Report 206 |
| Active substance: CICLOPIROX |
| Study summary document link (including results): Ciclopirox STUDY 306.xls |
| View full study record |
| Document reference: 24143 |
| Study title: Clinical/statistical report for ciclopirox olamine ( Loprox, HOE296) protocole 307 : a double-blind multicenter parallel group study comparing ciclopirox olamine 1% cream with Lotrimin (clotrimazole) cream 1% in subjects with Tinea versicolor - Stanley I Cullen et al. - No date - Publication in clinical studies ( volume 4) - |
| Active substance: CICLOPIROX |
| Study summary document link (including results): Ciclopirox STUDY 307.xls |
| View full study record |
| Document reference: 24126 |
| Study title: Clinical/Statistical report for ciclopirox olamine (Loprox, HOE 296) protocole 304- a double-blind multicenter parallel group study comparing ciclopirox olamine cream 1% and the vehicle, cream baste in subjects with cutaneous candiasis - Huberto Bogaert et al.- No date - Publication in clinical studies (volume 5) - |
| Active substance: CICLOPIROX |
| Study summary document link (including results): CICLOPIROX STUDY Protocol 304.xls |
| View full study record |
| Document reference: 24144 |
| Study title: Report on a double -blind study with HOE 296 cream versus vehicle in the treatment of dematophytose - T. Fredriksson et al. - 1981 - Publication in clinical studies (volume 6) - |
| Active substance: CICLOPIROX |
| Study summary document link (including results): Ciclopirox STUDY Fredriksson.xls |
| View full study record |
| Document reference: 24166 |
| Study title: Report on a double -blind study with HOE296 cream versus vehicle in the treatment of cutaneous candidiasis |
| Active substance: CICLOPIROX |
| Study summary document link (including results): CICLOPIROX STUDY Gip.xls |
| View full study record |
| Document reference: 47983 |
| Study title: Study on the efficacity and tolerabilityof mycoster lacquer (8% ciclopirox) versus Ketoconazole tablets in onychomycoses - Dr. Baran - 1990 - Publication in Clinical trials on ciclopirox 8% nail lacquer - |
| Active substance: CICLOPIROX |
| Study summary document link (including results): CICLOPIROX Report 2.8.xls |
| View full study record |
| Document reference: 24169 |
| Study title: A pilot, open study to evaluate the efficacy and safety of Sandimmun Neoral preventing graft rejection in paediatric ortotopic primary kidney transplant patients. |
| Active substance: CICLOSPORIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24122 |
| Study title: Effect of longer-term (4 month) treatment with cimetidine on the clinical status of children with cystic fibrosis |
| Active substance: CIMETIDINE |
| Study summary document link (including results): Study 334-E-SUI-03-02-GI-D451-Cimetidine_DR Approved.xls |
| View full study record |
| Document reference: 24182 |
| Study title: The effect of oral cimetidine in combination with an antibiotic on the serum excretion rate and clinical severity of disease in acne. |
| Active substance: CIMETIDINE |
| Study summary document link (including results): Study 334-E-UK-15-03-DER-D507-Cimetidine_DR Approved.xls |
| View full study record |
| Document reference: 24184 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Cinnamomum-Homaccord N (drops) [AWB-AT] |
| Active substance: Cinnamomum-Homaccord - Tropfen |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39828 |
| Study title: Ho PT et al A prospective evaluation of ifosfamide-related nephrotoxicity in children and young adults Cancer. 1995 Dec 15;76(12):2557-64Ho PT et al A prospective evaluation of ifosfamide-related nephrotoxicity in children and young adults Cancer. 1995 Dec 15;76(12):2557-64 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24927 |
| Study title: Prospective, Randomized, Third-Party Blind, Study to Compare the Safety and Efficacy of Ciprofloxacin (Sequential IV/PO) with intravenous Ceftazidime and Tobramycin in the Treatment of Pediatric Cystic Fibrosis Patients with Acute Pulmonary Exacerbation. |
| Active substance: CIPROFLOXACIN |
| Study summary document link (including results): 512.pdf |
| View full study record |
| Document reference: 24224 |
| Study title: Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. Ceftazidine/trobamycin in the treatment of acute pulmonary exacerbation. Pediatric Infections Disease Journal 1997; 16(1): 97-105Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. Ceftazidine/trobamycin in the treatment of acute pulmonary exacerbation. Pediatric Infections Disease Journal 1997; 16(1): 97-105 |
| Active substance: CIPROFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24211 |
| Study title: The effect of topical ciprofloxacin on postoperative otorrhea after tympanostomy tube insertion. Zipfel TE, Wood WE, Street DF, Wulffman J, Tipirneni A, Frey C, Gibson WS. Am J Otol. 1999 Jul;20(4):416-20. The effect of topical ciprofloxacin on postoperative otorrhea after tympanostomy tube insertion. Zipfel TE, Wood WE, Street DF, Wulffman J, Tipirneni A, Frey C, Gibson WS. Am J Otol. 1999 Jul;20(4):416-20. |
| Active substance: CIPROFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24233 |
| Study title: Kortmann RD et al Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91Int J Radiat Oncol Biol Phys 2000 Jan 15;46(2):269-79Kortmann RD et al Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91Int J Radiat Oncol Biol Phys 2000 Jan 15;46(2):269-79 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24965 |
| Study title: Bay b 5097 - 500-mg Vaginal Tablets. . Activity and Tolerability of Bay b 5097 500-mg Vaginal Tablets in Single or One-Day Treatment of Vaginal Candida Infections (Open, Mycologically Controlled Study) |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24460 |
| Study title: A study of the efficacy and side effects profile of sustained release acetaminophen pediatric chewable tablets compared to Children's Tylenol chewable tablets in the treatment of febrile children. Mar 1990. |
| Active substance: CODEINE_AND_PARACETAMOL |
| Study summary document link (including results): paracetamol 88-845.pdf |
| View full study record |
| Document reference: 24568 |
| Study title: An Evaluation of the Efficacy and Safety of C-30-13 Cough-Cold Formula in Adult and Pediatric Patients with Symptomatology of Upper Respiratory Infection or Allergic Rhinitis. May 1981. |
| Active substance: CODEINE_AND_PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24576 |
| Study title: Autret−E et al. Comparative efficacy and tolerance of ibuprofen syrup and acetaminophen syrup in children with pyrexia associated with infectious diseases and treated with antibiotics. {EUR−J−CLIN−PHARMACOL}, 1994, Vol/Iss/Pg. 46/3 (197−201) |
| Active substance: CODEINE_AND_PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24530 |
| Study title: Autret−Leca−E et al. Ibuprofen versus paracetamol in pediatric fever: Objective and subjective findings from a randomized, blinded study. {CURR−MED−RES−OPIN}, 2007, Vol /Iss/Pg. 23/9 (2205−2211) |
| Active substance: CODEINE_AND_PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24501 |
| Study title: Carabaño−Aguado−I et al. Antipyretic effectiveness of ibuprofen and paracetamol. {An−Pediatr−Barc}, Feb 2005, vol. 62, no. 2, p. 117−22 |
| Active substance: CODEINE_AND_PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24508 |
| Study title: Cedrato−A−E et al. (Comparison of the antipyretic effect of a single dose of dipyrone, paracetamol and diclofenac resinate. A multicenter clinical trial). {Medicina−B−Aires}, 1989, vol. 49, no. 6, p. 635−6 |
| Active substance: CODEINE_AND_PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24537 |
| Study title: Pharmacokinetics and hemodynamic response after an intravenous bolus injection of clonidine in children |
| Active substance: CLONIDINE |
| Study summary document link (including results): clonidine hydrochloride_U93-0224_synopsis.pdf |
| View full study record |
| Document reference: 47132 |
| Study title: A randomized, parallel, single dose, double-blind, double-dummy multicentre study to assess the antipyretic activity and tolerability of ibuprofen-arginine drops, in comparison to paracetamol in the treatment of likely infectious pediatric fever. |
| Active substance: CLOPERASTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24410 |
| Study title: Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of children with acute otitis media with otorrhea through tympanostomy tubes. Roland PS, Kreisler LS, Reese B, Anon JB, Lanier B, Conroy PJ, Wall GM, Dupre SJ, Potts S, Hogg G, Stroman DW, McLean C. Pediatrics. 2004 Jan;113(1 Pt 1):e40-6. ... |
| Active substance: CIPROFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24226 |
| Study title: Banodkar D, Al-Suwaid A. Colchicine as a novel therapeutic agent in chronic bullous dermatosis of childhood. International Journal of Dermatology 1997; 36:213-216Banodkar D, Al-Suwaid A. Colchicine as a novel therapeutic agent in chronic bullous dermatosis of childhood. International Journal of Dermatology 1997; 36:213-216 |
| Active substance: COLCHICINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24621 |
| Study title: Margolis FJ, Rheames HR, Freshman E et al. Fluoride: ten year prospective study of deciduous teeth and permanent dentition. Am J Dis Child 1975; 129: 794-800. |
| Active substance: COLECALCIFEROL AND SODIUM FLUORIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24633 |
| Study title: Meier C, Woitge HW, Witte K, Lemmer B, Seibel MJ. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial. J Bone Miner Res. 2004 Aug;19(8):1221-30. |
| Active substance: COLECALCIFEROL AND SODIUM FLUORIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24637 |
| Study title: Study Comparing Two Doses of Clarithromycin in Pediatric Tonsillitis |
| Active substance: CLARITHROMYCIN |
| Study summary document link (including results): clarithromycin-aca-grec-2001.pdf |
| View full study record |
| Document reference: 48061 |
| Study title: Treatment of acute pharyngitis in children using clarithromycin under usual clinical practice conditions |
| Active substance: CLARITHROMYCIN |
| Study summary document link (including results): clarithromycin-fran03-004.pdf |
| View full study record |
| Document reference: 48063 |
| Study title: Treatment of lower respiratory tract infections in children by clarithromycin under real practice conditions |
| Active substance: CLARITHROMYCIN |
| Study summary document link (including results): clarithromycin-fran03-005.pdf |
| View full study record |
| Document reference: 48064 |
| Study title: |
| Active substance: CLAVULANIC ACID AND TICARCILLIN |
| Study summary document link (including results): Study BRL-028500-TIM-14 Ticarcillin (Timentin).xlsx |
| View full study record |
| Document reference: 24305 |
| Study title: A pharmacokinetic evaluation of intravenously administered Timentin in paediatric patients. |
| Active substance: CLAVULANIC ACID AND TICARCILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24304 |
| Study title: Comparison of oxatomide and clemastine in the treatment of chronic urticaria. A double blind study.Dermatologica 1985; 171:49-51 Beck et al. |
| Active substance: CLEMASTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24308 |
| Study title: Salmeterol versus sodium cromoglycate for the protection of exercise induced asthma in children - a randomised cross-over study - Zimmermann T, Gulyas A, Bauer CP, Steinkamp G, Trautmann M - 2003 (Eur J Med Res 2003 29;8:428-34) Publication in CES clinical expert statement - Bruno Verdoncq - 28/08/07Salmeterol versus sodium cromoglycate for the protection of exercise induced asthma in children - a randomised cross-over study - Zimmermann T, Gulyas A, Bauer CP, Steinkamp G, Trautmann M - 2003 (Eur J Med Res 2003 29;8:428-34) Publication in CES clinical expert statement - Bruno Verdoncq - 28/08/07 |
| Active substance: CROMOGLICIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24678 |
| Study title: The effect of montelukast versus usual care on health care ressource utilization in children aged 2 to 5 years with asthma - 2004 - Davies GM, Dasbach EJ, Santanello NC, Knorr BA, Bratton DL (Clin. Ther. 2004;26:1895-904) Publication in CES clinical expert statement - Bruno Verdoncq - 28/08/07The effect of montelukast versus usual care on health care ressource utilization in children aged 2 to 5 years with asthma - 2004 - Davies GM, Dasbach EJ, Santanello NC, Knorr BA, Bratton DL (Clin. Ther. 2004;26:1895-904) Publication in CES clinical expert statement - Bruno Verdoncq - 28/08/07 |
| Active substance: CROMOGLICIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24681 |
| Study title: Bibas R, Kalil Gaspar N, Ramos-e-Silva M. Colchicine for dermatologic diseases. Journal of drugs in dermatology 2005; 4:196-204Bibas R, Kalil Gaspar N, Ramos-e-Silva M. Colchicine for dermatologic diseases. Journal of drugs in dermatology 2005; 4:196-204 |
| Active substance: COLCHICINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24614 |
| Study title: Djian B, Santoni A, Guilhou JJ, Meynadier J, Michel B, Aliserai M, Guillot B. Traitement de l'aphtose vulgaire récidivante par la colchicine. La Nouvelle Presse Médicale 1982 ; 11, 51 :3799Djian B, Santoni A, Guilhou JJ, Meynadier J, Michel B, Aliserai M, Guillot B. Traitement de l'aphtose vulgaire récidivante par la colchicine. La Nouvelle Presse Médicale 1982 ; 11, 51 :3799 |
| Active substance: COLCHICINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24584 |
| Study title: Nicolaidou P, Georgouli H, Kotsalis H, Matsinos Y, Papadopoulou A, Fretzayas A, Syriopoulou V, Krikos X, Karantana A, Karpathios T. Effects of anticonvulsant therapy on vitamin D status in children: prospective monitoring study. J Child Neurol. 2006 Mar;21(3):205-9. |
| Active substance: COLECALCIFEROL AND SODIUM FLUORIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24638 |
| Study title: Specker BL, Ho ML, Oestreich A, Yin TA, Shui QM, Chen XC, Tsang RC.Prospective study of vitamin D supplementation and rickets in China.J Pediatr. 1992 May;120(5):733-9. |
| Active substance: COLECALCIFEROL AND SODIUM FLUORIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24639 |
| Study title: Dal Monte A, Leonardi LM, Figura F, Cappozzo A, Marchetti M, De Santis AM. Effects of phosphocreatine administration on muscle strength in man. Gazz. Med. Ital. 1976; 135 (9): 439-448 Dal Monte A, Leonardi LM, Figura F, Cappozzo A, Marchetti M, De Santis AM. Effects of phosphocreatine administration on muscle strength in man. Gazz. Med. Ital. 1976; 135 (9): 439-448 |
| Active substance: CREATINE PHOSPHATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46924 |
| Study title: Ahrendt HJ, Karck U, Pichl T, Mueller T, Ernst, U. The effects of an oestrogen-free, desogestrel-containing oral contraceptive in women with cyclical symptoms: Results from two studies on oestrogen-related symptoms and dysmenorrhoea. Eu J Contraception R |
| Active substance: DESOGESTREL AND ETHINYLESTRADIOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25674 |
| Study title: BILATERAL REGIMEN EFFICACY COMPARISON OF DESOWEN (DESONIDE LOTION) LOTION, 0.05% VS DESOWEN (DESONIDE LOTION) LOTION, 0.05% PLUS CETAPHIL MOISTURIZING CREAM IN PATIENTS WITH ATOPIC DERMATITIS |
| Active substance: DESONIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25676 |
| Study title: EFFICACY AND SAFETY COMPARISON OF DESONIDE 0.05% LOTION (DESOWEN) VERSUS FLUOCORTOLONE 0.5% OINTMENT (ULTRALAN) IN THE TREATMENT OF ATOPIC DERMATITIS |
| Active substance: DESONIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25677 |
| Study title: Pickering DN, Beardsmore CS. Nasal flow limitation in children. Pediatr Pulmonol. 1999 Jan;27(1):32-6.Pickering DN, Beardsmore CS. Nasal flow limitation in children. Pediatr Pulmonol. 1999 Jan;27(1):32-6. |
| Active substance: DESONIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25678 |
| Study title: Efficacy of Esperson (desoxymethasone 0.05% oily cream) in psoriasis, eczema and dermatitis |
| Active substance: DESOXYMETHASONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25679 |
| Study title: A. Glerek - Clinical investigations of the effectiveness and tolerance of the preparation dexamethasone 0.1 % solution - eye drops from the Institute of Ophtalmology, Medical Academy in Katowicw Institute Director: Professor A. Gierek, M.D. |
| Active substance: DEXAMETHASONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25683 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Cutis compositum (injection solution) [AWB-029] |
| Active substance: Cutis compositum-Heel - Ampullen |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39836 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Cutis compositum (ampoules) [AWB-AT] |
| Active substance: Cutis compositum-Heel - Ampullen |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39837 |
| Study title: Jürgens H et al High-dose ifosfamide with mesna uroprotection in Ewing's sarcoma Cancer Chemother Pharmacol. 1989;24 Suppl 1:S40-4Jürgens H et al High-dose ifosfamide with mesna uroprotection in Ewing's sarcoma Cancer Chemother Pharmacol. 1989;24 Suppl 1:S40-4 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24943 |
| Study title: Treatment of painful diabetic neuropathy with capsaicin 0.075%. Scheffler NM, Sheitel PL, Lipton MN. Journal of the American Podiatric Medical Association, Jun 1991, vol. 81, no. 6, p. 288−93.Treatment of painful diabetic neuropathy with capsaicin 0.075%. Scheffler NM, Sheitel PL, Lipton MN. Journal of the American Podiatric Medical Association, Jun 1991, vol. 81, no. 6, p. 288−93. |
| Active substance: CAPSAICIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23226 |
| Study title: Stöhr W et al Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: a report from the Late Effects Surveillance System Pediatr Blood Cancer. 2007 Apr;48(4):447-52Stöhr W et al Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: a report from the Late Effects Surveillance System Pediatr Blood Cancer. 2007 Apr;48(4):447-52 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25137 |
| Study title: Zielinska E et al Role of GSTM1, GSTP1, and GSTT1 gene polymorphism in ifosfamide metabolism affecting neurotoxicity and nephrotoxicity in children J Pediatr Hematol Oncol. 2005 Nov;27(11):582-9Zielinska E et al Role of GSTM1, GSTP1, and GSTT1 gene polymorphism in ifosfamide metabolism affecting neurotoxicity and nephrotoxicity in children J Pediatr Hematol Oncol. 2005 Nov;27(11):582-9 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25178 |
| Study title: Pediatr Med Chir. 1999 May-Jun;21(3):129-33. IT Evaluation of diosmectite in acute diarrhea in children. Milocco C, Bolis A, Rizzo V, Suprani T, Cerasoli G, Marani M, Pocecco M |
| Active substance: DIOSMECTITE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26170 |
| Study title: Immunotherapy in children with allergic asthma: Effect on bronchial hyperreactivity and pharmacotherapy |
| Active substance: Felis domesticus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40001 |
| Study title: A multicenter, open-label, single-dose study of the safety, tolerability and pharmacokinetics of felodipine in pediatric subjects. |
| Active substance: FELODIPINE |
| Study summary document link (including results): US No. 235 (SH-FEH-0025) CSR Synopsis.pdf |
| View full study record |
| Document reference: 27020 |
| Study title: A multicenter, open-label, single-dose study of the safety, tolerability and pharmacokinetics of felodipine in pediatric subjects |
| Active substance: FELODIPINE |
| Study summary document link (including results): US No. 235 (SH-FEH-0025) CSR Synopsis.pdf |
| View full study record |
| Document reference: 27023 |
| Study title: AN 15447711 Medline 20070101. TI Cyproheptadine's antiserotonin effects are responsible for its antimigraine activity. SO Headache, {Headache}, Oct 2004, vol. 44, no. 9, p. 935, ISSN: 0017-8748. AU Lehrer-Joel-F. CM Comment on: Headache. 2004 Mar; 44(3):230-7. YR 2004.AN 15447711 Medline 20070101. TI Cyproheptadine's antiserotonin effects are responsible for its antimigraine activity. SO Headache, {Headache}, Oct 2004, vol. 44, no. 9, p. 935, ISSN: 0017-8748. AU Lehrer-Joel-F. CM Comment on: Headache. 2004 Mar; 44(3):230-7. YR 2004. |
| Active substance: CYPROHEPTADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25236 |
| Study title: BAY b 5097 Spray Efficacy and Tolerance in Dermatomycoses. Open, Mycologically Controlled Study |
| Active substance: CYPROTERONE + ETHINYLESTRADIOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25270 |
| Study title: Multicenter, double-blind, randomized parallel group study on efficacy of 0.035 mg ethinylestradiol / 2 mg cyproterone acetate and of 0.035 mg ethinylestradiol / 2 mg cyproterone acetate in combination with 10 mg cyproterone acetate in comparison to triphasic ethinylestradiol / norgestimate over 6 cycles in women with acne papulopustulosa |
| Active substance: CYPROTERONE + ETHINYLESTRADIOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25269 |
| Study title: Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group. |
| Active substance: DACTINOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25367 |
| Study title: Controlled assessment of the effects of deflazacort hemisuccinate and methylprednisolone hemisuccinate in patients with acute bronchial asthma - McDermott J and Marsden J - 1 June 1995 - Report in the Clinical Documentation Deflazacort injectable 60 mg and 300mg vials - 06/1995 |
| Active substance: DEFLAZACORT |
| Study summary document link (including results): Deflazacort STUDY MMD01.xls |
| View full study record |
| Document reference: 25637 |
| Study title: Treatment of acute bronchial asthma comparison between epinephrine (injections - subcutaneous) and fenoterol (inhalation). |
| Active substance: FENOTEROL |
| Study summary document link (including results): Fenoterol hydrobromide_U84-0556_synopsis.pdf |
| View full study record |
| Document reference: 27088 |
| Study title: Meyler, W.J. et al: The effect of dantrolene sodium in relation to blood levels in spastic patients after prolonged administration; J. Neurol. Neurosurg. Psychiatry 44, 334-339 (1981)Meyler, W.J. et al: The effect of dantrolene sodium in relation to blood levels in spastic patients after prolonged administration; J. Neurol. Neurosurg. Psychiatry 44, 334-339 (1981) |
| Active substance: DANTROLENE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25528 |
| Study title: Trimethoprim-polymyxin B ophthalmic solution in treatment of surface ocular bacterial infections. Nozik RA, Smolin G, Knowlton G, Austin R. Ann Ophthalmol. 1985 Dec;17(12):746-8. Trimethoprim-polymyxin B ophthalmic solution in treatment of surface ocular bacterial infections. Nozik RA, Smolin G, Knowlton G, Austin R. Ann Ophthalmol. 1985 Dec;17(12):746-8. |
| Active substance: DEXAMETHASONE AND NEOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25748 |
| Study title: A comparison of ciprofloxacin and tobramycin in bacterial conjunctivitis in children.Gross RD, Hoffman RO, Lindsay RN. Clin Pediatr (Phila). 1997 Aug;36(8):435-44 Comment in: Clin Pediatr (Phila). 1997 Aug;36(8):445-8. PMID: 9272317. A comparison of ciprofloxacin and tobramycin in bacterial conjunctivitis in children.Gross RD, Hoffman RO, Lindsay RN. Clin Pediatr (Phila). 1997 Aug;36(8):435-44 Comment in: Clin Pediatr (Phila). 1997 Aug;36(8):445-8. PMID: 9272317. |
| Active substance: DEXAMETHASONE AND TOBRAMYCIN |
| Study summary document link (including results): Comparison of ciprofloxacin and tobramycin in bacterial conj.pdf |
| View full study record |
| Document reference: 25753 |
| Study title: Paul IM et al. Effect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents. Arch Pediatr Adolesc Med 2007; 161(12):1140-1146Paul IM et al. Effect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents. Arch Pediatr Adolesc Med 2007; 161(12):1140-1146 |
| Active substance: DEXTROMETHOPRHAN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25800 |
| Study title: Yoder KE et al. Child assessment of dextromethorphan, diphenhydramine, and placebo for nocturnal cough due to upper respiratory infection. Clin Pediatr 2006; 45(7):633-640Yoder KE et al. Child assessment of dextromethorphan, diphenhydramine, and placebo for nocturnal cough due to upper respiratory infection. Clin Pediatr 2006; 45(7):633-640 |
| Active substance: DEXTROMETHOPRHAN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25788 |
| Study title: Lee PCL et al. Antitussive efficacy of dextromethorphan in cough associated with acute upper respiratory tract infection. J Pharm Pharmacol 2000; 52(9):1137-42Lee PCL et al. Antitussive efficacy of dextromethorphan in cough associated with acute upper respiratory tract infection. J Pharm Pharmacol 2000; 52(9):1137-42 |
| Active substance: DEXTROMETHOPRHAN AND PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25804 |
| Study title: Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study). |
| Active substance: DACTINOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25431 |
| Study title: Prognostic factors in patients with localized Ewing's sarcoma: the effect on survival of actual received drug dose intensity and of histologic response to induction therapy. |
| Active substance: DACTINOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25432 |
| Study title: Rarity of surgical complications after postchemotherapy nephrectomy for nephroblastoma. Experience of the International Society of Paediatric Oncology-Trial and Study 'SIOP-9'. International Society of Paediatric Oncology Nephroblastoma Trial and Study Committee. |
| Active substance: DACTINOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25439 |
| Study title: Cander B, et all.The effectiveness of analgesics in traumatic injuries of the extremities. Adv Ther. 2005 Sep-Oct;22(5):462-6.Cander B, et all.The effectiveness of analgesics in traumatic injuries of the extremities. Adv Ther. 2005 Sep-Oct;22(5):462-6. |
| Active substance: DICLOFENAC |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25979 |
| Study title: Cander B, et all.The effectiveness of analgesics in traumatic injuries of the extremities. Adv Ther. 2005 Sep-Oct;22(5):462-6.Cander B, et all.The effectiveness of analgesics in traumatic injuries of the extremities. Adv Ther. 2005 Sep-Oct;22(5):462-6. |
| Active substance: DICLOFENAC |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25990 |
| Study title: Rossi R et al Development of ifosfamide-induced nephrotoxicity: prospective follow-up in 75 Patients Med Pediatr Oncol. 1999 Mar;32(3):177-82Rossi R et al Development of ifosfamide-induced nephrotoxicity: prospective follow-up in 75 Patients Med Pediatr Oncol. 1999 Mar;32(3):177-82 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25091 |
| Study title: Rossi R et al Unilateral nephrectomy and cisplatin as risk factors of ifosfamide-inducednephrotoxicity: analysis of 120 patients J Clin Oncol. 1994 Jan;12(1):159-65Rossi R et al Unilateral nephrectomy and cisplatin as risk factors of ifosfamide-inducednephrotoxicity: analysis of 120 patients J Clin Oncol. 1994 Jan;12(1):159-65 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25094 |
| Study title: Sackmann-Muriel F et al. Hodgkin disease in children: results of a prospective randomized trial in a single institution in Argentina. Med Pediatr Oncol. 1997 Dec;29(6):544-52.Sackmann-Muriel F et al. Hodgkin disease in children: results of a prospective randomized trial in a single institution in Argentina. Med Pediatr Oncol. 1997 Dec;29(6):544-52. |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25096 |
| Study title: Paul IM et al. Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics 2004; 114(1):85-90 Paul IM et al. Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics 2004; 114(1):85-90 |
| Active substance: DEXTROMETHOPRHAN AND PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25803 |
| Study title: Effects of long-term maintenance therapy with a new glucocorticoid, deflazacort, on mineral metabolism and statural growth - Balsan S, Lenoir G, Steru D, Bourdeau A and Grimberg R - 1987 - Report (reference 82) in the Clinical Documentation Deflazacort 6 mg tablets April 1991 - |
| Active substance: DEFLAZACORT |
| Study summary document link (including results): Deflazacort STUDY report Balsan.xls |
| View full study record |
| Document reference: 25643 |
| Study title: Estimate of the potency ratio between DL 458 IT and prednisone in patients with rheumatoid arthritis using a direct biological test - Schiavetti L - 5 November 1975 - Report (reference 33) in the Clinical Documentation Deflazacort 6 mg tablets April 1991 - |
| Active substance: DEFLAZACORT |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25641 |
| Study title: In vitro and ex vivo effects of different corticosteroids on polymorphonuclear leukocyte functions - Marcolongo R, Lalumera M, Calabria A and Imbimbo B - 1984 - Report (reference 47) in the Clinical Documentation Defalzacort 6 mg tablets April 1991 - |
| Active substance: DEFLAZACORT |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25642 |
| Study title: Post-marketing surveillance study:retrospective data collection Novo-Helisen® oral – preparations for mite allergy Report for PEI (renewal of marketing authorisation, PSUR) prepared Age of patients: 6 – 80 Years |
| Active substance: DERMAPHAGOITES FARINAE AND DERMAPHAGOITES PTERONYSSIMUS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25646 |
| Study title: Retrospective Analysis about hypersensitation with NHD Mites, Allergologie, Jahrgang 17, Heft 4, S. 154-15 Age of patients: 9-81 Years, 494 Patients |
| Active substance: DERMAPHAGOITES FARINAE AND DERMAPHAGOITES PTERONYSSIMUS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25647 |
| Study title: A controlled dose-response study of immunotherapy with standardized, partially purified extract of house dust mite: Clinical efficacy and side effects |
| Active substance: DERMATOPHAGIODES PTERONYSSIMUS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25651 |
| Study title: Immunotherapy in children with allergic asthma: Effect on bronchial hyperreactivity and pharmacotherapy |
| Active substance: DERMATOPHAGIODES PTERONYSSIMUS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25650 |
| Study title: COMPARATIVE DOUBLE-BLIND STUDY WITH DICLOFENAC POTASSIUM DROPS VS BENZYDAMINE, COMBINED WITH AN ANTIBIOTIC, IN CHILDREN WITH UPPER RESPIRATORY TRACT INFECTIONSCOMPARATIVE DOUBLE-BLIND STUDY WITH DICLOFENAC POTASSIUM DROPS VS BENZYDAMINE, COMBINED WITH AN ANTIBIOTIC, IN CHILDREN WITH UPPER RESPIRATORY TRACT INFECTIONS |
| Active substance: DICLOFENAC |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26025 |
| Study title: Southeast Asian J Trop Med Public Health. 1994 Mar;25(1):157-62. Control randomized study of rehydration/rehydration with dioctahedral smectite in ambulatory Thai infants with acute diarrhea. Lexomboon U, Harikul S, Lortholary O |
| Active substance: DIOSMECTITE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26172 |
| Study title: Electrocardiographic Findings in Patients with Diphenhydramine Overdose, Zareba, W., Am. J. Cardiol. 1997; 80: 1168-1173Electrocardiographic Findings in Patients with Diphenhydramine Overdose, Zareba, W., Am. J. Cardiol. 1997; 80: 1168-1173 |
| Active substance: DIPHENHYDRAMINE AND GUAIFENESIN AND L-MENTHOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26175 |
| Study title: Russo−R−M, Gururaj−V−J, Allen−J−E. The effectiveness of diphenhydramine HCI in pediatric sleep disorders. Journal of clinical pharmacology, {J−Clin−Pharmacol}, May−Jun 1976, vol. 16, no. 5−6, p. 284−8.Russo−R−M, Gururaj−V−J, Allen−J−E. The effectiveness of diphenhydramine HCI in pediatric sleep disorders. Journal of clinical pharmacology, {J−Clin−Pharmacol}, May−Jun 1976, vol. 16, no. 5−6, p. 284−8. |
| Active substance: DIPHENHYDRAMINE AND GUAIFENESIN AND L-MENTHOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26177 |
| Study title: Kuhn−J−J, Hendley−J−O, Adams−K−F, Clark−J−W, Gwaltney−J−M−Jr. Antitussive effect of guaifenesin in young adults with natural colds. Objective and subjective assessment. Chest, {Chest}, Dec 1982, vol. 82, no. 6, p. 713−8.Kuhn−J−J, Hendley−J−O, Adams−K−F, Clark−J−W, Gwaltney−J−M−Jr. Antitussive effect of guaifenesin in young adults with natural colds. Objective and subjective assessment. Chest, {Chest}, Dec 1982, vol. 82, no. 6, p. 713−8. |
| Active substance: DIPHENHYDRAMINE AND MENTHOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26181 |
| Study title: Pujet−J−C, Keddad−K, Sévenier−F, Jolivet−Landreau−I. Comparative study of two antitussive drugs in the treatment of acute dry cough of infectious origin (prospective, randomized, single blind study). Thérapie, {Therapie}, Sep−Oct 2002, vol. 57, no. 5, p. 457−63.Pujet−J−C, Keddad−K, Sévenier−F, Jolivet−Landreau−I. Comparative study of two antitussive drugs in the treatment of acute dry cough of infectious origin (prospective, randomized, single blind study). Thérapie, {Therapie}, Sep−Oct 2002, vol. 57, no. 5, p. 457−63. |
| Active substance: DIPHENHYDRAMINE AND MENTHOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26182 |
| Study title: Child assessment of dextromethorphan, diphenhydramine, and placebo for nocturnal cough due to upper respiratory infection. Yoder KE, Shaffer ML, La Tournous SJ, Paul IM. Clin Pediatr (Phila). 2006 Sep;45(7):633-40.Child assessment of dextromethorphan, diphenhydramine, and placebo for nocturnal cough due to upper respiratory infection. Yoder KE, Shaffer ML, La Tournous SJ, Paul IM. Clin Pediatr (Phila). 2006 Sep;45(7):633-40. |
| Active substance: DIPHENHYDRAMINE_OR DIPHENHYDRAMINE AND CHLORHEXIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26202 |
| Study title: Sackmann-Muriel F et al. Hodgkin disease in children: results of a prospective randomized trial in a single institution in Argentina. Med Pediatr Oncol. 1997 Dec;29(6):544-52.Sackmann-Muriel F et al. Hodgkin disease in children: results of a prospective randomized trial in a single institution in Argentina. Med Pediatr Oncol. 1997 Dec;29(6):544-52. |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25097 |
| Study title: AN 17388752 Medline 20070507. TI The effect of a first-generation antihistamine on sputum viscoelasticity in cystic fibrosis. SO Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine, {J-Aerosol-Med}, Spring 2007, vol. 20, no. 1, p. 45-9, ISSN: 0894-2684.AN 17388752 Medline 20070507. TI The effect of a first-generation antihistamine on sputum viscoelasticity in cystic fibrosis. SO Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine, {J-Aerosol-Med}, Spring 2007, vol. 20, no. 1, p. 45-9, ISSN: 0894-2684. |
| Active substance: CYPROHEPTADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25186 |
| Study title: AN 17388752 Medline 20070507. TI The effect of a first-generation antihistamine on sputum viscoelasticity in cystic fibrosis. SO Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine, {J-Aerosol-Med}, Spring 2007, vol. 20, no. 1, p. 45-9, ISSN: 0894-2684.AN 17388752 Medline 20070507. TI The effect of a first-generation antihistamine on sputum viscoelasticity in cystic fibrosis. SO Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine, {J-Aerosol-Med}, Spring 2007, vol. 20, no. 1, p. 45-9, ISSN: 0894-2684. |
| Active substance: CYPROHEPTADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25240 |
| Study title: AN 1974155671 19740101. TI Effect of cyproheptadine on weight gain among convalescing children. AU Yap-L-C. IN Cent. Luzon Chapter, Philippine Ped. Soc., Manila, Philippines. SO Philippine Journal of Pediatrics {PHILIPP-J-PEDIATR}, 1973, Vol/Iss /Pg. 22/2 (60-69). YR 1973.AN 1974155671 19740101. TI Effect of cyproheptadine on weight gain among convalescing children. AU Yap-L-C. IN Cent. Luzon Chapter, Philippine Ped. Soc., Manila, Philippines. SO Philippine Journal of Pediatrics {PHILIPP-J-PEDIATR}, 1973, Vol/Iss /Pg. 22/2 (60-69). YR 1973. |
| Active substance: CYPROHEPTADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25242 |
| Study title: Torres Valdivieso MJ et al Ifosfamide-induced renal tubular defect Med Pediatr Oncol. 1994;22(2):144-6Torres Valdivieso MJ et al Ifosfamide-induced renal tubular defect Med Pediatr Oncol. 1994;22(2):144-6 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25147 |
| Study title: Adriamycin, bleomycin, DIC, CCNU, and prednisone (ABDIC) chemotherapy in MOPP-resistant Hodgkin disease. Cancer, 46; 2349-55 - Rodgers - 1980 - Publication in the dossier Dacarbazine injectable 100 and 200 mg - Data on human (dossier B) - |
| Active substance: DACARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25274 |
| Study title: Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamide. Cancer. 30; 6:1632-38 - Gottlieb - Dec 1972 - Publication in the dossier Dacarbazine injectable 100 and 200 mg - Data on human (dossier B) - |
| Active substance: DACARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25275 |
| Study title: Eight drug combination chemotherapy (MOPP and ABDV) and local radiotherapy for advanced Hodgkins' disease. Cancer Treat rep. 60; 1217-23 - Case - 1976 - Publication in the dossier Dacarbazine injectable 100 and 200 mg - Data on human (dossier B) - |
| Active substance: DACARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25278 |
| Study title: A prospective, randomized, national trial for treatment of ovarian cancer: the role of chemotherapy and external irradiation. |
| Active substance: DACTINOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25281 |
| Study title: Mann JR et al, The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity, J Clin Oncol. 2000 Nov 15;18(22):3809-18, Mann JR et al, The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity, J Clin Oncol. 2000 Nov 15;18(22):3809-18, |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24999 |
| Study title: Mann JR et al, UKCCSG's germ cell tumour (GCT) studies: improving outcome for children with malignant extracranial non-gonadal tumours--carboplatin, etoposide, and bleomycin, are effective and less toxic than previous regimens. United Kingdom Children's Cancer Study Group, Med Pediatr Oncol. 1998 Apr;30(4):217-27Mann JR et al, UKCCSG's germ cell tumour (GCT) studies: improving outcome for children with malignant extracranial non-gonadal tumours--carboplatin, etoposide, and bleomycin, are effective and less toxic than previous regimens. United Kingdom Children's Cancer Study Group, Med Pediatr Oncol. 1998 Apr;30(4):217-27 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25000 |
| Study title: Assessment of the effect of 2.5 mg and 5 mg Th 1165a Linctus in school children compared with placebo. |
| Active substance: FENOTEROL |
| Study summary document link (including results): Fenoterol hydrobromide_U75-0098_synopsis.pdf |
| View full study record |
| Document reference: 27047 |
| Study title: Assessment of the therapeutic effect and tolerance of Th 1165a Linctus in 12 infants and 12 school children at doses of 3 x 1.25 mg and 3 x 2.5 mg. |
| Active substance: FENOTEROL |
| Study summary document link (including results): Fenoterol hydrobromide_U75-0261_synopsis.pdf |
| View full study record |
| Document reference: 27048 |
| Study title: Assessment of the therapeutic effect of Th 1165a-linctus with several days' administration in infants. |
| Active substance: FENOTEROL |
| Study summary document link (including results): Fenoterol hydrobromide_U76-0088_synopsis.pdf |
| View full study record |
| Document reference: 27030 |
| Study title: Assessment of therapeutic effect and tolerance of Th 1165a suppositories after repeated administration in infants and school children. |
| Active substance: FENOTEROL |
| Study summary document link (including results): Fenoterol hydrobromide_U76-0080_synopsis.pdf |
| View full study record |
| Document reference: 27054 |
| Study title: AN 1975042349 19750101. TI Effect of a combination of DL carnitine and cyproheptadine on weight gain of anorexic children. AU Rodrigues-V-R. N Div. Ped., Osp. Univ., Oporto, Port Iugal. SO Gazzetta Medica Italiana {GAZZ-MED-ITAL}, 1974, Vol/Iss/Pg. 133/3 (107-109). YR 1974.AN 1975042349 19750101. TI Effect of a combination of DL carnitine and cyproheptadine on weight gain of anorexic children. AU Rodrigues-V-R. N Div. Ped., Osp. Univ., Oporto, Port Iugal. SO Gazzetta Medica Italiana {GAZZ-MED-ITAL}, 1974, Vol/Iss/Pg. 133/3 (107-109). YR 1974. |
| Active substance: CYPROHEPTADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25243 |
| Study title: Ploetz J. et al:Inhibitory Effect of Dantrolene on the Rise of Serum-Ck Activity After Combined Use of Halothane and Succinylcholine in Man; Anaesthesist 30 (7), 338-342 (1981)Ploetz J. et al:Inhibitory Effect of Dantrolene on the Rise of Serum-Ck Activity After Combined Use of Halothane and Succinylcholine in Man; Anaesthesist 30 (7), 338-342 (1981) |
| Active substance: DANTROLENE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25545 |
| Study title: Open study on the effect of dapiprazole eye-drops on the reversal of cyclopentolate Induced mydriasis; |
| Active substance: DAPIPRAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25554 |
| Study title: AN 00334082 Medline 20070101. TI Primary acquired cold urticaria. Double-blind comparative study of treatment with cyproheptadine, chlorpheniramine, and placebo. SO Archives of dermatology, {Arch-Dermatol}, Oct 1977, vol. 113, no. 10, p. 1375-7, ISSN: 0003-987X. AU Wanderer-A-A, St-Pierre-J-P, Ellis-E-F. YR 1977.AN 00334082 Medline 20070101. TI Primary acquired cold urticaria. Double-blind comparative study of treatment with cyproheptadine, chlorpheniramine, and placebo. SO Archives of dermatology, {Arch-Dermatol}, Oct 1977, vol. 113, no. 10, p. 1375-7, ISSN: 0003-987X. AU Wanderer-A-A, St-Pierre-J-P, Ellis-E-F. YR 1977. |
| Active substance: CYPROHEPTADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25189 |
| Study title: AN 00632998 Medline 20070101. TI The effect of cyproheptadine and human growth hormone on adrenocortical function in children with hypopituitarism. SO The Journal of pediatrics, {J-Pediatr}, Mar 1978, vol. 92, no. 3, p. 491-4, ISSN: 0022-3476. AU Kenien-A-G, Zeidner-D-L, Pang-S-J, Becker-D-J, Postellon-D-C, Gutai- J-P, Foley-T-P-Jr, Drash-A-L. YR 1978.AN 00632998 Medline 20070101. TI The effect of cyproheptadine and human growth hormone on adrenocortical function in children with hypopituitarism. SO The Journal of pediatrics, {J-Pediatr}, Mar 1978, vol. 92, no. 3, p. 491-4, ISSN: 0022-3476. AU Kenien-A-G, Zeidner-D-L, Pang-S-J, Becker-D-J, Postellon-D-C, Gutai- J-P, Foley-T-P-Jr, Drash-A-L. YR 1978. |
| Active substance: CYPROHEPTADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25191 |
| Study title: Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group. |
| Active substance: DACTINOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25482 |
| Study title: Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study. |
| Active substance: DACTINOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25492 |
| Study title: Studio di valutazione dell'efficacia del dapiprazolo collirio nella preparazione del paziente da sottoporre all'intervento di yag-laser iridotomia e argon-laser trabeculoplastica |
| Active substance: DAPIPRAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25560 |
| Study title: Acute and Long-Term Cytogenetic Effects of Childhood Cancer Chemotherapy and Radiotherapy - Miller, RG., Hill, R.B., Nichols, W. W., et al. - 1978 (Cancer Res. 38 (10), 3241) - Publication in the dos. Allemand jan 1981 - Acute and Long-Term Cytogenetic Effects of Childhood Cancer Chemotherapy and Radiotherapy - Miller, RG., Hill, R.B., Nichols, W. W., et al. - 1978 (Cancer Res. 38 (10), 3241) - Publication in the dos. Allemand jan 1981 - |
| Active substance: DAUNORUBICIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25562 |
| Study title: A prospective randomized study of medications after silicone intubation. Liu D. Ophthalmic Surg Lasers. 1996 Jun;27(6):434-7. A prospective randomized study of medications after silicone intubation. Liu D. Ophthalmic Surg Lasers. 1996 Jun;27(6):434-7. |
| Active substance: DEXAMETHASONE NEOMYCIN POLYMYXIN B |
| Study summary document link (including results): A prospective randomized study of medications.pdf |
| View full study record |
| Document reference: 25763 |
| Study title: Yoder KE et al. Child assessment of dextromethorphan, diphenhydramine, and placebo for nocturnal cough due to upper respiratory infection. Clin Pediatr 2006; 45(7):633-640Yoder KE et al. Child assessment of dextromethorphan, diphenhydramine, and placebo for nocturnal cough due to upper respiratory infection. Clin Pediatr 2006; 45(7):633-640 |
| Active substance: DEXTROMETHOPRHAN AND PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25801 |
| Study title: Long-term survival rates with various chemotherapeutic regimens in stages III and IV ovarian adenocarcinoma. The influence of optimum pretreatment surgical resection. |
| Active substance: DACTINOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25389 |
| Study title: Metastatic soft tissue sarcomas in children - A remaining challenge for paediatric oncology. A retrospective multicenter study from the Polish Pediatric Solid Tumors' Group |
| Active substance: DACTINOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25391 |
| Study title: Diphenhydramine toxicity in a child with varicella. A case report, McGann, K.P., J. Fam. Pract. 1992 August; 35(2): 210, 213-214Diphenhydramine toxicity in a child with varicella. A case report, McGann, K.P., J. Fam. Pract. 1992 August; 35(2): 210, 213-214 |
| Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25701 |
| Study title: Diphenhydramine toxicity in three children with varicella-zoster infection, Chan, C.Y.J., The Annals of Pharmacotherapy 1991; 25(2): 130-132Diphenhydramine toxicity in three children with varicella-zoster infection, Chan, C.Y.J., The Annals of Pharmacotherapy 1991; 25(2): 130-132 |
| Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25696 |
| Study title: Effects of fexofenadine, diphenhydramine, and placebo on performance of the test of variables of attention, Mansfield, L., Ann. Allergy Asthma Immunol. 2003 May; 90(5): 554-559Effects of fexofenadine, diphenhydramine, and placebo on performance of the test of variables of attention, Mansfield, L., Ann. Allergy Asthma Immunol. 2003 May; 90(5): 554-559 |
| Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25710 |
| Study title: Electrocardiographic Findings in Patients with Diphenhydramine Overdose, Zareba, W., Am. J. Cardiol. 1997; 80: 1168-1173Electrocardiographic Findings in Patients with Diphenhydramine Overdose, Zareba, W., Am. J. Cardiol. 1997; 80: 1168-1173 |
| Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25724 |
| Study title: Massive diphenhydramine poisoning resulting in a wide-complex tachycardia: successful treatment with sodium bicarbonate, Clark, R.F., Ann. Emerg. Med. 1992; 21: 318-320Massive diphenhydramine poisoning resulting in a wide-complex tachycardia: successful treatment with sodium bicarbonate, Clark, R.F., Ann. Emerg. Med. 1992; 21: 318-320 |
| Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25697 |
| Study title: Experience with dexibuprofen in infantile surgery; Alberto Abdulhadi; Pren.Med.Argent. 2001,88,499-503Experience with dexibuprofen in infantile surgery; Alberto Abdulhadi; Pren.Med.Argent. 2001,88,499-503 |
| Active substance: DEXIBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25773 |
| Study title: Studie mit Hydro-, Lipo- und Sebonorm Cordes |
| Active substance: DEXIBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25774 |
| Study title: Santini G et al. VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group. J Clin Oncol. 1998 Aug;16(8):2796-802Santini G et al. VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group. J Clin Oncol. 1998 Aug;16(8):2796-802 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25104 |
| Study title: Santini G et al. VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group. J Clin Oncol. 1998 Aug;16(8):2796-802.Santini G et al. VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group. J Clin Oncol. 1998 Aug;16(8):2796-802. |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25105 |
| Study title: Sawamura Y et al Combined irradiation and chemotherapy using ifosfamide, cisplatin, and etoposide for children with medulloblastoma/posterior fossa primitive neuroectodermal tumor--results of a pilot study Neurol Med Chir (Tokyo). 1996 Sep;36(9):632-8Sawamura Y et al Combined irradiation and chemotherapy using ifosfamide, cisplatin, and etoposide for children with medulloblastoma/posterior fossa primitive neuroectodermal tumor--results of a pilot study Neurol Med Chir (Tokyo). 1996 Sep;36(9):632-8 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25106 |
| Study title: Lee PCL et al. Antitussive efficacy of dextromethorphan in cough associated with acute upper respiratory tract infection. J Pharm Pharmacol 2000; 52(9):1137-42Lee PCL et al. Antitussive efficacy of dextromethorphan in cough associated with acute upper respiratory tract infection. J Pharm Pharmacol 2000; 52(9):1137-42 |
| Active substance: DEXTROMETHORPHAN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25840 |
| Study title: Paul IM et al. Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics 2004; 114(1):85-90 Paul IM et al. Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics 2004; 114(1):85-90 |
| Active substance: DEXTROMETHORPHAN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25839 |
| Study title: Post-marketing surveillance study:retrospective data collection Novo-Helisen® oral – preparations for mite allergy Report for PEI (renewal of marketing authorisation, PSUR) prepared Age of patients: 6 – 80 Years |
| Active substance: DERMATOPHAGIODES PTERONYSSIMUS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25655 |
| Study title: Retrospective Analysis about hypersensitation with NHD Mites, Allergologie, Jahrgang 17, Heft 4, S. 154-159 Age of patients: 9-81 Years, 494 Patients |
| Active substance: Dermatophagoides farinae;Dermatophagoides pteronyssinus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39840 |
| Study title: A controlled dose-response study of immunotherapy with standardized, partially purified extract of house dust mite: Clinical efficacy and side effects |
| Active substance: Dermatophagoides pteronyssinus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39844 |
| Study title: Immunotherapy in children with allergic asthma: Effect on bronchial hyperreactivity and pharmacotherapy |
| Active substance: Dermatophagoides pteronyssinus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39843 |
| Study title: A Placebo Controlled Study of the Efficacy and Safety of Desloratadine vs. Fexofenadine 180mg in the Treatment of Subjects with Symptomatic Seasonal Allergic Rhinitis (SAR). |
| Active substance: desloratadine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39694 |
| Study title: A Placebo Controlled Study of the Efficacy and Safety of Desloratadine vs. Fexofenadine 180mg in the Treatment of Subjects with Symptomatic Seasonal Allergic Rhinitis (SAR). |
| Active substance: desloratadine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39695 |
| Study title: A RANDOMIZED DOUBLE-BLIND COMPARISON OF THE EFFECTS OF DESLORATADINE VS DIPHENHYDRAMINE VS PLACEBO ON MANAGERIAL PERFORMANCE IN SUBJECTS WITH SEASONAL ALLERGIC RHINITIS. |
| Active substance: desloratadine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39693 |
| Study title: Over-the counter topical antipruritic agents are commonly recommended by office-based physicians: an analysis of US practice patterns, Duque, M.I., J. Dermatol. Treatment 2004; 15: 185-188Over-the counter topical antipruritic agents are commonly recommended by office-based physicians: an analysis of US practice patterns, Duque, M.I., J. Dermatol. Treatment 2004; 15: 185-188 |
| Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25698 |
| Study title: Paulides M et al Thyroid function in paediatric and young adult patients after sarcoma therapy: a report from the Late Effects Surveillance System Clin Endocrinol (Oxf). 2007 May;66(5):727-31. Epub 2007 Mar 23Paulides M et al Thyroid function in paediatric and young adult patients after sarcoma therapy: a report from the Late Effects Surveillance System Clin Endocrinol (Oxf). 2007 May;66(5):727-31. Epub 2007 Mar 23 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25056 |
| Study title: Shamberger RC et al. Ewing sarcoma of the rib: results of an intergroup study with analysis of outcome by timing of resection. J Thorac Cardiovasc Surg. 2000 Jun;119(6):1154-61Shamberger RC et al. Ewing sarcoma of the rib: results of an intergroup study with analysis of outcome by timing of resection. J Thorac Cardiovasc Surg. 2000 Jun;119(6):1154-61 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25114 |
| Study title: AN 1978059362 19780101. TI Effects of fenfluramine and cyproheptadine on growth hormone secretion. AU Mazzi-C, Riva-L-P, Bernasconi-D. IN Div. Endocrinol. Med. Costituz., Osp. Gen. Prov. S. Antonio Abate, Gallarate, Italy. SO Annales d'Endocrinologie {ANN-ENDOCRINOL}, 1976, Vol/Iss/Pg. 37/5 (355-364). YR 1976.AN 1978059362 19780101. TI Effects of fenfluramine and cyproheptadine on growth hormone secretion. AU Mazzi-C, Riva-L-P, Bernasconi-D. IN Div. Endocrinol. Med. Costituz., Osp. Gen. Prov. S. Antonio Abate, Gallarate, Italy. SO Annales d'Endocrinologie {ANN-ENDOCRINOL}, 1976, Vol/Iss/Pg. 37/5 (355-364). YR 1976. |
| Active substance: CYPROHEPTADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25249 |
| Study title: AN 1978076994 19780101. TI Effect of cyproheptadine (CPH), a serotonin antagonist, on adrenocortical function in hypopituitary children. AU Kenien-A-C, Zeidner-D-L, Becker-D-J, et-al. IN Univ. Pittsburgh, Sch. Med., Pittsburgh, Pa., United States. SO Pediatric Research {PEDIATR-RES}, 1977, Vol/Iss/Pg. 11/4 (No.333). YR 1977.AN 1978076994 19780101. TI Effect of cyproheptadine (CPH), a serotonin antagonist, on adrenocortical function in hypopituitary children. AU Kenien-A-C, Zeidner-D-L, Becker-D-J, et-al. IN Univ. Pittsburgh, Sch. Med., Pittsburgh, Pa., United States. SO Pediatric Research {PEDIATR-RES}, 1977, Vol/Iss/Pg. 11/4 (No.333). YR 1977. |
| Active substance: CYPROHEPTADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25250 |
| Study title: A six month study evaluating the suppression of wheal and flare following multiple dose administration of desloratadine (5 mg) to subjects with allergic conditions |
| Active substance: desloratadine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39689 |
| Study title: AN 1978208704 19780101. TI Effect of cyproheptadine (CPH), a serotonin antagonist, on adrenocortical function in children with hypopituitarism. AU Kenien-A-G, Zeidner-D-L, Becker-D-J, et-al. SO Journal of Pediatrics {J-PEDIATR}, 1977, Vol/Iss/Pg. 91/5 (836). YR 1977.AN 1978208704 19780101. TI Effect of cyproheptadine (CPH), a serotonin antagonist, on adrenocortical function in children with hypopituitarism. AU Kenien-A-G, Zeidner-D-L, Becker-D-J, et-al. SO Journal of Pediatrics {J-PEDIATR}, 1977, Vol/Iss/Pg. 91/5 (836). YR 1977. |
| Active substance: CYPROHEPTADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25252 |
| Study title: AN 1978307339 19780101. TI Toxicity of cyproheptadine side effects and accidental overdosage. AU Von-Muehlendahl-K-E, Krienke-E-G. IN Beratungsstelle Vergiftungserscheinungen, Univ. Kinderklin., Freie Univ., Berlin, Germany. SO Monatsschrift fur Kinderheilkunde {MONATSSCHR-KINDERHEILKD}, 1978, Vol/Iss/Pg. 126/3 (123-126). YR 1978.AN 1978307339 19780101. TI Toxicity of cyproheptadine side effects and accidental overdosage. AU Von-Muehlendahl-K-E, Krienke-E-G. IN Beratungsstelle Vergiftungserscheinungen, Univ. Kinderklin., Freie Univ., Berlin, Germany. SO Monatsschrift fur Kinderheilkunde {MONATSSCHR-KINDERHEILKD}, 1978, Vol/Iss/Pg. 126/3 (123-126). YR 1978. |
| Active substance: CYPROHEPTADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25254 |
| Study title: AN 1981016945 19810101. TI Effect of cyproheptadine on steroid hormone excretion by a young girl with Cushing's syndrome. AU Seaton-B, Johnston-P-G-B. IN Zool. Soc., London NW1 4RY, United Kingdom. SO Journal of Endocrinology {J-ENDOCRINOL}, 1980, Vol/Iss/Pg. 87/2 (61p-62p). YR 1980.AN 1981016945 19810101. TI Effect of cyproheptadine on steroid hormone excretion by a young girl with Cushing's syndrome. AU Seaton-B, Johnston-P-G-B. IN Zool. Soc., London NW1 4RY, United Kingdom. SO Journal of Endocrinology {J-ENDOCRINOL}, 1980, Vol/Iss/Pg. 87/2 (61p-62p). YR 1980. |
| Active substance: CYPROHEPTADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25255 |
| Study title: Chemotherapy of sarcomas-a perspective. |
| Active substance: DACTINOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25311 |
| Study title: Clinical trial of CCLSG OS-88 protocol in childhood osteosarcoma: Selection of postoperative chemotherapy based on histological tumor response. |
| Active substance: DACTINOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25315 |
| Study title: AN 01424795 Medline 20070101. TI Aquagenic urticaria. SO Cutis; cutaneous medicine for the practitioner, {Cutis}, Oct 1992, vol. 50, no. 4, p. 283-4, ISSN: 0011-4162. AU Parker-R-K, Crowe-M-J, Guin-J-D. IN Department of Dermatology, University of Arkansas for Medical Sciences, Little Rock 72205. YR 1992.AN 01424795 Medline 20070101. TI Aquagenic urticaria. SO Cutis; cutaneous medicine for the practitioner, {Cutis}, Oct 1992, vol. 50, no. 4, p. 283-4, ISSN: 0011-4162. AU Parker-R-K, Crowe-M-J, Guin-J-D. IN Department of Dermatology, University of Arkansas for Medical Sciences, Little Rock 72205. YR 1992. |
| Active substance: CYPROHEPTADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25194 |
| Study title: AN 02596504 Medline 20070101. TI Nocturnal rhythm of growth hormone in Duchenne patients: effect of different doses of mazindol and/or cyproheptadine. SO American journal of medical genetics, {Am-J-Med-Genet}, Aug 1989, vol. 33, no. 4, p. 457-67, ISSN: 0148-7299. AU Zatz-M, Rapaport-D, Pavanello-R-C, Rocha-J-M, Vainzof-M, Nicolau-W. IN Departamento de Biologia, Universidade de Sao Paulo, Brazil. YR 1989.AN 02596504 Medline 20070101. TI Nocturnal rhythm of growth hormone in Duchenne patients: effect of different doses of mazindol and/or cyproheptadine. SO American journal of medical genetics, {Am-J-Med-Genet}, Aug 1989, vol. 33, no. 4, p. 457-67, ISSN: 0148-7299. AU Zatz-M, Rapaport-D, Pavanello-R-C, Rocha-J-M, Vainzof-M, Nicolau-W. IN Departamento de Biologia, Univer... |
| Active substance: CYPROHEPTADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25195 |
| Study title: AN 04581629 Medline 20070101. TI (Effects of cyproheptadine in a sample of children in the second age of childhood). TT Osservazioni sugli effetti determinati dalla ciproeptadina su un campione di bambini della seconda infanzia. SO Minerva pediatrica, {Minerva-Pediatr}, 26 May 1973, vol. 25, no. 19, p. 833-43, ISSN: 0026-4946. AU Di-Marzo-G. YR 1973.AN 04581629 Medline 20070101. TI (Effects of cyproheptadine in a sample of children in the second age of childhood). TT Osservazioni sugli effetti determinati dalla ciproeptadina su un campione di bambini della seconda infanzia. SO Minerva pediatrica, {Minerva-Pediatr}, 26 May 1973, vol. 25, no. 19, p. 833-43, ISSN: 0026-4946. AU Di-Marzo-G. YR 1973. |
| Active substance: CYPROHEPTADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25198 |
| Study title: Treatment of unresectable or metastatic pediatric soft tissue sarcomas with surgery, irradiation, and chemotherapy: a Pediatric Oncology Group study. |
| Active substance: DACTINOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25500 |
| Study title: Value of postchemotherapy bioptical verification of complete clinical remission in previously incompletely resected (stage I and II pT3) malignant mesenchymal tumors in children: International Society of Pediatric Oncology 1984 Malignant Mesenchymal Tumors Study. |
| Active substance: DACTINOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25509 |
| Study title: Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease. |
| Active substance: DACTINOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25512 |
| Study title: A phase II clinical trial of cardioprotection with cardioxane (ICRF-187) in pediatric patients with Osteosarcoma. 30th November 1999. |
| Active substance: DEXPANTHENOL AND POLYVINYLALCOHOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25776 |
| Study title: EC-CX-012. A phase II clinical trial of cardioprotection with cardioxane (ICRF-187) in pediatric patients with Osteosarcoma. 30th November 1999. |
| Active substance: DEXRAZONANE |
| Study summary document link (including results): Cardioxane EC-CX-012.xls |
| View full study record |
| Document reference: 25777 |
| Study title: An Evaluation of the Efficacy and Safety of C-30-13 Cough-Cold Formula in Adult and Pediatric Patients with Symptomatology of Upper Respiratory Infection or Allergic Rhinitis. May 1981.An Evaluation of the Efficacy and Safety of C-30-13 Cough-Cold Formula in Adult and Pediatric Patients with Symptomatology of Upper Respiratory Infection or Allergic Rhinitis. May 1981. |
| Active substance: DEXTROMETHOPRHAN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25798 |
| Study title: Jawad SS & Eccles R. Effect of pseudoephedrine on nasal airflow in patients with nasal congestion associated with common cold. Rhinology 1998; 36(2):73-6Jawad SS & Eccles R. Effect of pseudoephedrine on nasal airflow in patients with nasal congestion associated with common cold. Rhinology 1998; 36(2):73-6 |
| Active substance: DEXTROMETHOPRHAN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25782 |
| Study title: Lee PCL et al. Antitussive efficacy of dextromethorphan in cough associated with acute upper respiratory tract infection. J Pharm Pharmacol 2000; 52(9):1137-42 |
| Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25882 |
| Study title: Nephrotoxicity of cisplatin and carboplatin in sarcoma patients: A report from the late effects surveillance system |
| Active substance: DACTINOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25400 |
| Study title: Paratesticular rhabdomyosarcoma in children. Is retroperitoneal lymphadenectomy necessary in disease limited to the scrotum? |
| Active substance: DACTINOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25407 |
| Study title: Preliminary evaluation of the toxicity and effectiveness of chemotherapy using the VAB-6 protocol in the treatment of non-seminoma of the testis |
| Active substance: DACTINOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25420 |
| Study title: A comparison of danazol and placebo in the treatment of adult idiopathic gynecomastia : results of a prospective study in 55 patients - Investigators : David J Jones et al. - Ann. R. Coll. Surg. Engl. 1990, 72(5), 296-298 - Publication CER - No author - 06/1996A comparison of danazol and placebo in the treatment of adult idiopathic gynecomastia : results of a prospective study in 55 patients - Investigators : David J Jones et al. - Ann. R. Coll. Surg. Engl. 1990, 72(5), 296-298 - Publication CER - No author - 06/1996 |
| Active substance: DANAZOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25515 |
| Study title: Danazol prophylaxis for delivery in hereditary angioneurotic oedema (HAE) - Investigators : AN Boulos et al. - Br. J. Obstet. Gynaecol., 1994, 101(12), Dec. 1094-1095 - Publication in CER - No author - 06/1996 -Danazol prophylaxis for delivery in hereditary angioneurotic oedema (HAE) - Investigators : AN Boulos et al. - Br. J. Obstet. Gynaecol., 1994, 101(12), Dec. 1094-1095 - Publication in CER - No author - 06/1996 - |
| Active substance: DANAZOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25523 |
| Study title: Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication, Ito, S., Am. J. Obstet. Gynecol. 1993; 168: 1393-1399Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication, Ito, S., Am. J. Obstet. Gynecol. 1993; 168: 1393-1399 |
| Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25707 |
| Study title: Sedation and performance impairment of diphenhydramine and secon-generation antihistamines: a meta-analysis, Bender, B.G., J. Allergy Clin. Immunol. 2003; 111:770-776Sedation and performance impairment of diphenhydramine and secon-generation antihistamines: a meta-analysis, Bender, B.G., J. Allergy Clin. Immunol. 2003; 111:770-776 |
| Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25694 |
| Study title: Suspected fatal diphenhydramine toxicity by application to the skin of an infant with varicella, Maswoswe, J.J., Hosp. Pharm. 1994 January; 29: 26, 28-30, 53Suspected fatal diphenhydramine toxicity by application to the skin of an infant with varicella, Maswoswe, J.J., Hosp. Pharm. 1994 January; 29: 26, 28-30, 53 |
| Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25711 |
| Study title: Topically induced diphenhydramine toxicity, Reilly, J.F. Jr., J. Emerg. Med. 1990; 8(1): 59-61Topically induced diphenhydramine toxicity, Reilly, J.F. Jr., J. Emerg. Med. 1990; 8(1): 59-61 |
| Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25718 |
| Study title: Toxic encephalopathy caused by topically applied diphenhydramine, Filloux, F., J. Pediatr. 1986, 108: 1018-1020Toxic encephalopathy caused by topically applied diphenhydramine, Filloux, F., J. Pediatr. 1986, 108: 1018-1020 |
| Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25699 |
| Study title: Lee PCL et al. Antitussive efficacy of dextromethorphan in cough associated with acute upper respiratory tract infection. J Pharm Pharmacol 2000; 52(9):1137-42Lee PCL et al. Antitussive efficacy of dextromethorphan in cough associated with acute upper respiratory tract infection. J Pharm Pharmacol 2000; 52(9):1137-42 |
| Active substance: DEXTROMETHOPRHAN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25791 |
| Study title: Paul IM et al. Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics 2004; 114(1):85-90 Paul IM et al. Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics 2004; 114(1):85-90 |
| Active substance: DEXTROMETHOPRHAN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25790 |
| Study title: Paul IM et al. Effect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents. Arch Pediatr Adolesc Med 2007; 161(12):1140-1146Paul IM et al. Effect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents. Arch Pediatr Adolesc Med 2007; 161(12):1140-1146 |
| Active substance: DEXTROMETHOPRHAN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25787 |
| Study title: Shamberger RC et al. Ewing sarcoma of the rib: results of an intergroup study with analysis of outcome by timing of resection. J Thorac Cardiovasc Surg. 2000 Jun;119(6):1154-61Shamberger RC et al. Ewing sarcoma of the rib: results of an intergroup study with analysis of outcome by timing of resection. J Thorac Cardiovasc Surg. 2000 Jun;119(6):1154-61 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25115 |
| Study title: Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication, Ito, S., Am. J. Obstet. Gynecol. 1993; 168: 1393-1399 |
| Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25860 |
| Study title: A Study of the Effect of Desloratadine (5mg) and Pseudoephedrine 240 mg on Nasal Stuffiness in Subjects with Seasonal Allergic Rhinitis |
| Active substance: desloratadine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39690 |
| Study title: AN OPEN LABEL TASTE EVALUATION OF DESLORATADINE 2.5MG RAPIDLY DISINTEGRATING TABLETS IN 6-11 YEAR OLD SUBJECTS WHO HAVE TAKEN CLARITIN REDITABS. |
| Active substance: desloratadine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39691 |
| Study title: AN OPEN LABEL TASTE EVALUATION OF DESLORATADINE 2.5MG RAPIDLY DISINTEGRATING TABLETS IN 6-11 YEAR OLD SUBJECTS WHO HAVE NEVER TAKEN CLARITIN REDITABS. |
| Active substance: desloratadine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39692 |
| Study title: Evaluation of the efficacy and the safety of DCL syrup in childhood atopic dermatitis. |
| Active substance: desloratadine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39698 |
| Study title: Long-term efficacy of Minirin Spray in monosymptomatic nocturnal enuresis: a multicenter comparative double-blind crossover placebo-controlled study with double-blind continuation of effective treatment for 3 to 6 months. |
| Active substance: DESMOPRESSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25664 |
| Study title: Ahrendt HJ, Karck U, Pichl T, Mueller T, Ernst, U. The effects of an oestrogen-free, desogestrel-containing oral contraceptive in women with cyclical symptoms: Results from two studies on oestrogen-related symptoms and dysmenorrhoea. Eu J Contraception R |
| Active substance: DESOGESTREL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25669 |
| Study title: Clinical Expert Statement of Framycetin sulfate containing formulations. - Dr R. Ohlrogge - 7 Apr.2004 |
| Active substance: DEXAMETHASONE AND FRAMYCETIN AND GRAMICIDIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25726 |
| Study title: Pinkerton CR et al, Response rates in relapsed Wilms' tumor. A need for new effective agents, Cancer. 1991 Feb 1;67(3):567-71Pinkerton CR et al, Response rates in relapsed Wilms' tumor. A need for new effective agents, Cancer. 1991 Feb 1;67(3):567-71 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25067 |
| Study title: Pratt CB et al. Role of adjuvant chemotherapy in the treatment of surgically resected pediatric non-rhabdomyosarcomatous soft tissue sarcomas: A Pediatric Oncology Group Study. J Clin Oncol. 1999 Apr;17(4):1219Pratt CB et al. Role of adjuvant chemotherapy in the treatment of surgically resected pediatric non-rhabdomyosarcomatous soft tissue sarcomas: A Pediatric Oncology Group Study. J Clin Oncol. 1999 Apr;17(4):1219 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25074 |
| Study title: Pratt CB et al. Treatment of unresectable or metastatic pediatric soft tissue sarcomas withsurgery, irradiation, and chemotherapy: a Pediatric Oncology Group study. Med Pediatr Oncol. 1998 Apr;30(4):201-9.Pratt CB et al. Treatment of unresectable or metastatic pediatric soft tissue sarcomas withsurgery, irradiation, and chemotherapy: a Pediatric Oncology Group study. Med Pediatr Oncol. 1998 Apr;30(4):201-9. |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25075 |
| Study title: Skinner R et al Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. United Kingdom Children's Cancer Study Group Br J Cancer. 2000 May;82(10):1636-45Skinner R et al Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. United Kingdom Children's Cancer Study Group Br J Cancer. 2000 May;82(10):1636-45 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25124 |
| Study title: Congenital sacrococcygeal primitive neuroectodermal tumor. |
| Active substance: DACTINOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25326 |
| Study title: Meyers PA et al Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate J Clin Oncol. 2005 Mar 20;23(9):2004-11Meyers PA et al Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate J Clin Oncol. 2005 Mar 20;23(9):2004-11 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25020 |
| Study title: Miser JS et al Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group Pediatr Blood Cancer. 2007 Dec;49(7):894-900Miser JS et al Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group Pediatr Blood Cancer. 2007 Dec;49(7):894-900 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25028 |
| Study title: AN 07416909 Medline 20070101. TI Effects of cyproheptadine on symptoms and attitudes in anorexia nervosa. SO Archives of general psychiatry, {Arch-Gen-Psychiatry}, Sep 1980, vol. 37, no. 9, p. 1083, ISSN: 0003-990X. AU Goldberg-S-C, Eckert-E-D, Halmi-K-A, Casper-R-C, Davis-J-M, Roper-M. YR 1980.AN 07416909 Medline 20070101. TI Effects of cyproheptadine on symptoms and attitudes in anorexia nervosa. SO Archives of general psychiatry, {Arch-Gen-Psychiatry}, Sep 1980, vol. 37, no. 9, p. 1083, ISSN: 0003-990X. AU Goldberg-S-C, Eckert-E-D, Halmi-K-A, Casper-R-C, Davis-J-M, Roper-M. YR 1980. |
| Active substance: CYPROHEPTADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25224 |
| Study title: AN 1999012398 19990205. TI A study of the effect of cyproheptadine on gait in hemiplegic children. AU Khodadadeh-S, Holstein-H, Purushotthaman-S, Patrick-J, IN S. Khodadadeh, Department of Computer Science, University of Wales, Aberystwyth, Ceredigion SY23 3DB, United Kingdom. SO Gait and Posture {GAIT-POSTURE}, 1998, Vol/Iss/Pg. 8/3 (205-213), ISSN: 0966-6362. YR 1998.AN 1999012398 19990205. TI A study of the effect of cyproheptadine on gait in hemiplegic children. AU Khodadadeh-S, Holstein-H, Purushotthaman-S, Patrick-J, IN S. Khodadadeh, Department of Computer Science, University of Wales, Aberystwyth, Ceredigion SY23 3DB, United Kingdom. SO Gait and Posture {GAIT-POSTURE}, 1998, Vol/Iss/Pg. 8/3 (205-213), ISSN: 0966-6362. YR 1998. |
| Active substance: CYPROHEPTADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25261 |
| Study title: Effect of duration of treatment on treatment outcome for patients with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group. |
| Active substance: DACTINOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25337 |
| Study title: Effectiveness of chemotherapy of advanced forms of neuroblastoma in children according to the program of the RWPG |
| Active substance: DACTINOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25338 |
| Study title: Effectiveness of rhGM-CSF mouthwashes on chemotherapy induced mucositis in childhood solid tumors |
| Active substance: DACTINOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25339 |
| Study title: Effects of different magnitudes of cyclic stretch on Na+-K+-ATPase in skeletal muscle cells in vitro. |
| Active substance: DACTINOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25340 |
| Study title: Effects of oral glutamine supplementation on children with solid tumors receiving chemotherapy |
| Active substance: DACTINOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25341 |
| Study title: A comparative study on the effects of L5458 and prednisone on the electrolyte and nitrogen balance and on oral glucose tolerance - Acocella G and Marchetti M - 5 March 1973 - Report in the Clinical Documentation Deflazacort 6 mg tablets April 1991 - |
| Active substance: DEFLAZACORT |
| Study summary document link (including results): Deflazacort STUDY report 57.xls |
| View full study record |
| Document reference: 25626 |
| Study title: AN 09374568 Medline 20070101. TI Effective prophylactic therapy for cyclic vomiting syndrome in children using amitriptyline or cyproheptadine. SO Pediatrics, {Pediatrics}, Dec 1997, vol. 100, no. 6, p. 977-81, ISSN: 1098-4275. AU Andersen-J-M, Sugerman-K-S, Lockhart-J-R, Weinberg-W-A. IN Department of Pediatrics, University of Texas Southwestern Medical Center and Children's Medical Center, Dallas, Texas, USA. YR 1997.AN 09374568 Medline 20070101. TI Effective prophylactic therapy for cyclic vomiting syndrome in children using amitriptyline or cyproheptadine. SO Pediatrics, {Pediatrics}, Dec 1997, vol. 100, no. 6, p. 977-81, ISSN: 1098-4275. AU Andersen-J-M, Sugerman-K-S, Lockhart-J-R, Weinberg-W-A. IN Department of Pediatrics, University of Texas Southwe... |
| Active substance: CYPROHEPTADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25229 |
| Study title: Danazol Therapy in Gynaecomastia ; Recent Experience and Indications for Therapy - Investigators : R Buckle - Postgrad. Med. J., 1979, 55(Suppl.5), 71-78 - Publication in CER - No author - 06/1996Danazol Therapy in Gynaecomastia ; Recent Experience and Indications for Therapy - Investigators : R Buckle - Postgrad. Med. J., 1979, 55(Suppl.5), 71-78 - Publication in CER - No author - 06/1996 |
| Active substance: DANAZOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25516 |
| Study title: Gynaecomastia of Puberty. Final Report on Drug Therapy with Danazol - Investigators : Dr Wolf Beck - Kinderarzt, 1986, 17(12), 1732-1738 - Publication in CER - No author - 06/1996Gynaecomastia of Puberty. Final Report on Drug Therapy with Danazol - Investigators : Dr Wolf Beck - Kinderarzt, 1986, 17(12), 1732-1738 - Publication in CER - No author - 06/1996 |
| Active substance: DANAZOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25517 |
| Study title: Long-term treatment of hereditary angiodema (HAE) with attenuated andogens : a survey of 13 years experience - Investigators : Marco Circadi et al. - J. Allergy Clin. Immunol. 1991, 87(4), Apr., 768-773 - Publication in CER - No author -06/1996Long-term treatment of hereditary angiodema (HAE) with attenuated andogens : a survey of 13 years experience - Investigators : Marco Circadi et al. - J. Allergy Clin. Immunol. 1991, 87(4), Apr., 768-773 - Publication in CER - No author -06/1996 |
| Active substance: DANAZOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25518 |
| Study title: Steroid Treatment of Puberty Gyneacomastia with Danazol - Investigators : W Swoboda and al. - P. Wein. Med. Woshr, 1981, (5), 127-132 - Publication in CER - No author - 06/1996Steroid Treatment of Puberty Gyneacomastia with Danazol - Investigators : W Swoboda and al. - P. Wein. Med. Woshr, 1981, (5), 127-132 - Publication in CER - No author - 06/1996 |
| Active substance: DANAZOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25519 |
| Study title: Treatment Dysfunctional Uterine Bleeding with Danazol - Investigators : IS Fraser - Aust N.Z.J. Obstet. Gynaecol., 1985, 25. Aug., 224-226 - Publication in CER - No author - 06/1996Treatment Dysfunctional Uterine Bleeding with Danazol - Investigators : IS Fraser - Aust N.Z.J. Obstet. Gynaecol., 1985, 25. Aug., 224-226 - Publication in CER - No author - 06/1996 |
| Active substance: DANAZOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25520 |
| Study title: Use of Danazol in hysteroscopic surgery for menorrhagia - Investigators : Milton H Goldrath - J. Reprod. Med., 1990, 35(1 suppl.), Janv. 91-96 - Publication CER - No author - No date -Use of Danazol in hysteroscopic surgery for menorrhagia - Investigators : Milton H Goldrath - J. Reprod. Med., 1990, 35(1 suppl.), Janv. 91-96 - Publication CER - No author - No date - |
| Active substance: DANAZOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25521 |
| Study title: Variable effects of Danazol on Endometriosis at 4 low-dose Levels - Investigators : Dr W. P. Dmowsky et al. - Obstetrics and Gynaecology, 1982, 59(4), 408-415 - Publication in CER - No author - 06/1996Variable effects of Danazol on Endometriosis at 4 low-dose Levels - Investigators : Dr W. P. Dmowsky et al. - Obstetrics and Gynaecology, 1982, 59(4), 408-415 - Publication in CER - No author - 06/1996 |
| Active substance: DANAZOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25522 |
| Study title: Adams, E.D.:Controlled evaluation of the Safety and Effectiveness of Dantrolene Sodium in a Pediatric Population;Adams, E.D.:Controlled evaluation of the Safety and Effectiveness of Dantrolene Sodium in a Pediatric Population; |
| Active substance: DANTROLENE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25546 |
| Study title: Adams, E.D.:Double-blind controlled evaluation of the Safety and Effectiveness of Dantrolene Sodium in relieving Spasticity Associated with Dystonia in Children with Cerebral Palsy;Adams, E.D.:Double-blind controlled evaluation of the Safety and Effectiveness of Dantrolene Sodium in relieving Spasticity Associated with Dystonia in Children with Cerebral Palsy; |
| Active substance: DANTROLENE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25547 |
| Study title: Paul IM et al. Effect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents. Arch Pediatr Adolesc Med 2007; 161(12):1140-1146Paul IM et al. Effect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents. Arch Pediatr Adolesc Med 2007; 161(12):1140-1146 |
| Active substance: DEXTROMETHORPHAN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25836 |
| Study title: Yoder KE et al. Child assessment of dextromethorphan, diphenhydramine, and placebo for nocturnal cough due to upper respiratory infection. Clin Pediatr 2006; 45(7):633-640Yoder KE et al. Child assessment of dextromethorphan, diphenhydramine, and placebo for nocturnal cough due to upper respiratory infection. Clin Pediatr 2006; 45(7):633-640 |
| Active substance: DEXTROMETHORPHAN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25837 |
| Study title: An overall summary of the tolerability and safety of deflazacort injectable - McDermott J and Marsden J - 25 May 1995 - Report in the Clinical Documentation Deflazacort injectable 60 mg and 300 mg vials June 1995 - |
| Active substance: DEFLAZACORT |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25629 |
| Study title: Comparative clinical study of the effects of two glucocorticoids (deflazacort and prednisone) in the combined chemotherapy of Hodgkin's lymphoma and chronic lymphocytic leukaemia - Tura S - 30 June 1979 - Report (reference 39) in the Clinical Documentation Deflazacort 6mg tablet - 04/1991 - |
| Active substance: DEFLAZACORT |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25633 |
| Study title: Comparative clinical trial of the effects of two steroids (DL 458 IT and prednisone) in acute and chronic skin diseases - Longhi A - 20 December 1978 - Report in the Clinical Documentation Deflazacort 6 mg tablets April 1991 - |
| Active substance: DEFLAZACORT |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25634 |
| Study title: Comparison of growth retarding effects induced by two different glucocorticoids in prepubertal sick children: an interim long-term analysis - AicardiG et al. - 1991 - Publication in Consolidated responses to questions Deflazacort 6 mg and 30 mg March 1992 - |
| Active substance: DEFLAZACORT |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25636 |
| Study title: Langer T et al Effects Working Group in the German Society of Pediatric Oncology and Hematology. Late effects surveillance system for sarcoma patients Pediatr Blood Cancer. 2004 Apr;42(4):373-9Langer T et al Effects Working Group in the German Society of Pediatric Oncology and Hematology. Late effects surveillance system for sarcoma patients Pediatr Blood Cancer. 2004 Apr;42(4):373-9 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24980 |
| Study title: Studio clinico aperto sulla efficacia e tollerabilità dell'associazione 2-4 dicloro benzil alcool, amilmetacresolo e vitamina C (open clinical study on the effectiveness and tolerability of a combination of DCBA, AMC and vit C) |
| Active substance: DICHLOROBENZYL-ALCOHOL AND LIDOCAINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25953 |
| Study title: A prospective study comparing oral sodium phosphate solution to a bowel cleansing preparation with nutrition food package in children. A prospective study comparing oral sodium phosphate solution to a bowel cleansing preparation with nutrition food package in children. |
| Active substance: DICLOFENAC |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25993 |
| Study title: Bertorini, T.E. et al:Effect of dantrolene in Duchenne Muscular Dystrophy; Musc. Nerve. 14, 503-507 (1991Bertorini, T.E. et al:Effect of dantrolene in Duchenne Muscular Dystrophy; Musc. Nerve. 14, 503-507 (1991 |
| Active substance: DANTROLENE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25524 |
| Study title: Diphenhydramine toxicity in three children with varicella-zoster infection, Chan, C.Y.J., The Annals of Pharmacotherapy 1991; 25(2): 130-132 |
| Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25849 |
| Study title: Effects of fexofenadine, diphenhydramine, and placebo on performance of the test of variables of attention, Mansfield, L., Ann. Allergy Asthma Immunol. 2003 May; 90(5): 554-559 |
| Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25863 |
| Study title: Electrocardiographic Findings in Patients with Diphenhydramine Overdose, Zareba, W., Am. J. Cardiol. 1997; 80: 1168-1173 |
| Active substance: Dextromethorphan + Diphenhydramine + L-Menthol |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25877 |
| Study title: Uncontrolled, open-label; case series; Antihistaminics with superior effect but less sideKaneko_1967 |
| Active substance: DIMETINDENE |
| Study summary document link (including results): 2011_EMAspreadsheet_Fenistil oral_Kaneko_1967.xls |
| View full study record |
| Document reference: 48157 |
| Study title: Aliment Pharmacol Ther. 2006 Jan 15;23(2):217-27. Meta-analysis: Smectite in the treatment of acute infectious diarrhoea in children. Szajewska H, Dziechciarz P, Mrukowicz J |
| Active substance: DIOSMECTITE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26167 |
| Study title: Efficacy and safety of Smecta in combination with Oral Rehydration in the treatment of acute watery diarrhoea in children. A placebo controlled, randomized, double-blind, parallel groups study. |
| Active substance: DIOSMECTITE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26164 |
| Study title: Efficacy and safety of Smecta in combination with Oral Rehydration in the treatment of acute watery diarrhoea in infants and children. A phase IIIb study, placebo controlled, randomized, double blind, parallel groups, multicenter study. |
| Active substance: DIOSMECTITE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26165 |
| Study title: Efficacy and safety of Smecta in combination with Oral Rehydration in the treatment of acute watery diarrhoea in infants and children. A phase IIIb study, placebo controlled, randomized, double blind, parallel groups, multicenter study. |
| Active substance: DIOSMECTITE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26166 |
| Study title: Emerg Med J. 2006 Jan;23(1):65-6. Review. Best evidence topic report. Smectite for acute diarrhoea in children. Yen ZS, Lai MS |
| Active substance: DIOSMECTITE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26173 |
| Study title: Fortschr Med. 1994 Aug 30;112(24):6p. Placebo-controlled, double-blind clinical trial of smectite in acute pediatric diarrhea. No authors listed |
| Active substance: DIOSMECTITE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26171 |
| Study title: J Pediatr Gastroenterol Nutr. 2001 Jan;32(1):71-5. Smectite in the treatment of acute diarrhea: a nationwide randomized controlled study of the Italian Society of Pediatric Gastroenterology and Hepatology (SIGEP) in collaboration with primary care pediatricians. SIGEP Study Group for Smectite in Acute Diarrhea. Guarino A, Bisceglia M, Castellucci G, Iacono G, Casali LG, Bruzzese E, Musetta A, Greco L; Italian Society of Pediatric Gastroenterology and Hepatology Study Group for Smectite in Acute Diarrhea |
| Active substance: DIOSMECTITE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26169 |
| Study title: Journal of Pediatric Gastroenterology and Nutrition 1993; 17:176-181 Smectite in acute diarrhea in children a double-blind placebo-controlled clinical trial. A.A. Madkour, E.M.H. Madina, O.E.Z. El-Azzouni, M.A. Amer, T.M.K. El-Walili, T. Abbass |
| Active substance: DIOSMECTITE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26168 |
| Study title: Rees JK et al. Dose intensification in acute myeloid leukaemia: greater effectiveness at lower cost. Principal report of the Medical Research Council's AML9 study. MRC Leukaemia in Adults Working Party. Br J Haematol. 1996 Jul;94(1):89-98.Rees JK et al. Dose intensification in acute myeloid leukaemia: greater effectiveness at lower cost. Principal report of the Medical Research Council's AML9 study. MRC Leukaemia in Adults Working Party. Br J Haematol. 1996 Jul;94(1):89-98. |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25079 |
| Study title: Rees JK et al. Dose intensification in acute myeloid leukaemia: greater effectiveness at lower cost. Principal report of the Medical Research Council's AML9 study. MRC Leukaemia in Adults Working Party. Br J Haematol. 1996 Jul;94(1):89-98. Rees JK et al. Dose intensification in acute myeloid leukaemia: greater effectiveness at lower cost. Principal report of the Medical Research Council's AML9 study. MRC Leukaemia in Adults Working Party. Br J Haematol. 1996 Jul;94(1):89-98. |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25080 |
| Study title: Reiter A et al Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients.Results and conclusions of the multicenter trial ALL-BFM 86 Blood. 1994 Nov 1;84(9):3122-33Reiter A et al Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients.Results and conclusions of the multicenter trial ALL-BFM 86 Blood. 1994 Nov 1;84(9):3122-33 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25081 |
| Study title: Reiter A et al Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies J Clin Oncol. 1994 May;12(5):899-908Reiter A et al Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies J Clin Oncol. 1994 May;12(5):899-908 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25083 |
| Study title: TO ASSESS THE EFFICACY AND SAFETY OF FLUCONAZOLE I.V. (+ AMPHOTERICIN B BY ORAL ROUTE) VS. PLACEBO I.V. (+AMPHOTERICIN B BY ORAL ROUTE) TO PREVENT THE ONSET OF INFECTIONS WITH A MYCOTIC ETIOLOGY IN MULTICOLONIZED NEUTROPENIC PATIENTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27825 |
| Study title: TO ASSESS THE EFFICACY AND TOLERATION OF VIBRAMYCINE (DOXYCYCLIN) IN THE TREATMENT OF PATIENTS WITH ACUTE RESPIRATORY TRACT INFECTIONS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27334 |
| Study title: Zuluaga A comparison of oral itraconazole with griseofulvin in the treaement of tinea corporis and tinea cruris. A double-blind study. Clinical summary on R51211, August 1987 (11-64 years, LMD56445)Zuluaga A comparison of oral itraconazole with griseofulvin in the treaement of tinea corporis and tinea cruris. A double-blind study. Clinical summary on R51211, August 1987 (11-64 years, LMD56445) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30787 |
| Study title: |
| Active substance: IVERMECTIN |
| Study summary document link (including results): J21_507_ivermectin.pdf |
| View full study record |
| Document reference: 47780 |
| Study title: A Multiclinic, Double-Blind Study of Ivermectin (MK-933) and Placebo in Patients with Onchocerciasis. |
| Active substance: IVERMECTIN |
| Study summary document link (including results): Stromectol_Ivermectin_519_Synopsis.pdf |
| View full study record |
| Document reference: 30824 |
| Study title: A Single-Blind, Comparative Study of Ivermectin (MK-933) and Placebo on the Effect and Intake and Development of Onchocerca Volvulus Microfilariae in Simulium Sirbanum Fed on Patients with Onchocerciasis. |
| Active substance: IVERMECTIN |
| Study summary document link (including results): Stromectol_Ivermectin_517_Synopsis.pdf |
| View full study record |
| Document reference: 45274 |
| Study title: An Open Study of the Tolerability, Safety, and Efficacy of Single Oral 150 mcg/kg Doses of Ivermectin in Children 5-12 Years of Age with Onchocerciasis. |
| Active substance: IVERMECTIN |
| Study summary document link (including results): Stromectol_Ivermectin_545_Synopsis.pdf |
| View full study record |
| Document reference: 30827 |
| Study title: An Open, Randomized Study of Efficacy, Safety, and Tolerability of Ivermectin Single Dose (One or Two Day Course) vs. Thiabendazole (Three-Day Course) in the Treatment of Patients Infected With Strongyloides Stercoralis |
| Active substance: IVERMECTIN |
| Study summary document link (including results): J17_020_ ivermectin.pdf |
| View full study record |
| Document reference: 47779 |
| Study title: Double-Blind Comparative Studies of Ivermectin, Diethylcarbamazine Citrate and Placebo in Patients with Onchocerciasis. |
| Active substance: IVERMECTIN |
| Study summary document link (including results): Stromectol_Ivermectin_514_Synopsis.pdf |
| View full study record |
| Document reference: 30823 |
| Study title: Open, Randomized Trial in Otherwise Healthy Ambulatory Patients (children) to Compare the Efficacy, Safety, and Tolerability of Ivermectin versus Albendazole in the Treatment of Strongyloidiasis of the Gastrointestinal Tract |
| Active substance: IVERMECTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30820 |
| Study title: Phase III Onchocerciasis - A Single-Blind, Placebo-Controlled Study of the Tolerability, Safety, and Efficacy of Successive Single Oral Doses of Ivermectin (MK-933). Approximately 150 to 220 mcg/kg in Adults with Onchocerciasis . |
| Active substance: IVERMECTIN |
| Study summary document link (including results): Stromectol_Ivermectin_548_Synopsis.pdf |
| View full study record |
| Document reference: 30825 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Kalmia compositum (drops) [AWB-AT] |
| Active substance: Kalmia compositum |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40042 |
| Study title: Non-interventional study on the use of Kanamycin-POS® in children; Küchle H. J., Busse H., Augenerkrankungen im Kindesalter, Thieme Verlag Stuttgart New York 1985 |
| Active substance: KANAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30828 |
| Study title: Infectodiarrstop LGG 2007: Observational post-marketing trial in children |
| Active substance: LACTIC ACID PRODUCING ORGANISMS AND COMBINATIONS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30977 |
| Study title: A Multicenter, Double-Blind, Randomized, Parallel-Group Study Investigating the linical Effect of Combination Montelukast/Loratadine in Patients With Seasonal Allergic Rhinitis Who Have a History of Asthma |
| Active substance: MONTELUKAST |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32416 |
| Study title: A multicenter, double-blind, randomized, placebo-controlled study to assess the clinical effect of montelukast in patients with seasonal allergic rhinitis |
| Active substance: MONTELUKAST |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32417 |
| Study title: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Study Investigating the Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis |
| Active substance: MONTELUKAST |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32419 |
| Study title: DIECKMANN-K, MAURAGE-C, ROLLAND-J-C, RAMPONI-N, JONVILLE-A-P, ET-AL. CHU CLOCHEVILLE, TOURS, FRANCE. TORTICOLLIS AS A SIDE EFFECT OF CISAPRIDE TREATMENT IN AN INFANT. JOURNAL-OF-PEDIATRIC-GASTROENTEROLOGY-AND-NUTRITION (J-PEDIATR- GASTROENTEROL-NUTR). 22: 336-337, APR 1996.DIECKMANN-K, MAURAGE-C, ROLLAND-J-C, RAMPONI-N, JONVILLE-A-P, ET-AL. CHU CLOCHEVILLE, TOURS, FRANCE. TORTICOLLIS AS A SIDE EFFECT OF CISAPRIDE TREATMENT IN AN INFANT. JOURNAL-OF-PEDIATRIC-GASTROENTEROLOGY-AND-NUTRITION (J-PEDIATR- GASTROENTEROL-NUTR). 22: 336-337, APR 1996. |
| Active substance: TRIMEBUTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46755 |
| Study title: AN OPEN NON-COMPARATIVE MULTICENTRE STUDY OF THE EFFICACY AND TOLERATION OF UNASYN (SULTAMICILLIN) ORAL IN THE TREATMENT OF COMMUNITY-ACQUIRED MILD-MODERATE BACTERIAL INFECTIONS IN GENERAL PRACTICE |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43041 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF THE EFFICACY AND TOLERATION OF STM IN THE TREATMENT OF GENERAL BACTERIAL INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42994 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL SULTAMICILLIN (25MG/KG) IN THE TREATMENT OF MILD TO MODERATE TONSILLITIS INFECTIONS BY STREPTOCOCCUS B HEMOLYTIC. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43026 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF UNASYN ORAL (BRAND OF SULTAMICILLIN ) IN VARIOUS INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43049 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF UNASYN ORAL (BRAND OF SULTAMICILLIN) IN VARIOUS INFECTIONS |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42974 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF UNASYN ORAL (BRAND OF SULTAMICILLIN) IN VARIOUS INFECTIONS |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43050 |
| Study title: A double-blind controlled trial of betamethasone dipropionate 0.05% (Diproderm) in comparison with fluocinolone acetonide 0.025% (Synalar) in psoriasis and other steroid-responsive dermatoses. |
| Active substance: FLUOROCINONIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28253 |
| Study title: Corticosteroid-induced glaucoma following treatment of the periorbital region. |
| Active substance: FLUOROCINONIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28251 |
| Study title: Fluocinonide in an adhesive base for treatment of oral lichen planus. A double-blind, placebo-controlled clinical study. |
| Active substance: FLUOROCINONIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28252 |
| Study title: Interval treatment with local corticosteroids and bases. |
| Active substance: FLUOROCINONIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28250 |
| Study title: Topical treatment of alopecia areata--a double blind test using 0.025 per cent and 1.2 per cent fluocinolone acetonide cream. |
| Active substance: FLUOROCINONIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28254 |
| Study title: A prospective study on ocular hypertensive and antiinflammatory response to different dosages of fluorometholone in children. Fan DS, Ng JS, Lam DS. Ophthalmology. 2001 Nov;108(11):1973-7. Comment in: Ophthalmology. 2003 Jun;110(6):1072-3; author reply 1073. PMID: 12799226. |
| Active substance: FLUOROMETHOLONE |
| Study summary document link (including results): A prospective study on ocular hypertensive.pdf |
| View full study record |
| Document reference: 28257 |
| Study title: Efficacy of nedocromil 2% versus fluorometholone 0.1%: a randomised, double masked trial comparing the effects on severe vernal keratoconjunctivitis. Tabbara KF, al-Kharashi SA. Br J Ophthalmol. 1999 Feb;83(2):180-4. |
| Active substance: FLUOROMETHOLONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28258 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF UNASYN ORAL (BRAND OF SULTAMICILLIN) IN VARIOUS INFECTIONS |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43051 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF UNASYN ORAL (BRAND OF SULTAMICILLIN) IN VARIOUS INFECTIONS |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43052 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF UNASYN ORAL (BRAND OF SULTAMICILLIN) IN VARIOUS INFECTIONS |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43053 |
| Study title: Kaopectate: Comparison of the efficacy of Kao-Con, Kaolin, Pectin, Lomitil and Placebo in the treatment of Acute Diarrhea in a Pediatric - Consumer Product Study #291 |
| Active substance: Kaolin, Pectin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40043 |
| Study title: OPEN LABEL RANDOMIZED, PARALLEL-GROUP STUDY TO COMPARE THE NEUROLOGICAL AND METABOLIC STATE OF THE NEW BORN CHILDREN AND THEIR MOTHERS HEMODYNAMIC PARAMETERS AFTER INDUCTION OF ANAESTHESIA FOR CAESARIAN SECTIONS WITH S-(+)- KETAMINE HYDROCHLORIDE (CI-9136) OR A COMBINATION OF S-(+)- KETAMINE HYDROCHLORIDE AND THIOPENTAL SODIUM (CI-653) (CT-9136-423010) |
| Active substance: KETAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30829 |
| Study title: 2% ketoconazole in shampoo for treating seborrheic dermatitits of the scalp: clinical trial at the hospital San Juan De Dios |
| Active substance: KETOCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30838 |
| Study title: A Double-Blind, Placebo- Controlled Study of Ketoconazole 2% Shampoo in the Treatment of Pityriasis Versicolor in Adolescents. (Jun 1999)" |
| Active substance: KETOCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30836 |
| Study title: A new therapeutic way to treat pityriasis versicolor. The use of ketoconazole in a 2% shampoo. |
| Active substance: KETOCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30837 |
| Study title: An open study of 2% ketoconazole shampoo in corticodependent seborrhoeic dermatitis of the scalp |
| Active substance: KETOCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30839 |
| Study title: comparison of 4 concentrations of a ketoconazole shampoo with a placebo shampoo in dandruff and/or seborrheic dermatitits |
| Active substance: KETOCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30832 |
| Study title: Ketoconazole 2 % shampoo in the treatment of dandruff and/or seborrheic dermatitits: a double-blind placebo-controlled study |
| Active substance: KETOCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30833 |
| Study title: Ketoconazole 2 % shampoo in the treatment of seborrhoeic dermatitits: an open multicentre study in Belgium |
| Active substance: KETOCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30834 |
| Study title: Multi-centre (6 centres), randomised, double-blind, placebo-controlled study |
| Active substance: KETOCONAZOLE |
| Study summary document link (including results): LMD124740_Interventional_Ketoconazole.xls |
| View full study record |
| Document reference: 47252 |
| Study title: Multi-centre (8 centres), parallel-group, randomised, double-blind, placebo-controlled clinical study. |
| Active substance: KETOCONAZOLE |
| Study summary document link (including results): LMD139895_Interventional_Ketoconazole.xls |
| View full study record |
| Document reference: 47254 |
| Study title: Open, comparative, cross-over study lasting for 4-weeks. |
| Active substance: KETOCONAZOLE |
| Study summary document link (including results): LMD124799_Interventional_Ketoconazole.xls |
| View full study record |
| Document reference: 47253 |
| Study title: Randomized, doble-blind, placebo-controlled evaluation in the treatment of moderate to severe dandruff |
| Active substance: KETOCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30830 |
| Study title: Schang-J-C, Devroede-G, Pilote-M. Department of Surgery, Faculte de Medecine, Universite de Sherbrooke, Quebec, Canada. Effects of trimebutine on colonic function in patients with chronic idiopathic constipation: evidence for the need of a physiologic rather than clinical selection. Diseases of the colon and rectum, {Dis-Colon-Rectum}, Apr 1993, vol.36, no. 4, p. 330-6, Schang-J-C, Devroede-G, Pilote-M. Department of Surgery, Faculte de Medecine, Universite de Sherbrooke, Quebec, Canada. Effects of trimebutine on colonic function in patients with chronic idiopathic constipation: evidence for the need of a physiologic rather than clinical selection. Diseases of the colon and rectum, {Dis-Colon-Rectum}, Apr 1993, vol.36, no. 4, p. 330-6, |
| Active substance: TRIMEBUTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46757 |
| Study title: A bacteriological study of the middle ear and upper respiratory tract in children with chronic secretory otitis media.Mills et al., Clin Otolaryngol Allied Sci. 1985 Dec;10(6):335-41A bacteriological study of the middle ear and upper respiratory tract in children with chronic secretory otitis media.Mills et al., Clin Otolaryngol Allied Sci. 1985 Dec;10(6):335-41 |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46818 |
| Study title: A clinical and therapeutic study of 29 patients with infantile acne.Cunliffe et al., Br J Dermatol. 2001 Sep;145(3):463-6.A clinical and therapeutic study of 29 patients with infantile acne.Cunliffe et al., Br J Dermatol. 2001 Sep;145(3):463-6. |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46793 |
| Study title: Paediatric nosocomial urinary tract infection at a regional hospital.Orrett et al., Int Urol Nephrol. 1999;31(2):173-9Paediatric nosocomial urinary tract infection at a regional hospital.Orrett et al., Int Urol Nephrol. 1999;31(2):173-9 |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46799 |
| Study title: Positive correlation between the age of patients and the degree of antimicrobial resistance among urinary strains of Escherichia coli.Arstila et al., J Infect. 1994 Jul;29(1):9-16Positive correlation between the age of patients and the degree of antimicrobial resistance among urinary strains of Escherichia coli.Arstila et al., J Infect. 1994 Jul;29(1):9-16 |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46804 |
| Study title: Prenatally diagnosed reflux: a follow-up study.Gordon et al., Br J Urol. 1990 Apr;65(4):407-12Prenatally diagnosed reflux: a follow-up study.Gordon et al., Br J Urol. 1990 Apr;65(4):407-12 |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46809 |
| Study title: Presence of bacteriuria caused by trimethoprim resistant bacteria in patients prescribed antibiotics: multilevel model with practice and individual patient data.Donnan et al., BMJ. 2004 May 29;328(7451):1297Presence of bacteriuria caused by trimethoprim resistant bacteria in patients prescribed antibiotics: multilevel model with practice and individual patient data.Donnan et al., BMJ. 2004 May 29;328(7451):1297 |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46779 |
| Study title: Prevalence of carriage of antimicrobial resistant strains of Streptococcus pneumoniae in primary school children in Hong Kong.Boost MV et al., Epidemiol Infect. 2001 Aug;127(1):49-55Prevalence of carriage of antimicrobial resistant strains of Streptococcus pneumoniae in primary school children in Hong Kong.Boost MV et al., Epidemiol Infect. 2001 Aug;127(1):49-55 |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46792 |
| Study title: Primary vesicoureteral reflux detected in neonates with a history of fetal renal pelvis dilatation: a prospective clinical and imaging study.Ismaili et al., J Pediatr. 2006 Feb;148(2):222-7.Primary vesicoureteral reflux detected in neonates with a history of fetal renal pelvis dilatation: a prospective clinical and imaging study.Ismaili et al., J Pediatr. 2006 Feb;148(2):222-7. |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46774 |
| Study title: Prior trimethoprim use and trimethoprim-resistant urinary tract infection: a nested case–control study with multivariate analysis for other risk factors.Steinke etal., Journal of Antimicrobial Chemotherapy (2001) 47, 781-787Prior trimethoprim use and trimethoprim-resistant urinary tract infection: a nested case–control study with multivariate analysis for other risk factors.Steinke etal., Journal of Antimicrobial Chemotherapy (2001) 47, 781-787 |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46780 |
| Study title: Response to antibiotics of women with symptoms of urinary tract infection but negative dipstick urine test results: double blind randomised controlled trial.Richards et al., BMJ. 2005 Jul 16;331(7509):143. Epub 2005 Jun 22.Response to antibiotics of women with symptoms of urinary tract infection but negative dipstick urine test results: double blind randomised controlled trial.Richards et al., BMJ. 2005 Jul 16;331(7509):143. Epub 2005 Jun 22. |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46777 |
| Study title: Risk factors for the nasopharyngeal carriage of respiratory pathogens by Portuguese children: phenotype and antimicrobial susceptibility of Haemophilus influenzae and Streptococcus pneumoniae.Neto et al., Microb Drug Resist. 2003 Spring;9(1):99-108Risk factors for the nasopharyngeal carriage of respiratory pathogens by Portuguese children: phenotype and antimicrobial susceptibility of Haemophilus influenzae and Streptococcus pneumoniae.Neto et al., Microb Drug Resist. 2003 Spring;9(1):99-108 |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46785 |
| Study title: 5-Fluorouracil and interferon-alpha-2a in advanced colorectal cancer: Results of two treatment schedules. John WJ et al. Cancer. December 22, 1993, 3191-5 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28290 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF UNASYN ORAL (BRAND OF SULTAMICILLIN) IN VARIOUS INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42973 |
| Study title: AN OPEN NON-COMPARATIVE STUDY, Q COMBINATION OF SULBACTAM SODIUM WITH AMPICILLIN IN SERIOUS INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42914 |
| Study title: AN OPEN NONCOMPARATIVE STUDY OF UNASYN ORAL (BRAND OF STM) IN VARIOUS INFECTIONS |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42972 |
| Study title: AN OPEN NONCOMPARATIVE STUDY OF UNASYN ORAL (BRAND OF STM) IN VARIOUS INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42996 |
| Study title: AN OPEN STUDY OF THE EFFICACY AND SAFETY OF SULBACTAM/AMPICILLIN ADMINISTERED PARENTERALLY AND SULTAMICILLIN ADMINISTERED ORALLY IN CHILDHOOD SKELETAL INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42918 |
| Study title: AN OPEN STUDY OF THE EFFICACY AND TOLERANCE OF SULTAMICILLIN IN THE IN THE TREATMENT OF PEDIATRIC PATIENTS WITH CHRONIC OTITIS MEDIA |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43014 |
| Study title: AN OPEN STUDY OF THE SAFETY AND EFFICACY OF ORAL SULTAMICILLIN IN THE TREATMENT OF MILD TO MODERATE UPPER RESPIRATORY TRACT INFECTIONS IN ADULTS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43039 |
| Study title: AN OPEN STUDY OF THE SAFETY AND EFFICACY OF ORAL SULTAMICILLIN IN THE TREATMENT OF MILD TO MODERATE URTI IN ADULTS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43040 |
| Study title: AN OPEN, NON COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF SULTAMICILLIN FOR THE TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS IN CHILDREN. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42995 |
| Study title: CLINICAL EVALUATION OF STM FINE GRANULES FOR THE TREATMENT OF ACUTE SINUSITIS OF CHILDREN. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43009 |
| Study title: CLINICAL EVALUATION OF STM FINE GRANULES FOR THE TREATMENT OF ACUTE SUPPURATIVE OTITIS MEDIA OF CHILDREN. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43008 |
| Study title: A Multi-centre randomised , double masked, vehicle controlled parallel group study evaluating the safety and tolerability of Ketorolac Tromethamine 0.5 % ophthalmic solution used four times daily for 6 weeks in normal paediatric subjects. |
| Active substance: KETOPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30889 |
| Study title: Antila, H., T. Manner, et al. "Ketoprofen and tramadol for analgesia during early recovery after tonsillectomy in children." ; Paediatr Anaesth 16(5): 548-53, 2006 |
| Active substance: KETOPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30878 |
| Study title: Celecoxib and ketoprofen for pain management during tonsillectomy: a placebo-controlled clinical trial - Nikanne E. & al. - 2005 (Otolaryngol Head Neck Surg., 2005; 132:287-94) |
| Active substance: KETOPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30843 |
| Study title: Comparative efficacy and tolerance of ibuprofen syrup and acetaminophen syrup in children with pyrexia associated with infectious diseases and treated with antibiotics - Autret E., Breart G., Jonville A.P., Courcier S., Lassale C., Goehrs J.M. - 1994 (Eur. J. Clin. Pharmacol. 1994; 46:197-201) |
| Active substance: KETOPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30845 |
| Study title: Comparison of peri operative ketoprofen 2,0 mg/kg with 0,5 mg/kg i.v. in samll children during adenoidectomy - Nikanne E, Kokki H., Tuovinen K. - 1997 (British Journal of Anaesthesia, 1997, 79, p 606-608) |
| Active substance: KETOPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30848 |
| Study title: Defining fever and other aspects of body temperature in infants and children - Bonadio W.A. - 1993 ( Pediatric Annals 1993, 22 (8), p.467) |
| Active substance: KETOPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30849 |
| Study title: A cross-national study of acute otitis media: risk factors, severity, and treatment at initial visit. Report from the International Primary Care Network (IPCN) and the Ambulatory Sentinel Practice Network (ASPN).Froom et al., J Am Board Fam Pract. 2001 Nov-Dec;14(6):406-17A cross-national study of acute otitis media: risk factors, severity, and treatment at initial visit. Report from the International Primary Care Network (IPCN) and the Ambulatory Sentinel Practice Network (ASPN).Froom et al., J Am Board Fam Pract. 2001 Nov-Dec;14(6):406-17 |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46789 |
| Study title: Acute lymphoblastic leukaemia: trimethoprim resistant organisms during treatment.McDowell et al., Arch Dis Child. 1987 Jun;62(6):573-5.Acute lymphoblastic leukaemia: trimethoprim resistant organisms during treatment.McDowell et al., Arch Dis Child. 1987 Jun;62(6):573-5. |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46816 |
| Study title: Age differences in trimethoprim pharmacokinetics: need for revised dosing in children?Hoppu K., Clin Pharmacol Ther. 1987 Mar;41(3):336-43.Age differences in trimethoprim pharmacokinetics: need for revised dosing in children?Hoppu K., Clin Pharmacol Ther. 1987 Mar;41(3):336-43. |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46817 |
| Study title: An open, comparative study on trimethoprim and doxycycline in the treatment of acute bronchitis.Haukijärvi et al., Br J Dermatol. 1989 Nov;121(5):623-8.J Chemother. 1989 Jul;1(4 Suppl):798-9An open, comparative study on trimethoprim and doxycycline in the treatment of acute bronchitis.Haukijärvi et al., Br J Dermatol. 1989 Nov;121(5):623-8.J Chemother. 1989 Jul;1(4 Suppl):798-9 |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46811 |
| Study title: Antibacterial prophylaxis in children with urinary tract infection.Bollgren I, Acta Paediatr Suppl. 1999 Nov;88(431):48-52.Antibacterial prophylaxis in children with urinary tract infection.Bollgren I, Acta Paediatr Suppl. 1999 Nov;88(431):48-52. |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46798 |
| Study title: Antibiotic failure in the treatment of urinary tract infections in young women.Lawrenson et al., J Antimicrob Chemother. 2001 Dec;48(6):895-901Antibiotic failure in the treatment of urinary tract infections in young women.Lawrenson et al., J Antimicrob Chemother. 2001 Dec;48(6):895-901 |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46790 |
| Study title: Antibiotic treatment for five days is effective in children with acute cystitis.Abrahamsson et al., Acta Paediatr. 2002;91(1):55-8.Antibiotic treatment for five days is effective in children with acute cystitis.Abrahamsson et al., Acta Paediatr. 2002;91(1):55-8. |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46787 |
| Study title: Antimicrobial resistance in Escherichia coli in urine samples from children and adults: a 12 year analysis.Abelson Storby et al., Acta Paediatr. 2004 Apr;93(4):487-91Antimicrobial resistance in Escherichia coli in urine samples from children and adults: a 12 year analysis.Abelson Storby et al., Acta Paediatr. 2004 Apr;93(4):487-91 |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46778 |
| Study title: Antimicrobial resistance in fecal flora: longitudinal community-based surveillance of children from urban Mexico.Calva et al., Antimicrob Agents Chemother. 1996 Jul;40(7):1699-702Antimicrobial resistance in fecal flora: longitudinal community-based surveillance of children from urban Mexico.Calva et al., Antimicrob Agents Chemother. 1996 Jul;40(7):1699-702 |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46802 |
| Study title: Antimicrobial resistance of Shigella spp isolated from diarrheal patients between 1989 and 1998 in Vietnam.Anh et al., Southeast Asian J Trop Med Public Health. 2001 Dec;32(4):856-62.Antimicrobial resistance of Shigella spp isolated from diarrheal patients between 1989 and 1998 in Vietnam.Anh et al., Southeast Asian J Trop Med Public Health. 2001 Dec;32(4):856-62. |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46786 |
| Study title: Percutaneous nephrostomy in children with ureteropelvic junction obstruction and poor renal function.Gupta et al., Urology. 2001 Mar;57(3):547-50.Percutaneous nephrostomy in children with ureteropelvic junction obstruction and poor renal function.Gupta et al., Urology. 2001 Mar;57(3):547-50. |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46794 |
| Study title: Skin reactions to antibacterial agents in general practice.van der Linden et al., J Clin Epidemiol. 1998 Aug;51(8):703-8Skin reactions to antibacterial agents in general practice.van der Linden et al., J Clin Epidemiol. 1998 Aug;51(8):703-8 |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46800 |
| Study title: Strategy of acne therapy with long-term antibiotics.Hughes et al., Br J Dermatol. 1989 Nov;121(5):623-8.Strategy of acne therapy with long-term antibiotics.Hughes et al., Br J Dermatol. 1989 Nov;121(5):623-8. |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46810 |
| Study title: [The treatment of uncomplicated lower-urinary tract infection: a single dose of trimethoprim as opposed to 10 days with pipemidic acid].Ponce de León Roca et al., Aten Primaria. 1992 Jan;9(1):53[The treatment of uncomplicated lower-urinary tract infection: a single dose of trimethoprim as opposed to 10 days with pipemidic acid].Ponce de León Roca et al., Aten Primaria. 1992 Jan;9(1):53 |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46806 |
| Study title: Transferable antibiotic resistance in Escherichia coli isolated from healthy Nigerian school children.Lamikanra et al., Int J Antimicrob Agents. 1996 May;7(1):59-64.Transferable antibiotic resistance in Escherichia coli isolated from healthy Nigerian school children.Lamikanra et al., Int J Antimicrob Agents. 1996 May;7(1):59-64. |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46803 |
| Study title: Trimethoprim in the treatment of acute urinary tract infections in children.Hoppu et al., Int J Clin Pharmacol Ther Toxicol. 1988 Feb;26(2):65-8.Trimethoprim in the treatment of acute urinary tract infections in children.Hoppu et al., Int J Clin Pharmacol Ther Toxicol. 1988 Feb;26(2):65-8. |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46812 |
| Study title: Trimethoprim pharmacokinetics in children with renal insufficiency.Hoppu et al., Clin Pharmacol Ther. 1987 Aug;42(2):181-6.Trimethoprim pharmacokinetics in children with renal insufficiency.Hoppu et al., Clin Pharmacol Ther. 1987 Aug;42(2):181-6. |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46815 |
| Study title: Uncomplicated urinary tract infections. Bacterial findings and efficacy of empirical antibacterial treatment.Grude et al., Scand J Prim Health Care. 2005 Jun;23(2):115-9.Uncomplicated urinary tract infections. Bacterial findings and efficacy of empirical antibacterial treatment.Grude et al., Scand J Prim Health Care. 2005 Jun;23(2):115-9. |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46776 |
| Study title: Urinary tract infections, antibiotic resistance and sales of antimicrobial drugs--an observational study of uncomplicated urinary tract infections in Icelandic women.Olafsson et al., Scand J Prim Health Care. 2000 Mar;18(1):35-8.Urinary tract infections, antibiotic resistance and sales of antimicrobial drugs--an observational study of uncomplicated urinary tract infections in Icelandic women.Olafsson et al., Scand J Prim Health Care. 2000 Mar;18(1):35-8. |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46796 |
| Study title: Single dose treatment of cystitis in children.Lidefelt et al., Acta Paediatr Scand. 1991 Jun-Jul;80(6-7):648-53Single dose treatment of cystitis in children.Lidefelt et al., Acta Paediatr Scand. 1991 Jun-Jul;80(6-7):648-53 |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46807 |
| Study title: CONCERNTRATIONS OF SULTAMICILLIN IN SERUM AND MIDDLE EAR FLUID OF CHILDREN WITH ACUTE SUPPURATIVE OTITIS MEDIA WITH EFFUSION. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42913 |
| Study title: DOUBLE BLIND COMPARATIVE STUDY OF SULTAMICILLIN IN THE TREATMENT OF DERMAL INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42906 |
| Study title: DOUBLE BLIND STUDY IN OTITIS MEDIA TREATED WITH SULTAMICILLIN VS. CEFACTOR. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42908 |
| Study title: DOUBLE BLIND STUDY IN TONSILLITIS TREATED WITH SULTAMICILLIN VS. CEFACLOR. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42907 |
| Study title: DOUBLE BLIND STUDY IN UTI TREATED WITH SULTAMICILLIN VS. CEFADROXIL. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42909 |
| Study title: DRUG SURVEILLANCE STUDY OF ORAL SULTAMICILLIN VS. AMOXICILLIN-CLAVULANIC ACID IN THE TREATMENT OF PATIENTS WITH COMMUNITY-ACQUIRED INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42976 |
| Study title: EFFICACY AND SAFETY OF SBT/AMP,STM IN PEDIATRIC PATIENTS WITH MOD-SEVERE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42945 |
| Study title: EFFICACY AND SAFETY OF STM IN CYSTIC FIBROSIS INFECTED WITH HAEMOPHILUS INFLUENZA AND/OR STAPHYLOCOCCUS AUREUS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43032 |
| Study title: EFFICACY AND SAFETY OF SULTAMICILLIN (DUOCID ORAL) IN THE TREATMENT OF ACUTE SUPPURATIVE OTITIS MEDIA AN OPEN NON-COMPARATIVE, MULTICENTER (3 CENTERS) STUDY. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43056 |
| Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN ACUTE URINARY INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43031 |
| Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN ADULTS WITH NOSOCOMIAL ACUTE BACTERIA INFECTIONS OF LOWER RESPIRATORY TRACT. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43001 |
| Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN CHILDREN WITH ARI. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43027 |
| Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN CHILDREN WITH BACTERIAL INFECTIONS OF UPPER RESPIRATORY TRACT. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43003 |
| Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN CHILDREN WITH NOT NOSOCOMIAL ACUTE BACTERIAL INFECTIONS OF LOWER RESPIRATORY TRACT. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43002 |
| Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN CHILDREN WITH SLIGHT AND MODERATE URTI |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42967 |
| Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN PATIENTS WITH ACUTE URINARY INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43029 |
| Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN PATIENTS WITH ORAL INFECTIONS |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43028 |
| Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN PEDIATRIC PATIENTS WITH UPPER RESPIRATORY TRACT INFECTION. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43000 |
| Study title: COMPARATIVE STUDY OF SULTAMICILLIN WITH OR WITHOUT LACTOBACILLUS. TO GET A PREVENTIVE MEASURE OF DIARRHEA AND LOOSE STOOL IN PEDIATRICS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43005 |
| Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN SKIN AND SOFT TISSUES INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43030 |
| Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN THE TREATMENT OF PEDIATRIC INFECTIONS OF BACTERIAL ETIOLOGY--OPEN, NON-COMPARATIVE STUDY |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43055 |
| Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN TREATMENT OF RESPIRATORY TRACT, SKIN AND SOFT TISSUE, UT AND ENT INFECTIONS OF BACTERIAL ETIOLOGY--OPEN PARALLEL COMPARATIVE STUDY VERSUS CLAVULANIC ACID + AMOXYCILLIN |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43054 |
| Study title: Effecti di divetti dosaggi di ketoprofen sale di lisina in supposto nelle efffezioni flogistiche nel lattente di 6-36 mesi et nel bambino di 3-13 anni - Carnelli V.E., Mei V.A., Cera R., Clemente VE. - 1995 (Previtali M. Minerva Pediatr., 1995, 47, p 199-205) |
| Active substance: KETOPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30852 |
| Study title: I.V. peri operative ketoprofen in small children during adenoidectomy - Nikanne E., Kokki H., Tuovinen K. - 1997 (British journal of Anaesthesia, 1997, 78, p 24-27) |
| Active substance: KETOPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30858 |
| Study title: Ketoprofen and tramadol for analgesia during early recovery after tonsillectomy in children - Antila H. & al. - 2006 ( Paediatric Anaesth., 2006; 16: 548) |
| Active substance: KETOPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30861 |
| Study title: Cephalosporin resistant urinary tract infections in young children. Mehr et al., J Paediatr Child Health. 2004 Jan-Feb;40(1-2):48-52.Cephalosporin resistant urinary tract infections in young children. Mehr et al., J Paediatr Child Health. 2004 Jan-Feb;40(1-2):48-52. |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46782 |
| Study title: Children with trimethoprim- and ampicillin-resistant fecal Escherichia coli in day care centers.Reves et al., J Infect Dis. 1987 Nov;156(5):758-62Children with trimethoprim- and ampicillin-resistant fecal Escherichia coli in day care centers.Reves et al., J Infect Dis. 1987 Nov;156(5):758-62 |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46814 |
| Study title: Cinoxacin vs trimethoprim--safety and efficacy in the prophylaxis of uncomplicated urinary tract infections.Seppänen J, Drugs Exp Clin Res. 1988;14(10):669-71Cinoxacin vs trimethoprim--safety and efficacy in the prophylaxis of uncomplicated urinary tract infections.Seppänen J, Drugs Exp Clin Res. 1988;14(10):669-71 |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46813 |
| Study title: Colonization and persistence of antibiotic-resistant Enterobacteriaceae strains in infants nursed in two neonatal intensive care units in East London, United Kingdom.Millar et al., J Clin Microbiol. 2008 Feb;46(2):560-7. Epub 2007 Nov 26.Colonization and persistence of antibiotic-resistant Enterobacteriaceae strains in infants nursed in two neonatal intensive care units in East London, United Kingdom.Millar et al., J Clin Microbiol. 2008 Feb;46(2):560-7. Epub 2007 Nov 26. |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46771 |
| Study title: Decision making, evidence, audit, and education: case study of antibiotic prescribing in general practice.Lipman et al., BMJ. 2000 Apr 22;320(7242):1114-8.Decision making, evidence, audit, and education: case study of antibiotic prescribing in general practice.Lipman et al., BMJ. 2000 Apr 22;320(7242):1114-8. |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46797 |
| Study title: Diagnosis-prescribing surveys in 2000, 2002 and 2005 in Swedish general practice: Consultations, diagnosis, diagnostics and treatment choices.Andre et al., Scand J Infect Dis. 2008 Apr 1:1-7. [Epub ahead of print]Diagnosis-prescribing surveys in 2000, 2002 and 2005 in Swedish general practice: Consultations, diagnosis, diagnostics and treatment choices.Andre et al., Scand J Infect Dis. 2008 Apr 1:1-7. [Epub ahead of print] |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46770 |
| Study title: Difference in trimethoprim pharmacokinetics between children and adults.Hoppu et al., Chemotherapy. 1984;30(5):283-7.Difference in trimethoprim pharmacokinetics between children and adults.Hoppu et al., Chemotherapy. 1984;30(5):283-7. |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46819 |
| Study title: Distribution of patterns of sensitivity and associated phenotypes of resistance in nosocomial and community acquired Escherichia coli during 2005.García et al., Rev Esp Quimioter. 2008 Sep;21(3):157-65Distribution of patterns of sensitivity and associated phenotypes of resistance in nosocomial and community acquired Escherichia coli during 2005.García et al., Rev Esp Quimioter. 2008 Sep;21(3):157-65 |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46769 |
| Study title: Drug utilisation in outpatient children. A comparison among Tenerife, Valencia, and Barcelona (Spain), Toulouse (France), Sofia (Bulgaria), Bratislava (Slovakia) and Smolensk (Russia.Sanz et al., Eur J Clin Pharmacol. 2004 Apr;60(2):127-34. Epub 2004 Mar 12Drug utilisation in outpatient children. A comparison among Tenerife, Valencia, and Barcelona (Spain), Toulouse (France), Sofia (Bulgaria), Bratislava (Slovakia) and Smolensk (Russia.Sanz et al., Eur J Clin Pharmacol. 2004 Apr;60(2):127-34. Epub 2004 Mar 12 |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46781 |
| Study title: Treatment of itching in atopic eczema with antihistamines with a low sedative profile. Doherty V, Sylvester DG, Kennedy CT, Harvey SG, Calthrop JG, Gibson JR. BMJ. 1989 Jan 14;298(6666):96. Treatment of itching in atopic eczema with antihistamines with a low sedative profile. Doherty V, Sylvester DG, Kennedy CT, Harvey SG, Calthrop JG, Gibson JR. BMJ. 1989 Jan 14;298(6666):96. |
| Active substance: TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46857 |
| Study title: Retrospective study of triptorelin CR in central precocious puberty. |
| Active substance: TRIPTORELIN |
| Study summary document link (including results): DECAPEPTYL Synopsis Kauli 1994.pdf |
| View full study record |
| Document reference: 47466 |
| Study title: STUDY OF THE EFFECT OF TREATMENT WITH LHRH-ANALOGUE (DECAPEPTYL) ALONE OR IN COMBINATION WITH BIOSYNTHETIC HUMAN GROWTH HORMONE (GENOTROPIN) IN ADOPTED CHILDREN WITH EARLY PUBERTY |
| Active substance: TRIPTORELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46859 |
| Study title: EFFICACY AND SECURITY OF SULTAMICILLIN IN PATIENTS WITH MILD TO MODERATE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42966 |
| Study title: EFFICACY AND TOLERANCE OF PARENTERAL SULBACTAM/AMPICILLIN AND ORAL UNASYN IN CHILDREN AND ADULTS WITH MODERATE TO SEVERE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43058 |
| Study title: EFFICACY AND TOLERANCE OF SULTAMICILLIN IN THE TREATMENT OF MILD TO MODERATE INFECTIONS IN CHILDREN AND ADULTS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43057 |
| Study title: EFFICACY AND TOLERANCE OF SULTAMICILLIN VS. AMPICILLIN IN CHILDREN WITH ACUTE DIARRHEA. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43013 |
| Study title: EFFICACY AND TOLERATION OF SULBACTAM/AMPICILLIN IM FOLLOWED BY SULTAMICILLIN PO IN NON-SEVERE INFECTIONS IN GENERAL PRACTICE. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42946 |
| Study title: EFFICACY AND TOLERATION OF SULTAMICILLIN GIVEN ORALLY B.I.D. IN ADULTS WITH GYNECOLOGICAL OR OBSTETRIC INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42985 |
| Study title: EFFICACY AND TOLERATION OF SULTAMICILLIN GIVEN ORALLY IN PATIENTS WITH RESPIRATORY TRACT INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42984 |
| Study title: EFFICACY AND TOLERATION OF SULTAMICILLIN PO IN ADULTS WITH ENT INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42987 |
| Study title: TO COMPARE DOXYCYCLINE 50 MG WITH OXYTETRACYCLINE 250 MG BID IN THE TREATMENT OF INFLAMMATORY ACNE VULGARIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27335 |
| Study title: TO COMPARE THE CLINICAL AND MYCOLOGIC EFFECTIVENESS AND SAFETY OF A SINGLE 150 MG ORAL DOSE OF FLUCONAZOLE VS. 3 DAYS OF ORAL DOSES OF ITRACONAZOLE GIVEN AT 200 MG PER DAY IN THE TREATMENT OF VAGINAL |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27595 |
| Study title: TO COMPARE THE CLINICAL AND MYCOLOGIC EFFECTIVENESS AND SAFETY OF A SINGLE 150 MG ORAL DOSE OF FLUCONAZOLE VS. 3 DAYS OF ORAL DOSES OF ITRACONAZOLE GIVEN AT 200 MG PER DAY IN THE TREATMENT OF VAGINAL |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27958 |
| Study title: TO COMPARE THE EFFICACY AND SAFETY OF FLUCONAZOLE AND AMPHOTERICIN B IN THE PREVENTION OF FUNGAL INFECTIONS; WITH ACUTE LEUKEMIA DURING THE PERIOD OF APLASIA. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27450 |
| Study title: TO COMPARE THE EFFICACY AND SAFETY OF FLUCONAZOLE AND AMPHOTERICIN B IN THE PREVENTION OF FUNGAL INFECTIONS; WITH ACUTE LEUKEMIA DURING THE PERIOD OF APLASIA. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27814 |
| Study title: TO COMPARE THE EFFICACY AND SAFETY OF FLUCONAZOLE VS. AMPHOTERICIN IN THE TREATMENT OF CHRONIC ATROPHIC ERYTHEMATOUS CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27667 |
| Study title: TO COMPARE THE EFFICACY AND SAFETY OF FLUCONAZOLE VS. AMPHOTERICIN IN THE TREATMENT OF CHRONIC ATROPHIC ERYTHEMATOUS CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28029 |
| Study title: EFFICACY AND TOLERATION OF SULTAMICILLIN PO IN ADULTS WITH SKIN AND SOFT TISSUE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42986 |
| Study title: EFFICACY AND TOLERATION OF SULTAMICILLIN PO IN CHILDREN WITH BACTERIAL INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42988 |
| Study title: EFFICACY AND TOLERATION OF SULTAMICILLIN VS AMOXICILLIN IN PEDIATRIC INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42998 |
| Study title: EFFICACY AND TOLERATION OF UNASYN IN PEDIATRIC INFECTIONS |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43015 |
| Study title: Kokki, H., A. Salonen, et al. "Perioperative intravenous ketoprofen neither prolongs operation time nor delays discharge after adenoidectomy in children." ; Paediatr Anaesth 11(1): 59-64, 2001.Kokki, H., A. Salonen, et al. "Perioperative intravenous ketoprofen neither prolongs operation time nor delays discharge after adenoidectomy in children." ; Paediatr Anaesth 11(1): 59-64, 2001. |
| Active substance: KETOPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30881 |
| Study title: Kokki, H., A. Salonen, et al. "Perioperative intravenous ketoprofen neither prolongs operation time nor delays discharge after adenoidectomy in children." ; Paediatr Anaesth 11(1): 59-64, 2001.Kokki, H., A. Salonen, et al. "Perioperative intravenous ketoprofen neither prolongs operation time nor delays discharge after adenoidectomy in children." ; Paediatr Anaesth 11(1): 59-64, 2001. |
| Active substance: KETOPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30886 |
| Study title: Kokki, H., E. Nikanne, et al."The feasibility of pain treatment at home after adenoidectomy with ketoprofen tablets in small children." ; Paediatr Anaesth 10(5): 531-5, 2000Kokki, H., E. Nikanne, et al."The feasibility of pain treatment at home after adenoidectomy with ketoprofen tablets in small children." ; Paediatr Anaesth 10(5): 531-5, 2000 |
| Active substance: KETOPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30880 |
| Study title: Kokki, H., H. Tuomilehto, et al. "Pain management after adenoidectomy with ketoprofen: comparison of rectal and intravenous routes." ; Br J Anaesth 85(6): 836-40, 2000.Kokki, H., H. Tuomilehto, et al. "Pain management after adenoidectomy with ketoprofen: comparison of rectal and intravenous routes." ; Br J Anaesth 85(6): 836-40, 2000. |
| Active substance: KETOPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30882 |
| Study title: Salonen, A., H. Kokki, et al. "The effect of ketoprofen on recovery after tonsillectomy in children: a 3-week follow-up study." Int J Pediatr Otorhinolaryngol 62(2): 143-50, 2002 |
| Active substance: KETOPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30883 |
| Study title: Enterotoxigenic Escherichia coli causing cholerogenic syndrome during an interepidemic period of cholera in North India.Taneja et al., Jpn J Infect Dis. 2006 Aug;59(4):245-8Enterotoxigenic Escherichia coli causing cholerogenic syndrome during an interepidemic period of cholera in North India.Taneja et al., Jpn J Infect Dis. 2006 Aug;59(4):245-8 |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46772 |
| Study title: Factors associated with antibiotic resistance in coliform organisms from community urinary tract infection in Wales.Howard et al., J Antimicrob Chemother. 2001 Mar;47(3):305-13.Factors associated with antibiotic resistance in coliform organisms from community urinary tract infection in Wales.Howard et al., J Antimicrob Chemother. 2001 Mar;47(3):305-13. |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46795 |
| Study title: High rates of antibiotic resistance among normal fecal flora Escherichia coli isolates in children from Greece.Vatopoulos et al., Clin Microbiol Infect. 1998;4(10):563-569.High rates of antibiotic resistance among normal fecal flora Escherichia coli isolates in children from Greece.Vatopoulos et al., Clin Microbiol Infect. 1998;4(10):563-569. |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46788 |
| Study title: Incidence & enteropathogenicity of Aeromonas spp in children suffering from acute diarrhoea in Chennai.Komathi et al., Indian J Med Res. 1998 Jun;107:252-6Incidence & enteropathogenicity of Aeromonas spp in children suffering from acute diarrhoea in Chennai.Komathi et al., Indian J Med Res. 1998 Jun;107:252-6 |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46801 |
| Study title: Increased rates of trimethoprim resistance in uncomplicated urinary tract infection: cause for concern?Mangin et al., N Z Med J. 2005 Nov 11;118(1225):U1726Increased rates of trimethoprim resistance in uncomplicated urinary tract infection: cause for concern?Mangin et al., N Z Med J. 2005 Nov 11;118(1225):U1726 |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46775 |
| Study title: Increasing antibiotic resistance among urinary tract isolates.Ladhani et al., Arch Dis Child. 2003 May;88(5):444-5.Increasing antibiotic resistance among urinary tract isolates.Ladhani et al., Arch Dis Child. 2003 May;88(5):444-5. |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46784 |
| Study title: Long-term antibiotics for preventing recurrent urinary tract infection in children.(2)Williams et al., Cochrane Database Syst Rev. 2001;(4):CD001534.Long-term antibiotics for preventing recurrent urinary tract infection in children.(2)Williams et al., Cochrane Database Syst Rev. 2001;(4):CD001534. |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46791 |
| Study title: Long-term antibiotics for preventing recurrent urinary tract infection in children.Williams et al., Cochrane Database Syst Rev. 2006 Jul 19;3:CD001534Long-term antibiotics for preventing recurrent urinary tract infection in children.Williams et al., Cochrane Database Syst Rev. 2006 Jul 19;3:CD001534 |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46773 |
| Study title: Nitrofurantoin versus trimethoprim prophylaxis in recurrent urinary tract infection in children. A randomized, double-blind study.Brendstrup et al., Acta Paediatr Scand. 1990 Dec;79(12):1225-34.Nitrofurantoin versus trimethoprim prophylaxis in recurrent urinary tract infection in children. A randomized, double-blind study.Brendstrup et al., Acta Paediatr Scand. 1990 Dec;79(12):1225-34. |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46808 |
| Study title: Occurrence of Salmonella typhi and Salmonella paratyphi in Jordan.Battikhi MN., New Microbiol. 2003 Oct;26(4):363-73.Occurrence of Salmonella typhi and Salmonella paratyphi in Jordan.Battikhi MN., New Microbiol. 2003 Oct;26(4):363-73. |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46783 |
| Study title: Oral trimethoprim as a third-line antibiotic in the management of acne vulgaris.Bottomley et al., Dermatology. 1993;187(3):193-6.Oral trimethoprim as a third-line antibiotic in the management of acne vulgaris.Bottomley et al., Dermatology. 1993;187(3):193-6. |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46805 |
| Study title: A comparison of the pupillary and cardiovascular effects of various mydriatic agents in preterm infants. Sindel BD, Baker MD, Maisels MJ, Weinstein J. J Pediatr Ophthalmol Strabismus. 1986 Nov-Dec;23(6):273-6. A comparison of the pupillary and cardiovascular effects of various mydriatic agents in preterm infants. Sindel BD, Baker MD, Maisels MJ, Weinstein J. J Pediatr Ophthalmol Strabismus. 1986 Nov-Dec;23(6):273-6. |
| Active substance: TROPICAMIDE |
| Study summary document link (including results): A comparison of the pupillary and cardiovascular effects.pdf |
| View full study record |
| Document reference: 46880 |
| Study title: Safety and efficacy of pressure limited power injection of iodinated contrast medium through central lines in childrenRIGSBY CK; AJR; 2007 vol.188 p.726 732Safety and efficacy of pressure limited power injection of iodinated contrast medium through central lines in childrenRIGSBY CK; AJR; 2007 vol.188 p.726 732 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30427 |
| Study title: Suspected appendicitis in children : focused CT technique for evaluation; FEFFERMAN NR; Radiology; 2001 vol.220 p.691-695Suspected appendicitis in children : focused CT technique for evaluation; FEFFERMAN NR; Radiology; 2001 vol.220 p.691-695 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30430 |
| Study title: Suspected appendicitis in children: rectal and intravenous contrast enhanced versus intravenous contrast-enhanced CT.; KHARBANDA AB; Radiology; 2007 vol.243 n.3 p.520 526Suspected appendicitis in children: rectal and intravenous contrast enhanced versus intravenous contrast-enhanced CT.; KHARBANDA AB; Radiology; 2007 vol.243 n.3 p.520 526 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30431 |
| Study title: Symptomatic intracranial stenosis : cerebrovascular complication from elective stent placement; JIANG WJ; Radiology; 2007 vol.243 n.1 188 197Symptomatic intracranial stenosis : cerebrovascular complication from elective stent placement; JIANG WJ; Radiology; 2007 vol.243 n.1 188 197 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30432 |
| Study title: TO COMPARE THE EFFICACY AND SAFETY OF ORAL FLUCONAZOLE GIVEN AS A SINGLE ORAL DOSE OF 150 MG PER WEEK OR 50 MG 3 TIMES PER WEEK FOR THE PREVENTION OF ORO-PHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27451 |
| Study title: TO COMPARE THE EFFICACY AND SAFETY OF ORAL FLUCONAZOLE GIVEN AS A SINGLE ORAL DOSE OF 150 MG PER WEEK OR 50 MG 3 TIMES PER WEEK FOR THE PREVENTION OF ORO-PHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27815 |
| Study title: TO COMPARE THE EFFICACY OF FLUCONAZOLE TO ORAL AMPHOTERICIN AND NYSTATIN IN THE PREVENTION OF FUNGAL INFECTION IN PATIENTS WITH HEMATOLOGICAL DISEASE RECEIVING CHEMOTHERAPY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27668 |
| Study title: TO COMPARE THE EFFICACY OF FLUCONAZOLE TO ORAL AMPHOTERICIN AND NYSTATIN IN THE PREVENTION OF FUNGAL INFECTION IN PATIENTS WITH HEMATOLOGICAL DISEASE RECEIVING CHEMOTHERAPY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28030 |
| Study title: TO COMPARE THE EFFICACY OF FLUCONAZOLE VS. ORAL KETOCONAZOLE IN THE PREVENTION OF FUNGAL INFECTION IN PATIENTS RECEIVING CHEMOTHERAPY FOR HEMATOLOGICAL DISEASE. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27666 |
| Study title: TO COMPARE THE EFFICACY OF FLUCONAZOLE VS. ORAL NYSTATIN IN THE PREVENTION OF FUNGAL INFECTION IN PATIENTS RECEIVING CHEMOTHERAPY FOR HEMATOLOGICAL DISEASE. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27665 |
| Study title: TO COMPARE THE EFFICACY OF FLUCONAZOLE VS. ORAL NYSTATIN IN THE PREVENTION OF FUNGAL INFECTION IN PATIENTS RECEIVING CHEMOTHERAPY FOR HEMATOLOGICAL DISEASE. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28027 |
| Study title: A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma. Hareyama M. Cancer. April 15, 2002, 2217-23 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28271 |
| Study title: Adjuvant chemotherapy for colorectal cancer: A Malaysian experience. Lim GCC et al. Medical Journal of Malaysia. September 8, 1997, 117-23 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28283 |
| Study title: Chemotherapy for unresectable pancreatoblastoma. Hord JD, Janco RL. Med Pediatr Oncol. 1996 Jun;26(6):432-3 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28313 |
| Study title: Tuomilehto, H. and H. Kokki "Parenteral ketoprofen for pain management after adenoidectomy: comparison of intravenous and intramuscular routes of administration." ; Acta Anaesthesiol Scand 46(2): 184-9, 2002. |
| Active substance: KETOPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30885 |
| Study title: Kokki H, et all. The feasibility of pain treatment at home after adenoidectomy with ketoprofen tablets in small children. Paediatr Anaesth. 2000;10(5):531-5. Kokki H, et all. The feasibility of pain treatment at home after adenoidectomy with ketoprofen tablets in small children. Paediatr Anaesth. 2000;10(5):531-5. |
| Active substance: KETOPROFEN AND SUCRALFATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30890 |
| Study title: Nikanne E, et all. Postoperative pain after adenoidectomy in children. Br J Anaesth. 1999 Jun;82(6):886-9. Nikanne E, et all. Postoperative pain after adenoidectomy in children. Br J Anaesth. 1999 Jun;82(6):886-9. |
| Active substance: KETOPROFEN AND SUCRALFATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30891 |
| Study title: A Multi-centre randomised , double masked, vehicle controlled parallel group study evaluating the safety and tolerability of Ketorolac Tromethamine 0.5 % ophthalmic solution used four times daily for 6 weeks in normal paediatric subjects. |
| Active substance: KETOROLAC |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45109 |
| Study title: A randomised , double blind, 3-Way Crossover study to compare the protective effect o single doses of an alternative propellanst (HFA-227) - Formulation of sodium Cromoglycate 2x5mg with Intal (Lomudal) MDI 2x5mg and HFA-227 placebo in asthmatic volunteer |
| Active substance: MONTELUKAST |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32427 |
| Study title: A randomized, double-blind, multicenter study evaluating the effect of montelukast sodium as compared to salmeterol on the inhibition of exercise-induced bronchoconstriction in adult asthmatics |
| Active substance: MONTELUKAST |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32429 |
| Study title: A Randomized, Double-Blind, Multicenter Study to Evaluate the Effect of Adding Either Montelukast Sodium or Salmeterol Xinafoate to Inhaled Fluticasone in Adult Asthmatics |
| Active substance: MONTELUKAST |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32430 |
| Study title: A Randomized, Double-Blind, Multicenter Study to Evaluate the Effect of Adding Either Montelukast Sodium or Salmeterol Xinafoate to Inhaled Fluticasone in Adult Asthmatics (IMPACT Study – Investigation of Montelukast as a Partner Agent for Complementary Therapy) |
| Active substance: MONTELUKAST |
| Study summary document link (including results): 908.pdf |
| View full study record |
| Document reference: 32431 |
| Study title: A Randomized, Double-Blind, Multicenter Study to Evaluate the Effect of Oral Montelukast Sodium Versus Inhaled Fluticasone Propionate in Patients With MIld Persistent Asthma |
| Active substance: MONTELUKAST |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32432 |
| Study title: A Randomized, Double-Blind, Multicenter Study to Evaluate the Effect of Oral Montelukast Sodium versus inhaled Fluticasone Proportionate in Patients With Persistent Asthma |
| Active substance: MONTELUKAST |
| Study summary document link (including results): 905 synopsis.pdf |
| View full study record |
| Document reference: 32433 |
| Study title: A randomized, multicenter, double blind study to evaluate the effect of adding montelukast sodium to inhaled budesonide compared to doubling the dose of inhaled budesonide in adult patients with asthma |
| Active substance: MONTELUKAST |
| Study summary document link (including results): 909.pdf |
| View full study record |
| Document reference: 47560 |
| Study title: Randomized, Open-label Pilot Study Comparing the Effects of Montelukast Sodium Tablets, Fluticasone Aerosol (MDI) or Budesonide Turbuhaler® on Asthma Control in Mild Adult Asthmatics |
| Active substance: MONTELUKAST |
| Study summary document link (including results): 076 CSR.pdf |
| View full study record |
| Document reference: 47559 |
| Study title: A mydriatic eye-drop combination without systemic effects for premature infants: a prospective double-blind study. Bolt B, Benz B, Koerner F, Bossi E. J Pediatr Ophthalmol Strabismus. 1992 May-Jun;29(3):157-62. Comment in: J Pediatr Ophthalmol Strabismus. 1994 Mar-Apr;31(2):130. PMID: 8014788. A mydriatic eye-drop combination without systemic effects for premature infants: a prospective double-blind study. Bolt B, Benz B, Koerner F, Bossi E. J Pediatr Ophthalmol Strabismus. 1992 May-Jun;29(3):157-62. Comment in: J Pediatr Ophthalmol Strabismus. 1994 Mar-Apr;31(2):130. PMID: 8014788. |
| Active substance: TROPICAMIDE |
| Study summary document link (including results): A mydriatic eye-drop combination without systemic effects.pdf |
| View full study record |
| Document reference: 46878 |
| Study title: Additive mydriatic effect of 2.5% phenylephrine and 0.5% tropicamide eyedrops in premature babies. Fleck BW, Dhillon B, Mitchell A. J Pediatr Ophthalmol Strabismus. 1994 Mar-Apr;31(2):130. Comment on: J Pediatr Ophthalmol Strabismus. 1992 May-Jun;29(3):157-62. PMID: 1432499. Additive mydriatic effect of 2.5% phenylephrine and 0.5% tropicamide eyedrops in premature babies. Fleck BW, Dhillon B, Mitchell A. J Pediatr Ophthalmol Strabismus. 1994 Mar-Apr;31(2):130. Comment on: J Pediatr Ophthalmol Strabismus. 1992 May-Jun;29(3):157-62. PMID: 1432499. |
| Active substance: TROPICAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46876 |
| Study title: [Cardiovascular and digestive effects of 2 mydriatics in the low-birth-weight newborn infant] Walti H, Daoud P, Broussin B, Ryzman P, Moriette G, Relier JP. Arch Fr Pediatr. 1987 Jan;44(1):31-3. [Cardiovascular and digestive effects of 2 mydriatics in the low-birth-weight newborn infant] Walti H, Daoud P, Broussin B, Ryzman P, Moriette G, Relier JP. Arch Fr Pediatr. 1987 Jan;44(1):31-3. |
| Active substance: TROPICAMIDE |
| Study summary document link (including results): Cardiovascular and digestive effects of 2 mydriatics.pdf |
| View full study record |
| Document reference: 46879 |
| Study title: Effective adjuvant chemotherapy for advanced nasopharyngeal carcinoma in children: A final update of a long-term prospective study in a single institution. Ghim TT et al. J Pediatr Hematol Oncol. March 1, 1998, 131-5 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28280 |
| Study title: Effectiveness of novel combination chemotherapy, consisting of 5-fluorouracil, vincristine, cyclophosphamide and etoposide, in the treatment of low-grade gliomas in children. Lee MJ et al. J Neuro-Oncol. December 1, 2006, 277-84 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): 16807782.pdf |
| View full study record |
| Document reference: 28263 |
| Study title: Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy. Leung TWT et al. Cancer, January 15, 2002, 421-7 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28272 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Naso-Heel S (drops) [AWB-AT] |
| Active substance: Naso-Heel - Tropfen |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40080 |
| Study title: Kostromina V.P.et al: Estimation of detoxicational effects of antihomotoxic medicines in the treatment of children suffering from relapsing bronchitis and infected with mycobacteria. Biological Therapy (Ukraine), 2007, 3: 20-23 [IIT-publication] |
| Active substance: Mucosa compositum |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40077 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Mucosa compositum (ampoules) [AWB-AT] |
| Active substance: Mucosa compositum |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40076 |
| Study title: Samoilenko I.G.,Yulish E.I., Gadetskaya S.G., Buchtiarov E.V.: New approach to treat pediatric patients suffering from bronchial asthma associated with intracellular infection. Biological Therapy (Ukraine), 2006, 4: 10-13 [IIT-publication] |
| Active substance: Mucosa compositum |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40075 |
| Study title: A prospective, open label, multicenter, international protocol to assess the efficacy and safety of Myfortic® in kidney transplant recipients |
| Active substance: MYCOPHENOLIC ACID |
| Study summary document link (including results): Myfortic_publication of Article 45 result-related information_final Aug 2011.xls |
| View full study record |
| Document reference: 32437 |
| Study title: Vena cavography with CO(2) versus with iodinated contrast material for inferior vena cava filter placement : a prospective evaluation; DEWALD CL; Radiology; 2000 vol.216 p.752 757Vena cavography with CO(2) versus with iodinated contrast material for inferior vena cava filter placement : a prospective evaluation; DEWALD CL; Radiology; 2000 vol.216 p.752 757 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30437 |
| Study title: Evaluation of optimal effective dose and action duration of ipratropium bromide in reducing bronchospasm in children with reversible chronic obstructive airway disease. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30549 |
| Study title: Evaluation of optimal effective dose and action duration of ipratropium bromide in reducing bronchospasm in children with reversible chronic obstructive airway disease. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U90-0054_synopsis.pdf |
| View full study record |
| Document reference: 30699 |
| Study title: Evaluation of the therapeutic effect and tolerance of 4.5 mg Th 1165a suppositories in newborns and infants. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30587 |
| Study title: Evaluation of the therapeutic effect of Th 1165a-suppositories in children during the night compared with placebo. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30592 |
| Study title: A Double-Blind Multicenter Group Comparison Study of the Safety and Effectiveness of 0,5% Nedocromil Sodium Nebulizer Solution QID vs. Placebo in the Management of Bronchila Asthma in Children (6-12 Years old), 1993, Medical Report |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47017 |
| Study title: Habre-Analgesic and respiratory effect of nalbuphine and pethidine for adenotonsillectomy in children with obstructive sleep disorder. |
| Active substance: NALBUPHINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32451 |
| Study title: "A meta-analysisi of randomized, controlled trials comparing short and long-course antibiotic therapy for urinary tract infections in children - Keren R. - 2002 (Pediatrics, 109,5) - Publication in CES EXPCRC-CES0164-EN01 - Eugène D. - 25 Apr. 2003 -" |
| Active substance: Nalidixic acid |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32455 |
| Study title: Nalidixic acid : Critical assessment on the pharmacotoxicological documentation - Gouy D. - 23 May 2003 |
| Active substance: NALIDIXIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32454 |
| Study title: Publication in the critical assessment on the pharmacotoxicological documentation - Gouy D. - 23 May 2003 : Quinolone arthropathy in juvenile New Zealand White rabbits.- Sharpnack DD. - 1994 |
| Active substance: Nalidixic acid |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32456 |
| Study title: Publication in the critical assessment on the pharmacotoxicological documentation - Gouy D. - 23 May 2003 : Review of quinolone arthropathy in the dog. - Burkhardt JE - 1996 (Chemotherapy Journal, 5, 13:14-18) |
| Active substance: Nalidixic acid |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32457 |
| Study title: Effects of Naltrexone on the Autistic Syndrome, Double-Blind, Placebo Controlled Crossover Design Study |
| Active substance: NALTREXONE |
| Study summary document link (including results): Protocol DuP 393-015 Naltrexone.pdf |
| View full study record |
| Document reference: 32462 |
| Study title: arcon-Vargas D, Zhang Z, Agarwal B, Challagulla K, Mani S, Kalpana GV. Targeting cyclin D1, a downstream effector of INI1/hSNF5, in rhabdoid tumors. Oncogene 2006; 25(5):722-734.arcon-Vargas D, Zhang Z, Agarwal B, Challagulla K, Mani S, Kalpana GV. Targeting cyclin D1, a downstream effector of INI1/hSNF5, in rhabdoid tumors. Oncogene 2006; 25(5):722-734. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43133 |
| Study title: A double-blind parallel group study comparing the effect of nedocromil sodium (4 mg TID) via a Nebuhaler. Device and placebo on bronchial hyperreactivity and diurnal variation in PEFR in children with asthma - P. Sly - 1993 (J. Asthma vol 30) - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46974 |
| Study title: A double-blind study to assess the efficacy and duration of protection of nedocromil sodium given by pressurised aerosol in asthmatic children in exercise challenge tests - A. Boner - 1985 - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46976 |
| Study title: Comparison of the curative effect of IK 6 metered aerosol and its individual constituents in a provocation test with antigen inhalation. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30567 |
| Study title: Comparison of the curative effect of IK 6 metered aerosol and its individual constituents in a provocation test with antigen inhalation. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30668 |
| Study title: Comparison of the long term effect of Fenoterol hydrobromide and Theophylline syrups in pre-school asthmatic children. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30610 |
| Study title: Comparison of the protective action of Berodual solution (IK 37) and Intal in cases of allergen-provoked bronchoconstriction in children. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30606 |
| Study title: Comparison of the protective action of Berodual solution (IK 37) and Intal in cases of allergen-provoked bronchoconstriction in children. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30667 |
| Study title: Multicentre, double-masked, parallel-group, prospective, balanced-randomized, comparative trial using a vehicle and an active control. |
| Active substance: KETOTIFEN |
| Study summary document link (including results): Zaditen Ophtha Paediatric Studies_NHDR 42000-97-3_ EMA spreadsheet.xls |
| View full study record |
| Document reference: 47299 |
| Study title: Antipyretic effect of naproxen in children. |
| Active substance: NAPROXEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46935 |
| Study title: Comparison of naproxen sodium, Advil® and placebo in subjects with acute ankle sprains. |
| Active substance: NAPROXEN |
| Study summary document link (including results): Bayer CC_Naproxen Sodium_CC-01269_study_synopsis.pdf |
| View full study record |
| Document reference: 47145 |
| Study title: Double-blind clinical trial - naproxen sodium suspension vs placebo in postoperative adeno-tonsillectomy in children. |
| Active substance: NAPROXEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46934 |
| Study title: Methodology Study Comparing Naproxen, Ibuprofen and Placebo in Subjects with Acute Ankle Sprains |
| Active substance: NAPROXEN |
| Study summary document link (including results): Bayer CC_Naproxen Sodium_CC-00919_study_synopsis.pdf |
| View full study record |
| Document reference: 47140 |
| Study title: Determination of an effective dose of fenoterol, as free as possible from side effects for regular therapeutic use in obstructive respiratory tract diseases. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30619 |
| Study title: Effect of ipratropium bromide on the diurnal variation of asthma in children |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U85-0252_synopsis.pdf |
| View full study record |
| Document reference: 30620 |
| Study title: Effect of ipratropium bromide on the diurnal variation of asthma in children. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30547 |
| Study title: To evaluate, in an open pilot study, the effect on lungfunction of Ipratropium bromide inhalation solution and the additional effect of a beta 2-agonist (Salbutamol inhalation solution) in children with an acute attack of asthma. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30542 |
| Study title: To evaluate, in an open pilot study, the effect on lungfunction of Ipratropium bromide inhalation solution and the additional effect of a beta 2-agonist (Salbutamol inhalation solution) in children with an acute attack of asthma. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30629 |
| Study title: To evaluate, in an open pilot study, the effect on lungfunction of Ipratropium bromide inhalation solution and the additional effect of a beta 2-agonist (Salbutamol inhalation solution) in children with an acute attack of asthma. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U93-0136_synopsis.pdf |
| View full study record |
| Document reference: 30708 |
| Study title: Treatment of acute bronchial asthma comparison between epinephrine (injections - subcutaneous) and fenoterol (inhalation). |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30616 |
| Study title: Effect of the combination of ipratropium bromide and fenoterol (berodual) in patients with asthmatic crises comparative study with fenoterol (Berotec). |
| Active substance: IPRATROPIUM AND FENOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30729 |
| Study title: De Beule K, Van Cutsem J, Cauwenbergh G, Wesel S, Herman PH, Baekelandt J, Houben PWM, Scheurwegh W, Godts P. Oral itraconazole versus topical clotrimazole in acute vulvovaginal candidosis: a randomized comparative trial. Clinical research report on R051211 no-101, May 1989.(16-65 years, LMD68115)De Beule K, Van Cutsem J, Cauwenbergh G, Wesel S, Herman PH, Baekelandt J, Houben PWM, Scheurwegh W, Godts P. Oral itraconazole versus topical clotrimazole in acute vulvovaginal candidosis: a randomized comparative trial. Clinical research report on R051211 no-101, May 1989.(16-65 years, LMD68115) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30816 |
| Study title: De Beulke K, Van Cutsem J, Cauwenbergh G. Itraconazole: A one-day oral treatment for vaginal candidosis: results of an open multicentre study. Clinical research report on R051211 no-100, March 1989. (15-64 years, LMD65820)De Beulke K, Van Cutsem J, Cauwenbergh G. Itraconazole: A one-day oral treatment for vaginal candidosis: results of an open multicentre study. Clinical research report on R051211 no-100, March 1989. (15-64 years, LMD65820) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30815 |
| Study title: Decroix J, et al Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea pedis and tinea manus. Clinical research report on R051211 no-70, May 1987. (10-75 years, LMD56441)Decroix J, et al Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea pedis and tinea manus. Clinical research report on R051211 no-70, May 1987. (10-75 years, LMD56441) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30786 |
| Study title: Decroix J, et al Open evaluation of itraconazole at daily doses of 50, 100, and 150 mg in the treatment of dermatophyte infections of the skin. A study of the time to response. Clinical summary on R51211, August 1987. (6-81 years, LMD56453)Decroix J, et al Open evaluation of itraconazole at daily doses of 50, 100, and 150 mg in the treatment of dermatophyte infections of the skin. A study of the time to response. Clinical summary on R51211, August 1987. (6-81 years, LMD56453) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30795 |
| Study title: An open-label assessment of modafinil on attention and fatigue in adolescent and adult AD(H)D subjects.Duane D; Heimberger G; Welch A;Sleep 2004; 27(s)/A47 An open-label assessment of modafinil on attention and fatigue in adolescent and adult AD(H)D subjects.Duane D; Heimberger G; Welch A;Sleep 2004; 27(s)/A47 |
| Active substance: MODAFINIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45667 |
| Study title: "An open-label assessment of modafinil on attention and fatigue in adolescent and adult AD(H)D subjects.Duane D; Heimberger G; Welch A;Sleep 2004; 27(s)/A47 "An open-label assessment of modafinil on attention and fatigue in adolescent and adult AD(H)D subjects.Duane D; Heimberger G; Welch A;Sleep 2004; 27(s)/A47 |
| Active substance: MODAFINIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45675 |
| Study title: Double Blind Study on the Effect of Modafinil in Urinary Incontinence of Neurologic Origin. |
| Active substance: MODAFINIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45285 |
| Study title: "Effects of modafinil in children with attention-deficit/hyperactivity disorder: an open-label study. TA Rugino & TC Copley, Journal of the American Academy of Child and Adolescent Psychiatry 2001, 40(2): 230-5. "Effects of modafinil in children with attention-deficit/hyperactivity disorder: an open-label study. TA Rugino & TC Copley, Journal of the American Academy of Child and Adolescent Psychiatry 2001, 40(2): 230-5. |
| Active substance: MODAFINIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45663 |
| Study title: [Effects of modafinil on visual and auditory reaction abilities and subjective fatigue level during 48 h sleep deprivation] Y Li, et al., Hang Tian Yi Xue Yu Yi Xue Gong Cheng = Space Medicine & Medical Engineering 2003, 16(4): 277-80.[Effects of modafinil on visual and auditory reaction abilities and subjective fatigue level during 48 h sleep deprivation] Y Li, et al., Hang Tian Yi Xue Yu Yi Xue Gong Cheng = Space Medicine & Medical Engineering 2003, 16(4): 277-80. |
| Active substance: MODAFINIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45660 |
| Study title: Comparison of the effectiveness of a nondilated versus dilated fundus examination in the pediatric population. Parisi ML, Scheiman M, Coulter RS. J Am Optom Assoc. 1996 May;67(5):266-72. Comparison of the effectiveness of a nondilated versus dilated fundus examination in the pediatric population. Parisi ML, Scheiman M, Coulter RS. J Am Optom Assoc. 1996 May;67(5):266-72. |
| Active substance: TROPICAMIDE |
| Study summary document link (including results): Comparison of the effectiveness of a nondilated versus dilat.pdf |
| View full study record |
| Document reference: 46874 |
| Study title: Cost-effectiveness of cycloplegic agents: results of a randomized controlled trial in nigerian children. Ebri A, Kuper H, Wedner S. Invest Ophthalmol Vis Sci. 2007 Mar;48(3):1025-31. Cost-effectiveness of cycloplegic agents: results of a randomized controlled trial in nigerian children. Ebri A, Kuper H, Wedner S. Invest Ophthalmol Vis Sci. 2007 Mar;48(3):1025-31. |
| Active substance: TROPICAMIDE |
| Study summary document link (including results): Cost-effectiveness of cycloplegic agents.pdf |
| View full study record |
| Document reference: 46862 |
| Study title: Effect of mydriatics on blood pressure in premature infants. Merritt JC, Kraybill EN. J Pediatr Ophthalmol Strabismus. 1981 Sep-Oct;18(5):42-6. Effect of mydriatics on blood pressure in premature infants. Merritt JC, Kraybill EN. J Pediatr Ophthalmol Strabismus. 1981 Sep-Oct;18(5):42-6. |
| Active substance: TROPICAMIDE |
| Study summary document link (including results): Effect of mydriatics on blood pressure in premature infants.pdf |
| View full study record |
| Document reference: 46881 |
| Study title: aTargeting cyclin D1, a downstream effector of INI1/hSNF5, in rhabdoid tumors. arcon-Vargas D, Zhang Z, Agarwal B, Challagulla K, Mani S, Kalpana GV. Oncogene~ 25(5):722-734, FEB 2006 2006;(5):-734, FEB.aTargeting cyclin D1, a downstream effector of INI1/hSNF5, in rhabdoid tumors. arcon-Vargas D, Zhang Z, Agarwal B, Challagulla K, Mani S, Kalpana GV. Oncogene~ 25(5):722-734, FEB 2006 2006;(5):-734, FEB. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43253 |
| Study title: Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia. Lawrence SE, Arnold FK, Vethamuthu J, Lawson ML. Journal of Pediatrics 145(1)()(pp 71-76), 2004 Date of Publication: Jul 2004 2004;(1):71-76.Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia. Lawrence SE, Arnold FK, Vethamuthu J, Lawson ML. Journal of Pediatrics 145(1)()(pp 71-76), 2004 Date of Publication: Jul 2004 2004;(1):71-76. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43267 |
| Study title: Degreef H, Marien K, De Veylder H, Duprez K, Borghys A, Verhoeve L Itraconazole in the treatment of dermatophytoses: A comparison of two daily dosages. Reviews of infectious diseases 9 suppl.1, p.S104-S108, 1987. (6-81 years, LMD45556)Degreef H, Marien K, De Veylder H, Duprez K, Borghys A, Verhoeve L Itraconazole in the treatment of dermatophytoses: A comparison of two daily dosages. Reviews of infectious diseases 9 suppl.1, p.S104-S108, 1987. (6-81 years, LMD45556) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30798 |
| Study title: Del Palacio Hernanz A double-blind randomized comparison of itraconazole with griseofulvin in the treatment of tinea pedis and tinea manus. Clinical research report on R051211 no-62, May 1987. (17-54 years, LMD56440)Del Palacio Hernanz A double-blind randomized comparison of itraconazole with griseofulvin in the treatment of tinea pedis and tinea manus. Clinical research report on R051211 no-62, May 1987. (17-54 years, LMD56440) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30785 |
| Study title: Del Palacio Hernanz A double-blind randomized comparison of itraconazole with griseofulvin in the treatment ot tinea corporis ans tinea cruris. Clinical research report on R051211 no-64, May 1987. (17-67 years, LMD56219)Del Palacio Hernanz A double-blind randomized comparison of itraconazole with griseofulvin in the treatment ot tinea corporis ans tinea cruris. Clinical research report on R051211 no-64, May 1987. (17-67 years, LMD56219) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30783 |
| Study title: Del Palacio Hernanz A, Delgado Vicente S, Menendez Ramos F, Rodriquez-Noriega Belaustegui A. Radomized comparative clinical trial of itraconazole and selenium sulfide shampoo for the treatment of pityriasis vesicolor. Reviews of infectious diseases 9 suppl.1, p.S121-S127, 1987. (17-63 years, LMD45550)Del Palacio Hernanz A, Delgado Vicente S, Menendez Ramos F, Rodriquez-Noriega Belaustegui A. Radomized comparative clinical trial of itraconazole and selenium sulfide shampoo for the treatment of pityriasis vesicolor. Reviews of infectious diseases 9 suppl.1, p.S121-S127, 1987. (17-63 years, LMD45550) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30802 |
| Study title: Del Palacio Hernanz A, Frias-Iniesta J, Gonzalez-Valle O, Borgers M, Van Cutsem J, Cauvwenbergh G. Itraconazole therapy in pityriasis versicolor. British journal of dermatology 115, p.217-225, 1986. (17-71 years, LMD45458)Del Palacio Hernanz A, Frias-Iniesta J, Gonzalez-Valle O, Borgers M, Van Cutsem J, Cauvwenbergh G. Itraconazole therapy in pityriasis versicolor. British journal of dermatology 115, p.217-225, 1986. (17-71 years, LMD45458) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30803 |
| Study title: SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27422 |
| Study title: SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27424 |
| Study title: SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27787 |
| Study title: SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27789 |
| Study title: SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FLUCONAZOLE IN PATIENTS WITH SYSTEMIC CANDIDIASIS OR CRYPTOCOCCAL MENINGITIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27410 |
| Study title: SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FLUCONAZOLE IN PATIENTS WITH SYSTEMIC CANDIDIASIS OR CRYPTOCOCCAL MENINGITIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27775 |
| Study title: F. Rosaschino, L. Cattaneo, Strategies for optimizing compliance of paediatric patients for seasonal antibacterial vaccination with sublingually administered Polyvalent Mechanical Bacterial Lysates (PMBL), ACTA BIO MEDICA ATENEO PARMENSE 2004; 75; 171-178, |
| Active substance: Klebsiella pneumoniae;Streptococcus pyogenes;Diplococcus pneumoniae;Staphylococcus aureus;Neisseria catarrhalis;Streptococcus viridans;Haemophilus influenzae;Klebsiella ozaenae; |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41339 |
| Study title: I. La Mantia, F. Nicolosi, L. Maiolino, A. Serra, Immunoprophylaxis of recurring bacterial infections of respiratory tracts in pediatric age: clinical experience through a new immunostimulating vaccine, GIMMOC Quaderni di Microbiologia e Clinica, Vol XI, Q2, 2007, p1-8. |
| Active substance: Klebsiella pneumoniae;Streptococcus pyogenes;Diplococcus pneumoniae;Staphylococcus aureus;Neisseria catarrhalis;Streptococcus viridans;Haemophilus influenzae;Klebsiella ozaenae; |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41338 |
| Study title: Effects and side effects of mydriatic eyedrops in neonates. O?üt MS, Bozkurt N, Ozek E, Birgen H, Kazoko?lú H, O?üt M. Eur J Ophthalmol. 1996 Apr-Jun;6(2):192-6. Effects and side effects of mydriatic eyedrops in neonates. O?üt MS, Bozkurt N, Ozek E, Birgen H, Kazoko?lú H, O?üt M. Eur J Ophthalmol. 1996 Apr-Jun;6(2):192-6. |
| Active substance: TROPICAMIDE |
| Study summary document link (including results): Effects and side effects of mydriatic eyedrops in neonates.pdf |
| View full study record |
| Document reference: 46875 |
| Study title: Evaluation of potentiating effect of a drop of lignocaine on tropicamide-induced mydriasis. Ghose S, Garodia VK, Sachdev MS, Kumar H, Biswas NR, Pandey RM. Invest Ophthalmol Vis Sci. 2001 Jun;42(7):1581-5. Evaluation of potentiating effect of a drop of lignocaine on tropicamide-induced mydriasis. Ghose S, Garodia VK, Sachdev MS, Kumar H, Biswas NR, Pandey RM. Invest Ophthalmol Vis Sci. 2001 Jun;42(7):1581-5. |
| Active substance: TROPICAMIDE |
| Study summary document link (including results): Evaluation of potentiating effect of a drop of lignocaine.pdf |
| View full study record |
| Document reference: 46871 |
| Study title: Seasonal variation in myopia progression and ocular elongation. Fulk GW, Cyert LA, Parker DA. Optom Vis Sci. 2002 Jan;79(1):46-51. 9. Baseline refractive and ocular component measures of children enrolled in the correction of myopia evaluation trial (COMET). Gwiazda J, Marsh-Tootle WL, Hyman L, Hussein M, Norton TT; COMET Study Group. Invest Ophthalmol Vis Sci. 2002 Feb;43(2):314-21. Seasonal variation in myopia progression and ocular elongation. Fulk GW, Cyert LA, Parker DA. Optom Vis Sci. 2002 Jan;79(1):46-51. 9. Baseline refractive and ocular component measures of children enrolled in the correction of myopia evaluation trial (COMET). Gwiazda J, Marsh-Tootle WL, Hyman L, Hussein M, Norton TT; COMET Study Group. Invest Ophthalmol Vis Sci. 2002 Feb;43(2):314-21. |
| Active substance: TROPICAMIDE |
| Study summary document link (including results): Seasonal variation in myopia progression and ocular elongati.pdf |
| View full study record |
| Document reference: 46869 |
| Study title: Taggart AJ, McDermott BJ, Roberts SD. The effect of age and acetylator phenotype on the pharmacokinetics of sulfasalazine in patients with rheumatoid arthritis. Clin Pharmacokinet 23 (1992) 311-320.Taggart AJ, McDermott BJ, Roberts SD. The effect of age and acetylator phenotype on the pharmacokinetics of sulfasalazine in patients with rheumatoid arthritis. Clin Pharmacokinet 23 (1992) 311-320. |
| Active substance: SULFASALAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42899 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Sulfur-Heel (tablets) [AWB-AT] |
| Active substance: Sulfur comp.-Heel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40247 |
| Study title: SAFETY AND EFFICACY OF TWO DIFFERENT DOSAGE OF FLUCONAZOLE IN PATIENTS WITH TINEA VERSICOLOR. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27370 |
| Study title: SAFETY AND EFFICACY OF TWO DIFFERENT DOSAGE OF FLUCONAZOLE IN PATIENTS WITH TINEA VERSICOLOR. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27735 |
| Study title: SAFETY, ACCEPTANCE, TOLERATION AND EFFICACY OF FLUCONAZOLE IN COMPARISON WITH ORAL POLYENES IN PATIENTS ON ISOLATION. ALSO TO ESTIMATE FEASIBILITY OF SUCH A TRIAL IN MULTICENTER SETTING. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27395 |
| Study title: SAFETY, ACCEPTANCE, TOLERATION AND EFFICACY OF FLUCONAZOLE IN COMPARISON WITH ORAL POLYENES IN PATIENTS ON ISOLATION. ALSO TO ESTIMATE FEASIBILITY OF SUCH A TRIAL IN MULTICENTER SETTING. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27760 |
| Study title: SECONDARY PREVENTION OF OROPHARYNGEAL CANDIDIASIS IN HIV+ PATIENTS. A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, CONTROLLED STUDY WITH FOCUS ON RESISTANCE TO FLUCONAZOLE THERAPY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27402 |
| Study title: SECONDARY PREVENTION OF OROPHARYNGEAL CANDIDIASIS IN HIV+ PATIENTS. A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, CONTROLLED STUDY WITH FOCUS ON RESISTANCE TO FLUCONAZOLE THERAPY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27767 |
| Study title: SINGLE DOSE THERAPY FOR ORAL CANDIDIASIS WITH FCA IN HIV-INFECTED ADULTS: A PILOT STUDY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27392 |
| Study title: SINGLE DOSE THERAPY FOR ORAL CANDIDIASIS WITH FCA IN HIV-INFECTED ADULTS: A PILOT STUDY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27757 |
| Study title: STUDY TO ASSESS THE PHARMACOKINETICS OF A SINGLE ORAL OR INTRAVENOUS DOSE OF FLUCONAZOLE ADMINISTERED TO FULL TERM NEONATES |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27339 |
| Study title: Di Fonzo EM, Biggio P, Tulli A, Binazzi M, Ippolito F Oral itraconazole in the treatment of dermatomycoses. August 1987. (12-68 years, LMD56449)Di Fonzo EM, Biggio P, Tulli A, Binazzi M, Ippolito F Oral itraconazole in the treatment of dermatomycoses. August 1987. (12-68 years, LMD56449) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30791 |
| Study title: Dom J, Goyvaerts H, Moens M, Schuermans V, Cauwenbergh G. Itraconazole in the treatment of pityriasis versicolor. A combined analysis of 15 clinical trials including about 600 patients. Clinical research report on R051211 no-68, June 1987. (10-78 years, LMD56299)Dom J, Goyvaerts H, Moens M, Schuermans V, Cauwenbergh G. Itraconazole in the treatment of pityriasis versicolor. A combined analysis of 15 clinical trials including about 600 patients. Clinical research report on R051211 no-68, June 1987. (10-78 years, LMD56299) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30812 |
| Study title: Dominguez L, Lavalle P, Peremans W, 'T Kint R, Willemsen M, Mertens RLJ. Itraconazole for 2 or 4 weeks in the treatment of dermatophyte infections of the skin: A combined analysis of double-blind placebo-controlled studies. Clinical research report on R051211 no-78, June 1987. (15-69 years, LMD56443)Dominguez L, Lavalle P, Peremans W, 'T Kint R, Willemsen M, Mertens RLJ. Itraconazole for 2 or 4 weeks in the treatment of dermatophyte infections of the skin: A combined analysis of double-blind placebo-controlled studies. Clinical research report on R051211 no-78, June 1987. (15-69 years, LMD56443) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30781 |
| Study title: Duran de Rueda MM Oral itraconazole in the treatment of tinea pedis. Clinical summary on R51211, August 1987. (16-83 years, LMD56455)Duran de Rueda MM Oral itraconazole in the treatment of tinea pedis. Clinical summary on R51211, August 1987. (16-83 years, LMD56455) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30797 |
| Study title: O. T.Aksic, F.Rosaschino, L. Cattaneo, The evaluation of the clinical efficacy of a Polyvalent Mechanical Bacterial Lysate (PMBL) in a sample of 180 children of school age with recurrent respiratory infections, European Journal of Aerobiology, Environmental Medicine and Air-borne Infections, Vol 1, number 1/2005, p3-7 |
| Active substance: Klebsiella pneumoniae;Streptococcus pyogenes;Diplococcus pneumoniae;Staphylococcus aureus;Neisseria catarrhalis;Streptococcus viridans;Haemophilus influenzae;Klebsiella ozaenae; |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41340 |
| Study title: Effect of a Symphytum Ointment with Sports Injuries of the Knee Joint (Wirkung einer Symphytum-Salbe bei Sportver-letzungen des Kniegelenkes) |
| Active substance: Kulturbeinwell / Preparation of fresh Symphytum x uplandicum herb (2-3:1) consisting of: 0.4 g of pressed juice of fresh Symphytum x uplandicum herb (3-8:1) and 0.6 g extract of the press residue of fresh Symphytum x uplandicum herb (3-10:1); solvent ethanol 30 % V/V - "HERB"/ Symphyti herbae recens succus liquidum (2-3:1), extr. solvent ethanol 30 % (Symphytum concentrat... |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40044 |
| Study title: Non-stimulant treatment of attention-deficit/hyperactivity disorder. SR Pliszka, CNS Spectrums 2003, 8(4): 253-8. Non-stimulant treatment of attention-deficit/hyperactivity disorder. SR Pliszka, CNS Spectrums 2003, 8(4): 253-8. |
| Active substance: MODAFINIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45672 |
| Study title: 13C-Urea breath test threshold calculation and evaluation for the detection of Helicobacter pylori infection in childrenStudy of the efficacy and tolerability of sodium valproate in the treatment of partial seizure and generalized epilepsy - Bittencourt P.R.M. - 4/03/1996 |
| Active substance: UREA |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39145 |
| Study title: 13C-Urea Breath Test to Diagnose Helicobactyer Pylori Infection in Children Aged up to 6 Years |
| Active substance: UREA |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39146 |
| Study title: A 13C –urea breath test in children with Helicobacter pylori infection: assessment of eradication therapy and follow-up treatmentStatus Epilepticus in children. Experience with intravenous valproate. Update of treatment guidelines - Campistol and al. - 1999 ( Rev. Neurol.1999 - 29 : 359-65 ) Publication 1 in Ergenyl Via Expert report on the clinical documentation - Hufnagel A. - 14/11/2006 |
| Active substance: UREA |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39144 |
| Study title: A rapid lateral flow stool antigen immunoassay and 14C-urea breath test for the diagnosis and eradication of Helicobacter pylori infection in childrenSodium Vallproate in status epilepticus - S. JHA 2003 (Neurol. India - 2003 - 51:421-2) Publication in Epilim-Reports of clinical studies Vol II - E. TRINKA - 06/11/2006 |
| Active substance: UREA |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39141 |
| Study title: Diagnostic accuracy of the 13C-urea breath test in children: Adjustment of the cut-off value according to ageTeratogenic effects of antiepileptic drugs: use of an international database on malformations and drug exposure (MADRE). - Arpino C et al. - Epilepsia 2000;41(11):1436-43. |
| Active substance: UREA |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39147 |
| Study title: Frequency of Helicobacter Pylori infection in children under 4 years of ageThe epilepsies – febrile convulsions. - Trescher WH et al. - In : WG Bradley et al. Neurology in clinical practice. 4th edition. Elsevier edition 2004; vol II, chapter 73: 1963-64. |
| Active substance: UREA |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39148 |
| Study title: Helicobacter pylori Infection in Pediatrics |
| Active substance: UREA |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39150 |
| Study title: No radiation protection reasons for restrictions on 14C urea breath tests in childrenSodium Vallproate in status epilepticus - S. JHA 2003 (Neurol. India - 2003 - 51:421-2) Publication in Epilim-Reports of clinical studies Vol II - E. TRINKA - 06/11/2006 |
| Active substance: UREA |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39142 |
| Study title: Retrospective survey for documentation of appllication and dosage of Sulfur comp.-Heel (tablets) in children < 12 years of age [Bef-020] |
| Active substance: Sulfur comp.-Heel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40246 |
| Study title: A CLINICAL EVALUATION OF STM FINE GRANULES FOR SUPPURATIVE OTITIS MEDIA OF CHILDREN. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43007 |
| Study title: A COMPARATIVE PHARMACOKINETIC STUDY OF SULTAMICILLIN (CP-49,952) AND AMPICILLIN IN INFANTS AND YOUNG CHILDREN. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42915 |
| Study title: A COMPARATIVE STUDY OF STM IN THE TREATMENT OF ACUTE TONSILLITIS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42958 |
| Study title: A COMPARATIVE STUDY OF STM IN THE TREATMENT OF SUPPURATIVE OTITIS MEDIA |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42959 |
| Study title: A COMPARATIVE STUDY OF SULTAMICILLIN AND AUGMENTIN IN THE TREATMENT OF ACUTE SUPPURATIVE OTITIS MEDIA IN CHILDREN. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42911 |
| Study title: A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH AMOXYCILLIN OR CLOXACILLIN, AS APPROPRIATE, IN THE TREATMENT OF INFECTION IN CHILDREN. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42938 |
| Study title: A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH AMOXYCILLIN OR CLOXACILLIN, AS APPROPRIATE, IN THE TREATMENT OF INFECTION IN CHILDREN. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42939 |
| Study title: A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH AMOXYCILLIN OR CLOXACILLIN, AS APPROPRIATE, IN THE TREATMENT OF INFECTION IN CHILDREN. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42940 |
| Study title: A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH AMOXYCILLIN OR CLOXACILLIN, AS APPROPRIATE, IN THE TREATMENT OF INFECTION IN CHILDREN. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42941 |
| Study title: A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH AMOXYCILLIN OR CLOXACILLIN, AS APPROPRIATE, IN THE TREATMENT OF INFECTION IN CHILDREN. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42942 |
| Study title: A DOUBLE BLIND COMPARATIVE STUDY OF STM IN THE TREATMENT OF DERMAL INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42957 |
| Study title: A DOUBLE-BLIND COMPARATIVE STUDY OF STM IN THE TREATMENT OF COMPLICATED URINARY TRACT INFECTIONS |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42960 |
| Study title: A MULTICENTER NON-COMPARATIVE STUDY FOR THE TREATMENT OF MODERATE UPPER RESPIRATORY TRACT INFECTION IN ADULT PATIENTS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43045 |
| Study title: A MULTICENTER NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF STM FOR THE TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS IN PEDIATRIC PATIENTS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43044 |
| Study title: A MULTICENTER STUDY OF SULTAMICILLIN (CP-49,952) A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICLLIN COMPARED WITH FLUCLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42943 |
| Study title: Evaluation of itraconazole oral solution in infants with oral thrush: an open trial comparing three, five or seven days of treatment with ten days of nystatin treatment. |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45128 |
| Study title: Evaluation of itraconazole solution in infants with oral thrush: a multicentre trial comparing four different treatment durations. |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): LMD129326_Interventional_Itraconazole.xls |
| View full study record |
| Document reference: 45127 |
| Study title: Feuilhade M Oral itraconazole in the treatment of tinea pedis and tinea manus. Clinical summary on R51211, August 1987. (16-57 years, LMD56452)Feuilhade M Oral itraconazole in the treatment of tinea pedis and tinea manus. Clinical summary on R51211, August 1987. (16-57 years, LMD56452) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30794 |
| Study title: Goyvaerts H, Dom J, De Dier AM, Schuermans V, Cauwenbergh G. Itraconazole in the treatment of vulvovaginal yeast infections. A combined analysis of 18 clinical trials in 1374 patients. Clinical research report on R051211 no-72, June 1987. (16-79 years, LMD56319)Goyvaerts H, Dom J, De Dier AM, Schuermans V, Cauwenbergh G. Itraconazole in the treatment of vulvovaginal yeast infections. A combined analysis of 18 clinical trials in 1374 patients. Clinical research report on R051211 no-72, June 1987. (16-79 years, LMD56319) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30814 |
| Study title: Graybill J. Bone radiography and serum calcium and phosphorus levels during itraconazole treatment in a young patient with progressive coccidioidomycosis. Clinical research report on R051211 no-66, June 1987. (1.5 years, LMD56178)Graybill J. Bone radiography and serum calcium and phosphorus levels during itraconazole treatment in a young patient with progressive coccidioidomycosis. Clinical research report on R051211 no-66, June 1987. (1.5 years, LMD56178) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30806 |
| Study title: Hay RJ, Clayton YM Treatment of chronic dermatophytosis and chronic oral candidosis with oral itraconazole. Reviews of infectious diseases 9 suppl.1, p.S114-S118, 1987. (16-52 years, LMD45551)Hay RJ, Clayton YM Treatment of chronic dermatophytosis and chronic oral candidosis with oral itraconazole. Reviews of infectious diseases 9 suppl.1, p.S114-S118, 1987. (16-52 years, LMD45551) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30799 |
| Study title: Hay RJ, Clayton YM. Treatment of chronic dermatophytosis and chronic oral candidosis with itraconazole. Reviews of infectious diseases 9 suppl.1, p.S114-S118, 1987. (16-52 years, LMD45551)Hay RJ, Clayton YM. Treatment of chronic dermatophytosis and chronic oral candidosis with itraconazole. Reviews of infectious diseases 9 suppl.1, p.S114-S118, 1987. (16-52 years, LMD45551) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30801 |
| Study title: Hull PR, Decroix J Double-blind comparison of itraconazole 100 MG o.d. with griseofulvin 500 mg o.d. in the treatment of dermatophyte infections of the skin. A combined analysis of two studies ot the time to negativation and time to response. Clinical research report on R051211 no-80, August 1987. (6-58 years, LMD56457)Hull PR, Decroix J Double-blind comparison of itraconazole 100 MG o.d. with griseofulvin 500 mg o.d. in the treatment of dermatophyte infections of the skin. A combined analysis of two studies ot the time to negativation and time to response. Clinical research report on R051211 no-80, August 1987. (6-58 years, LMD56457) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30782 |
| Study title: Kamp H, et al Oral itraconazole in the treatment of dermatomycoses. Clinical summary on R51211, August 1987. (13-82 years, LMD56446)Kamp H, et al Oral itraconazole in the treatment of dermatomycoses. Clinical summary on R51211, August 1987. (13-82 years, LMD56446) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30788 |
| Study title: Ketele A et al. Itraconazole in the treatment of dermatomycoses. A combined analysis of 18 clinical trials including over 1400 patients.Clinical research on R051211 no-70, May 1987. (10-75 years, LMD56441)Ketele A et al. Itraconazole in the treatment of dermatomycoses. A combined analysis of 18 clinical trials including over 1400 patients.Clinical research on R051211 no-70, May 1987. (10-75 years, LMD56441) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30776 |
| Study title: Lachapelle JM et al. Itraconazole compared with griseofulvin in the treatment of Tinea corporis/cruris and Tinea pedis/manus: an interpretation of the clinical results of all completed double-blind studies with respect to the pharmacokinetic profile. Dermatology 184:45, 1992. (6-58 years, LMD81740)Lachapelle JM et al. Itraconazole compared with griseofulvin in the treatment of Tinea corporis/cruris and Tinea pedis/manus: an interpretation of the clinical results of all completed double-blind studies with respect to the pharmacokinetic profile. Dermatology 184:45, 1992. (6-58 years, LMD81740) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30780 |
| Study title: Open Study of the Effect of Modafinil on Urinary Disorders in Relation to “Stress” Incontinence. |
| Active substance: MODAFINIL |
| Study summary document link (including results): EUdraCT_reduced_datafields_for_Interim_publication-Modafinil.xls |
| View full study record |
| Document reference: 45286 |
| Study title: Pharmacokinetics and effect of modafinil in children with ADHD.Labellarte MJ; 47th Meet Am Acad Child Adolesc Psychiatry 2000;116 |
| Active substance: MODAFINIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45658 |
| Study title: "Sleep latency on the maintenance of wakefulness test (MWT) for 530 patients with narcolepsy while free of psychoactive drugs. MM Mitler, et al., Electroencephalography and Clinical Neurophysiology 1998, 107(1): 33-8. "Sleep latency on the maintenance of wakefulness test (MWT) for 530 patients with narcolepsy while free of psychoactive drugs. MM Mitler, et al., Electroencephalography and Clinical Neurophysiology 1998, 107(1): 33-8. |
| Active substance: MODAFINIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45665 |
| Study title: Study of the Effect of Modafinil in Children Presenting Psycho-intellectual and Motor Retardation. |
| Active substance: MODAFINIL |
| Study summary document link (including results): EUdraCT_reduced_datafields_for_Interim_publication-Modafinil.xls |
| View full study record |
| Document reference: 45287 |
| Study title: A comparison of once-daily application of mometasone furoate 0.1% cream compared with twice-daily hydrocortisone valerate 0.2% cream in pediatric atopic dermatitis patients who failed to respond to hydrocortisone. Lebwohl, Mark MD; The mometasone furoate study group. International Journal of Dermatology. 38(8):604-606, August 1999.A comparison of once-daily application of mometasone furoate 0.1% cream compared with twice-daily hydrocortisone valerate 0.2% cream in pediatric atopic dermatitis patients who failed to respond to hydrocortisone. Lebwohl, Mark MD; The mometasone furoate study group. International Journal of Dermatology. 38(8):604-606, August 1999. |
| Active substance: MOMETAZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32284 |
| Study title: Tropicamide (1%): an effective cycloplegic agent for myopic children. Manny RE, Hussein M, Scheiman M, Kurtz D, Niemann K, Zinzer K; COMET Study Group. Invest Ophthalmol Vis Sci. 2001 Jul;42(8):1728-35. Tropicamide (1%): an effective cycloplegic agent for myopic children. Manny RE, Hussein M, Scheiman M, Kurtz D, Niemann K, Zinzer K; COMET Study Group. Invest Ophthalmol Vis Sci. 2001 Jul;42(8):1728-35. |
| Active substance: TROPICAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46870 |
| Study title: Assessment of tolerance and immunogenicity of a ViCPs vaccine at 2 dosages |
| Active substance: Typhoid Vi Polysaccharide Vaccine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47480 |
| Study title: Double blind, controlled trial testing the immunogenicity and side effects of parenteral Vi polysaccharide typhoid vaccine in Indonesian children and adults |
| Active substance: Typhoid Vi Polysaccharide Vaccine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47483 |
| Study title: Effectiveness of a Vi capsular polysaccharide vaccine |
| Active substance: Typhoid Vi Polysaccharide Vaccine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47481 |
| Study title: Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi |
| Active substance: Typhoid Vi Polysaccharide Vaccine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47479 |
| Study title: Safety and dose related immunogenicity of the Vi capsular polysaccharide of Salmonella typhi (Pilot study) |
| Active substance: Typhoid Vi Polysaccharide Vaccine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47478 |
| Study title: Safety and immunogenicity of Vi CPS vaccine in teenagers |
| Active substance: Typhoid Vi Polysaccharide Vaccine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47482 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Ubichinon compositum Ampullen (ampoules) [AWB-AT] |
| Active substance: Ubichinon compositum |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40295 |
| Study title: The effect of coenzyme Q10 in ideopathic dilated cardiomyopathy in children. |
| Active substance: UBIDECARENONE (CO-ENZYME Q10) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39140 |
| Study title: A MULTICENTER SULTAMICILLIN (CP-45,952) PHASE II STUDY. A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH CLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42927 |
| Study title: A MULTICENTER SULTAMICILLIN (CP-45,952) PHASE II STUDY. A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH CLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42928 |
| Study title: A MULTICENTER SULTAMICILLIN (CP-45,952) PHASE II STUDY. A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH CLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42929 |
| Study title: A MULTICENTER SULTAMICILLIN (CP-45,952) PHASE II STUDY. A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH CLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42930 |
| Study title: A MULTICENTER SULTAMICILLIN (CP-45,952) PHASE II STUDY. A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH CLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42931 |
| Study title: A MULTICENTER SULTAMICILLIN (CP-45,952) PHASE II STUDY. A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH CLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42932 |
| Study title: A MULTICENTER SULTAMICILLIN (CP-45,952) PHASE II STUDY. A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH CLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42933 |
| Study title: A MULTICENTER SULTAMICILLIN (CP-45,952) PHASE II STUDY. A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH CLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42934 |
| Study title: A MULTICENTER SULTAMICILLIN (CP-45,952) PHASE II STUDY. A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH CLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42935 |
| Study title: A MULTICENTER SULTAMICILLIN (CP-45,952) PHASE II STUDY. A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH CLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42936 |
| Study title: A MULTICENTER SULTAMICILLIN (CP-45,952) PHASE II STUDY. A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH CLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42937 |
| Study title: A MULTICENTER SULTAMICILLIN (CP-49,952-15) PHASE III STUDY. A THIRD PARTY BLINDED COMPARATIVE STUDY OF SULTAMICILLIN (CP-49,952-15) AND AUGMENTIN FOR THE ASSESSMENT OF EFFICACY IN THE TREATMENT OF LOWER RESPIRATORY TRACT INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42912 |
| Study title: A NON COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF SULTAMICILLIN FOR THE TREATMENT OF SKIN AND SOFT TISSUE PEDIATRIC INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43037 |
| Study title: A NON COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF SULTAMICILLIN FOR THE TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42971 |
| Study title: A NON-COMPARATIVE SHORT-TERM, OPEN STUDY OF EFFICACY AND TOLERABILITY OF ORAL SULTAMICILLIN SUSPENSION IN THE TREATMENT OF VARIOUS INFECTIONS IN PEDIATRIC INPATIENTS/OUTPATIENTS |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42989 |
| Study title: A NON-COMPARATIVE STUDY OF SAFETY AND EFFICACY OF ORAL SULTAMICILLIN IN THE TREATMENT OF MODERATE PEDIATRIC INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43042 |
| Study title: A NON-COMPARATIVE STUDY OF SAFETY AND EFFICACY OF ORAL SULTAMICILLIN IN THE TREATMENT OF MODERATE PEDIATRIC INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43043 |
| Study title: A NON-COMPARATIVE STUDY OF SULTAMICILLIN SUSPENSION IN THE TREATMENT OF ACUTE SUPPURATIVE OTITIS MEDIA IN CHILDREN. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42920 |
| Study title: Månsson T., Blychert LO, Åberg Å. The efficacy of itraconazole in dermatophyte infections in comparison with griseofulvin. Clinical study report, Janssen Pharma, Sweden, 1993. (12-72 years, LMD102676)Månsson T., Blychert LO, Åberg Å. The efficacy of itraconazole in dermatophyte infections in comparison with griseofulvin. Clinical study report, Janssen Pharma, Sweden, 1993. (12-72 years, LMD102676) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30778 |
| Study title: Mariano A, Rocha MM Oral itraconazole in the treatment of dermatomycoses. Clinical summary on R51211, August 1987. (10-84 years, LMD56450)Mariano A, Rocha MM Oral itraconazole in the treatment of dermatomycoses. Clinical summary on R51211, August 1987. (10-84 years, LMD56450) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30792 |
| Study title: Moens M, Van Meensel A, Willems W, Schuermans V, Cauwenbergh G. Combined analyses of adverse experiences and clinical laboratory data related to safety in patients treated with itraconazole for vulvovaginal candidosis, pityriasis versicolor, dermatomycoses, oral candidosis and fungal keratitis. Clinical research report on R051211 no-87, September 1987. (<15->65 years, LMD56766).Moens M, Van Meensel A, Willems W, Schuermans V, Cauwenbergh G. Combined analyses of adverse experiences and clinical laboratory data related to safety in patients treated with itraconazole for vulvovaginal candidosis, pityriasis versicolor, dermatomycoses, oral candidosis and fungal keratitis. Clinical research report on R051211 no-87, September 1987. (<15->65 years, LMD56766). |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30817 |
| Study title: Open-label, single-centre, active control (nystatin), four parallel group study. |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): LMD118956_Interventional_Itraconazole.xls |
| View full study record |
| Document reference: 47579 |
| Study title: Panagiotidou D et al. A comparison of itraconazole and griseofulvin in the treatment of tinea corporis and tinea cruris: a double-blind study.The journal of international medical research 20, p.392-400, 1992. (17-70 years, LMD88424)Panagiotidou D et al. A comparison of itraconazole and griseofulvin in the treatment of tinea corporis and tinea cruris: a double-blind study.The journal of international medical research 20, p.392-400, 1992. (17-70 years, LMD88424) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30777 |
| Study title: Panconesi E, Difonzo E Treatment of dermatophytoses and pityriasis versicolor with itraconazole. Reviews of infectious diseases 9 suppl.1, p.S109-S113, 1987. (15-45 years, LMD51772)Panconesi E, Difonzo E Treatment of dermatophytoses and pityriasis versicolor with itraconazole. Reviews of infectious diseases 9 suppl.1, p.S109-S113, 1987. (15-45 years, LMD51772) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30790 |
| Study title: Pharmacokinetic study of itraconazole oral solution during chronic treatment in neutropenic children. (ITR-FRA-7) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): LMD129355_Interventional_Itraconazole.xls |
| View full study record |
| Document reference: 45126 |
| Study title: Phillips P, Graybill JR, Fetchick R, Dunn JF. Adrenal response to corticotropin during therapy with itraconazole. Antimicrobial agents and chemotherapy 31 (4), p.647-649, 1987. (7-72 years, LMD54302)Phillips P, Graybill JR, Fetchick R, Dunn JF. Adrenal response to corticotropin during therapy with itraconazole. Antimicrobial agents and chemotherapy 31 (4), p.647-649, 1987. (7-72 years, LMD54302) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30807 |
| Study title: Rees T, Phillips R. Multicenter comparison of one-day oral therapy with fluconazole or itraconazole in vaginal candidiasis. International journal of gynecology and obstetrics 37 (suppl.), p.33-38, 1992. (17-68 years, LMD95334)Rees T, Phillips R. Multicenter comparison of one-day oral therapy with fluconazole or itraconazole in vaginal candidiasis. International journal of gynecology and obstetrics 37 (suppl.), p.33-38, 1992. (17-68 years, LMD95334) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30800 |
| Study title: Repeated-dose pharmacokinetics of itraconazole in oral solution, 5 mg/kg once daily for two weeks, in infants and children.(ITR-INT-21) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): LMD118873_Interventional_Itraconazole.xls |
| View full study record |
| Document reference: 45125 |
| Study title: Comparison of mometasone furoate 0.1% cream and hydrocortisone 1.0% cream in the treatment of childhood atopic dermatitis. Vernon HJ, Lane AT, Weston W. J Am Acad Dermatol. 1991 Apr; 24(4):603-7.Comparison of mometasone furoate 0.1% cream and hydrocortisone 1.0% cream in the treatment of childhood atopic dermatitis. Vernon HJ, Lane AT, Weston W. J Am Acad Dermatol. 1991 Apr; 24(4):603-7. |
| Active substance: MOMETAZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32282 |
| Study title: Efficacy and Safety of Nasonex vs. Placebo in Subjects with SAR and Concomitant Asthma |
| Active substance: MOMETAZONE |
| Study summary document link (including results): Nasonex_Mometasone furoate_P03280.pdf |
| View full study record |
| Document reference: 47645 |
| Study title: Mometasone furoate in the treatment of atopic dermatitis in children; Publication on Journal of the European Academy of dermatology & Dermatology 2(1993)225 Mometasone furoate in the treatment of atopic dermatitis in children; Publication on Journal of the European Academy of dermatology & Dermatology 2(1993)225 |
| Active substance: MOMETAZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32281 |
| Study title: Mometasone furoate nasal spray vs placebo in subjects with allergic rhinitis and cough. |
| Active substance: MOMETAZONE |
| Study summary document link (including results): P01970.pdf |
| View full study record |
| Document reference: 48186 |
| Study title: One-Year, Double-Blind Safety Study of the Effects of Mometasone Furoate (SCH 32088) Dry Powder Inhaler (MF DPI) vs. Placebo on Growth of Children With Asthma |
| Active substance: MOMETAZONE |
| Study summary document link (including results): C97-384_mometasone furoate.pdf |
| View full study record |
| Document reference: 48178 |
| Study title: Rockland L, et al. Effects of trihexyphenidyl on plasma chlorpromazine in young schizophrenics. Can J Psychiatry 1990 Oct; 35(7): 604-7. Erratum Can J Psychiatry 1991 Feb;36(1):73Rockland L, et al. Effects of trihexyphenidyl on plasma chlorpromazine in young schizophrenics. Can J Psychiatry 1990 Oct; 35(7): 604-7. Erratum Can J Psychiatry 1991 Feb;36(1):73 |
| Active substance: TRIHEXYPHENIDYL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46742 |
| Study title: Sanger TD, et al. Prospective open-label clinical trial of trihexyphenidyl in children with secondary dystonia due to cerebral palsy. J Child Neurol 2007 May; 22(5): 530-7.Sanger TD, et al. Prospective open-label clinical trial of trihexyphenidyl in children with secondary dystonia due to cerebral palsy. J Child Neurol 2007 May; 22(5): 530-7. |
| Active substance: TRIHEXYPHENIDYL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46736 |
| Study title: A NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL SULTAMICILLIN IN PEDIATRIC PATIENTS WITH MODERATE RESPIRATORY TRACT OR SKIN/SOFT TISSUE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43020 |
| Study title: A NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL SULTAMICILLIN IN THE TREATMENT OF MODERATE PEDIATRIC INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43038 |
| Study title: A PROSPECTIVE, RANDOMIZED, THIRD-PARTY BLINDED, PLACEBO CONTROLLED EVALUATION OF AMPICILLIN/SULBACTAM VERSUS CLINDAMYCIN AS ADJUNCTIVE TREATMENT FOR WOMEN EXPERIENCING PRETERM LABOR |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42944 |
| Study title: A RANDOMIZED, OPEN LABEL, MULTICENTER TRIAL COMPARING ORAL SULTAMICILLIN 750 MG DAILY FOR 10 DAYS WITH AMOXICILLIN/CLAVULANIC 1500 MG DAILY FOR 10 DAYS FOR THE TREATMENT OF ACUTE EAR, NOSE AND THROAT INFECTIONS |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42919 |
| Study title: A STUDY OF THE PENETRATION CHARACTERISTICS OF SULTAMICILLIN (CP-49,952) INTO THE MIDDLE EAR FLUID OF PEDIATRIC PATIENTS WITH CHRONIC SERIOUS OTITIS MEDIA. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42910 |
| Study title: A THIRD PARTED BLINDED COMPARATIVE STUDY OF SULTAMICILLIN (CP-49,952) AND PENICILLIN V-K FOR THE ASSESSMENT OF SAFETY AND EFFICACY IN THE TREATMENT OF UPPER RESPIRATORY INFECTIONS IN PEDIATRIC PATIENTS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42926 |
| Study title: A THIRD PARTY BLINDED COMPARATIVE STUDY OF SULTAMACILLIN (CP-49,952-15) AND PENICILLIN V-K FOR THE ASSESSMENT OF SAFETY AND EFFICACY IN THE TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42925 |
| Study title: A THIRD PARTY BLINDED COMPARATIVE STUDY OF SULTAMICILLIN (CP-49,952-15) AND AMOXICILLIN FOR THE ASSESSMENT OF SAFETY AND EFFICACY IN THE TREATMENT LOWER RESPIRATORY TRACT INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43063 |
| Study title: A THIRD PARTY BLINDED COMPARATIVE STUDY OF SULTAMICILLIN (CP-49,952-15) AND CECLOR FOR THE ASSESSMENT OF SAFETY AND EFFICACY IN THE TREATMENT OF LOWER RESPIRATORY TRACT INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43064 |
| Study title: A THIRD PARTY BLINDED COMPARATIVE STUDY OF SULTAMICILLIN (CP-49,952-15) AND CLOXACILLIN FOR THE ASSESSMENT OF SAFETY AND EFFICACY IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42923 |
| Study title: A THIRD PARTY BLINDED COMPARATIVE STUDY OF SULTAMICILLIN (CP-49,952) AND CLOXICILLIN FOR THE ASSESSMENT OF SAFETY AND EFFICACY IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS IN PEDIATRIC PATIENTS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42924 |
| Study title: A THIRD PARTY BLINDED COMPARATIVE STUDY OF SULTAMICILLIN (CP-49,952) AND PENICILLIN V-K FOR THE ASSESSMENT OF SAFETY AND EFFICACY IN THE TREATMENT OF STREPTOCOCCAL PHARYNGITIS IN PEDIATRIC PATIENTS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42917 |
| Study title: AN OPEN COMPARATIVE MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF STM VS. CEFACLOR IN THE TREATMENT OF ACUTE OTITIS MEDIA IN CHILDREN. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42997 |
| Study title: AN OPEN COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL (STM 25-50MK)VS. ORAL AMOXYCILLIN (25-40 MK) IN THE TREATMENT OF MILD TO MODERATE UPPER RESPIRATORY TRACT INFECTIONS IN CHILDREN. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43004 |
| Study title: AN OPEN COMPARATIVE STUDY TO COMPARE THE SAFETY AND EFFICACY OF A SINGLE ORAL DOSE OF SULTAMICILLIN VS DOUBLE STRENGTH OF TRIMETHOPRIM-SULF. TABLETS FOR UNCOMPLICATED LOWER URINARY TRACT INFECTIONS IN WOMEN. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43019 |
| Study title: AN OPEN MULTICENTER NON-COMPARATIVE SHORT TERM STUDY OF EFFICACY AND TOLERABILITY OF ORAL SULTAMICILLIN SUSPENSION IN THE TREATMENT OF UPPER AND LOWER RESPIRATORY TRACT INFECTIONS IN PEDIATRIC INPATIENTS/ OUTPATIENTS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42990 |
| Study title: AN OPEN NON COMPARATIVE STUDY OF UNASYN ORAL (BRAND OF SULTAMICILLIN) IN VARIOUS INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42975 |
| Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY ON THE EFFICACY AND TOLERABILITY OF SULTAMICILLIN (SULBACTAM/AMPICILLIN) IN THE TREATMENT OF PEDIATRIC PATIENTS WITH ACUTE OTITIS MEDIA. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42964 |
| Study title: Saul A, Bonifaz A, Arias I Itraconazole in the treatment of superficial mycoses: an open trial of 40 cases. Reviews of infectious diseases 9 suppl.1, p.S100-S103, 1987. (13-74 years, LMD45549)Saul A, Bonifaz A, Arias I Itraconazole in the treatment of superficial mycoses: an open trial of 40 cases. Reviews of infectious diseases 9 suppl.1, p.S100-S103, 1987. (13-74 years, LMD45549) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30796 |
| Study title: Thomas PA, Abraham DJ, Kalavathy CM, Rajasekaran J. Oral itraconazole therapy in keratomycosis. March 1986. (5-60 years, LMD45894)Thomas PA, Abraham DJ, Kalavathy CM, Rajasekaran J. Oral itraconazole therapy in keratomycosis. March 1986. (5-60 years, LMD45894) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30804 |
| Study title: Thomas PA, Kalavathy CM, Abraham DJ, Rajasekaran J. Combined oral and topical itraconazole therapy in the treatment of keratomycosis. August 1986. (13-55 years, LMD51269)Thomas PA, Kalavathy CM, Abraham DJ, Rajasekaran J. Combined oral and topical itraconazole therapy in the treatment of keratomycosis. August 1986. (13-55 years, LMD51269) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30805 |
| Study title: Van Peer A, Van de Velde V, Heykants J, Woestenborghs R, Meuldermans W, Cauwenbergh G. Itraconazole pharmacokinetics in healthy volunteers and patients. A review of the data available until August '90. Clinical Research report on R051211 no-79, revised August 1990. (4-78 years, LMD74817)Van Peer A, Van de Velde V, Heykants J, Woestenborghs R, Meuldermans W, Cauwenbergh G. Itraconazole pharmacokinetics in healthy volunteers and patients. A review of the data available until August '90. Clinical Research report on R051211 no-79, revised August 1990. (4-78 years, LMD74817) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30813 |
| Study title: Viviani MA, Van de Velde V, Cilli P, Van de Poel S, Van Peer A, Woestenborghs R, Heykants J, Cauwenbergh G. Pharmacokinetics of itraconazole in patients with systemic mycoses. Clinical research report on R051211 no-112, January 1990. (4-66 years, LMD67873)Viviani MA, Van de Velde V, Cilli P, Van de Poel S, Van Peer A, Woestenborghs R, Heykants J, Cauwenbergh G. Pharmacokinetics of itraconazole in patients with systemic mycoses. Clinical research report on R051211 no-112, January 1990. (4-66 years, LMD67873) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30809 |
| Study title: Wishart JM. The influence of food on the pharmacokinetics of itraconazole in patients with superficial fungal infection. Journal of the american academy of dermatology 17 (2) (part 1), p.220-223, 1987. (13-64 years, LMD49681)Wishart JM. The influence of food on the pharmacokinetics of itraconazole in patients with superficial fungal infection. Journal of the american academy of dermatology 17 (2) (part 1), p.220-223, 1987. (13-64 years, LMD49681) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30808 |
| Study title: STUDY TO ASSESS THE PHARMACOKINETICS OF A SINGLE ORAL OR INTRAVENOUS DOSE OF FLUCONAZOLE ADMINISTERED TO FULL TERM NEONATES |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27705 |
| Study title: SYSTEMIC TREATMENT OF INTRACTABLE ONYCHOMYCOSIS WITH FLUCONAZOLE. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27493 |
| Study title: SYSTEMIC TREATMENT OF INTRACTABLE ONYCHOMYCOSIS WITH FLUCONAZOLE. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27857 |
| Study title: THE PHARMACOKINETICS OF FCA DURING HEMODIALYSIS IN PATIENTS WITH CHRONIC RENAL DYSFUNCTION. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27503 |
| Study title: THE PHARMACOKINETICS OF FCA DURING HEMODIALYSIS IN PATIENTS WITH CHRONIC RENAL DYSFUNCTION. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27867 |
| Study title: THREE OPEN COMPARATIVE STUDIES OF THE EFFICAY AND SAFETY OF FLUCONAZOLE AND KETOCONAZOLE, ITRACONAZOLE OR CLOTRIMAZOLE IN THE TREATMENT OF PATIENTS WITH PITYRIASIS VERSICOLOR |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27578 |
| Study title: TO ASSESS THE EFFICACY AND SAFETY OF FLUCONAZOLE I.V. (+ AMPHOTERICIN B BY ORAL ROUTE) VS. PLACEBO I.V. (+AMPHOTERICIN B BY ORAL ROUTE) TO PREVENT THE ONSET OF INFECTIONS WITH A MYCOTIC ETIOLOGY IN MULTICOLONIZED NEUTROPENIC PATIENTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27461 |
| Study title: Primotic ring topical corticoid cream (0.1% mometasone furoate) treatment in children. Pileggi Fde O, Vicente YA. J Pediatr Surg. 2007 Oct; 42(10):1749-52.Primotic ring topical corticoid cream (0.1% mometasone furoate) treatment in children. Pileggi Fde O, Vicente YA. J Pediatr Surg. 2007 Oct; 42(10):1749-52. |
| Active substance: MOMETAZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32283 |
| Study title: A Multicenter, Double-Blind, Crossover Study Comparing the Clinical Effect of Combination MK-0476/Loratadine to MK-0476 in Patients With Chronic Asthma |
| Active substance: MONTELUKAST |
| Study summary document link (including results): 0476_various_synopses.pdf |
| View full study record |
| Document reference: 47561 |
| Study title: A Multicenter, Double-Blind, Randomized, Crossover Study Investigating the Clinical Effect of Montelukast in Patients With Concomitant Asthma and Allergic Rhinitis Upon Controlled Exposure to Cat Allergen |
| Active substance: MONTELUKAST |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32407 |
| Study title: A Multicenter, Double-Blind, Randomized, Parallel-Group Study Comparing the Effect on Linear Growth of Montelukast with Placebo and Inhaled Beclomethasone in Pediatric Patients (Prepubertal, Tanner Stage I) With Mild Asthma |
| Active substance: MONTELUKAST |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32410 |
| Study title: A Multicenter, Double-Blind, Randomized, Parallel-Group Study Investigating the Clinical Effect of Combination Montelukast/Loratadine in Patients With Seasonal Allergic Rhinitis (Fall Study) |
| Active substance: MONTELUKAST |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32411 |
| Study title: a Multicenter, Double-blind, Randomized, Parallel-Group Study Investigating the Clinical Effect of Montelukast in Patients With Seasonal Allergic Rhinitis - Fall Study |
| Active substance: MONTELUKAST |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32412 |
| Study title: A Multicenter, Double-Blind, Randomized, Parallel-Group Study Investigating the Clinical Effect of Montelukast in Patients With Seasonal Allergic Rhinitis-Spring 2001 Study " |
| Active substance: MONTELUKAST |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32413 |
| Study title: A Multicenter, Double-Blind, Randomized, Parallel-Group Study Investigating the Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis |
| Active substance: MONTELUKAST |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32414 |
| Study title: A Multicenter, Double-Blind, Randomized, Parallel-Group Study Investigating the Clinical Effects of Montelukast in Patients With Seasonal Allergic Rhinitis Over a 4-Week Treatment Period-Fall 2001 |
| Active substance: MONTELUKAST |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32415 |
| Study title: DELVAUX-M, WINGATE-D. GASTROENTEROLOGY UNIT, CHU RANGUEIL, TOULOUSE, FRANCE. TRIMEBUTINE: MECHANISM OF ACTION, EFFECTS ON GASTROINTESTINAL FUNCTION AND CLINICAL RESULTS. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH {J-INT-MED-RES} 1997 SEP- OCT, VOL: 25 (5), P: 225-46.DELVAUX-M, WINGATE-D. GASTROENTEROLOGY UNIT, CHU RANGUEIL, TOULOUSE, FRANCE. TRIMEBUTINE: MECHANISM OF ACTION, EFFECTS ON GASTROINTESTINAL FUNCTION AND CLINICAL RESULTS. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH {J-INT-MED-RES} 1997 SEP- OCT, VOL: 25 (5), P: 225-46. |
| Active substance: TRIMEBUTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46754 |
| Study title: A double-blind, single oral dose study comparing the anti-pyretic properties of Ibuprofen, acetaminophen and placebo in the treatment of pyrexia associated with infectious disease in children and Pharmacodynamics of fever treatment with Ibuprofen |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29426 |
| Study title: A double-blind, single oral dose study comparing the anti-pyretic property of Ibuprofen, Acetaminophen, and placebo in the treatment of pyrexia associated with infectious disease in children. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29400 |
| Study title: A study of the effects of Ibuprofen on post-operative pain in children undergoing adenotonsillectomy when given preoperative |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29416 |
| Study title: Neurology. 1994 Dec;44(12):2331-6. Predictors of outcome after anterior temporal lobectomy: positron emission tomography. Manno EM, Sperling MR, Ding X, Jaggi J, Alavi A, O'Connor MJ, Reivich M. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28203 |
| Study title: Acute oral toxicity of compound HOE 296 for neonatal rats - F.R Springman et al. - 6/02/1976 (Hoescht AG) - Publication in Part III - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24123 |
| Study title: Avaliacao clinica de um novo antimicotico, piridonico topico, HOE 296, em dermatofitoses - Clinical evaluation of a new topical pyridonium antimycotic, HOE 296, in dermatophytoses -L.N. Ermetice et al. - 1973 (Rev bras. Clin Ter vol 2) - Publication in Part Clinical documentation Batrafen Losung -No author-11/1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24134 |
| Study title: Behandlung bakteriell superinfizierter hautpilzerkrankungen - K. Jablonski - 1987 (Kassenartz vol 27) - Publication in clinical studies (volume 6) - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24135 |
| Study title: Behandlung von schimmelpliz-mykosen mit iclopiroxolamin - B. Deichmann - 1986 (Schwerpunktmedizin vol 9) - Publication in Part clinical documentation- Batrafen Losung Study CIOMS - No author -11/ 1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24136 |
| Study title: Bericht über eine doppleblind-studie mit HOE 296 -creme - und canesten- creme (clotrimazol) - W. Adam et al. - 03/03/1978 - Publication in clinical studies (volume 6) - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24124 |
| Study title: Breite Praxis-Prufung (Phase III) mit HOE 296 (Ciclopirox -olamin) - H.G.Peil - No date - Publication in Part IV volume 3 - Batafren creme, Batafren Vaginalcreme, Batafren Duo klinische prufung - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24137 |
| Study title: Childhood white superficial onychomycosis caused by Trichophyton rubrum: Repor tof seven cases and review of the literature, Tanusin Ploysangam, Anne W. Lucky, J Am Acad Dermatol, 1997;36:29 32 |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24138 |
| Study title: Ciclopiroxolamin bei der Behandlundg von dermatomykosenbei kindern - E. Briscik et al. - 1988 (Min Ped vol 40) - Publication in Part clinical documentation- Batrafen Losung Study CIOMS - No author -11/ 1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24139 |
| Study title: Clinical results with the Antimycotic agent ciclopirox olamine - W. Adam et al. - No date - Publication in clinical studies (volume 6) - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24140 |
| Study title: Clinical study of HOE 296 Solution in Trichophytia Superficialis- Espesially on systemic Influence after application - S. Yoshida - 1975 (Clinical Medecine vol 17) - Publication in Part clinical documentation- Batrafen Losung Study CIOMS- No author - 11/ 1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24125 |
| Study title: Clinical trial with ciclopirox vaginal cream in vulvovaginal candidiasis - José Leal de Queiroz et al . - september 1990 - Publication in Part clinical documentation - Batrafen Losung Study CIOMS - No author - 11/ 1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24141 |
| Study title: Clinical/statistical report for ciclopirox olamine ( Loprox, HOE296) - Humberto Bogaert et al. - No date - Publication in clinical studies ( volume 4)- a double blind multicentre parallel study group comparing ciclopirox olamine 1% cream and vehicle, cream base in the subjects with Tinea corporis or Tinea cruris - No author - 08/1988 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24142 |
| Study title: Consideracoes terapeuticas sobre o uso de um novo antimicotico piridonico, o HOE 296, no tratamento topico de dermatofitoses - Therapeutical considerations about the use of a new piridonic antimycotic, HOE 296, in the topical treatment of dermatophytoses - Jarbas Porto et al. - 1974 (Rev Bras Clin Ter vol 3, n°10, suppl 7) - Publication in Part clinical Documentation Batrafen Losung- No author - 11/1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24145 |
| Study title: Dopplelblind - Vergleichsstuddie mit Ciclopiroxolamin-und Plazebo -Creme bei dermatophytosen - T Fredriksson et al.- 1981 (Arzneim. Forsch/ Drug Res ) - Publication in clinical studies (volume 6) - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24146 |
| Study title: An Open Multicenter Study in Pakistan to Investigate the Effects of Ibuprofen Syrup in Juvenile Pyrexia |
| Active substance: IBUPROFEN |
| Study summary document link (including results): Ibuprofen-MS85 592.pdf |
| View full study record |
| Document reference: 47556 |
| Study title: Caniggia A, Vattimo A. Kinetics of 99mtechnetium-tin-methylene-diphosphonate in normal subjects and pathological conditions: a simple index of bone metabolism. Calcif Tissue Int. 1980;30(1):5-13. No abstract available. Caniggia A, Vattimo A. Kinetics of 99mtechnetium-tin-methylene-diphosphonate in normal subjects and pathological conditions: a simple index of bone metabolism. Calcif Tissue Int. 1980;30(1):5-13. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44144 |
| Study title: Groves AM, Cheow H, Balan K, Courtney H, Bearcroft P, Dixon A. 16-MDCT in the detection of occult wrist fractures: a comparison with skeletal scintigraphy. AJR Am J Roentgenol. 2005 May;184(5):1470-4. Groves AM, Cheow H, Balan K, Courtney H, Bearcroft P, Dixon A. 16-MDCT in the detection of occult wrist fractures: a comparison with skeletal scintigraphy. AJR Am J Roentgenol. 2005 May;184(5):1470-4. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43388 |
| Study title: Groves AM, Cheow HK, Balan KK, Housden BA, Bearcroft PW, Dixon AK. 16-Detector multislice CT in the detection of stress fractures: a comparison with skeletal scintigraphy. Clin Radiol. 2005 Oct;60(10):1100-5. Groves AM, Cheow HK, Balan KK, Housden BA, Bearcroft PW, Dixon AK. 16-Detector multislice CT in the detection of stress fractures: a comparison with skeletal scintigraphy. Clin Radiol. 2005 Oct;60(10):1100-5. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43384 |
| Study title: Multimodal treatment of children with unresectable or recurrent desmoid tumors: An 11-year longitudinal observational study. Multimodal treatment of children with unresectable or recurrent desmoid tumors: An 11-year longitudinal observational study. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43266 |
| Study title: Noncytotoxic Drug Therapy in Children with Unresectable Desmoid Tumors. Noncytotoxic Drug Therapy in Children with Unresectable Desmoid Tumors. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43297 |
| Study title: Double blind comparative study of 1% cicloprirox olamine (Batrafen) powder vs 2% Miconazole nitrate (Daktarin) powder in patients suffering from tinea pedis - F. Arreaza et al. - May 1991 - Publication in Part I -Expert report on clinical documentation- H |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24147 |
| Study title: Double blind comparative study of 1% cicloprirox olamine (Batrafen) powder vs 2% Miconazole nitrate (Daktarin) powder in patients suffering from tinea pedis - F. Arreaza et al. - May 1991 - Publication in Part I -Expert report on clinical documentation- H.G Vogel - No date - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24148 |
| Study title: Empleo de HOE 296 (ciclopirox) en micosis superficiales - Dr Mario Magana Lorenzo - 1976 (Sem Med (Mex) vol 88) - Publication in Part Clinical documentation Batrafen Losung - No author - 11/1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24149 |
| Study title: Emprego de novo antimicotico, HOE-296, no tratamento topico de micoses superficiais - A.F Defina et al. -1973 (Rev bras. Clin Ter vol 2) - Publication in Part Clinical documentation Batrafen Losung -No author - 11/1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24150 |
| Study title: A SINGLE-BLIND (EVALUATOR BLIND) COMPARATIVE STUDY OF ORAL CLINDAMYCIN HYDROCHLORIDE 300 MG BID COMPARED AGAINST ORAL AUGMENTIN 1G BID IN THE TREATMENT OF ACUTE RECURRENT TONSILLITIS/PHARYNGITIS DUE TO GROUP A-B HEMOLYTIC STREPTOCOCCI. A MULTINATIONAL MUL |
| Active substance: CLINDAMYCIN |
| Study summary document link (including results): 251F-INF-9052-0280 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 24363 |
| Study title: A STUDY TO COMPARE THE EFFICACY AND TOLERANCE OF CLINDAMYCIN WITH ERYTHROMYCIN IN THE TREATMENT OF FEMALES WITH CONFIRMED CHLAMYDIA TRACHOMARIS CERVICITIS |
| Active substance: CLINDAMYCIN |
| Study summary document link (including results): M11200134 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 24373 |
| Study title: COMPARATIVE EFFICACY AND TOLERANCE OF CLEOCIN T GEL VERSUS ORAL MINOCYCLINE IN THE TREATMENT OF ACNE VULGARIS (PROTOCOL M/1112/0005) |
| Active substance: CLINDAMYCIN |
| Study summary document link (including results): M11120005 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 24372 |
| Study title: COMPARATIVE EVALUATION OF CLINDAMYCIN VS CLINDAMYCIN PLUS TOBRAMYCIN IN THE TREATMENT OF PELVIC INFLAMMATORY DISEASE |
| Active substance: CLINDAMYCIN |
| Study summary document link (including results): M11000093 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 24368 |
| Study title: DOUBLE-BLIND RANDOMIZED COMPARISON OF 2% CLINDAMYCIN VAGINAL CREAM VS ORAL METRONIDAZOLE CAPSULES FOR THE TREATMENT OF BACTERIAL VAGINOSIS |
| Active substance: CLINDAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24367 |
| Study title: EFFICACY & SAFETY OF DALACIN C (CLINIDAMYCIN) IN ACUTE OR RECURRENT PHARYNGO-TONSILLITIS |
| Active substance: CLINDAMYCIN |
| Study summary document link (including results): CLIND-9052-285-INDIA EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 24366 |
| Study title: INTERIM REPORT OF AN ON-GOING NON-COMPARATIVE INTERNATIONAL MULTICENTRE STUDY OF CEFOPERAZONE NA IN THE TREATMENT OF ORTHOPEDIC SURGICAL AND GENERAL MEDICAL INFECTIONS. |
| Active substance: CLINDAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24358 |
| Study title: INTERIM REPORT OF AN ON-GOING NON-COMPARATIVE MULTICENTRE STUDY OF CEFOPERAZONE NA IN THE TREATMENT OF SKIN AND SKIN STRUCTURE INFECTIONS. |
| Active substance: CLINDAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24359 |
| Study title: OPEN LABEL COMPARATIVE, RANDOMIZED STUDY ASSESSING USEFULNESS OF RAPID MICROBIOLOGICAL DIAGNOSTICS IN PATIENTS WITH TONSILLITIS/PHARYNGITIS TREATED WITH CLINDAMYCIN |
| Active substance: CLINDAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24364 |
| Study title: PHASE IV CLINICAL STUDY OF CLINDAMYCIN PHAOSPHATE TOPICAL GEL IN THE TREATMENT OF ACNE VULGARIS |
| Active substance: CLINDAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24365 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Psorinoheel (drops) [AWB-AT] |
| Active substance: Psorinoheel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40141 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Psorinoheel (ampoules) [AWB-AT] |
| Active substance: Psorinoheel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40142 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Psorinoheel (ampoules) [AWB-AT] |
| Active substance: Psorinoheel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40143 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Psorinoheel (drops) [AWB-AT] |
| Active substance: Psorinoheel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40144 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Pulsatilla compositum (ampoules) [AWB-AT] |
| Active substance: Pulsatilla compositum |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40145 |
| Study title: TO INVESTIGATE THE SAFETY AND EFFICACY OF A SINGLE ORAL DOSE OF FCA 150 MG CAPS FOR THE TX OF WOMEN WITH VAGINAL CANDIDIASIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28045 |
| Study title: TO MAKE FLUCONAZOLE AVAILABLE FOR USE IN PATIENTS WITH NON-LIFE THREATENING MYCOSES, WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS. ALSO SAFETY AND EFFICACY OF DRUG. THIS PROTOCOL NUMBER ORIGINALLY WAS FCA-BRA-90-002C. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27383 |
| Study title: TO MAKE FLUCONAZOLE AVAILABLE FOR USE IN PATIENTS WITH NON-LIFE THREATENING MYCOSES, WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS. ALSO SAFETY AND EFFICACY OF DRUG. THIS PROTOCOL NUMBER ORIGINALLY WAS FCA-BRA-90-002C. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27748 |
| Study title: TO MAKE FLUCONAZOLE AVAILABLE IN PATIENTS WITH CRYPTOCOCCAL MENINGITIS WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS. ALSO SAFETY AND EFFECTIVENESS OF THE DRUG. THIS PROTOCOL NUMBER WAS ORIGINALLY FCA-BRA-90-002A. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27381 |
| Study title: Three-phase radionuclide bone imaging and magnetic resonance imaging detection of occult knee fractures in athletes. Giammarile F, Masciocchi C, Barile A, di Pietro M, Carducci A, Baschieri I. Eur J Nucl Med. 1994 Jun;21(6):493-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43622 |
| Study title: Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL et al. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin 2 and Interferon Alfa-2b. Journal of Clinical Oncology 1999; 17(3):968-975.Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL et al. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin 2 and Interferon Alfa-2b. Journal of Clinical Oncology 1999; 17(3):968-975. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43168 |
| Study title: Novoa FJ, Boronat M, Carrillo A, Tapia M, Diaz CJ, Chirino R. Effects of tamoxifen on lipid profile and coagulation parameters in male patients with pubertal gynecomastia. Hormone Research 2002;57(5-6):187-91 2002;(5-6):187-191.Novoa FJ, Boronat M, Carrillo A, Tapia M, Diaz CJ, Chirino R. Effects of tamoxifen on lipid profile and coagulation parameters in male patients with pubertal gynecomastia. Hormone Research 2002;57(5-6):187-91 2002;(5-6):187-191. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43101 |
| Study title: Pediatric desmoid tumor: Retrospective analysis of 63 cases. Faulkner LB, Hajdu SI, Kher U, La QM, Exelby PR, Heller G et al. Journal of Clinical Oncology 13(11)()(pp 2813-2818), 1995 Date of Publication: Nov 1995 1995;(11):2813-2818.Pediatric desmoid tumor: Retrospective analysis of 63 cases. Faulkner LB, Hajdu SI, Kher U, La QM, Exelby PR, Heller G et al. Journal of Clinical Oncology 13(11)()(pp 2813-2818), 1995 Date of Publication: Nov 1995 1995;(11):2813-2818. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43302 |
| Study title: Comparison of SPECT lung perfusion with transbronchial lung biopsy after lung transplantation. Colt HG, Cammilleri S, Khelifa F, Dumon JF, Garbe L, Noirclerc M, Kaphan G Am J Respir Crit Care Med. 1994 Aug;150(2):515-20. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48267 |
| Study title: Clobetasone butyrate eye drops. Effect on ocular inflammation and intraocular pressure.Williamson J, Eilon LA, Walker SR. Trans Ophthalmol Soc U K. 1981;101(1):27-9Clobetasone butyrate eye drops. Effect on ocular inflammation and intraocular pressure.Williamson J, Eilon LA, Walker SR. Trans Ophthalmol Soc U K. 1981;101(1):27-9 |
| Active substance: CLOBETASONE |
| Study summary document link (including results): Clobetasone butyrate eye drops effect on ocular inflammation.pdf |
| View full study record |
| Document reference: 24379 |
| Study title: multicentre study of the efficacy and tolerability of clotrimazole 10% vaginal cream in the treatment of vaginal candidosis |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0524_study_synopsis.pdf |
| View full study record |
| Document reference: 24447 |
| Study title: safety and efficacy of bay b 5097 2vaginal cream in 3-day treatment as compared with 7-day treatment with econazole cream (gyno-pevaryl cream). |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0583_study_synopsis.pdf |
| View full study record |
| Document reference: 24454 |
| Study title: Vergleichende Prüfung von vier Clotrimazol-Zubereitungen |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24464 |
| Study title: Essai randomisé, ouvert, en groupes parallèles, afin d'évaluer la non infériorité de la cloxacilline versus la pristinamycine en termes d'efficacité et de tolérance dans les infections cutanées à staphylocoque ou à streptocoque |
| Active substance: CLOTRIMAZOLE + SALICYLIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24467 |
| Study title: "Essai randomisé, ouvert, en groupes parallèles, afin d'évaluer la non infériorité de la cloxacilline versus la pristinamycine en termes d'efficacité et de tolérance dans les infections cutanées à staphylocoque ou à streptocoque" |
| Active substance: CLOXACILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24468 |
| Study title: "Evaluation de l'acceptabilité et de la tolérance de la cloxacilline poudre pédiatrique pour suspension buvable 250 mg, en sachets, dans les angines streptococciques et infections cutanées de l'enfant" |
| Active substance: CLOXACILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24469 |
| Study title: 48 hour human patch test for primary irritation of ciclopirox olamine shampoos (Tarmed included as a comparator). |
| Active substance: COAL TAR |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24474 |
| Study title: 48 hour human patch test for primary irritation of ciclopirox olamine shampoos (Tarmed included as a comparator). |
| Active substance: Coal tar solution |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40134 |
| Study title: TO MAKE FLUCONAZOLE AVAILABLE IN PATIENTS WITH CRYPTOCOCCAL MENINGITIS WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS. ALSO SAFETY AND EFFECTIVENESS OF THE DRUG. THIS PROTOCOL NUMBER WAS ORIGINALLY FCA-BRA-90-002A. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27746 |
| Study title: TO STUDY THE EFFICACY AND TOLERATION OF FCA WHEN GIVEN AT A SINGLE 400 MG DOSE IN THOSE PATIENTS WITH OP IN WHOM THE SINGLE 150 MG DOSE DID NOT INDUCE SYMPTOMS WITHIN 3-10 DAYS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27393 |
| Study title: TO STUDY THE EFFICACY AND TOLERATION OF FCA WHEN GIVEN AT A SINGLE 400 MG DOSE IN THOSE PATIENTS WITH OP IN WHOM THE SINGLE 150 MG DOSE DID NOT INDUCE SYMPTOMS WITHIN 3-10 DAYS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27758 |
| Study title: TO STUDY THE SAFETY AND EFFICACY OF ORAL IV FLUCONAZOLE IN THE TREATMENT OF PATIENTS WITH NON-CANDIDA MYCOSES. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27588 |
| Study title: TO STUDY THE SAFETY AND EFFICACY OF ORAL IV FLUCONAZOLE IN THE TREATMENT OF PATIENTS WITH NON-CANDIDA MYCOSES. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27951 |
| Study title: TOLERATION AND EFFECTIVENESS OF FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27376 |
| Study title: TOLERATION AND EFFECTIVENESS OF FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27741 |
| Study title: TOLERATION AND SAFETY OF ORAL FLUCONAZOLE IN THE PROPHYLAXIS OF FUNGAL COLONIZATION AND INFECTION IN PATIENTS UNDERGOING BONE MARROW TRANSPLANTATION. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27463 |
| Study title: TOLERATION AND SAFETY OF ORAL FLUCONAZOLE IN THE PROPHYLAXIS OF FUNGAL COLONIZATION AND INFECTION IN PATIENTS UNDERGOING BONE MARROW TRANSPLANTATION. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27827 |
| Study title: TREATMENT OF OROPHARYNGEAL CANDIDIASIS RESISTANT TO FLUCONAZOLE A DAILY DOSE OF 400 MG FOR 7 DAYS. A PILOT DOSE STUDY USING 800, 1200 AND 1600 MG DAILY TO 7 DAYS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27401 |
| Study title: A double-blind, single oral dose study, comparing the anti-pyretic properties of Ibuprofen, Acetaminophen, and placebo in the treatment of pyrexia associated with infectious disease in children |
| Active substance: IBUPROFEN |
| Study summary document link (including results): ibuprofen-bpi302.pdf |
| View full study record |
| Document reference: 29399 |
| Study title: A double-blind, single-dose analgesic study comparing the safety and effectiveness of ibuprofen lysine 200 mg, acetylsalicylic acid 500 mg and placebo for the treatment of outpatients experiencing moderate to severe postoperative dental pain / A double-blind, single-dose study to investigate plasma ibuprofen concentrations and their relationship to clinicalanalgesic response in patients treated with dexibuprofen lysine, ibuprofen lysinate, ibuprofen (Motrin) or placebo for the relief of moderate or severe postoperative dental pain / a double-blind single-dose, analgesic pilot study comparing the safety and effectiveness of dexiprofen lysine ((s)-ibuprofen lysinate) 400 mg, (R)-Ibuprofen Lysinate 400mg, and placebo for the treatment of outpatients experiencing moderate or severe postope... |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29608 |
| Study title: Eur J Nucl Med Mol Imaging. 2005 Dec;32(12):1429-39. Epub 2005 Aug 26. Respiration artifacts in whole-body (18)F-FDG PET/CT studies with combined PET/CT tomographs employing spiral CT technology with 1 to 16 detector rows. Beyer T, Rosenbaum S, Veit P, Stattaus J, Müller SP, Difilippo FP, SchÃder H, Mawlawi O, Roberts F, Bockisch A, Kühl H. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28099 |
| Study title: Eur J Nucl Med Mol Imaging. 2006 Jan;33(1):13-21. Epub 2005 Sep 9. Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer. Hellwig D, GrÃschel A, Graeter TP, Hellwig AP, Nestle U, Schäfers HJ, Sybrecht GW, Kirsch CM. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28096 |
| Study title: Eur J Nucl Med Mol Imaging. 2006 Jun;33(6):683-91. Epub 2006 Feb 28. Glut-1 expression and enhanced glucose metabolism are associated with tumour grade in bone and soft tissue sarcomas: a prospective evaluation by [18F]fluorodeoxyglucose positron emission tomography. Tateishi U, Yamaguchi U, Seki K, Terauchi T, Arai Y, Hasegawa T. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28088 |
| Study title: Eur J Nucl Med Mol Imaging. 2006 Jun;33(6):692-6. Epub 2006 Mar 3. Accuracy of transmission CT and FDG-PET in the detection of small pulmonary nodules with integrated PET/CT. Aquino SL, Kuester LB, Muse VV, Halpern EF, Fischman AJ. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28086 |
| Study title: Eur J Nucl Med. 1998 Jul;25(7):721-8. Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography. Stumpe KD, Urbinelli M, Steinert HC, Glanzmann C, Buck A, von Schulthess GK. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28192 |
| Study title: Detection of multiple thromboembolism in congenital antithrombin III deficiency with indium-111-platelet scintigraphy. Kawasugi K, Gohchi K, Kuniyasu Y, Matsuda J, Kinoshita T J Nucl Med. 1994 Nov;35(11):1811-4. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): Kawasugi K 1994.pdf |
| View full study record |
| Document reference: 48263 |
| Study title: Diaphragmatic hernia producing a perfusion defect and diffuse pulmonary vascular hypoplasia on lung imaging. Siraj QH, Clarke SE. Clin Nucl Med. 1994 Oct;19(10):917-8. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48265 |
| Study title: Early decortication for postpneumonic empyema in children. Effect on pulmonary perfusion. Eren N, Ozçelic C, Ener BK, Ozgen G, Solak H, Balci AE, Tas S. Scand J Thorac Cardiovasc Surg. 1995;29(3):125-9. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48261 |
| Study title: Early radionuclide detection of intrapulmonary shunts in children with liver disease. Grimon G, André L, Bernard O, Raffestin B, Desgrez A. J Nucl Med. 1994 Aug;35(8):1328-32. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48268 |
| Study title: Einfachblinde, randomisierte, Verum-kontrollierte, monozentrische Studie zum Nachweis der Nicht-Unterlegenheit von Leukichtan Gel vs. Betaisodona Salbe in der Behandlung von Schnitt-, Schürfwunden und Verbrennungen |
| Active substance: COD LIVER OIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24475 |
| Study title: Diaper dermatitis - Schanzer MC, Wilkin JK. - 1982 (Am Fam Physician 1982; 25(4):127-132) |
| Active substance: COD LIVER OIL/ZINC OXIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24476 |
| Study title: Diaper dermatitis. Value of Vitamin A topically applied - Bosch-Banyeras M, Catala M et al - 1988 (Clin. Pediat. 1988, 27, 9:448-450) |
| Active substance: COD LIVER OIL/ZINC OXIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24477 |
| Study title: Efficacy of topical application of eosin compared with zinc oxide paste and corticosteroid cream for diaper dermatitis - Arad A, Mimouni D, Ben Amitai D, Zeharia A, Mimouni M. - 1999 (Dermatology 1999; 199(4):319-322) |
| Active substance: COD LIVER OIL/ZINC OXIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24478 |
| Study title: Empfehlungen zur Lokaltherapie banaler Dermatosen im Kindesalter [Recommendations for local therapy of common dermatoses in children] - Stogmann W - 1984 (Wien Med.Wochenschr. 1984, 134(1):19-24) |
| Active substance: COD LIVER OIL/ZINC OXIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24479 |
| Study title: Monographie-Entwürfe für Arzneimittel zur Behandlung des Windelekzems - no autor - 1991 ((Sonderdruck). Pharm Ind 1991; 53(I):152-158) |
| Active substance: COD LIVER OIL/ZINC OXIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24480 |
| Study title: Delépine N et al CNS-side effects induced by Ifosfamide-Mesna in children with osteosarcomas Biomed Pharmacother. 1986;40(5):173-5Delépine N et al CNS-side effects induced by Ifosfamide-Mesna in children with osteosarcomas Biomed Pharmacother. 1986;40(5):173-5 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24846 |
| Study title: A Double-Blind, Single-Oral-Dose Study Comparing the Antipyretic Properties of Ibuprofen, Acetaminophen, and Placebo in the Treatment of Pyrexia Associated with Infectious Diseases in Children |
| Active substance: IBUPROFEN |
| Study summary document link (including results): Ibuprofen-BPI303.pdf |
| View full study record |
| Document reference: 47544 |
| Study title: A multi-centre, double blind, parallel group, prospective, randomised study to compare the efficacy of a single dose of 10 mg/kg ibuprofen with 15 mg/kgparacetamol in febrile children aged from 3 months to 12 years followed by tolerability over up to three days of open label dosing |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29397 |
| Study title: Eur Spine J. 2001 Dec;10(6):534-9. Fluorine-18 fluorodeoxyglucose positron emission tomography findings in spondylodiscitis: preliminary results. Schmitz A, Risse JH, Grünwald F, Gassel F, Biersack HJ, Schmitt O. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28163 |
| Study title: An open multicentre study in Pakistan to investigate the effects of Ibuprofen syrup in juvenile pyrexia |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29424 |
| Study title: An open multicentre study in Pakistan to investigate the effects of Ibuprofen syrup in juvenile pyrexia |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29439 |
| Study title: Connolly LP, Drubach LA, Treves ST. Localization of Tc-99m MDP in the rectus abdominis muscle without associated symptoms. Clin Nucl Med. 2003 Sep;28(9):769-70. Connolly LP, Drubach LA, Treves ST. Localization of Tc-99m MDP in the rectus abdominis muscle without associated symptoms. Clin Nucl Med. 2003 Sep;28(9):769-70. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43415 |
| Study title: Nucl Med Commun. 2002 Aug;23(8):773-7. Cerebral metabolic changes associated with Lyme disease. Newberg A, Hassan A, Alavi A. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28157 |
| Study title: Ensaio clinico e terapeutico com um novo antimicotico piridonico de emprego topico o HOE 296-Clinical and therapeutic trial with a new pyridonic anti-mycotic compound for topical use, the HOE 296 - Luiz Carlos Pereira et al. - 1974 (Rev Bras Clin Ter vol 3) - Publication in Part Clinical documentation Batrafen Losung-No author - 11/1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24151 |
| Study title: Estudo sobre o uso do ciclopirox (HOE 296) em Dermatologia : Resultados clinicos das micoses superficiais- Clinical effects of use of ciclopirox (HOE 296) in dermatology : therapeutic efficacy in superficial mycosis- Marcio lobo Jardim et al. - 1975 ( Rev Bras Clin Ter vol 4) - Publication in Part Clinical documentation Batrafen Losung - No author - 11/1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24152 |
| Study title: Estudo sobre o uso do ciclopirox (HOE 296) em Dermatologia : Resultados clinicos das micoses superficiais- Clinical effects of use of ciclopirox (HOE 296) in dermatology : therapeutic efficacy in superficial mycosis- Marcio lobo Jardim et al. - 1975 ( Rev Bras Clin Ter vol 4) - Publication in Part Clinical documentation Batrafen Losung -No author - 11/1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24153 |
| Study title: Evaluation of a new antifungal cream, ciclopirox alamine 1% in the treatment of cutaneous candidosis - Fillmore K. Bagatell et al. - 1985 (Clincals Therapeutics vol 8, N°1) -Publication in clinical studies (volume 5) - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24154 |
| Study title: Evaluation of a new antifungal cream, ciclopirox alamine 1% in the treatment of cutaneous candidosis - Fillmore K. Bagatell et al. - 1985 (Clincals Therapeutics vol 8, N°1) -Publication in clinical studies (volume 5) - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24155 |
| Study title: Evaluation of ciclopirox olamine for the treatment of tinea pedis : multicenter, double-blind comparatives studies - Albert M. Kligman et al.- 1985 (Clinical therapeutics vol 7, n°4) - Publication in clinical studies ( volume 4)- a double blind multicentre parallel study group comparing ciclopirox olamine 1% cream and vehicle, cream base in the subjects with Tinea corporis or Tinea cruris - No author - 08/1988 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24156 |
| Study title: Experiencia clinica com um novo antimicotico : HOE 296-Clinical experience with HOE 296, a new antimycotic agent- R.D Azulay et al. - 1973 (Rev bras. Clin Ter vol 2) - Publication in Part Clinical documentation Batrafen Losung - No author - 11/1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24157 |
| Study title: Fungal colonization in the very low birth weight infants - J.E Baley et al. - 1986 (Pedriatrics vol 78) - Publication in Part clinical documentation- Batrafen Losung Study CIOMS - No author -11/ 1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24158 |
| Study title: High prevalence of cervical dysplasia in female consorts of men with genital warts- T. Hockenstrom et al.- No date (Acta Derm Venereol vol 67) - Publication in clinical studies (volume 6) - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24159 |
| Study title: Orenstein SR, Blumer JL, Faessel HM, McGuire JA, Fung K, Li BU, Lavine JE, Grunow JE, Treem WR, Ciociola AA. Ranitidine, 75 mg, over-the-counter dose: pharmacokinetic and pharmacodynamic effects in children with symptoms of gastro-oesophageal reflux. Aliment Pharmacol Ther. 2002 May;16(5):899-907.Orenstein SR, Blumer JL, Faessel HM, McGuire JA, Fung K, Li BU, Lavine JE, Grunow JE, Treem WR, Ciociola AA. Ranitidine, 75 mg, over-the-counter dose: pharmacokinetic and pharmacodynamic effects in children with symptoms of gastro-oesophageal reflux. Aliment Pharmacol Ther. 2002 May;16(5):899-907. |
| Active substance: RANITIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35278 |
| Study title: Ranitidine, 75 mg, over-the-counter dose: pharmacokinetic and pharmacodynamic effects in children with symptoms of gastro-oesophageal reflux. |
| Active substance: RANITIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35274 |
| Study title: Autret−E et al. Comparative efficacy and tolerance of ibuprofen syrup and acetaminophen syrup in children with pyrexia associated with infectious diseases and treated with antibiotics. {EUR−J−CLIN−PHARMACOL}, 1994, Vol/Iss/Pg. 46/3 (197−201)Autret−E et al. Comparative efficacy and tolerance of ibuprofen syrup and acetaminophen syrup in children with pyrexia associated with infectious diseases and treated with antibiotics. {EUR−J−CLIN−PHARMACOL}, 1994, Vol/Iss/Pg. 46/3 (197−201) |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29590 |
| Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43096 |
| Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43124 |
| Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43182 |
| Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43192 |
| Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43202 |
| Study title: Nucl Med Commun. 2003 Jun;24(6):643-9. Persistent vegetative state: evaluation of brain metabolism and brain perfusion with PET and SPECT. Beuthien-Baumann B, Handrick W, Schmidt T, Burchert W, Oehme L, Kropp J, Schackert G, Pinkert J, Franke WG. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28147 |
| Study title: Nucl Med Commun. 2006 Nov;27(11):893-9. Pre-surgical identification of epileptogenic areas in temporal lobe epilepsy by 123I-iomazenil SPECT: a comparison with IMP SPECT and FDG PET.Kaneko K, Sasaki M, Morioka T, Koga H, Abe K, Sawamoto H, Ohya N, Yoshiura T, Mihara F, Honda H. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28074 |
| Study title: Ophthalmic Genet. 2004 Mar;25(1):31-5. Fluorine-18 fluorodeoxyglucose positron emission tomography (PET) to detect vital retinoblastoma in the eye: preliminary experience. Moll AC, Hoekstra OS, Imhof SM, Comans EF, Schouten-van Meeteren AY, van der Valk P, Boers M. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28121 |
| Study title: Comparison of bone scan and radiograph sensitivity in the detection of steroid-induced ischemic necrosis of bone. Conklin JJ, Alderson PO, Zizic TM, Hungerford DS, Densereaux JY, Gober A, Wagner HN. Radiology. 1983 Apr;147(1):221-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44043 |
| Study title: HOE 296 - Its safety evaluated by laboratory test and its clinical effect- Y. Watanabe - 1975 (Journal of new Remedies and Clinicals vol 24) - Publication in Part clinical documentation-Batrafen Losung Study CIOMS -No author - 11/1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24160 |
| Study title: HOE 296, um novo antimicotico piridonicode emprego topico,com atividade antibacteriana adicional - Ney Romiti - 1974 (Rev Bras Clin Ter vol 3, n°10, suppl 7) - Publication in Part clinical documentation Batrafen Losung - Study CIOMS - No author - 11/ 1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24161 |
| Study title: HOE 296, um novo antimicotico piridonicode emprego topico,com atividade antibacteriana adicional - Ney Romiti - 1974 (Rev Bras Clin Ter vol 3, n°10, suppl 7) - Publication in Part clinical documentation Batrafen Losung - Study CIOMS - No author - 11/ 1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24162 |
| Study title: Investigacion clinica sobre el HOE 296 en demafitosis de la piel lampina y en pitiriasis versicolor - Antonio Gonzalvez-Ochoa et al. - 1974 (Rev Int Salud publica vol 34) - Publication in Part clinical Documentation Batrafen Losung - No author - 11/ 1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24163 |
| Study title: La ciclopiroxolamina nel trattamento della pityriasis versicolor (Ciclopiroxolamine in the treatment of pityriasis versicolor) - G. Trevisan et al. - 1988 (Giornale Italiano Di Dermatologica e Venerologica vol 123) - Publication in Part clinical documenta |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24164 |
| Study title: Multicentre Double-blind clinical trials of ciclopirox olamine cream 1%in the treatment of tinea corporis or tinea cruris -Humberto Bogaert et al. - 1986 (J Int Med Res vol 14) - Publication in clinical studies ( volume 3) - a double bind multicentre parallel study group comparing ciclopirox olamine 1% cream and vehicle, cream base in the subjects with Tinea corporis or Tinea cruris - No author - 08/ 1988 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24165 |
| Study title: effects of anafranil 10 mg in enuresic children |
| Active substance: CLOMIPRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24389 |
| Study title: PRUEBA SOBRE POSIBLES EFECTOS PERJUDICIALES EN EL EMBRION. RATON, VIA ORAL |
| Active substance: CLOMIPRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24380 |
| Study title: Bozkurt MF, Uğur O. Intra-arterial Tc-99m MDP injection mimicking reflex sympathetic dystrophy. Clin Nucl Med. 2001 Feb;26(2):154-6. No abstract available. Bozkurt MF, Uğur O. Intra-arterial Tc-99m MDP injection mimicking reflex sympathetic dystrophy. Clin Nucl Med. 2001 Feb;26(2):154-6. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43462 |
| Study title: TREATMENT OF OROPHARYNGEAL CANDIDIASIS RESISTANT TO FLUCONAZOLE A DAILY DOSE OF 400 MG FOR 7 DAYS. A PILOT DOSE STUDY USING 800, 1200 AND 1600 MG DAILY TO 7 DAYS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27766 |
| Study title: TREATMENT OF SYSTEMIC MYCOSIS WITH FLUCONAZOLE AND ITS IN VITRO ANTIFUNGAL ACTIVITY |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27498 |
| Study title: TREATMENT OF SYSTEMIC MYCOSIS WITH FLUCONAZOLE AND ITS IN VITRO ANTIFUNGAL ACTIVITY |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27862 |
| Study title: TREATMENT OF VAGINAL CANDIDIASIS WITH A SINGLE ORAL DOSE OF FCA. MULTICENTER NON-COMPARATIVE OPEN STUDY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27407 |
| Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43217 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Tanacet-Heel (drops) [AWB-037] |
| Active substance: Tanacet-Heel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40251 |
| Study title: Double blind, placebo controlled study of the efficacy of polytar in treatment of seborrhoeic dermatitis and eczema of the scalp. |
| Active substance: TAR AND ZINC |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43358 |
| Study title: To study the effects of Fongitar (Polytar AF) in Pityriasis and squamous conditions of the scalp. |
| Active substance: TAR AND ZINC |
| Study summary document link (including results): Article 45_Ref_C0202_Final For Submission_27 Oct 2011.xlsx |
| View full study record |
| Document reference: 43359 |
| Study title: Dose-dependant Resoption of quinine after intrarectal administration to children with moderate Plasmodium falciparum Malaria - Eric Pussard et al. - 11/2004 (Antimicrobial agents and Chimiotherapy;vol. 48,No. 11:4422-4426)Dose-dependant Resoption of quinine after intrarectal administration to children with moderate Plasmodium falciparum Malaria - Eric Pussard et al. - 11/2004 (Antimicrobial agents and Chimiotherapy;vol. 48,No. 11:4422-4426) |
| Active substance: QUININE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45065 |
| Study title: Effects of corticosteroid inhalation therapy on the deposition pattern of Tc-99m human serum albumin radioaerosols in asthma. Kao CH, Lin HT, Yu SL, Wang SJ, Lan JL. Lung. 1995;173(5):291-6. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48262 |
| Study title: Eur J Radiol. 1990 Sep-Oct;11(2):131-7. Contrast venography: from gold standard to 'golden backup' in clinically suspected deep vein thrombosis. de Valois JC, van Schaik CC, Verzijlbergen F, van Ramshorst B, Eikelboom BC, Meuwissen OJ. Eur J Radiol. 1990 Sep-Oct;11(2):131-7. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): de valois JC 1990.pdf |
| View full study record |
| Document reference: 48282 |
| Study title: Hepatopulmonary syndrome: a prospective study of relationships between severity of liver disease, PaO(2) response to 100% oxygen, and brain uptake after (99m)Tc MAA lung scanning. Krowka MJ, Wiseman GA, Burnett OL, Spivey JR, Therneau T, Porayko MK, Wiesner RH. Chest. 2000 Sep;118(3):615-24. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48233 |
| Study title: TEST FOR TERATOGENIC EFFECT, MOUSE, ORALLY.; ORIGIN=PCS CH; CONTRACTOR=1; |
| Active substance: CLOMIPRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24399 |
| Study title: TEST ON TERATOGENIC EFFECT - MICE, ORAL ADMINISTRATION |
| Active substance: CLOMIPRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24402 |
| Study title: TEST ON TERATOGENIC EFFECT - RATS |
| Active substance: CLOMIPRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24382 |
| Study title: THE EFFECT OF G34586 UPON PREGNANCY IN THE NEW ZEALAND WHITE RABBIT.; ORIGIN=HUNTINGDON LIFE SCIENCES; CONTRACTOR=1; |
| Active substance: CLOMIPRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24400 |
| Study title: Greene−S−L, Reed−C−E, Schroeter−A−L. Double−blind crossover study comparing doxepin with diphenhydramine for the treatment of chronic urticaria. Journal of the American Academy of Dermatology, {J−Am−Acad−Dermatol}, Apr 1985, vol. 12, no. 4, p. 669−75. |
| Active substance: CODEINE_AND_DIPHENHYDRAMINE_AND_L-MENTHOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24486 |
| Study title: Moscati−R−M, Moore−G−P. Comparison of cimetidine and diphenhydramine in the treatment of acute urticaria. Annals of emergency medicine, {Ann−Emerg−Med}, Jan 1990, vol. 19, no. 1, p. 12−5. |
| Active substance: CODEINE_AND_DIPHENHYDRAMINE_AND_L-MENTHOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24483 |
| Study title: Moscati−R−M, Moore−G−P. Comparison of cimetidine and diphenhydramine in the treatment of acute urticaria. Annals of emergency medicine, {Ann−Emerg−Med}, Jan 1990, vol. 19, no. 1, p. 12−5. |
| Active substance: CODEINE_AND_DIPHENHYDRAMINE_AND_L-MENTHOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24485 |
| Study title: Russo−R−M, Gururaj−V−J, Allen−J−E. The effectiveness of diphenhydramine HCI in pediatric sleep disorders. Journal of clinical pharmacology, {J−Clin−Pharmacol}, May−Jun 1976, vol. 16, no. 5−6, p. 284−8. |
| Active substance: CODEINE_AND_DIPHENHYDRAMINE_AND_L-MENTHOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24482 |
| Study title: Yoder−K−E, Shaffer−M−L, La−Tournous−S−J, Paul−I−M. Child assessment of dextromethorphan, diphenhydramine, and placebo for nocturnal cough due to upper respiratory infection. Clinical Pediatrics {CLIN−PEDIATR}, 2006, Vol/Iss/Pg. 45/7 (633−640). |
| Active substance: CODEINE_AND_DIPHENHYDRAMINE_AND_L-MENTHOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24481 |
| Study title: A multi-centre, double blind, parallel group, prospective, randomised study to compare the efficacy of a single dose of 10 mg/kg ibuprofen with 15 mg/kgparacetamol in febrile children aged from 3 months to 12 years followed by tolerability over up to thre |
| Active substance: CODEINE_AND_IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24499 |
| Study title: TREATMENT OF VAGINAL CANDIDIASIS WITH A SINGLE ORAL DOSE OF FCA. MULTICENTER NON-COMPARATIVE OPEN STUDY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27772 |
| Study title: USEFULNESS OF DIFLUCAN THERAPY FOR SYSTEMIC FUNGAL INFECTIONS ASSOCIATED WITH HEMATOLOGIC DISEASES |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27486 |
| Study title: USEFULNESS OF DIFLUCAN THERAPY FOR SYSTEMIC FUNGAL INFECTIONS ASSOCIATED WITH HEMATOLOGIC DISEASES |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27850 |
| Study title: Acta Neurol Belg. 2001 Dec;101(4):196-209. Guidelines for brain radionuclide imaging. Perfusion single photon computed tomography (SPECT) using Tc-99m radiopharmaceuticals and brain metabolism positron emission tomography (PET) using F-18 fluorodeoxyglucose. The Belgian Society for Nuclear Medicine. Vander Borght T, Laloux P, Maes A, Salmon E, Goethals I, Goldman S; Belgian Society for Nuclear Medicine. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28162 |
| Study title: Ann Nucl Med. 2004 Apr;18(2):131-6. Lesion detectability of a gamma camera based coincidence system with FDG in patients with malignant tumors: a comparison with dedicated positron emission tomography. Koga H, Sasaki M, Kuwabara Y, Nakagawa M, Hayashi K, Kaneko K, Chen T, Honda H. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28123 |
| Study title: Ann Nucl Med. 2005 Apr;19(2):101-8. The effect of oral contrast on large bowel activity in FDG-PET/CT. Otsuka H, Graham MM, Kubo A, Nishitani H. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28103 |
| Study title: Khan SA et al.The treatment of chronic psoriasis a two centre comparative study 1981;225;(1356):932-4Khan SA et al.The treatment of chronic psoriasis a two centre comparative study 1981;225;(1356):932-4 |
| Active substance: TARS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43362 |
| Study title: Langner A et al. Treatment of psoriasis of the scalp with coal tar gel and shampoo preparations. Cutaneous medicine for the practitioner 1983;32;(3):290-1;295-6 Langner A et al. Treatment of psoriasis of the scalp with coal tar gel and shampoo preparations. Cutaneous medicine for the practitioner 1983;32;(3):290-1;295-6 |
| Active substance: TARS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43361 |
| Study title: Hepatology. 2006 Dec;44(6):1572-80. Comment in: Liver Transpl. 2007 Apr;13(4):622-3. Dynamic FDG-PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation.Prytz H, Keiding S, BjÃrnsson E, Broomé U, Almer S, Castedal M, Munk OL; Swedish Internal Medicine Liver Club. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28071 |
| Study title: IEEE Trans Biomed Eng. 2005 Sep;52(9):1574-81. Application of an objective method for localizing bilateral cortical FDG PET abnormalities to guide the resection of epileptic foci. Muzik O, Pourabdollah S, Juhasz C, Chugani DC, Janisse J, Draghici S. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28095 |
| Study title: Int J Nurs Stud. 2007 Aug;44(6):973-81. Epub 2006 Jun 16. Effects of acupressure on dysmenorrhea and skin temperature changes in college students: a non-randomized controlled trial. Jun EM, Chang S, Kang DH, Kim S. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28080 |
| Study title: J Am Coll Cardiol. 2000 Nov 1;36(5):1676-83. Myocardial viability assessed by positron emission tomography in infants and children after the arterial switch operation and suspected infarction. Rickers C, Sasse K, Buchert R, Stern H, van den Hoff J, Lübeck M, Weil J. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28173 |
| Study title: Treatment of Pyrexia Associated with Infectious Disease in Children |
| Active substance: CODEINE_AND_IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24497 |
| Study title: Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma. Malogolowkin MH et al. J Clin Oncol. 2006 Jun 20;24(18):2879-84 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28299 |
| Study title: Intraarterial chemotherapy with Lipiodol for initially unresectable hepatoblastomas in children. Ogita S. Regional Cancer Treatment. December 1, 1992, 106-9 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28291 |
| Study title: A pilot comparative study evaluating the analgesic effect of using a single dose of an ibuprofen 200 mg / acetaminophen 650 mg combination or ibuprofen 400 mg in post-operative dental pain |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29491 |
| Study title: J Neurol Neurosurg Psychiatry. 1997 Dec;63(6):743-8. Comparison of [18F]FDG-PET, [99mTc]-HMPAO-SPECT, and [123I]-iomazenil-SPECT in localising the epileptogenic cortex. Lamusuo S, Ruottinen HM, Knuuti J, HärkÃnen R, Ruotsalainen U, Bergman J, Haaparanta M, Solin O, Mervaala E, Nousiainen U, Jääskeläinen S, Ylinen A, Kälviäinen R, Rinne JK, Vapalahti M, Rinne JO. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28193 |
| Study title: Autret−Leca−E et al. Ibuprofen versus paracetamol in pediatric fever: Objective and subjective findings from a randomized, blinded study. {CURR−MED−RES−OPIN}, 2007, Vol /Iss/Pg. 23/9 (2205−2211)Autret−Leca−E et al. Ibuprofen versus paracetamol in pediatric fever: Objective and subjective findings from a randomized, blinded study. {CURR−MED−RES−OPIN}, 2007, Vol /Iss/Pg. 23/9 (2205−2211) |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29567 |
| Study title: Brufen syrup in juvenile chronic polyarthritis, rheumatic fever soft tissue injuries and infectious disorders in children, The Boots Company, India |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29431 |
| Study title: Pharmacotherapy. 1992;12(5):369-75. Comparative assessment of the effect of lomefloxacin, ciprofloxacin, and placebo on cerebral blood flow, and glucose and oxygen metabolism in healthy subjects by positron emission tomography. Bednarczyk EM, Green JA, Nelson AD, Leisure GP, Little D, Adler LP, Berridge MS, Panacek EA, Miraldi FD. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28206 |
| Study title: New combination of triamcinolone, 5-fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars. Asilian A, Darougheh A, Shariati F. Dermatol Surg. July 1, 2006, 907-15 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28266 |
| Study title: Sposto-R, Ertel-I-J, Jenkin-R-D, Boesel-C-P, Venes-J-L, Ortega-J-A, Evans-A-E, Wara-W, Hammond-D. University of Southern California School of Medicine, Los Angeles. The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group. Journal of neuro-oncology, {J-Neurooncol}, Jul 1989, vol. 7, no. 2, p. 165-77, ISSN: 0167-594X.Sposto-R, Ertel-I-J, Jenkin-R-D, Boesel-C-P, Venes-J-L, Ortega-J-A, Evans-A-E, Wara-W, Hammond-D. University of Southern California School of Medicine, Los Angeles. The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group. Journal of neuro... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34849 |
| Study title: Brown JN. The suspected scaphoid fracture and isotope bone imaging. Injury. 1995 Sep;26(7):479-82. Brown JN. The suspected scaphoid fracture and isotope bone imaging. Injury. 1995 Sep;26(7):479-82. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43590 |
| Study title: Comparison of dextranomer and streptokinase-streptodornase in the treatment of venous leg ulcers and other infected wounds.Hulkko A, Holopainen YV, Orava S, Kangas J, Kuusisto P, Hyvärinen E, Ervasti E, Silvennoinen E. Ann Chir Gynaecol. 1981;70(2):65-70. |
| Active substance: streptokinase and streptodornase |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48946 |
| Study title: Cervelli V, Cipriani C, Migliano E, Giudiceandrea F, Cervelli G, Grimaldi M. SPECT in the long-term evaluation of osteointegration in intraoral and extraoral implantology. J Craniofac Surg. 1997 Sep;8(5):379-82. Cervelli V, Cipriani C, Migliano E, Giudiceandrea F, Cervelli G, Grimaldi M. SPECT in the long-term evaluation of osteointegration in intraoral and extraoral implantology. J Craniofac Surg. 1997 Sep;8(5):379-82. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43536 |
| Study title: Respiration. 2006;73(5):634-41. Epub 2006 May 5. Comment in: Respiration. 2006;73(5):587-9. The solitary pulmonary nodule--is it malignant or benign? Diagnostic performance of Tc-depreotide SPECT. Naalsund A, Maublant J. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28081 |
| Study title: Stereotact Funct Neurosurg. 1995;64 Suppl 1:258-69. Early irradiation effects observed on magnetic resonance imaging and angiography, and positron emission tomography for arteriovenous malformations treated by Gamma Knife radiosurgery. Guo WY, Pan DH, Liu RS, Chung WY, Shiau CY, Cheng SS, Chang CY, Chen KY, Yeh SH, Lee LS. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28200 |
| Study title: Bentzinger C*,Biziere K,Plovin P,Dulac O,Chiron C,Girod R,Hewson G,Metcalfe S,Siegel J L, Clinical Final Study Report: Open-label exploratory study of the effects of acute i.v. flumazenil on interictal epileptic activity in pediatric patients with treated or untreated Lennox-Gastaut syndrome |
| Active substance: FLUMAZENIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28213 |
| Study title: The effectiveness of Varidase was evaluated in the local treatment of skin lesions, particularly wounds with fibrinous or necrotic crusts.Luger et al. 1981 |
| Active substance: streptokinase and streptodornase |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48949 |
| Study title: Varidase topical (Streptokinase-Streptodornase) has been clinically evaluated in patients for its efficacy, tolerance, and side effects.Chang et al. 1980 |
| Active substance: streptokinase and streptodornase |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48948 |
| Study title: Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL et al. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin-2 and Interferon Alfa-2b. Journal of Clinical Oncology 1999;17(3):968-975 1999;(3):968-975.Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL et al. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin-2 and Interferon Alfa-2b. Journal of Clinical Oncology 1999;17(3):968-975 1999;(3):968-975. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43130 |
| Study title: Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL et al. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin 2 and Interferon Alfa-2b. Journal of Clinical Oncology 1999; 17(3):968-975.Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL et al. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin 2 and Interferon Alfa-2b. Journal of Clinical Oncology 1999; 17(3):968-975. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43150 |
| Study title: Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL et al. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin 2 and Interferon Alfa-2b. Journal of Clinical Oncology 1999; 17(3):968-975.Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL et al. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin 2 and Interferon Alfa-2b. Journal of Clinical Oncology 1999; 17(3):968-975. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43173 |
| Study title: Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL et al. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin 2 and Interferon Alfa-2b. Journal of Clinical Oncology 1999; 17(3):968-975.Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL et al. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin 2 and Interferon Alfa-2b. Journal of Clinical Oncology 1999; 17(3):968-975. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43179 |
| Study title: Bozzo TM. The Effect of Encephabol in School Children with States of Mental Exhaustion (Minerva Medicopsicologica 1970; 2 (12): 44-47); Bozzo TM. The Effect of Encephabol in School Children with States of Mental Exhaustion (Minerva Medicopsicologica 1970; 2 (12): 44-47); |
| Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35145 |
| Study title: TO DETERMINE FLUCONAZOLE EFFICACY AND SAFETY IN AIDS PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27405 |
| Study title: TO DETERMINE FLUCONAZOLE EFFICACY AND SAFETY IN AIDS PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27770 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF A SINGLE ORAL DOSE OF FLUCONAZOLE (150 MG) IN THE TREATMENT OF NON-SEVERE ORAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27590 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF A SINGLE ORAL DOSE OF FLUCONAZOLE (150 MG) IN THE TREATMENT OF NON-SEVERE ORAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27953 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL AND/OR IV FLUCONAZOLE 100-400 MG ONCE A DAY IN THE TREATMENT OF CRYPTOCOCCAL MENINGITIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27592 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL AND/OR IV FLUCONAZOLE 100-400 MG ONCE A DAY IN THE TREATMENT OF CRYPTOCOCCAL MENINGITIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27955 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL AND/OR IV FLUCONAZOLE 200-400 MG ONCE A DAY IN THE TREATMENT OF SYSTEMIC CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27591 |
| Study title: Brain Res Cogn Brain Res. 2004 Jan;18(2):142-8. Hostility differentiates the brain metabolic effects of nicotine. Fallon JH, Keator DB, Mbogori J, Turner J, Potkin SG. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28138 |
| Study title: Cancer Treat Rev. 2004 Feb;30(1):83-101. The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis. Bastiaannet E, Groen H, Jager PL, Cobben DC, van der Graaf WT, Vaalburg W, Hoekstra HJ. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28134 |
| Study title: Cancer. 2001 Jul 15;92(2):434-9. Comparing 18-fluoro-2-deoxyglucose positron emission tomography with a combination of technetium 99m tetrofosmin single photon emission computed tomography and computed tomography to detect recurrent or persistent nasopharyngeal carcinomas after radiotherapy. Kao CH, Tsai SC, Wang JJ, Ho YJ, Yen RF, Ho ST. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28169 |
| Study title: Cancer. 2001 Mar 1;91(5):889-99. 2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial. Buchmann I, Reinhardt M, Elsner K, Bunjes D, Altehoefer C, Finke J, Moser E, Glatting G, Kotzerke J, Guhlmann CA, Schirrmeister H, Reske SN. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28172 |
| Study title: Chin Med J (Engl). 1997 Nov;110(11):875-8. Early intervention improves intellectual development in asphyxiated newborn infants. Intervention of Asphyxiated Newborn Infants Cooperative Research Group. Bao X, Sun S, Yu R, Sun J. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28188 |
| Study title: J Neurosurg. 2006 Feb;104(2):238-53. Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures. Pirotte B, Goldman S, Dewitte O, Massager N, Wikler D, Lefranc F, Ben Taib NO, Rorive S, David P, Brotchi J, Levivier M. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28087 |
| Study title: J Nucl Med. 2001 Aug;42(8):1139-43. Effect of whole-body (18)F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma. SchÃder H, Meta J, Yap C, Ariannejad M, Rao J, Phelps ME, Valk PE, Sayre J, Czernin J. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28168 |
| Study title: Pierzynski P, Swiatecka J, Oczeretko E, Laudanski P, Batra S, Laudanski T. Effect of short-term, low-dose treatment with tamoxifen in patients with primary dysmenorrhea. Gynecological Endocrinology 2006; 22(12):698-703.Pierzynski P, Swiatecka J, Oczeretko E, Laudanski P, Batra S, Laudanski T. Effect of short-term, low-dose treatment with tamoxifen in patients with primary dysmenorrhea. Gynecological Endocrinology 2006; 22(12):698-703. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43136 |
| Study title: Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin-2 and Interferon Alfa-2b. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin-2 and Interferon Alfa-2b. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43288 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL AND/OR IV FLUCONAZOLE 200-400 MG ONCE A DAY IN THE TREATMENT OF SYSTEMIC CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27954 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL FLUCONAZOLE (CAPSULES AND SYRUP) ONCE DAILY IN THE TREATMENT OF PATIENTS SUFFERING FROM ORAL ATROPHIC CANDIDIASIS WITH DENTURES. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27439 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL FLUCONAZOLE (CAPSULES AND SYRUP) ONCE DAILY IN THE TREATMENT OF PATIENTS SUFFERING FROM ORAL ATROPHIC CANDIDIASIS WITH DENTURES. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27804 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FCA 50 TO 200 O.D. IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27418 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FCA 50 TO 200 O.D. IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27783 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FLUCONAZOLE 100-400 MG/DAY IN THE TREATMENT OF SYSTEMIC CANDIDIASIS/CRYPTOCOCCAL MENINGITIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27580 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FLUCONAZOLE 100-400 MG/DAY IN THE TREATMENT OF SYSTEMIC CANDIDIASIS/CRYPTOCOCCAL MENINGITIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27943 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FLUCONAZOLE 50/100 MG O.D. IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27420 |
| Study title: Preoperative UFT and calcium folinate and radiotherapy in rectal cancer. Hoff PM et al. Oncology (Williston Park). 1999 Jul;13(7 Suppl 3):129-31 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28309 |
| Study title: A single dose study to compare the efficacy and side effects of ibuprofen suspension to placebo in children 5 through 11 years of age with post-operative pain secondary to either inguinal or umbilical herniorrhaphy. Jul 1995. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29556 |
| Study title: A single dose study to compare the efficacy and side effects of ibuprofen suspension to placebo in children 5 through 11 years of age with post-operative pain secondary to either inguinal or umbilical herniorrhaphy. Jul 1995. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29626 |
| Study title: A single dose study to compare the efficacy and side effects of ibuprofen suspension to placebo in children 5 through 11 years of age with post-operative pain secondary to either inguinal or umbilical herniorrhaphy. CSR 187 Revised. Protocol 90-048, Unpublished Report 385. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): ibuprofen 90-048.pdf |
| View full study record |
| Document reference: 47451 |
| Study title: J Nucl Med. 2005 Feb;46(2):283-91. Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error? Yau YY, Chan WS, Tam YM, Vernon P, Wong S, Coel M, Chu SK. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28111 |
| Study title: J Nucl Med. 2005 Mar;46(3):405-10. The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx. Yen TC, Chang JT, Ng SH, Chang YC, Chan SC, Lin KJ, Lin WJ, Fu YK, Lin CY. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28107 |
| Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43227 |
| Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43237 |
| Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43247 |
| Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43319 |
| Study title: Hoffman J, Stoll P, Yoo K, et al, An open-label study of the safety of flumazenil (Ro 15-1788) when used in children to reverse the residual CNS depressant effects of benzodiazepine-induced conscious sedation |
| Active substance: FLUMAZENIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28211 |
| Study title: Min B*,Song D,Khayksi V,Zhang S,Choma N,Koss-Twardy S, An Open-label Study of the Safety of Flumazenil when Used in Children to Reverse the Residual Effects of Benzodiazepine-Induced Conscious Sedation-Bioanalytical Results, 02.12.94 |
| Active substance: FLUMAZENIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28214 |
| Study title: NDA 20-073 (USA) Romazicon ® (flumazenil) injection, S-008 NDA 20-073 (USA) Pediatric labelling supplement December 12,1996 |
| Active substance: FLUMAZENIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28212 |
| Study title: Efficacy and safety of Ro-1788 in reversing the central effects of flunitrazepam used for induction of anesthesia. A double blind comparative clinical study Ro 15-1788 versus placebo |
| Active substance: FLUNITRAZEPAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28238 |
| Study title: Screening and diagnosis of beta-ureidopropionase deficiency by gas chromatographic/mass spectrometric analysis of urine. Ohse M et al. J Mass Spectrom. 2002 Sep;37(9):954-62 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28304 |
| Study title: The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcninoma. Zhang Z, Wu M, Liu Q. Chin J Oncol. July 6, 1999, 214-6 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28279 |
| Study title: The preventive effect of granisetron on digestive tract symptoms induced by arterial infusion of anticancer and hypertensive agents in combination with radiotherapy--a study of forty patients with bladder cancer. Hayashida S et al. Gan To Kagaku Ryoho. 1995 Apr;22(5):639-46 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28316 |
| Study title: Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study. Katzenstein HM et al. J Clin Oncol. 2002 Aug 15;20(16):3438-44 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): 12177104.pdf |
| View full study record |
| Document reference: 28305 |
| Study title: UFT plus calcium folinate/irinotecan in colorectal cancer. Twelves C. Oncology (Williston Park). 1999 Jul;13(7 Suppl 3):51-4 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28310 |
| Study title: Logue G. The Effects of Pyrithioxine on the Behaviour and Intellectual Functioning of Learning-Disabled Children (S Afr Med J1974; 48: 2245-2246); Logue G. The Effects of Pyrithioxine on the Behaviour and Intellectual Functioning of Learning-Disabled Children (S Afr Med J1974; 48: 2245-2246); |
| Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35149 |
| Study title: An open, controlled, randomized and single-centre study to evaluate the effectiveness of a new economical schedule of rabies postexposure prophylaxis using purified chick embryo cell tissue culture (PCEC) rabies vaccine (Rabipur®, Behring Vaccines; now Novartis Vaccines) in the patients of 1 to 61 years of age. |
| Active substance: RABIES VACCINE FOR HUMAN USE PREPARED FROM CELL CULTURE (DIPLOID CELLS) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48381 |
| Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: JMeza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: J |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43328 |
| Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43337 |
| Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43347 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Tartephedreel (drops) [AWB-072] |
| Active substance: Tartephedreel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40252 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Tartephedreel (drops) [AWB-AT] |
| Active substance: Tartephedreel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40253 |
| Study title: A pilot study of the role of TC-99 radionuclide in localization of pulmonary nodular lesions for thoracoscopic resection. Chella A, Lucchi M, Ambrogi MC, Menconi G, Melfi FM, Gonfiotti A, Boni G, Angeletti CA. Eur J Cardiothorac Surg. 2000 Jul;18(1):17-21. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48234 |
| Study title: Study of the efficacy and safety of Ro 15-1788 in reversing the central effects of flunitrazepam used to induce and maintain general anesthesia |
| Active substance: FLUNITRAZEPAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28239 |
| Study title: [Current therapy aspects of intraocular tumors] Schüler AO, Bornfeld N. Ophthalmologe. 2000 Mar;97(3):207-22. |
| Active substance: FLUORESCEIN |
| Study summary document link (including results): Current therapy aspects of intraocular tumors.pdf |
| View full study record |
| Document reference: 28244 |
| Study title: Diabetic retinopathy in pediatric patients with type-1 diabetes: effect of diabetes duration, prepubertal and pubertal onset of diabetes, and metabolic control. Holl RW, Lang GE, Grabert M, Heinze E, Lang GK, Debatin KM. J Pediatr. 1998 May;132(5):790-4. Comment in: J Pediatr. 1998 May;132(5):760-2. PMID: 9602180. |
| Active substance: FLUORESCEIN |
| Study summary document link (including results): Diabetic retinopathy in pediatric patients with type-1 diabe.pdf |
| View full study record |
| Document reference: 28247 |
| Study title: Collier BD, Carrera GF, Messer EJ, Ryan DE, Gingrass D, Angell D, Palmer DW, Isitman AT, Hellman RS. Internal derangement of the temporomandibular joint: detection by single-photon emission computed tomography. Work in progress. Radiology. 1983 Nov;149(2):557-61. Collier BD, Carrera GF, Messer EJ, Ryan DE, Gingrass D, Angell D, Palmer DW, Isitman AT, Hellman RS. Internal derangement of the temporomandibular joint: detection by single-photon emission computed tomography. Work in progress. Radiology. 1983 Nov;149(2):557-61. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44277 |
| Study title: Prospective study on immunogenicity of VERORAB® rabies vaccine administered by intramuscular or intradermal route concomitantly with TETRACOQ® to infants followed up at the Center of Pediatrics, Development and Health of Ho Chi Minh Ville, Vietnam |
| Active substance: Rabies virus (Wistar rabies PM/WI38-1503-3M strain), grown on a continuous Vero cell line, inactivated with betapropiolactone |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47472 |
| Study title: Jenkin-R-D-T, Boesel-C, Ertel-I, et-al. Childrens Cancer Study Group, University of Southern California, Pasadena, CA, United States. Brain-stem tumors in childhood: A prospective randomized trial of irradiation with and without adjuvant CCNU, VCR, and prednisone. A report of the Children's Cancer Study Group. Journal of Neurosurgery {J-NEUROSURG}, 1987, Vol/Iss/Pg. 66/2 (227-233).Jenkin-R-D-T, Boesel-C, Ertel-I, et-al. Childrens Cancer Study Group, University of Southern California, Pasadena, CA, United States. Brain-stem tumors in childhood: A prospective randomized trial of irradiation with and without adjuvant CCNU, VCR, and prednisone. A report of the Children's Cancer Study Group. Journal of Neurosurgery {J-NEUROSURG}, 1987, Vol/Iss/Pg. 66/2... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34756 |
| Study title: Jenkin-R-D-T, Brown-T-C, Peters-M-V, Sonley-M-J. Princess Margaret Hosp., Toronto, Canada. Hodgkin's disease in children. A retrospective analysis: 1958-73. Cancer {CANCER}, 1975, Vol/Iss/Pg. 35/3 sup (979-990).Jenkin-R-D-T, Brown-T-C, Peters-M-V, Sonley-M-J. Princess Margaret Hosp., Toronto, Canada. Hodgkin's disease in children. A retrospective analysis: 1958-73. Cancer {CANCER}, 1975, Vol/Iss/Pg. 35/3 sup (979-990). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34757 |
| Study title: Immunogenicity and efficacy of PCECV in a population bitten by animals at high risk of rabies infection |
| Active substance: RABIES VACCINE FOR HUMAN USE PREPARED FROM CELL CULTURE (DIPLOID CELLS) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48383 |
| Study title: Bilateral deep venous thrombosis in protein S deficiency. Detection by radionuclide venography. Wegener WA, Heyman S. Clin Nucl Med. 1990 Sep;15(9):618-22. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48283 |
| Study title: Clinical significance of nonfocal scintigraphic findings in suspected tibial stress fractures.Chisin R, Milgrom C, Giladi M, Stein M, Margulies J, Kashtan H. Clin Orthop Relat Res. 1987 Jul;(220):200-5. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43858 |
| Study title: A DOUBLE-BLIND MULTICENTER COMPARATIVE STUDY OF TWO DOSE REGIMENS OF ORAL CLINDAMYCIN HYDROCHLORIDE IN THE TREATMENT OF ACUTE TONSILLITIS/PHARYNGITIS DUE TO GROUP A BETA-HEMOLYTIC STREPTOCOCCI. |
| Active substance: CLINDAMYCIN |
| Study summary document link (including results): 251F-INF-0496-001 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 24361 |
| Study title: A PROSPECTIVE, STRATIFIED, RANDOMIZED, THIRD-PARTY BLINDED COMPARISON OF THE SAFETY AND EFFICACY OF CEFOPERAZONE PLUS PIPERACILLIN VERSUS CEFOPERAZONE PLUS AMIKACIN IN THERAPY OF INFECTED SOLID TUMOR PATIENTS RECEIVING CISPLATIN |
| Active substance: CLINDAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24360 |
| Study title: bay b 5097 500 mg vaginal tablet: efficacy and tolerance of bay b 5097 500 mg vaginal tablet as single or one day therapy of vaginal yeast infections |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0420_study_synopsis.pdf |
| View full study record |
| Document reference: 24457 |
| Study title: BAY b 5097 Solution N Activity and Tolerability in Dermatomycoses. |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24441 |
| Study title: BAY b 5097 Solution N Activity and Tolerance in Otomycoses. |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24442 |
| Study title: BAY b 5097 Solution N Activity and Tolerance in Otomycoses. |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0220_study_synopsis.pdf |
| View full study record |
| Document reference: 24443 |
| Study title: Comparative study on the efficacy of clotrimazole vaginal cream 10 & econazole depot ovule 150 mg in the treatment of candida vaginitis. |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24445 |
| Study title: Comparative study on the efficacy of clotrimazole vaginal cream 10% and econazole depot ovule 150 mg in the treatment of Candida vaginitis |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0595_study_synopsis.pdf |
| View full study record |
| Document reference: 24448 |
| Study title: effectiveness and tolerance of bay b 5097 2 per cent vaginal cream on therapy for 3 days compared to therapy for 7 days with econazole 1 per cent vaginal cream (gyno-pevaryl cream) |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0396_study_synopsis.pdf |
| View full study record |
| Document reference: 24455 |
| Study title: Efficacy and tolerability of clotrimazole vaginal cream 10 in comparison with clotrimazole vaginal tablets 500 mg after a single application in patients with vaginal yeast infections |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0345_study_synopsis.pdf |
| View full study record |
| Document reference: 24444 |
| Study title: Efficacy and tolerability of clotrimazole vaginal cream 10 in comparison with clotrimazole vaginal tablets 500 mg after a single application in patients with vaginal yeast infections |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0473_study_synopsis.pdf |
| View full study record |
| Document reference: 24462 |
| Study title: efficacy and tolerability of clotrimazole vaginal tablets 100 mg (galenic formulation with lactic acid) in the 6-day-therapy in vaginal candida-infections |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0516_study_synopsis.pdf |
| View full study record |
| Document reference: 24451 |
| Study title: efficacy and tolerance of bay b 5097 vaginal cream 2% in the 3-day therapy compared to a 6-day therapy with Canesten vaginal cream 1% |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24453 |
| Study title: efficacy and tolerance of two galenical product formulations of canesten vaginal tablets containing 500 mg of the active ingredient clotrimazole after a single administration to patients with vaginal yeast infections |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0444_study_synopsis.pdf |
| View full study record |
| Document reference: 24458 |
| Study title: Gutachten über die klinische Prüfung von Mykichthol Paste |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0524_study_synopsis.pdf |
| View full study record |
| Document reference: 24465 |
| Study title: Kiltie-A-E, Lashford-L-S, Gattamaneni-H-R. Dr. H.R. Gattamaneni, NHS Trust, Christie Hospital, Wilmslow Road, Manchester M20 9BX, United Kingdom. Survival and late effects in medulloblastoma patients treated with craniospinal irradiation under three years old. Medical and Pediatric Oncology {MED-PEDIATR-ONCOL}, 1997, Vol/Iss/Pg. 28/5 (348-354), ISSN: 0098-1532.Kiltie-A-E, Lashford-L-S, Gattamaneni-H-R. Dr. H.R. Gattamaneni, NHS Trust, Christie Hospital, Wilmslow Road, Manchester M20 9BX, United Kingdom. Survival and late effects in medulloblastoma patients treated with craniospinal irradiation under three years old. Medical and Pediatric Oncology {MED-PEDIATR-ONCOL}, 1997, Vol/Iss/Pg. 28/5 (348-354), ISSN: 0098-1532. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34759 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FLUCONAZOLE 50/100 MG O.D. IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27785 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FLUCONAZOLE 50/100 MG/DAY IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27589 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FLUCONAZOLE 50/100 MG/DAY IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27952 |
| Study title: TO EVALUATE THE EFFICACY AND SAFETY OF FLUCONAZOLE IN THE TREATMENT OF DISSEMINATED CANDIDIASIS AND CRYPTOCOCCAL MENINGITIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27623 |
| Study title: TO EVALUATE THE EFFICACY AND SAFETY OF FLUCONAZOLE IN THE TREATMENT OF DISSEMINATED CANDIDIASIS AND CRYPTOCOCCAL MENINGITIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27985 |
| Study title: TO EVALUATE THE EFFICACY AND TOLERATION OF A SINGLE 400 MG ORAL/IV DOSE OF FLUCONAZOLE IN PATIENTS SUFFERING FROM CANDIDAL ESOPHAGITIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27394 |
| Study title: Clin Nucl Med. 2002 Aug;27(8):572-7. F-18 FDG versus Ga-67 for detecting splenic involvement in Hodgkin's disease. Rini JN, Manalili EY, Hoffman MA, Karayalcin G, Mehrotra B, Tomas MB, Palestro CJ. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28156 |
| Study title: Diabetes Care. 2001 Mar;24(3):555-60. Blood pressure does not rise before the onset of microalbuminuria in children followed from diagnosis of type 1 diabetes. Oxford Regional Prospective Study Group. Schultz CJ, Neil HA, Dalton RN, Konopelska Bahu T, Dunger DB; Oxford Regional Prospective Study Group. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28171 |
| Study title: Eur J Nucl Med Mol Imaging. 2002 Mar;29(3):346-50. CT vs 68Ge attenuation correction in a combined PET/CT system: evaluation of the effect of lowering the CT tube current. Kamel E, Hany TF, Burger C, Treyer V, Lonn AH, von Schulthess GK, Buck A. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28158 |
| Study title: Eur J Nucl Med Mol Imaging. 2003 Apr;30(4):581-7. Epub 2003 Jan 30. Extratemporal hypometabolism on FDG PET in temporal lobe epilepsy as a predictor of seizure outcome after temporal lobectomy. Choi JY, Kim SJ, Hong SB, Seo DW, Hong SC, Kim BT, Kim SE. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28152 |
| Study title: Eur J Nucl Med Mol Imaging. 2004 Jun;31(6):811-9. Epub 2004 Feb 5. Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology. Amthauer H, Denecke T, Rau B, Hildebrandt B, Hünerbein M, Ruf J, Schneider U, Gutberlet M, Schlag PM, Felix R, Wust P. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28135 |
| Study title: Eur J Nucl Med Mol Imaging. 2005 Dec;32(12):1422-8. Epub 2005 Aug 31. Respiratory motion artefact in the liver dome on FDG PET/CT: comparison of attenuation correction with CT and a caesium external source. Papathanassiou D, Becker S, Amir R, Menéroux B, Liehn JC. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28098 |
| Study title: Klin Padiatr. 2003 May-Jun;215(3):146-50. [18-FDG-PET-findings in children and adolescents with Hodgkin's disease: retrospective evaluation of the correlation to other imaging procedures in initial staging and to the predictive value of follow up examinations] [Article in German] Wickmann L, Lüders H, DÃrffel W. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28146 |
| Study title: Investigation of the effectiveness and tolerance of a single administration of clotrimazole vaginal tablet of 500 mg in cases of vaginal candida infection in comparison with a 6-day theraphy with clotrimazole vaginal tablets of 100 mg |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0581_study_synopsis.pdf |
| View full study record |
| Document reference: 24450 |
| Study title: Investigation of the effectiveness and tolerance of a single administration of clotrImazole vaginal tablet of 500 mg in cases of vaginal candida infection in comparison with a 6-day theraphy with clotrimazole vaginal tablets of 100 mg |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0460_study_synopsis.pdf |
| View full study record |
| Document reference: 24461 |
| Study title: Chow LM et al, Survival and late effects in children with Hodgkin's lymphoma treated with, MOPP/ABV and low-dose, extended-field irradiation, J Clin Oncol. 2006 Dec 20;24(36):5735-41Chow LM et al, Survival and late effects in children with Hodgkin's lymphoma treated with, MOPP/ABV and low-dose, extended-field irradiation, J Clin Oncol. 2006 Dec 20;24(36):5735-41 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24828 |
| Study title: TO EVALUATE THE EFFICACY AND TOLERATION OF A SINGLE 400 MG ORAL/IV DOSE OF FLUCONAZOLE IN PATIENTS SUFFERING FROM CANDIDAL ESOPHAGITIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27759 |
| Study title: TO EVALUATE THE PHARMACOKINETIC PARAMETERS AFTER IV FLUCONAZOLE IN PATIENTS WITH EITHER 1. AIDS WITHOUT LIVER DISEASE OR 2. LIVER CIRRHOSIS OR SEVERE HEPATIC DISEASE IN COMPARISON WITH HEALTHY SUBJECTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27427 |
| Study title: TO EVALUATE THE PHARMACOKINETIC PARAMETERS AFTER IV FLUCONAZOLE IN PATIENTS WITH EITHER 1. AIDS WITHOUT LIVER DISEASE OR 2. LIVER CIRRHOSIS OR SEVERE HEPATIC DISEASE IN COMPARISON WITH HEALTHY SUBJECTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27792 |
| Study title: TO EVALUATE THE SAFETY AND EFFICACY OF FLUCONAZOLE CAPSULES VS. NYSTATIN SUSPENSION IN THE PREVENTION OF CANDIDIASIS IN LEUKEMIC PATIENTS UNDERGOING CHEMOTHERAPY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27593 |
| Study title: TO EVALUATE THE SAFETY AND EFFICACY OF FLUCONAZOLE CAPSULES VS. NYSTATIN SUSPENSION IN THE PREVENTION OF CANDIDIASIS IN LEUKEMIC PATIENTS UNDERGOING CHEMOTHERAPY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27956 |
| Study title: TO GATHER ADDITIONAL DATA ON THE SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN PATIENTS CRYPTOCOCCAL MENINGITIS. TO MAKE FLUCONAZOLE AVAILABLE FOR USE IN PATIENTS WITH CRYPTOCOCCAL MENINGITIS WHO IN THE INVESTIGATOR JUDGEMENT WOULD BENEFIT FROM TREATMENT WITH THIS AGENT |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27594 |
| Study title: TO GATHER ADDITIONAL DATA ON THE SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN PATIENTS CRYPTOCOCCAL MENINGITIS. TO MAKE FLUCONAZOLE AVAILABLE FOR USE IN PATIENTS WITH CRYPTOCOCCAL MENINGITIS WHO IN THE INVESTIGATOR JUDGEMENT WOULD BENEFIT FROM TREATMENT WITH THIS AGENT |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27957 |
| Study title: TO INVESTIGATE THE SAFETY AND EFFICACY OF A SINGLE ORAL DOSE OF FCA 150 MG CAPS FOR THE TX OF WOMEN WITH VAGINAL CANDIDIASIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27683 |
| Study title: Warts in children: Treatment with 5-fluorouracil 5% cream and other painless alternatives. Cunningham B.B. Cosmetic Dermatology ( Cosmet. Dermatol. ) (United States) , May 1, 2004 , 17/5 SUPPL. 1 (9-12) Warts in children: Treatment with 5-fluorouracil 5% cream and other painless alternatives. Cunningham B.B. Cosmetic Dermatology ( Cosmet. Dermatol. ) (United States) , May 1, 2004 , 17/5 SUPPL. 1 (9-12) |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28262 |
| Study title: Young patient trabeculectomy: Assessment of risk factors for failure. Sturmer J. Ophthalmology. June 18, 1993, 928-39 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28292 |
| Study title: Diagnosis, clinical picture and treatment of cytomegaloviral infection in children. Rossiiskii Vestnik Perinatologii i Pediatrii 1994; 39(3):16-19.Bendel A, Gross T, Woods W, Edelman C, Balfour H.Diagnosis, clinical picture and treatment of cytomegaloviral infection in children. Rossiiskii Vestnik Perinatologii i Pediatrii 1994; 39(3):16-19.Bendel A, Gross T, Woods W, Edelman C, Balfour H. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Bendel A et al 1993.pdf |
| View full study record |
| Document reference: 28569 |
| Study title: Ding H, Ren H, Guo N, Huang X, Xu L, Zhang Y et al. [Risk factors of cytomegalovirus infection and antiviral efficacy in recipients of hematopoietic stem cell transplantation]. [Chinese]. Ding H, Ren H, Guo N, Huang X, Xu L, Zhang Y et al. [Risk factors of cytomegalovirus infection and antiviral efficacy in recipients of hematopoietic stem cell transplantation]. [Chinese]. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Ding H et al 2003.pdf |
| View full study record |
| Document reference: 28592 |
| Study title: Dini G, Castagnola E, Comoli P, van Tol MJD, Vossen JM. Infections after stem cell transplantation in children: state of the art and recommendations. Bone Marrow Transplantation. 2001; 28 (Suppl 1):S18-S21.Dini G, Castagnola E, Comoli P, van Tol MJD, Vossen JM. Infections after stem cell transplantation in children: state of the art and recommendations. Bone Marrow Transplantation. 2001; 28 (Suppl 1):S18-S21. |
| Active substance: Foscarnet |
| Study summary document link (including results): Dini G et al 2001.pdf |
| View full study record |
| Document reference: 39644 |
| Study title: Eddleston M, Peacock S, Juniper M, Warrell DA. Severe cytomegalovirus infection in immunocompetent patients. Clinical Infectious Diseases 1997; 24(1):52-56.Eddleston M, Peacock S, Juniper M, Warrell DA. Severe cytomegalovirus infection in immunocompetent patients. Clinical Infectious Diseases 1997; 24(1):52-56. |
| Active substance: Foscarnet |
| Study summary document link (including results): Eddleston M et al 1997.pdf |
| View full study record |
| Document reference: 39660 |
| Study title: Fucidin® ointment versus its vehicle and Bactroban® in the treatment of impetigoH Rockl. Unpublished. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28646 |
| Study title: Fucidin® ointment versus its vehicle in the treatment of impetigo |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28647 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to the treatment of Galium-Heel (drops) [AWB-055] |
| Active substance: Galium-Heel /Galium-Heel - Tropfen |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40004 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Galium-Heel (drops) [AWB-AT] |
| Active substance: Galium-Heel/ Galium-Heel - Tropfen |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40003 |
| Study title: Prospective, multicenter, reference-controlled observational study for the documentation of therapeutic efficay and tolerability in the use of Gastricumeel (tablets) or proton pump inhibitors in the treatment of gastritis or heartburn [AWB-502] |
| Active substance: Gastricumeel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40005 |
| Study title: Sperber SJ et al. Effectiveness of pseudoephedrine plus acetaminophen for treatment of symptoms attributed to the paranasal sinuses associated with the common cold. Arch Fam Med 2000; 9(10):979-85 |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29510 |
| Study title: St. Charles CS et al.: A comparison of ibuprofen versus acetaminophen with codeine in the young tonsillectomy. PubMed. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29544 |
| Study title: St. Charles CS et al.: A comparison of ibuprofen versus acetaminophen with codeine in the young tonsillectomy. PubMed. St. Charles CS et al.: A comparison of ibuprofen versus acetaminophen with codeine in the young tonsillectomy. PubMed. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29605 |
| Study title: Study of the efficacy and tolerance of Ibuprofen on hectic fever in systemic juvenile chronic arthritis (JCA) |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29406 |
| Study title: Enright AM, Prober C. Antiviral therapy in children with varicella zoster virus and herpes simplex virus infections. [Review] [99 refs]. Herpes 2003; 10(2):32-37.Enright AM, Prober C. Antiviral therapy in children with varicella zoster virus and herpes simplex virus infections. [Review] [99 refs]. Herpes 2003; 10(2):32-37. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Enright AM et al 2003.pdf |
| View full study record |
| Document reference: 28594 |
| Study title: Gambertoglio JG, Lilleby K, Meyers JD, Reusser P. 1992.Phase i-ii trial of foscarnet for prevention of cytomegalovirus infection in autologous and allogeneic marrow transplant recipients. Journal of Infectious Diseases 1992;166(3):473-9 1992;(3):473-479.Gambertoglio JG, Lilleby K, Meyers JD, Reusser P. 1992.Phase i-ii trial of foscarnet for prevention of cytomegalovirus infection in autologous and allogeneic marrow transplant recipients. Journal of Infectious Diseases 1992;166(3):473-9 1992;(3):473-479. |
| Active substance: Foscarnet |
| Study summary document link (including results): Reusser et al 1992.pdf |
| View full study record |
| Document reference: 39626 |
| Study title: Gershon AA. Prevention and treatment of VZV infections in patients with HIV. Herpes. 2001; 8(2):32-36.Gershon AA. Prevention and treatment of VZV infections in patients with HIV. Herpes. 2001; 8(2):32-36. |
| Active substance: Foscarnet |
| Study summary document link (including results): Gershon AA 2001.pdf |
| View full study record |
| Document reference: 39645 |
| Study title: Glassner CL, Noormohamed SE. Pediatric HIV infection: a primer for pharmacists. Journal of the American Pharmaceutical Association (1996) 1996;36(10):580-95 1999;(1996):580-595.Glassner CL, Noormohamed SE. Pediatric HIV infection: a primer for pharmacists. Journal of the American Pharmaceutical Association (1996) 1996;36(10):580-95 1999;(1996):580-595. |
| Active substance: Foscarnet |
| Study summary document link (including results): Glassner CL et al 1996.pdf |
| View full study record |
| Document reference: 39648 |
| Study title: Griffiths PD. Progress in the clinical management of herpes virus infections. Antiviral-Chemistry- Chemotherapy 1995; 6(4):191-209.Griffiths PD. Progress in the clinical management of herpes virus infections. Antiviral-Chemistry- Chemotherapy 1995; 6(4):191-209. |
| Active substance: Foscarnet |
| Study summary document link (including results): Griffiths PD 1995.pdf |
| View full study record |
| Document reference: 39671 |
| Study title: Grose C. Childhood infections with human herpesviruses types 6, 7, and 8. Advances in Pediatric Infectious Diseases 1996; 12:181-208.Grose C. Childhood infections with human herpesviruses types 6, 7, and 8. Advances in Pediatric Infectious Diseases 1996; 12:181-208. |
| Active substance: Foscarnet |
| Study summary document link (including results): Grose C. 1996.pdf |
| View full study record |
| Document reference: 39666 |
| Study title: Bronchial secretion and serum levels in children with cystic fibrosis treated with gentamicin. - Vogt E. - 1973 ( Praxis, 62 : 444-447) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28891 |
| Study title: Clinical an dLaboratory evaluation of Gentaimicin in Infants and Children. - Riley HD. & Al - 1971 (J. of infectious Dis. 124 Suppl: S236) - Publication in Gentamicin Registration Dossier - No author - 1977 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28892 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Graphites-Homaccord (drops) [AWB-AT] |
| Active substance: Graphites-Homaccord |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40014 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Graphites-Homaccord (ampoules) [AWB-AT] |
| Active substance: Graphites-Homaccord |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40015 |
| Study title: Taste Test Study by RSSL Pharma A taste testing study in healthy volunteers to investigate preference for Nurofen for Children Project Scrumptious |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29520 |
| Study title: Pharmacovigilance of AlphanineSD; affinity purified, solvent detergent treated: An open label study of viral safety in previously untreated subjects with Haemophilia B. |
| Active substance: HUMAN COAGULATION FACTOR IX |
| Study summary document link (including results): 02 ATC 96-04 (synopsis).pdf |
| View full study record |
| Document reference: 47317 |
| Study title: 'Post marketing study in haemophilia B patients using Nonafact® 100 IU/ml powder and solvent for solution for injection (human coagulation factor IX) |
| Active substance: HUMAN COAGULATION FACTOR IX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29134 |
| Study title: Low risk if viral infection after administration of vapor heated factor VII concentrate or factor IX complex in first time recipients of blood components |
| Active substance: HUMAN COAGULATION FACTOR VII |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29140 |
| Study title: Efficacy of factor VIII/von Willebrand factor concentrate Alphanate in preventing excessive bleeding during surgery or invasive procedures in subjects with congenital von Willebrand disease |
| Active substance: HUMAN COAGULATION FACTOR VIII |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29146 |
| Study title: Evaluation of the Pharmacokinetic, Clinical Efficacyand Safety of the Concentrate of Factor VIII, Emoclot D.I., in patients affected by Haemophilia A |
| Active substance: HUMAN COAGULATION FACTOR VIII |
| Study summary document link (including results): 06 IG95-01B (full).pdf |
| View full study record |
| Document reference: 29154 |
| Study title: Han YX, Xue R, Zhao W, Zhou ZX, Li JN, Chen HS et al. 2005.Antiviral therapeutic efficacy of foscarnet in hepatitis B virus infection.Antiviral Research. 68(3):147-153, DEC 2005 2005;(3):-153, Dec.2005.Han YX, Xue R, Zhao W, Zhou ZX, Li JN, Chen HS et al. 2005.Antiviral therapeutic efficacy of foscarnet in hepatitis B virus infection.Antiviral Research. 68(3):147-153, DEC 2005 2005;(3):-153, Dec.2005. |
| Active substance: FOSCARNET |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39592 |
| Study title: Hatchette T, Tipples GA, Peters G, Alsuwaidi A, Zhou J, Mailman TL. Foscarnet salvage therapy for acyclovir-resistant varicella zoster: report of a novel thymidine kinase mutation and review of the literature. Pediatr Infect Dis J. 2008 Jan;27(1):75-7.Hatchette T, Tipples GA, Peters G, Alsuwaidi A, Zhou J, Mailman TL. Foscarnet salvage therapy for acyclovir-resistant varicella zoster: report of a novel thymidine kinase mutation and review of the literature. Pediatr Infect Dis J. 2008 Jan;27(1):75-7. |
| Active substance: Foscarnet |
| Study summary document link (including results): Hatchette T et al 2008.pdf |
| View full study record |
| Document reference: 39615 |
| Study title: Idanpaan H, Aranko K. Miscellaneous antibacterial and antiviral drugs. In: Side effects of drugs. MNG Dukes & JK Aronsen (ed). Elsevier Science Publishers. 1992;322- 340.Idanpaan H, Aranko K. Miscellaneous antibacterial and antiviral drugs. In: Side effects of drugs. MNG Dukes & JK Aronsen (ed). Elsevier Science Publishers. 1992;322- 340. |
| Active substance: Foscarnet |
| Study summary document link (including results): Idanpaan H et al 1992.pdf |
| View full study record |
| Document reference: 39627 |
| Study title: Ippoliti C, Morgan A, Warkentin D, Van BK, Mehra R, Khouri I. Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovir.Ippoliti C, Morgan A, Warkentin D, Van BK, Mehra R, Khouri I. Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovir. |
| Active substance: Foscarnet |
| Study summary document link (including results): Ippoliti C et al 1997.pdf |
| View full study record |
| Document reference: 39661 |
| Study title: Jacobson MA, Kramer F, Bassiakos Y, Hooton T, Polsky B, Geheb H et al. Randomized phase I trial of two different combination foscarnet and ganciclovir chronic maintenance therapy regimens for AIDS patients with cytomegalovirus retinitis: AIDS Clinical Trial Group Protocol 151. Journal-of-Infectious- Diseases 1994; 170 (July): 189-193.Jacobson MA, Kramer F, Bassiakos Y, Hooton T, Polsky B, Geheb H et al. Randomized phase I trial of two different combination foscarnet and ganciclovir chronic maintenance therapy regimens for AIDS patients with cytomegalovirus retinitis: AIDS Clinical Trial Group Protocol 151. Journal-of-Infectious- Diseases 1994; 170 (July): 189-193. |
| Active substance: Foscarnet |
| Study summary document link (including results): Jacobson MA _Kramer F et al 1994.pdf |
| View full study record |
| Document reference: 39633 |
| Study title: Jacobson MA,Causey D, Polsky B, Hardy D, Chown M, Davis R. A dose-ranging study of daily maintenance intravenous foscarnet therapy for cytomegalovirus retinitis in AIDS. Journal of Infectious Diseases 1993; 168(2):444-448.Jacobson MA,Causey D, Polsky B, Hardy D, Chown M, Davis R. A dose-ranging study of daily maintenance intravenous foscarnet therapy for cytomegalovirus retinitis in AIDS. Journal of Infectious Diseases 1993; 168(2):444-448. |
| Active substance: Foscarnet |
| Study summary document link (including results): Jacobson MA et al 1993.pdf |
| View full study record |
| Document reference: 39622 |
| Study title: |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28723 |
| Study title: |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28724 |
| Study title: |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28725 |
| Study title: 4A. A report of patients with superficial skin sepsis treated with fucidin cream. An open assessment of Fucidin Cream as a treatment for superficial sepsis (Newby) |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28669 |
| Study title: A clinical investigation of the pharmacokinetics of MULTIHANCE in healthy normal subjects from two to fifteen years of age. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28720 |
| Study title: A comparative study of Fucidin® ointment (sodium fusidate 2%) and Cicatrin cream (neomycin sulphate 0.5%, bacitracin zinc 250u/g |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28692 |
| Study title: A comparison of Fucidin tablets and Flucloxacillin in skin and soft-tissue infections |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28694 |
| Study title: A comparison of Fucithalmic® eye drops and Chloramphenicol® eye ointment as single treatment in brasion corneae, corpus alieni corneae |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28650 |
| Study title: A comparison of Fusidic acid 1% viscous eye drops (Fucithalmic LEO) and neosporin eye ointment (Wellcome) in patients with external eye infections; Yacinto U Dy, Llacco Int. J. of clinical practices, Vol 7., No. 3., 1991 82 pts (4-75) |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28708 |
| Study title: A comparison of fusidic acid gel 1% (Fucithalmic®) and chloramphenicol 0.5% in acute bacterial conjunctivits Carr WD, Journal Clin Research 1998;1:403-411 |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28713 |
| Study title: A comparison of fusidic acid viscous eye drops and Chloramphenicol eye ointment in acute conjunctivitis |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28697 |
| Study title: A comparison of low dose and standard dose systemic Fucidin® in skin and soft tissue infections |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28716 |
| Study title: A comparison of sodium fusidate ointment and mupirocin ointment in superficial skin sepsis |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28693 |
| Study title: A comparison of the efficacy of Fucidin® H cream(2% fusidic acid/1%hydrocortisone acetate) with Fucidin® cream(2% fusidic acid) in the management of patients with mild to moderate atopic eczema |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28672 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Gripp-Heel (tablets) in children aged up to 11 years old [AWB-063] |
| Active substance: Gripp-Heel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40018 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to the treatment of Gripp-Heel (tablets) [AWB-056] |
| Active substance: Gripp-Heel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40016 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to the treatment of Gripp-Heel (injection solution) [AWB-056] |
| Active substance: Gripp-Heel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40020 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Gripp-Heel (ampoules) [AWB-AT] |
| Active substance: Gripp-Heel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40017 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Gripp-Heel (tablets) [AWB-AT] |
| Active substance: Gripp-Heel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40019 |
| Study title: Lee PCL et al. Antitussive efficacy of dextromethorphan in cough associated with acute upper respiratory tract infection. J Pharm Pharmacol 2000; 52(9):1137-42Lee PCL et al. Antitussive efficacy of dextromethorphan in cough associated with acute upper respiratory tract infection. J Pharm Pharmacol 2000; 52(9):1137-42 |
| Active substance: GUAIFENESIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29028 |
| Study title: Open clinical study to evaluate the reactogenicity of SmithKline Beecham Biologicals' Hib conjugate vaccine mixed with SmithKline Beecham Biologicals' DTPa vaccine when given as a booster dose to children at 15 to 18 months of age, previously primed with SB Bio's Hib tetanus conjugate and DTPa vaccines in study HIB-012. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41133 |
| Study title: Open label, randomised comparative assessment of the immunogenicity and reactogenicity of SmithKline Beecham's (SB's) diphteria/tetanus/acellular pertussis (DTPa) vaccine and SB's Hib with commercially available diphtheria/tetanus/whole cell pertussis (DTPw) and SB's Hib. Vaccines to be combined in the same syringe and administered to healthy infants as three consecutive doses at 2, 3 and 4 months of age. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41137 |
| Study title: Open randomised clinical study to evaluate the immunogenicity and reactogenicity of SB Biologicals' Hib tetanus conjugate vaccine, co-administered with SB Biologicals' DTPa vaccine either mixed in one syringe, or in two separate injections into opposite limbs, to healthy children around two years of age. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41141 |
| Study title: Open study to assess the immunogenicity and reactogenicity of a three-dose primary vaccination course against Haemophilus influenzae type b, diphtheria, tetanus, pertussis and hepatitis B in healthy infants at 6, 10 and 14 weeks of age. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41155 |
| Study title: Open, phase II clinical trial to assess long-term antibody persistence, before Td booster vaccination, in healthy children 5 to 6 years old, previously vaccinated with 4 doses of SB Biologicals¿ DTPa vaccine mixed with SB Biologicals¿ Hib conjugate vaccine in primary vaccination study Hib-006 (208108/005) and in booster vaccination study Hib-017 (208108/017). |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41156 |
| Study title: A double blind, single oral dose study, comparing the antipyretic properties of ibuprofen, acetaminophen and placebo in the treatment of pyrexia associated with infectious disease in children. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29464 |
| Study title: A Double-Blind Parallel Study to Compare the Efficacy and Side Effects of an Ibuprofen 400 mg/Pseudoephedrine 60 mg Combination, an Ibuprofen 200 mg/Pseudoephedrine 30 mg Combination, and Placebo in the Treatment of Sinus Headache |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29502 |
| Study title: Kimberlin DW. Antiviral therapy for cytomegalovirus infections in pediatric patients. Seminars in Pediatric Infectious Diseases. 2002; 13(1):22-30.Kimberlin DW. Antiviral therapy for cytomegalovirus infections in pediatric patients. Seminars in Pediatric Infectious Diseases. 2002; 13(1):22-30. |
| Active substance: Foscarnet |
| Study summary document link (including results): Kimberlin DW. et al 2002.pdf |
| View full study record |
| Document reference: 39637 |
| Study title: Kist-van Holthe JE, Goedvolk CA, Brand R, van Weel MH, Bredius RG, van Oostayen JA et al. Prospective study of renal insufficiency after bone marrow transplantation. Pediatric Nephrology. 2002; 17(12):1032-1037.Kist-van Holthe JE, Goedvolk CA, Brand R, van Weel MH, Bredius RG, van Oostayen JA et al. Prospective study of renal insufficiency after bone marrow transplantation. Pediatric Nephrology. 2002; 17(12):1032-1037. |
| Active substance: Foscarnet |
| Study summary document link (including results): Kist-van Holthe JE et al 2002.pdf |
| View full study record |
| Document reference: 39638 |
| Study title: Leport C, Perronne C, Vilde JL. Antiviral treatment of varicella in adults and immunocompromised hosts (adults and children). Medecine et Maladies Infectieuses 1998; 28(Special Issue SI):837-842.Leport C, Perronne C, Vilde JL. Antiviral treatment of varicella in adults and immunocompromised hosts (adults and children). Medecine et Maladies Infectieuses 1998; 28(Special Issue SI):837-842. |
| Active substance: Foscarnet |
| Study summary document link (including results): Leport C et al 1998.pdf |
| View full study record |
| Document reference: 39652 |
| Study title: Ljungman P, Oberg G, Aschan J, Ehrnst A, Lonnqvist B, Pauksen K et al. Foscarnet for pre-emptive therapy of cmv infection detected by a leukocyte-based nested pcr in allogeneic bone marrow transplant patients. Bone Marrow Transplantation 1996;18(3):565-56Ljungman P, Oberg G, Aschan J, Ehrnst A, Lonnqvist B, Pauksen K et al. Foscarnet for pre-emptive therapy of cmv infection detected by a leukocyte-based nested pcr in allogeneic bone marrow transplant patients. Bone Marrow Transplantation 1996;18(3):565-56 |
| Active substance: Foscarnet |
| Study summary document link (including results): Ljungman P et al 1996.pdf |
| View full study record |
| Document reference: 39667 |
| Study title: Ljungman P. 1995 Cytomegalovirus pneumonia: presentation, diagnosis, and treatment. Seminars in Respiratory Infections 1995; 10(4):209-215. Ljungman P. 1995 Cytomegalovirus pneumonia: presentation, diagnosis, and treatment. Seminars in Respiratory Infections 1995; 10(4):209-215. |
| Active substance: Foscarnet |
| Study summary document link (including results): Ljungman P 1995.pdf |
| View full study record |
| Document reference: 39672 |
| Study title: Marshall BC, Koch WC. Antivirals for cytomegalovirus infection in neonates and infants: focus on pharmacokinetics, formulations, dosing, and adverse events.Paediatr Drugs. 2009;11(5):309-21.Marshall BC, Koch WC. Antivirals for cytomegalovirus infection in neonates and infants: focus on pharmacokinetics, formulations, dosing, and adverse events.Paediatr Drugs. 2009;11(5):309-21. |
| Active substance: Foscarnet |
| Study summary document link (including results): Marshall BC et al 2009.pdf |
| View full study record |
| Document reference: 39606 |
| Study title: Mattes FM, Hainsworth EG, Geretti AM, Nebbia G, Prentice G, Potter M et al. A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients. Journal of Infectious Diseases 189(8), 1355-1361. 2004. Mattes FM, Hainsworth EG, Geretti AM, Nebbia G, Prentice G, Potter M et al. A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients. Journal of Infectious Diseases 189(8), 1355-1361. 2004. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Mattes FM et al 2004.pdf |
| View full study record |
| Document reference: 28588 |
| Study title: A Prospective Blinded Read to Explore the Efficacy of MULTIHANCE and MAGNEVIST (0.10 mmol/kg) in Magnetic Resonance Imaging (MRI) of Brain and Spine Tumors in Pediatric Population |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28722 |
| Study title: Fucidin® tablets in cutaneous infection in comparison with pristinamycin tablets |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28695 |
| Study title: Fucithalmic in external eye infections. Fucithalmic in The Baltic States (adults & children) |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28648 |
| Study title: Fucithalmic viscous eye drops in acute conjunctivitis Single-Blind, Ramdomized Comparison with Chloramphenicol Eye Drops ; J. Hvidberg Acta Ophthalmologica, vol 65, no 1. 1987 |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28699 |
| Study title: Fucithalmic viscous eye drops in superficial eye infections Open non-comparative study |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28652 |
| Study title: Fucithalmic, chloramphenicol or no treatment after squint surgery in children: a single blind randomised study |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28719 |
| Study title: Fucithalmic® versus 1% rifamycin in acute conjunctivitis.Adenis J P, Arrata M, Gastaud P, Limon S, Massin M. J. Fr Ophtalmol 1989; 12(4): 317-322 |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28653 |
| Study title: Fusidic Acid and the Treatment of Patients with Skin and Soft Tissue Infections |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28698 |
| Study title: Fusidic acid versus tobramycin in suspected bacterial conjunctivitis |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28680 |
| Study title: Garborg-O, Nyjordet-R. Pyogenic Cutaneous Infections In East African Children Treated With Fucidin Ointment. Journal of Tropical Pediatrics and Environmental Child Health, 1971, vol. 17, no. 4, p. 153-157. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28663 |
| Study title: Garborg-O. Cutaneous staphylococcal infections in children treated by 2 per cent sodium fusidate ointment. Bruxelles medical, {Brux-Med}, Jun 1968, vol. 48, no. 6, p. 377-82, ISSN: 0068-3027. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28664 |
| Study title: Koning-S, van-Suijlekom-Smit-LWA, Nouwen-JL, Verduin-CM, Bernsen-RMD, et-al. Erasmus University and University Hospital Rotterdam, Rotterdam, The Netherlands. Fusidic acid cream in the treatment of impetigo in general practice: double blind randomised placebo controlled trial. BMJ, {BMJ}, 26 Jan 2002, vol. 324, p. 203-206, ISSN: 0959-8138. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28656 |
| Study title: Koning-S, van-Suijlekom-Smit-LWA, Nouwen-JL, Op-t-Veld-Mulders-M, Snijders-S, et-al. Erasmus University Medical Center, Rotterdam, The Netherlands. Fusidic acid cream versus placebo in the treatment of impetigo: a double blind placebo controlled randomized trial. 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, {41st-ICAAC}, 22 Sep 2001, p. 269. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28657 |
| Study title: Liddy-N. Intravenous fusidic acid in the newborn. Lancet, {Lancet}, 17 Mar 1973, vol. 1, no. 7803, p. 621, ISSN: 0140-6736. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28662 |
| Study title: Gentamycin in the treatment of infections in the premature infant. - Forti G. - 1968 (Antibiotica, Dec, 4:255)- Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28925 |
| Study title: Intravenous Gentamicin for infections complications in children wth acute leukemia. - Haghbin M. -1971 (J. Infectious Dis. Dec. Suppl 124:192) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28928 |
| Study title: Is the primary suture indicated in infected wounds in pediatric surgery?Is the primary suture indicated in infected wounds in pediatric surgery? |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28887 |
| Study title: Pharmacokinetics of gentamicin in children and adults. - Siber GR. - 1975 (J. Infect. Dis., 132, 6: 637-631) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28934 |
| Study title: Pharmacologic evaluation of gentamicin in newborn infants. - McCracken - 1971 (J. of Infectious Dis. 124, Suppl: S214) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28935 |
| Study title: Study of a new antibiotic: injectable gentamicin therapy in paediatrics. - D'Oelsnitz M. - 1967 - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28938 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Hepar compositum (ampoules) [AWB-AT] |
| Active substance: Hepar compositum-Heel - Ampullen |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40024 |
| Study title: Prospective, bicenter, randomised, placebo-controlled, parallel group comparison trial to investigate the antiphlogistic efficacy and tolerance of a fixed combination of levomenol and heparin (Sensicutan ointment) in patients with atopic eczema |
| Active substance: HEPARIN AND LEVOMENOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29118 |
| Study title: Ibuprofen in children with infective disorders - anti-pyretic efficacy - M A Phadke, P V Paranjape and,A S Joshi, B.J. Medical, College, India |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29450 |
| Study title: Jawad SS & Eccles R. Effect of pseudoephedrine on nasal airflow in patients with nasal congestion associated with common cold. Rhinology 1998; 36(2):73-6 |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29511 |
| Study title: Mocroft A, Youle M, Gazzard B, Morcinek J, Halai R, Phillips AN. Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group.Mocroft A, Youle M, Gazzard B, Morcinek J, Halai R, Phillips AN. Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. |
| Active substance: Foscarnet |
| Study summary document link (including results): Mocroft A et al 1996.pdf |
| View full study record |
| Document reference: 39669 |
| Study title: Naik HR, Siddique N, Chandrasekar PH. Foscarnet therapy for acyclovir resistant herpes simplex virus 1 infection in allogeneic bone marrow transplant recipients. Clinical Infectious Diseases 1995; 21(6):1514-1515. Naik HR, Siddique N, Chandrasekar PH. Foscarnet therapy for acyclovir resistant herpes simplex virus 1 infection in allogeneic bone marrow transplant recipients. Clinical Infectious Diseases 1995; 21(6):1514-1515. |
| Active substance: Foscarnet |
| Study summary document link (including results): Naik HR et al 1995.pdf |
| View full study record |
| Document reference: 39674 |
| Study title: Narimatsu H, Kami M, Kato D, Matsumura T, Murashige N, Kusumi E et al. 2007; Reduced dose of foscarnet as preemptive therapy for cytomegalovirus infection following reduced-intensity cord blood transplantation. Transplant Infectious Disease 2007; 9(1):11-15.Narimatsu H, Kami M, Kato D, Matsumura T, Murashige N, Kusumi E et al. 2007; Reduced dose of foscarnet as preemptive therapy for cytomegalovirus infection following reduced-intensity cord blood transplantation. Transplant Infectious Disease 2007; 9(1):11-15. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Narimatsu H et al. 2007.pdf |
| View full study record |
| Document reference: 39588 |
| Study title: New approaches to drug therapy in HIV infection and AIDS. AIDS-Forschung 1994; 9(6):283-294.Tabolin VA, Volodin NN, Geras k, V, Il i, I, Tikhonov VV.New approaches to drug therapy in HIV infection and AIDS. AIDS-Forschung 1994; 9(6):283-294.Tabolin VA, Volodin NN, Geras k, V, Il i, I, Tikhonov VV. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Tabolin VA et al 1994.pdf |
| View full study record |
| Document reference: 28570 |
| Study title: Numazaki K, Chiba S. Current aspects of diagnosis and treatment of cytomegalovirus infections in infants. Clinical & Diagnostic Virology 1997; 8(3):169-181.Numazaki K, Chiba S. Current aspects of diagnosis and treatment of cytomegalovirus infections in infants. Clinical & Diagnostic Virology 1997; 8(3):169-181. |
| Active substance: Foscarnet |
| Study summary document link (including results): Numazaki K et al 1997.pdf |
| View full study record |
| Document reference: 39662 |
| Study title: Numazaki K. Cytomegalovirus infection.Nippon Rinsho - Japanese Journal of Clinical Medicine. 2001; 59:Suppl-8.Numazaki K. Cytomegalovirus infection.Nippon Rinsho - Japanese Journal of Clinical Medicine. 2001; 59:Suppl-8. |
| Active substance: Foscarnet |
| Study summary document link (including results): Numazaki K 2001.pdf |
| View full study record |
| Document reference: 39646 |
| Study title: Paris C, Kopp K, King A, Santolaya ME, Zepeda AJ, Palma J. Cytomegalovirus infection in children undergoing hematopoietic stem cell transplantation in Chile.Pediatr Blood Cancer. 2009 Sep;53(3):453-8.Paris C, Kopp K, King A, Santolaya ME, Zepeda AJ, Palma J. Cytomegalovirus infection in children undergoing hematopoietic stem cell transplantation in Chile.Pediatr Blood Cancer. 2009 Sep;53(3):453-8. |
| Active substance: Foscarnet |
| Study summary document link (including results): Paris C et al 2009.pdf |
| View full study record |
| Document reference: 39607 |
| Study title: Occella-C, Schiazza-L, Nemelka-O, Persi-A, Rampini-E. Ist.Sci. "G.Gaslini", Div.Dermatologica, Genova, Italia. Garze medicate con acido fusidico nella terapia topica Rassegna di Dermatologia e Sifilografia, vol.XXXV, n.unico, genn-dic 1982. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28660 |
| Study title: Perianal streptococcal dermatitis treated with oral fusidic acid: report of two cases |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28718 |
| Study title: Pharmacokinetics of fusidic acid given as an oral suspension to children |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28687 |
| Study title: Pharmacokinetics of fusidic acid in children after single dose administration |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28689 |
| Study title: Pyogenic cutaneous infections in east African children treated with Fucidin® ointment; Garborg O and Nyjordet R. 1971 J Trop Pediatr. Child Health, 17: 153-157 |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28677 |
| Study title: Chu WCW 2000; INCIDENCE OF ADVERSE EVENTS AFTER I.V. INJECTION OF MR CONTRAST AGENTS IN A CHINESE POPULATIONChu WCW 2000; INCIDENCE OF ADVERSE EVENTS AFTER I.V. INJECTION OF MR CONTRAST AGENTS IN A CHINESE POPULATION |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): Chu WCW 2000.pdf |
| View full study record |
| Document reference: 47567 |
| Study title: Contrast Enhanced Magnetic Resonance Imaging of the Central Nervous System in Patients Between 2 and 18 Years of Age by Intravenous Administration: A Randomized Double-Blind Comparison of Gadodiamide Injection (Gd DTPA BMA) 0.1 mmol/kg with MAGNEVIST®(G d DTPA) 0.1 mmol/kg |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): SW1357 Redacted.pdf |
| View full study record |
| Document reference: 47577 |
| Study title: Contrast Enhanced Magnetic Resonance Imaging of the Central Nervous System in Patients Between 2 and 18 Years of Age by Intravenous Administration: A Randomized Double-Blind Comparison of Gadodiamide Injection (Gd DTPA BMA) 0.1 mmol/kg with MAGNEVIST® (Gd DTPA) 0.1 mmol/kg (Protocol 50678-005, Study B) |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): SW1358 Redacted.pdf |
| View full study record |
| Document reference: 47578 |
| Study title: Contrast Enhanced Magnetic Resonance Imaging of the Central Nervous System in Patients Less Than 2 Years of Age by Intravenous Administration: An Open Label Study of Gadodiamide Injection (Gd DTPA BMA) 0.1 mmol/kg |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): SW1356 Redacted.pdf |
| View full study record |
| Document reference: 47576 |
| Study title: Effectiveness and tolerance in the MRT of pediatric patients with CNS lesions; 1X I.V. PH. III - Berlex Report No. 88 488Radiology. 1994 Apr;191(1):155-64.Gadolinium-enhanced MR aortography. Prince MR. |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28813 |
| Study title: Effectiveness and tolerance in the MRT of pediatric patients with CNS lesions; 1X I.V. PH. III - Berlex Report No. 88 489 |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28814 |
| Study title: Effectiveness and tolerance in the MRT of pediatric patients with CNS lesions; 1X I.V. PH. III - Berlex Report No. 88 490 |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28815 |
| Study title: Invest Ophthalmol Vis Sci. 2001 Jan;42(1):17-22. Structure-function correlation of laminar vascularity in human rectus extraocular muscles. Oh SY, Poukens V, Cohen MS, Demer JL. Invest Ophthalmol Vis Sci. 2001 Jan;42(1):17-22. Structure-function correlation of laminar vascularity in human rectus extraocular muscles. Oh SY, Poukens V, Cohen MS, Demer JL. |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28804 |
| Study title: Treatment of Pyrexia Associated with Infectious Disease in Children |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29395 |
| Study title: Xiao Z. An open label multi-center clinical trial to evaluate the efficacy of compound pseudoephedrine (corrected) hydrochloride sustained release capsules in patients with nasal symptoms associated with common cold. Chinese journal of internal medicine 2002; 41(8):547-9 |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29509 |
| Study title: Patel SR, Ridwan RU, Ortin M. Cytomegalovirus reactivation in pediatric hemopoietic progenitors transplant: a retrospective study on the risk factors and the efficacy of treatment.Journal of Pediatric Hematology/Oncology. 2005; 27(8):411-415.Patel SR, Ridwan RU, Ortin M. Cytomegalovirus reactivation in pediatric hemopoietic progenitors transplant: a retrospective study on the risk factors and the efficacy of treatment.Journal of Pediatric Hematology/Oncology. 2005; 27(8):411-415. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Patel SR 2005.pdf |
| View full study record |
| Document reference: 39594 |
| Study title: Reusser P, Einsele H, Lee J, Volin L, Rovira M, Engelhard D et al. Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation. Blood. 2002; 99(4):1159- 1164.Reusser P, Einsele H, Lee J, Volin L, Rovira M, Engelhard D et al. Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation. Blood. 2002; 99(4):1159- 1164. |
| Active substance: Foscarnet |
| Study summary document link (including results): Reusser P Einsele H et al 2002.pdf |
| View full study record |
| Document reference: 39639 |
| Study title: Reusser P. 2002 Challenges and options in the management of viral infections after stem cell transplantation. Supportive Care in Cancer. 2002; 10(3):197-203.Reusser P. 2002 Challenges and options in the management of viral infections after stem cell transplantation. Supportive Care in Cancer. 2002; 10(3):197-203. |
| Active substance: Foscarnet |
| Study summary document link (including results): Reusser P et al 2002..pdf |
| View full study record |
| Document reference: 39640 |
| Study title: Reusser PE. 2002 Management of viral infections in immunocompromised cancer patients. Swiss Medical Weekly. 2002; 132(27-28):374- 378.Reusser PE. 2002 Management of viral infections in immunocompromised cancer patients. Swiss Medical Weekly. 2002; 132(27-28):374- 378. |
| Active substance: Foscarnet |
| Study summary document link (including results): Reusser PE 2002.pdf |
| View full study record |
| Document reference: 39641 |
| Study title: Sarin P. GENITAL HERPES-SIMPLEX INFECTIONS IN PATIENTS WITH THE ACQUIRED- IMMUNODEFICIENCY-SYNDROME. Pharmacotherapy 1994; 14(5):529-542.Sarin P. GENITAL HERPES-SIMPLEX INFECTIONS IN PATIENTS WITH THE ACQUIRED- IMMUNODEFICIENCY-SYNDROME. Pharmacotherapy 1994; 14(5):529-542. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Sarin P. 1994.pdf |
| View full study record |
| Document reference: 28571 |
| Study title: Satwani P, Baldinger L, Freedman J, Jacobson JS, Guerra J, van de Ven C, Morris E, Garvin J, George D, Bradley MB, Bhatia M, Tallamy B, Schwartz J, Jin Z, Cairo MS.Incidence of Viral and fungal infections following busulfan-based reduced-intensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipients. Biol Blood Marrow Transplant. 2009 Dec;15(12):1587-95.Satwani P, Baldinger L, Freedman J, Jacobson JS, Guerra J, van de Ven C, Morris E, Garvin J, George D, Bradley MB, Bhatia M, Tallamy B, Schwartz J, Jin Z, Cairo MS.Incidence of Viral and fungal infections following busulfan-based reduced-intensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipients. Biol Blood Marrow Transplant. 2009 Dec;15(12):1587-95. |
| Active substance: Foscarnet |
| Study summary document link (including results): Satwani P et al 2009.pdf |
| View full study record |
| Document reference: 39605 |
| Study title: Schleiss MR, McVoy MA. Overview of congenitally and perinatally acquired cytomegalovirus infections: recent advances in antiviral therapy. [Review] [109 refs]. Expert Review of Antiinfective Therapy 2004; 2(3):389-403.Schleiss MR, McVoy MA. Overview of congenitally and perinatally acquired cytomegalovirus infections: recent advances in antiviral therapy. [Review] [109 refs]. Expert Review of Antiinfective Therapy 2004; 2(3):389-403. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Schleiss MR and McVoy MA 2004.pdf |
| View full study record |
| Document reference: 28590 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Hepeel (tablets) [AWB-AT] |
| Active substance: Hepeel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40025 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Hepeel (ampoules) [AWB-AT] |
| Active substance: Hepeel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40026 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Hamamelis-Salbe-Heel (ointment) [AWB-AT] |
| Active substance: Hamamelis-Salbe-Heel S |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40021 |
| Study title: IG 95-01B: Retrospective pharmacovilance study. Safety study on the double-inactivated human antihaemophilic factor concentrate (Fanhdi) Grifols, during prophylaxis and/or treatment of patients with haemophilia A. |
| Active substance: HUMAN COAGULATION FACTOR VIII |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29151 |
| Study title: Report UK 95-02: Retrospective review of inhibitor formation in a cohort of haemophilia A patients who received Alphanate (Alpha 8 ST) prophylactically |
| Active substance: HUMAN COAGULATION FACTOR VIII |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29152 |
| Study title: Baker CJ, Melish NM, Hall RT, et al. and the multicenter group for the study of immune globulin in neonates. Intravenous immune globulin for the prevention of nosocomial infection in low-birth-weight neonates. N Engl J Med 1992; 327 (4): 213-219Baker CJ, Melish NM, Hall RT, et al. and the multicenter group for the study of immune globulin in neonates. Intravenous immune globulin for the prevention of nosocomial infection in low-birth-weight neonates. N Engl J Med 1992; 327 (4): 213-219 |
| Active substance: HUMAN NORMAL IMMUNOGLOBULIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29161 |
| Study title: Evaluation of prophylactic passive immunization using IGIV to prevent late onset neonatal infection among low birth weight(< 1750 grams) neonates. Baxter Internal ReportBB IND 1628: June, 1992Evaluation of prophylactic passive immunization using IGIV to prevent late onset neonatal infection among low birth weight(< 1750 grams) neonates. Baxter Internal ReportBB IND 1628: June, 1992 |
| Active substance: HUMAN NORMAL IMMUNOGLOBULIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45133 |
| Study title: Schleiss MR. 2005. Antiviral therapy of congenital cytomegalovirus infection.Seminars in Pediatric Infectious Diseases. 2005; 16(1):50-59.Schleiss MR. 2005. Antiviral therapy of congenital cytomegalovirus infection.Seminars in Pediatric Infectious Diseases. 2005; 16(1):50-59. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Schleiss MR 2005.pdf |
| View full study record |
| Document reference: 39595 |
| Study title: Schuster FR, Simon A, Laws HJ, Beutel K, Groll AH, Jager G et al. 2005. Viral infections in pediatric cancer patients. Klinische Padiatrie. 2005; 217(Suppl 1):S67-S84.Schuster FR, Simon A, Laws HJ, Beutel K, Groll AH, Jager G et al. 2005. Viral infections in pediatric cancer patients. Klinische Padiatrie. 2005; 217(Suppl 1):S67-S84. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Schuster FR et al 2005.pdf |
| View full study record |
| Document reference: 39596 |
| Study title: Shapira MY, Resnick IB, Chou S, Neumann AU, Lurain NS, Stamminger T, Caplan O, Saleh N, Efferth T, Marschall M, Wolf DG. Artesunate as a potent antiviral agent in a patient with late drug resistant cytomegalovirus infection after hematopoietic stem cell transplantation. Clin Infect Dis. 2008 May 1;46(9):1455-7.Shapira MY, Resnick IB, Chou S, Neumann AU, Lurain NS, Stamminger T, Caplan O, Saleh N, Efferth T, Marschall M, Wolf DG. Artesunate as a potent antiviral agent in a patient with late drug resistant cytomegalovirus infection after hematopoietic stem cell transplantation. Clin Infect Dis. 2008 May 1;46(9):1455-7. |
| Active substance: Foscarnet |
| Study summary document link (including results): Shapira MY et al 2008.pdf |
| View full study record |
| Document reference: 39613 |
| Study title: Snoeck R, Andrei G, De CE. Current pharmacological approaches to the therapy of varicella zoster virus infections - A guide to treatment. Drugs 1999; 57(2):187-206.Snoeck R, Andrei G, De CE. Current pharmacological approaches to the therapy of varicella zoster virus infections - A guide to treatment. Drugs 1999; 57(2):187-206. |
| Active substance: Foscarnet |
| Study summary document link (including results): Snoeck R et al 1999.pdf |
| View full study record |
| Document reference: 39649 |
| Study title: Snoeck R, Andrei G, De CE. Novel agents for the therapy of varicella-zoster virus infections. Expert Opinion on Investigational Drugs. 2000; 9(8):1743-1751.Snoeck R, Andrei G, De CE. Novel agents for the therapy of varicella-zoster virus infections. Expert Opinion on Investigational Drugs. 2000; 9(8):1743-1751. |
| Active substance: Foscarnet |
| Study summary document link (including results): Snoeck R et al 2000.pdf |
| View full study record |
| Document reference: 39647 |
| Study title: SOCA, Lewis RA, Clogston P, Fainstein V, Gross R, Samo T Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trial Group. Arch. Intern. Med. 1995; 155: 65-74.SOCA, Lewis RA, Clogston P, Fainstein V, Gross R, Samo T Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trial Group. Arch. Intern. Med. 1995; 155: 65-74. |
| Active substance: Foscarnet |
| Study summary document link (including results): SOCA, Lewis RA et al 1995.pdf |
| View full study record |
| Document reference: 39675 |
| Study title: Sohal A, Riordan A, Mallewa M, Solomon T, Kneen R. Successful treatment of cytomegalovirus polyradiculopathy in a 9-year-old child with congenital human immunodeficiency virus infection. J Child Neurol. 2009 Feb;24(2):215-8. Sohal A, Riordan A, Mallewa M, Solomon T, Kneen R. Successful treatment of cytomegalovirus polyradiculopathy in a 9-year-old child with congenital human immunodeficiency virus infection. J Child Neurol. 2009 Feb;24(2):215-8. |
| Active substance: Foscarnet |
| Study summary document link (including results): Sohal etal 2009.pdf |
| View full study record |
| Document reference: 39608 |
| Study title: Stocchi R, Ward KN, Fanin R, Baccarani M, Apperley JF. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation. Haematologica 1999; 84(1):71-79.Stocchi R, Ward KN, Fanin R, Baccarani M, Apperley JF. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation. Haematologica 1999; 84(1):71-79. |
| Active substance: Foscarnet |
| Study summary document link (including results): Stocchi R et al 1999.pdf |
| View full study record |
| Document reference: 39650 |
| Study title: Efficacy and tolerability of Hametum® wound and healing ointment in children with superficial skin injuries and local inflammation of skin and mucosa |
| Active substance: HERB: aqueous distillate from fresh leaves and twigs of Hamamelis virginiana./ HERB: distillate from fresh leaves and twigs of Hamamelis virginiana (1 : 1.6)/ HERB: distillate from fresh leaves and twigs of Hamamelis virginiana (1 : 1.6), corresponding to 0.64 mg Hamamelis ketones./ HERB: distillate from fresh leaves and twigs of Hamamelis virginiana (1 : 1.6)./ HERB: Distillate from fresh leav... |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40027 |
| Study title: Götte and Roschke; päd (7) 2001 A supportive measure in the treatment of acute infections of the respiratory tract in children with recurring infections of the upper respiratory tract |
| Active substance: (HERB) Purple cone flower, pressed juice, 1.7 - 2.5 : 1 |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39727 |
| Study title: Künzer Th., Retrospective investigation on children (0-12 years) concerning safety and tolerability and dosage of Echinacin Liquidum |
| Active substance: (HERB) Purple cone flower, pressed juice, 1.7 - 2.5 : 1 |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39730 |
| Study title: A phase IIb randomised, multi-site clinical study to assess the immunogenicity and reactogenicity of formulation B of SB Biologicals¿ Hib conjugate vaccine administered mixed as single injection with SB Biologicals¿ DTPa vaccine versus formulation A of SB Biologicals¿ Hib conjugate vaccine administered either mixed as single injection or separately into opposite thighs with SB Biologicals¿ DTPa vaccine as a three-dose primary vaccination course in healthy infants at 3, 4, and 5 months of age. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41147 |
| Study title: A post-marketing surveillance study of GlaxoSmithKline Biologicals¿ Haemophilus influenzae type b (Hib) tetanus conjugate vaccine in 3,000 Filipino subjects. Phase IV single-blind randomised study to assess the feasibility of syringe mixing of combined diphtheria, tetanus, whole cell Bordetella pertussis (DTPw) vaccine and Haemophilus influenzae type b (Hib) conjugate vaccine as a three dose primary vaccination course in healthy infants. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41151 |
| Study title: An open multicentric post marketing surveillance study of SmithKline Beecham haemophilus influenzae type B tetanus conjugate vaccine-Hiberix- administered according to local recommendations in infants and children up to the age of 5 years. Only Korean version-English title to be provided. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41157 |
| Study title: An open, parallel, randomised clinical study to assess the reactogenicity of SB Biologicals¿ Hib conjugate vaccine mixed with SB Biologicals¿ DTPa vaccine in comparison to the Pasteur-Mérieux´s Hib conjugate vaccine mixed with Pasteur-Mérieux´s DTPw vaccine as a booster vaccination to healthy children at 15 to 20 months, previously primed with three doses of commercially available DTPw and Hib conjugate vaccines. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41154 |
| Study title: An open, parallel, randomized clinical study to assess the reactogenicity of SmithKline Beecham (SB) Biologicals¿ Hib conjugate vaccine mixed with SB Biologicals¿ DTPa vaccine in comparison to Pasteur-Mérieux Connaught¿s (PMC) Hib conjugate vaccine mixed with PMCs¿ DTPw vaccine, as a three-dose primary vaccination course to healthy infants at 2, 4 and 6 months of age. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41153 |
| Study title: An open, randomised clinical study to assess the reactogenicity of SB Biologicals¿ Hib conjugate vaccine administered mixed as single injection with SB Biologicals¿ DTPa vaccine in comparison to commercially available Hib conjugate vaccine and DTPw vaccine administered separately into opposite limbs as a booster vaccination in healthy infants at 18 months of age, previously primed with three doses of DTPw and Hib conjugate vaccines. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41149 |
| Study title: Treatment of urinary tract infection with gentamicin once or three times daily - Chong CY. - 2003 (Acta Paediatr 2003;92:291-6) - Publication in CES Renewal Application for Gentamicin sulfate - T. Darragon - 13 Sept. 2004 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28944 |
| Study title: Acta Psychiatr Scand. 2004 Feb;109(2):140-6. Dopamine transporter binding in Gilles de la Tourette syndrome: a [123I]FP-CIT/SPECT study. Serra-Mestres J, Ring HA, Costa DC, Gacinovic S, Walker Z, Lees AJ, Robertson MM, Trimble MR.Acta Psychiatr Scand. 2004 Feb;109(2):140-6. Dopamine transporter binding in Gilles de la Tourette syndrome: a [123I]FP-CIT/SPECT study. Serra-Mestres J, Ring HA, Costa DC, Gacinovic S, Walker Z, Lees AJ, Robertson MM, Trimble MR. |
| Active substance: Gentian (root |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41500 |
| Study title: Petukhova Z.N., Yablonskaya L.V., Burakhova S.V. Clinical effectiveness of Aflubin in the treatment of ARVI and influenza in children with joint diseases, Novosibirsk |
| Active substance: Gentiana D1, Aconitum D6, Bryonia D6, Ferrum phosphoricum D12, Acidum sarcolacticum D12 |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40011 |
| Study title: Kuhn−J−J, Hendley−J−O, Adams−K−F, Clark−J−W, Gwaltney−J−M−Jr. Antitussive effect of guaifenesin in young adults with natural colds. Objective and subjective assessment. Chest, {Chest}, Dec 1982, vol. 82, no. 6, p. 713−8.Kuhn−J−J, Hendley−J−O, Adams−K−F, Clark−J−W, Gwaltney−J−M−Jr. Antitussive effect of guaifenesin in young adults with natural colds. Objective and subjective assessment. Chest, {Chest}, Dec 1982, vol. 82, no. 6, p. 713−8. |
| Active substance: GUAIFENESIN AND PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29052 |
| Study title: A Double-Blind, Parallel Study to Compare the Efficacy and Side Effects of an Ibuprofen 400 mg/Pseudoephedrine 60 mg Combination, An Ibuprofen 200 mg/Pseudoephedrine 30 mg Combination, and Placebo in the Treatment of Sinus Headache |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29562 |
| Study title: A double-blind, parallel-group, multiple-dose study to compare the efficacy and tolerability of Ibuprofen suspension (Junifen) and Paracetamol suspension in the treatment of children undergoing tonsillectomy |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29411 |
| Study title: Zerr DM, Gupta D, Huang ML, Carter R, Corey L. Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. Clinical Infectious Diseases. 2002; 34(3):309-317.Zerr DM, Gupta D, Huang ML, Carter R, Corey L. Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. Clinical Infectious Diseases. 2002; 34(3):309-317. |
| Active substance: Foscarnet |
| Study summary document link (including results): Zerr DM et al 2002.pdf |
| View full study record |
| Document reference: 39643 |
| Study title: Brunelli A. - Children's Recurrent Urinary Tract Infections. Single -Dose Therapy with Fosfomycin Trometamol In: Neu, Williams (eds), New Trends in Urinary Tract Infections. Int Symp., Rome 1987 Karger, Basel, pp. 307-311, 1988 Brunelli A. - Children's Recurrent Urinary Tract Infections. Single -Dose Therapy with Fosfomycin Trometamol In: Neu, Williams (eds), New Trends in Urinary Tract Infections. Int Symp., Rome 1987 Karger, Basel, pp. 307-311, 1988 |
| Active substance: FOSFOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45047 |
| Study title: Careddu et al. Treatment of lower Urinary Tract infections in Children: single Dose Fosfomycin Trometamol Versus Pipemidic Acid. Chemioterapia, 6 pp 290-294, 1987Careddu et al. Treatment of lower Urinary Tract infections in Children: single Dose Fosfomycin Trometamol Versus Pipemidic Acid. Chemioterapia, 6 pp 290-294, 1987 |
| Active substance: FOSFOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45045 |
| Study title: Principi N. et al. Fosfomycin Trometamol versus Netilmicin in Children's Lower Urinary Tract Infections. Chemotherapy, 36 suppl. 1 pp 41-45 1990 Principi N. et al. Fosfomycin Trometamol versus Netilmicin in Children's Lower Urinary Tract Infections. Chemotherapy, 36 suppl. 1 pp 41-45 1990 |
| Active substance: FOSFOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45046 |
| Study title: Varese L.A., et al. - Z1282 (Fosfomycin Trometamol) an Antibacterial Agent as a single-Dose Therapy of lower Uncomplicated Urinary Tract Infection in Children - In: Joji Ishigami ed Recent advances in chemotherapy, Kyoto 1985. Tokyo University of Tokyo PrVarese L.A., et al. - Z1282 (Fosfomycin Trometamol) an Antibacterial Agent as a single-Dose Therapy of lower Uncomplicated Urinary Tract Infection in Children - In: Joji Ishigami ed Recent advances in chemotherapy, Kyoto 1985. Tokyo University of Tokyo Pr |
| Active substance: FOSFOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45050 |
| Study title: Clinical study to assess the immunogenicity and reactogenicity of a booster dose of formulation B of SB Biologicals¿ Hib conjugate vaccine administered either mixed as a single injection or separate into opposite sites with SB Biologicals¿ DTPa vaccine, or formulation A of SB Biologicals¿ Hib conjugate vaccine separately into opposite sites with SB Biologicals¿ DTPa vaccine at 13 months of age in infants primed in study 208108/032 (Hib-032). |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41150 |
| Study title: Clinical study to assess the immunological memory induced by a primary course using different formulations of Hib conjugate vaccines in several combinations with acellular pertussis vaccines by giving one dose of unconjugated PRP co-administered with SB Biologicals¿ DTPa-HBV combined vaccine at 12-24 months of age in infants primed in study DTPa-HBV-037. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41146 |
| Study title: Report on clinical study with iv fucidin in the treatment of severe staphylococcal infection |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28686 |
| Study title: Sputum penetration of fusidic acid in patients with cystic fibrosis |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28717 |
| Study title: Staemmler-H-G, Rodeck-H, Linzenmeier-G. On the treatment of superficial staphylococcal diseases in childhood with Fucidin-gel. Deutsche medizinische Wochenschrift (1946), {Dtsch-Med-Wochenschr}, 6 Sep 1968, vol. 93, no. 36, p. 1714-6, ISSN: 0012-0472. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28665 |
| Study title: Staemmler-H-G, Rodeck-H, Loss-G. The Effect Of Fusidic-Acid Anti Infect On Staphylococcus Infections In Children Abstract From Deutsch-Med-Wschr 91-45 2013-2017 November 11 1996 |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28666 |
| Study title: Study of fusidic acid administered intravenously for the treatment of severe staphylococcus infection |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28685 |
| Study title: Systemic or Local Treatment of Erythrasma. Thorn P Scand J Prim Health Care 1991 9 35-39 |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28671 |
| Study title: Therapeutic assessment of application of calcipotriol ointment (Daivonex®) in children with psoriasis |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28704 |
| Study title: Treatment of skin infections with two dosages of fusidic acid (500 mg/day and 1 g/day) compared with pristinamycin 2 g/day : a multicentre randomised study; L. Machet, A. Puissant, L. Vaillant t le groupe d’étude des infections cutanéesNouvelles Dermatologiques 1994; 13: 512-9 |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28683 |
| Study title: A comparative study of Fucidin H cream and Hydrocortisone cream in children (4-17 years) with a flare-up of atopic dermatitis. A study using non-invasive bioengineering techniques. |
| Active substance: FUSIDIC ACID AND HYDROCORTISONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28726 |
| Study title: Open, randomised, clinical study to evaluate the interference on the immunogenicity of vaccine antigens, when Haemophilus influenzae type b tetanus conjugate and combined diphtheria, tetanus, acellular pertussis vaccines are co-administered, either in one single or two separate injections as a primary vaccination course to healthy infants at 2, 4 and 6 months of age. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41136 |
| Study title: Open, randomized clinical study of the immunogenicity and reactogenicity of the SB Biologicals¿ DTPa and Hib conjugate vaccines, either mixed in one syringe or given in two separate injections, to healthy infants at the age of 2, 4, 6 and 18 months, or the administration of a dose of plain PRP at the age of 12 months in infants primed with Hib conjugate vaccine. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41135 |
| Study title: Phase II open randomized primary vaccination study to assess the immunogenicity and reactogenicity of GlaxoSmithKline Biologicals (GSK) Haemophilus influenzae type b (Hib) conjugate vaccine administered either mixed or in two separated injections with commercially available DTPw vaccine (Government Pharmaceutical Organization: GPO) as compared to GSK Biologicals¿ Hib administered mixed with GSK Biologicals¿ DTPw vaccine in healthy infants, aged 2, 4 and 6 months. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41158 |
| Study title: Phase IV primary vaccination study to assess the immunogenicity and reactogenicity of concomitant administration of Haemophilus influenzae type b (Hib) vaccine with either diphtheria-tetanus-whole cell pertussis vaccine and hepatitis B vaccine or with quadrivalent diphtheria-tetanus-whole cell pertussis-hepatitis B vaccine |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41152 |
| Study title: Kraemer C. und Evers S.: Eine randomisierte, doppelblinde, placebokontrollierte, Crossover Studie zur Wirksamkeit von Ibuprofen und Zolmitriptan akuten Migräneattacke bei Kindern; Neurology 2006;67;497-499; original published online Jun 14, 2006. Lewis D. et al.: Children`s Ibuprofen Suspension for the Acute Treatment of Pediatirc Migraine; Headache September 2002. pp:780-786.St. Charles CS et al.: A comparison of ibuprofen versus acetaminophen with codein in the young tonsillectomy. PubMed. Bennie RE et al.: Postoperative analgesia with preoperative oral ibuprofen or acetaminophen in children undergoing myringotomy. PubMed. Kokki H. et al.: Cerebrospinal Fluid Distribution of Ibuprofen After Intravenous Administration in Children;PEDIATRICS Volume 120, Number 4, October 2007. Clark E.... |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29609 |
| Study title: A PHASE IV RANDOMIZED STUDY OF THE USE OF FLUCONAZOLE AS CHRONIC SUPPRESSIVE THERAPY VERSUS EPISODIC THERAPY IN HIV POSITIVE SUBJECTS WITH RECURRENT OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FOSPHENYTOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28603 |
| Study title: A RANDOMIZED, DOUBLE-BLIND COMPARATIVE MULTICENTER STUDY OF FLUCONAZOLE PLUS AMPHOTERICIN B VERSUS FLUCONAZOLE PLUS PLACEBO IN THE TREATMENT OF CANDIDEMIA AND ITS CONSEQUENCES IN NON-NEUTROPENIC PATIENTS |
| Active substance: FOSPHENYTOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28602 |
| Study title: PILOT STUDY TO DETERMINE THE FEASIBILITY OF FLUCONAZOLE FOR INDUCTION TREATMENT AND SUPPRESSION OF RELAPSE OF HISTOPLASMOSIS IN PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME |
| Active substance: FOSPHENYTOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28601 |
| Study title: Safety and pharmacokinetic profile of the pasteurized purified antitetanus serum (pasteurized pats) associated with adsorbed Td vaccine |
| Active substance: Fragments F(ab')2 of Antitetanus Immunoglobulins (Pasteurized) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41392 |
| Study title: A randomized clinical trial of two topical preparations (framycitin/gramicidin and oxytetracycline/hydrocortisone with polymyxin B) in the treatment of external otitis. Wadsten CJ, Bertilsson CA, Sieradzki H, Edström S. Arch Otorhinolaryngol. 1985;242(2):135-9. |
| Active substance: FRAMYCETIN |
| Study summary document link (including results): A randomized clinical trial of two topical preparations.pdf |
| View full study record |
| Document reference: 28623 |
| Study title: Clinical Expert Statement of Framycetin sulfate containing formulations. - Dr R. Boyer - 21 Feb. 2002 |
| Active substance: FRAMYCETIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45272 |
| Study title: Comparative clinical trial of anti-diarrhoeal drugs. - Gupta S. - 1977 (14:639-644) - Micromedex ref. in CES - Ohlrogge R. - 24 July 2004 - |
| Active substance: FRAMYCETIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28621 |
| Study title: Diffusion weighted MR imaging sequence in the detection of postoperative recurrent cholesteatoma; Dubrulle F; Radiology; 2006 vol.238 n.2 p.604-610Diffusion weighted MR imaging sequence in the detection of postoperative recurrent cholesteatoma; Dubrulle F; Radiology; 2006 vol.238 n.2 p.604-610 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28868 |
| Study title: Terregino C, Nairn S, Chansky M. The effect of heliox on croup: a pilot study. Acad Emerg Med 1998;5:1130 1133.Terregino C, Nairn S, Chansky M. The effect of heliox on croup: a pilot study. Acad Emerg Med 1998;5:1130 1133. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29109 |
| Study title: Treatment of acute tonsillo−pharyngitis: a comparative study of spiramycin and erythromycin. Suprihati, Noersinggih, Hoedijono R. Current medical research and opinion, {Curr−Med−Res−Opin}, 1984, vol. 9, no. 3, p. 192−6. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26523 |
| Study title: Micromedex ref. in CES - Ohlrogge R. - 24 July 2004 : Comparative clinical trial of anti-diarrhoeal drugs. - Gupta S. - 1977 (14:639-644) |
| Active substance: FRAMYCETIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28617 |
| Study title: Open dose finding study on effects and tolerability of Egb 761 in children with attention deficit/hyperactovity syndrome (ADHS) |
| Active substance: Ginkgo biloba (herb)/ Ginkgo biloba leaves (35-67:1), (herb)/ HERB: 40 mg Ginkgo bilobae fol. extr. sicc. (35 - 67 : 1), corresponding to 9.6 mg ginkgo flavone glycosides and 2.4 mg terpene lactones./ HERB: Dry extract of Ginkgo biloba leaves 40 mg, standardized to 9.6 mg (24%) Ginkgo flavone glycosides and 2.4 mg (6%) terpene lactones (ginkgolides and bilobalide)./ HERB: extract (50:1) from Gi... |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40012 |
| Study title: Glimipiride versus Metformin as Monotherapy in Paediatric Subject with Type 2 Diabetes Mellitus : A Single Bind Comparaison Study - sponsor sanofi - 15/11/2004 |
| Active substance: GLIMEPIRIDE |
| Study summary document link (including results): Glimepiride-Study 1.pdf |
| View full study record |
| Document reference: 28972 |
| Study title: Prospective investigation to assess the efficacy of one monotherapy (NAAGA) versus one bitherapy (NAAGA + Levocabastine) in the treatment of mild and moderate seasonal and intra-annual allergic conjunctivitis. Treatment of common ocular allergic disorders; a comparison of lodoxamide and NAAGA |
| Active substance: GLUTAMIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28978 |
| Study title: Bieber T; Randomised, placebo-controlled, double-blind efficacy study of the emollient V0034CR in addition to a moderately potent corticosteroid in the acute phase of treatment of atopic dermatitis in infants. |
| Active substance: GLYCEROL AND LIQUID PARAFFIN |
| Study summary document link (including results): V0034CR3041B.xls |
| View full study record |
| Document reference: 28980 |
| Study title: Blanchet-Bardon C; Efficacité et tolérance de la préparation RD 569B – NY2903 dans le traitement symptomatique des ichtyoses modérées. 1995 |
| Active substance: GLYCEROL AND LIQUID PARAFFIN |
| Study summary document link (including results): RD569B94CR301.xls |
| View full study record |
| Document reference: 28981 |
| Study title: Intraarticular diffusion of Gd-DOTA after intravenous injection in the knee: MR imaging evaluation;Drape JL; Radiology; 1993 vol.188 p.227-234Intraarticular diffusion of Gd-DOTA after intravenous injection in the knee: MR imaging evaluation;Drape JL; Radiology; 1993 vol.188 p.227-234 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28847 |
| Study title: Double-blind, randomised clinical study to evaluate the consistency of the immunogenicity and reactogenicity of three consecutive production lots of SB Biologicals¿ Hib formulation B vaccine, co-administered with SB Biologicals¿ DTPa vaccine into opposite limbs, and in comparison to the SB Biologicals¿ Hib formulation A vaccine co-administered with SB Biologicals¿ DTPa vaccine into opposite limbs, as a primary vaccination course to healthy infants at 3, 4 and 5 months of age. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41140 |
| Study title: Double-blind, randomised clinical study to evaluate the immunogenicity and reactogenicity of four different lots of SB Biologicals' Hib vaccine co-administered with SB Biologicals¿ DTPa vaccine into opposite limbs, as a primary vaccination course to healthy infants at the age of 3, 4½ and 6 months. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41138 |
| Study title: Double-blind, randomised, comparative, multicentre, clinical study to assess the immunogenicity and reactogenicity of three lots of SmithKline Beecham Biologicals' Haemophilus influenzae type b (Hib) tetanus conjugate vaccine when administered simultaneously with SmithKline Beecham Biologicals' tricomponent DTPa vaccine, reconstituted in one single injection, as a primary vaccination course in healthy infants at the age of 3 and 5 months (referred to in this report as Hib-10). |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41131 |
| Study title: Open clinical study to assess the immunogenicity and reactogenicity of a booster dose of formulation B of SB Biologicals¿ Hib conjugate vaccine mixed with SB Biologicals¿ DTPa vaccine as a single injection at 12 or 15-18 months of age in healthy children primed with SB Biologicals¿ Hib conjugate vaccines co-administrated with DTPa-HBV vaccine in study DTPa-HBV-038 |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41144 |
| Study title: Open clinical study to assess the immunogenicity and reactogenicity of a dose of SB Biologicals¿ plain PRP vaccine at 12 months of age followed by SB Biologicals¿ DTPa-HBV vaccine at 15 to 18 months of age in children primed with a new formulation of SB Biologicals¿ Hib conjugate vaccine mixed with DTPa-HBV combined vaccine as a single injection (group 5 of study DTPa-HBV-023). |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41143 |
| Study title: Open clinical study to assess the safety of SmithKline Beecham Biologicals' Haemophilus influenzae type b conjugate vaccine mixed with SmithKline Beecham Biologicals' diphtheria, tetanus, tricomponent acellular pertussis vaccine and administered in one single injection, given as a primary vaccination course to healthy infants at 3, 4 and 5 months of age. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41132 |
| Study title: Immunogenicity and safety of AVAXIM-Pediatric and HAVRIX 720, in chilean subjects from 1 to 15 years of age |
| Active substance: Hepatitis A Vaccine for Children (80 U/dose) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47489 |
| Study title: An open label, prospective, post-marketing surveillance study to evaluate the safety of Euvax B inj. |
| Active substance: Hepatitis B Surface Antigen |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47186 |
| Study title: Paul IM et al. Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics 2004; 114(1):85-90 Paul IM et al. Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics 2004; 114(1):85-90 |
| Active substance: GUAIFENESIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29030 |
| Study title: Paul IM et al. Effect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents. Arch Pediatr Adolesc Med 2007; 161(12):1140-1146Paul IM et al. Effect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents. Arch Pediatr Adolesc Med 2007; 161(12):1140-1146 |
| Active substance: GUAIFENESIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29031 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Husteel (drops) [AWB-AT] |
| Active substance: Husteel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40028 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Husteel (drops) [AWB-085] |
| Active substance: Husteel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40029 |
| Study title: A Randomized, Double-Blind, Vehicle-Controlled Clinical Trial of the Efficacy and Safety of 1.0% Hydrocortisone and a Mixture of Antioxidants, Separately and in Combination, in Reducing the Severity of Disease Symptoms in Children, Aged 2 to 6 Years, with Atopic Dermatitis |
| Active substance: HYDROCORTIZONE |
| Study summary document link (including results): hydrocortisone 957-010.pdf |
| View full study record |
| Document reference: 47742 |
| Study title: Blanchet-Bardon C; Efficacy and tolerance of the emollient cream V0034 CR in the symptomatic treatment of ichthyosis in children. International, multicentric, randomised, controlled, double blind study, in parallel groups V0034 CR versus vehicle. Study Report ongoing. |
| Active substance: GLYCEROL AND LIQUID PARAFFIN |
| Study summary document link (including results): V0034CR3091B.xls |
| View full study record |
| Document reference: 28982 |
| Study title: Tomasik T, Opozda A, Pietrzyk JJ. 2010.Cytomegalovirus infection-- diagnostic and therapeutic difficulties in neonatal intensive care unit. Przegl Lek. 2010;67(1):18-24.Tomasik T, Opozda A, Pietrzyk JJ. 2010.Cytomegalovirus infection-- diagnostic and therapeutic difficulties in neonatal intensive care unit. Przegl Lek. 2010;67(1):18-24. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Tomasik T et al 2010.pdf |
| View full study record |
| Document reference: 39603 |
| Study title: Tomonari A, Takahashi S, Ooi J, Tsukada N, Konuma T, Kobayashi T, Takasugi K, Iseki T, Tojo A, Asano S.Preemptive therapy with ganciclovir 5 mg/kg once daily for cytomegalovirus infection after unrelated cord blood transplantation. Bone Marrow Transplant. 2008 Feb;41(4):371-6.Tomonari A, Takahashi S, Ooi J, Tsukada N, Konuma T, Kobayashi T, Takasugi K, Iseki T, Tojo A, Asano S.Preemptive therapy with ganciclovir 5 mg/kg once daily for cytomegalovirus infection after unrelated cord blood transplantation. Bone Marrow Transplant. 2008 Feb;41(4):371-6. |
| Active substance: Foscarnet |
| Study summary document link (including results): Tomonari A et al 2008.pdf |
| View full study record |
| Document reference: 39616 |
| Study title: Treatment of congenital cytomegalovirus: where are we now? Expert Review of Antiinfective Therapy 2007; 5(3):441-448Treatment of congenital cytomegalovirus: where are we now? Expert Review of Antiinfective Therapy 2007; 5(3):441-448 |
| Active substance: FOSCARNET |
| Study summary document link (including results): Michaels MG 2007.pdf |
| View full study record |
| Document reference: 39587 |
| Study title: Open clinical study to evaluate persistence of antibodies induced by a primary vaccination course using SmithKline Beecham Biologicals¿ Hib vaccine mixed with SmithKline Beecham Biologicals' DTPa vaccine, and to assess immunogenicity and reactogenicity of a booster dose of the same vaccines at 15-20 months of age (referred to in this report as Hib-21). |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41134 |
| Study title: Open clinical study to evaluate the immunogenicity and reactogenicity of SB Biologicals' Hib vaccine, co-administered with routine DTPw vaccine into opposite limbs, as a primary vaccination course to healthy infants at the age of 2, 4 and 6 months. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41142 |
| Study title: Open clinical study to evaluate the priming, in terms of antibody persistence and immunological memory, induced by the administration of SB Biologicals¿ Hib conjugate vaccine administered with DTPa-HBV vaccine in study DTPa-HBV-039 and to evaluate the immunogenicity and reactogenicity of a booster dose of SB Biologicals¿ Hib conjugate vaccine when administered mixed with DTPa-HBV combined vaccine. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41145 |
| Study title: Open clinical study to evaluate the priming, in terms of antibody persistence and immunological memory, induced by the administration of SB Biologicals¿ Hib conjugate vaccine administered with DTPa-HBV vaccine in study DTPa-HBV-043 and to evaluate the immunogenicity and reactogenicity of a booster dose of SB Biologicals¿ Hib conjugate vaccine when administered either mixed or separately with DTPa-HBV combined vaccine. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41148 |
| Study title: GABAPENTIN PEDIATRIC MONOTHERAPY TRIAL: A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY IN PEDIATRIC PATIENTS WITH BENIGN CHILDHOOD EPILEPSY WITH CENTROTEMPORAL SPIKES (BECTS) (PROTOCOL 945-094). |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28781 |
| Study title: Clinical experience with gentamicin in neonates. - Sila R. - 1973 (Acta Pat. Microbiol. Scand. 81? sUPPL; 241: 130-136) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28894 |
| Study title: Clinical Expert Statement - Renewal Application for Gentamicin sulfate (all strengths in EU) - T. Darragon - 13 Sept. 2004 Clinical Expert Statement - Renewal Application for Gentamicin sulfate (all strengths in EU) - T. Darragon - 13 Sept. 2004 |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28895 |
| Study title: Clinical Pharmacology evaluation of gentamicin in newborn infants. - McCracken - 1972 (J. of Infectious Dis. 124 : 884) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28896 |
| Study title: Comparative in-vitro studies of Knamycin and gentamicin : E-coli isolated from newborn infants -Backer CJ. - 1970 (Clin Res. Vol. 20 :1) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28897 |
| Study title: Consideration of Gentamicin for therapy of neonatal sepsis. - Klein JO. - 1969 (J. Infectious Dis. 119,4-5:361) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28898 |
| Study title: Diffusion dans le liquide céphalorachidien de gentamycine injectée par voie IM. Etude chez 5 enfants attents de méningite purulente. - Mariel C - 1971 (Therapie, 26:511-6) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28899 |
| Study title: Emploi de la gentamicine dans les infections graves du nouveau né. - Raynaud EJ. - 1971 (Gaz. Med. De France, 79, 38: 133-9) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28900 |
| Study title: Emploi de la Gentamicine dans les infections graves du nouveau-né - Raynaud EJ. & Al. - 1971 (Gazette Médicale de France) - Publication in Gentamicin Registration Dossier - No author - 1977 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28901 |
| Study title: Essai therapeutique en pédiatrie d'un nouvel antibiotique : la gentamicine. - Thieffry S. - 1968 (Medecine Infantile, 6 : 444-52) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28902 |
| Study title: A multicenter, randomized, double-blind, parallel group vehicle-controlled study of the efficacy and safety of fluticasone propionate lotion 0.05% applied once daily for four weeks in the treatment of adult and pediatric subjects with moderate to severe atopic dermatitis Report No. NI1999/00008/00 |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Synopsis-Fluticasone Propionate-CUTIVATE-FPL30003.pdf |
| View full study record |
| Document reference: 45116 |
| Study title: A multiple-dose, open-label, 2-way crossover study in pediatric subjects with asthma aged 1 to < 4 years to compare the systemic exposure of fluticasone propionate 88mcg administered via the hydrofluoroalkane metered-dose inhaler using the valved holding chambers, Aerochamber Plus™ and Babyhaler™, with face-masks |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FAS10002-ICHE3.pdf |
| View full study record |
| Document reference: 28438 |
| Study title: Williams DN, Rehm SJ, Tice AD, Bradley JS, Kind AC, Craig WA. Practice guidelines for communitybased parenteral anti-infective therapy. Clinical Infectious Diseases 1997; 25(4):787-801.Williams DN, Rehm SJ, Tice AD, Bradley JS, Kind AC, Craig WA. Practice guidelines for communitybased parenteral anti-infective therapy. Clinical Infectious Diseases 1997; 25(4):787-801. |
| Active substance: Foscarnet |
| Study summary document link (including results): Williams DN et al 1997.pdf |
| View full study record |
| Document reference: 39663 |
| Study title: Belkum-A, Snijders-S, van-leeuwen-W, Verbrugh-H, NouwenJ, Op--t-Veld- Koning-S, Van-M, van-Suijlekom-Smit-LW, van-der-Wouden-JC, Verduin-C. Severity of nonbullous Staphylococcus aureus impetigo in children is associated with strains harboring genetic markers for exfoliative toxin B, Panton-Valentine leukocidin, and the multidrug resistance plasmid pSK41. Journal of Clinical Microbiology, {J-Clin-Microbiol}, 1 Jul 2003, vol. 41, p. 3017-3021, ISSN: 0095-1137. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28667 |
| Study title: Bourget-P, Duhamel-J-F, Soerensen-H, Roiron-R. Clinical Pharmacy Department, Antoine Beclere Hospital, Clamart, France. Pharmacokinetics of fusidic acid after a single dose of a new paediatric suspension. Journal of clinical pharmacy and therapeutics, {J-Clin-Pharm-Ther}, Jun 1993, vol. 18, no. 3, p. 171-7, ISSN: 0269-4727. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28659 |
| Study title: Cannarozzo-C, Zagni-G-F. Osp.Gen.Reg. "Vittorio Emanuele II", Div.Dermatologica, Catania, Italia. Studio clinico sul fusidato di sodio in polvere per uso topico. Clin.Europea, anno xx, n.3, maggio-giugno 1981. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28661 |
| Study title: Chu-AC. Imperial College of Science, London, England. Incidence of resistance to fusidic acid in atopic eczema patients treated with topical fusidic acid, with or without topical steroid. 59th Annual Meeting American Academy of Dermatology, {59th-AAD}, 2 Mar 2001, p. abstr. 091. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28658 |
| Study title: Clinical study report Fucidin Creme Vol II (Efficacy and compatibility of Fucidin Crème)West German trial. 337 patients. 90 patients were under the age of 10, 63 patients aged 11-20. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28709 |
| Study title: Clinical trial of fusidic acid for lepromatous leprosy Franzblau S.G. et al ACC 1994; 38(7):1651-1654 LEO provided tablets |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28710 |
| Study title: Comparative effect of fusidic acid (Fucithalmic®) and ofloxacin (tarivid®) eye drops in acute conjunctivitis. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28649 |
| Study title: Comparative effect of fusidic acid gel 1% (Fucithalmic®) and norfloxacin 0.3% (Noroxin®) in acute bacterial conjunctivitis |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28681 |
| Study title: Comparative effects of fusidic acid (1%) viscous eye drops (Fucithalmic® Unit Dose) and Chloramphenicol (0.5% ) eye drops (Minims® Chloramphenicol) in acute neonatal bacterial conjunctivitis |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28679 |
| Study title: Comparative trial of Fucidin ointment and Fucidin cream in skin sepsis; Pakrooh H. J Int Med Res 1980; 8(6): 425-429 (LEO sponsored) |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28644 |
| Study title: Comparison of Fusidic acid and Oxacillin in bacterial skin infections |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28711 |
| Study title: Comparison of Safety and Efficacy of Gadobenate Dimeglumine and Gadopentetate Dimeglumine in Magnetic Resonance Imaging of Central Nervous System Disorders in Pediatric Patients. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28721 |
| Study title: Data collection and treatment of children with Daivonex® ointment |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28706 |
| Study title: Efficacy and acceptability of Fusidic acid cream and mupirocin ointment in acute skin sepsis |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28700 |
| Study title: Habib DM, Garner SS, Brandeburg S. Effect of Helium-Oxygen on Delivery of Albuterol in a Pediatric, Volume-Cycled, Ventilated Lung Model. Pharmacotherapy 1999;19(2):143-149.Habib DM, Garner SS, Brandeburg S. Effect of Helium-Oxygen on Delivery of Albuterol in a Pediatric, Volume-Cycled, Ventilated Lung Model. Pharmacotherapy 1999;19(2):143-149. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29082 |
| Study title: A LONG-TERM, MULTICENTER, OPEN LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF GABAPENTIN AS ADD-ON THERAPY IN SUBJECTS WITH REFRACTORY EPILEPSY (PARTIAL SEIZURE) AND WHO TRANSFERRED FROM A DOUBLE BLIND BRIDGING STUDY |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28745 |
| Study title: A clinical investigation of the pharmacokinetics of MULTIHANCE in healthy normal subjects from two to fifteen years of age. |
| Active substance: GADOBENIC ACID |
| Study summary document link (including results): EUdraCT-datafields for publication-Bracco-MultiHance_43779_10.xls |
| View full study record |
| Document reference: 28799 |
| Study title: A phase III, double-blind, parallel-group, randomized, comparative, two-centre study on gadodiamide injection (Omniscan) and Magnevist® at 0.1 mmol/kg b.w. in MR examinations of the CNS in children and adolescents in a 0.5 T Philips Gyroscan MR unit at the University Hospital Eppendorf, Hamburg, Germany, and in a 1.5T Philips Gyroscan S15 MR unit at the Department of Diagnostic Radiology, University of Cologne, Cologne, Germany |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): SOV033 Redacted.pdf |
| View full study record |
| Document reference: 47574 |
| Study title: A phase IVIII open study of gadodiamide injection (OMNISCAN(D) 0.3 mmol/kg b.w. used for MR examinations of patients with bone or soft tissue tumours |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): ISOV026 Redacted.pdf |
| View full study record |
| Document reference: 47568 |
| Study title: Gentamicin in the treatment of meningitis in neonates. Leelom JM. - 1969 (J. Infectious Dis., 119,4-5: 476) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28921 |
| Study title: Gentamicin in the treatment of sepsis in new born infants. - Elfving L. - 1973 (Acta path; microbio. Scand., section B 81 Suppl. 241: 124-129) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28922 |
| Study title: Gentamicin in urinary infections of children. - Holt RJ. - 1968 (Arch. Dis. Childhood, 43:329) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28923 |
| Study title: A prospective dose titration study of the efficay and safety (fluvastatin sodium) in the treatment of children with heterozygous familial hypercholesterolemia |
| Active substance: FLUVASTATIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28455 |
| Study title: Monaldi Arch Chest Dis. 2006 Dec;66(4):275-85. Review.IT Hyperhomocysteinemia in pediatric age and nutritional aspects of folates: an early cardiovascular risk factor. Caramia G, Belardinelli R. |
| Active substance: FOLIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28462 |
| Study title: Efficacy and acceptability of fusidic acid cream and mupirocin ointment in facial impetigo |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28701 |
| Study title: Efficacy and acceptability of fusidic acid cream and mupirocin ointment in facial impetigo. Sutton J.B. Curr Ther Res 1992; 51(5): 673-678 |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28670 |
| Study title: Efficacy and safety of calcipotriol ointment in treating children (2-14 years) with psoriasis vulgaris |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28705 |
| Study title: Lundby B 1996; MRI in children given gadodiamide injection: safety and efficacy in CNS and body indicationsLundby B 1996; MRI in children given gadodiamide injection: safety and efficacy in CNS and body indications |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): Lundby B 1996.pdf |
| View full study record |
| Document reference: 47570 |
| Study title: Magn Reson Imaging. 1999 Feb;17(2):229-35. Effect of a gadodiamide contrast agent on the reliability of brain tissue T1 measurements. Steen RG, Reddick WE, Ogg RJ, Langston JW. Magn Reson Imaging. 1999 Feb;17(2):229-35. Effect of a gadodiamide contrast agent on the reliability of brain tissue T1 measurements. Steen RG, Reddick WE, Ogg RJ, Langston JW. |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28806 |
| Study title: Yoder KE et al. Child assessment of dextromethorphan, diphenhydramine, and placebo for nocturnal cough due to upper respiratory infection. Clin Pediatr 2006; 45(7):633-640Yoder KE et al. Child assessment of dextromethorphan, diphenhydramine, and placebo for nocturnal cough due to upper respiratory infection. Clin Pediatr 2006; 45(7):633-640 |
| Active substance: GUAIFENESIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29033 |
| Study title: Jayaram S, Desai A. Efficacy and safety of Ascoril expectorant and other cough formula in the treatment of cough management in paediatric and adult patients--a randomised double-blind comparative trial. J Indian Med Assoc.2000 Feb;98(2):68-70.Jayaram S, Desai A. Efficacy and safety of Ascoril expectorant and other cough formula in the treatment of cough management in paediatric and adult patients--a randomised double-blind comparative trial. J Indian Med Assoc.2000 Feb;98(2):68-70. |
| Active substance: GUAIFENESIN AND CHLOROCYCLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29034 |
| Study title: An open label, phase II/III, non-drug comparative study of gadodiamide injection (Omniscan*) at 0.1 mmol/kg b.w. in MR examinations of the body (excluding the CNS) in children and adolescents at the University Hospital Eppendorf, Hamburg, Germany |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): SOV035 Redacted.pdf |
| View full study record |
| Document reference: 47575 |
| Study title: An open phase III study of gadodiamide injection (Omniscan®) 0.1 mmol/kg b.w. used for MR examinations of the body (including the CNS) in children |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): SOV032 Redacted.pdf |
| View full study record |
| Document reference: 47573 |
| Study title: An open, non-comparative, phase III study of gadodiamide injection (Omniscan®) 0.1 mmol/kg b.w. used for magnetic resonance examinations of the CNS in children from 6 months to 14 years of age in a 0.5 T Esaote MR unit |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): SOV031 Redacted.pdf |
| View full study record |
| Document reference: 47572 |
| Study title: Pediatrics. 2006 Jul;118(1):180-8. A randomized, controlled trial of the effects of adding vitamin B12 and folate to erythropoietin for the treatment of anemia of prematurity. Haiden N, Klebermass K, Cardona F, Schwindt J, Berger A, Kohlhauser-Vollmuth C, Jilma B, Pollak A. |
| Active substance: FOLIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28465 |
| Study title: CLINICAL TRIAL TO COMPARE THE DURATION OF BRONCHODILATOR EFFECT OF FORMOTEROL METERED DOSE AEROSOL WITH SALBUTAMOL METERED DOSE AEROSOL IN CHILDREN WITH PERENNIAL ASTHMA. CLINICAL TRIAL SUMMARY AND REPORT |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 GS 20-GS20 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47830 |
| Study title: Double-blind, within-patient placebo-controlled trial comparing the effect of inhalation of formoterol dry powder capsules 12 ug at two different flow rates on the time-course of protection against exercise-induced bronchoconstriction in children with asthma |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 DP-FL2 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47833 |
| Study title: DOUBLE-BLIND, WITHIN-PATIENT, PLACEBO-CONTROLLED STUDY TO EVALUATE THE ONSET AND DURATION OF THE PROTECTIVE EFFECT OF A SINGLE DOSE OF INHALED FORMOTEROL DRY POWDER AGAINST EXERCISE-INDUCED ASTHMA IN ADOLESCENT AND ADULT ATHLETES. |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 25827 02 069 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47834 |
| Study title: Effectiveness and tolerance in the MRT of pediatric patients with CNS lesions; 1X I.V. PH. III - Berlex Report No. 88 493 |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_88493_study_synopsis.pdf |
| View full study record |
| Document reference: 28818 |
| Study title: Cambazard; Double blind, randomised, parallel group. Study of V0034CR cream versus vehicle in the management of atopic dermatitis in infants aged from 3 months to 24 months. |
| Active substance: GLYCEROL AND LIQUID PARAFFIN |
| Study summary document link (including results): V0034CR201.xls |
| View full study record |
| Document reference: 28983 |
| Study title: Stalder; A multicentre, parallel group, double blind versus vehicle study, to evaluate the benefit of topical V0034CR compared to the vehicle in the treatment of atopic dermatitis in children between 4 and 24 months. Study Report 2004 |
| Active substance: GLYCEROL AND LIQUID PARAFFIN |
| Study summary document link (including results): V0034CR301.xls |
| View full study record |
| Document reference: 28984 |
| Study title: Szepietowski J; Efficacy, local tolerance and patient acceptability of an moisturising emollient on xerosis with or without pruritus, in patients undergoing maintenance renal dialysis (MRD). Study Report 2006 |
| Active substance: GLYCEROL AND LIQUID PARAFFIN |
| Study summary document link (including results): V0034CR302.xls |
| View full study record |
| Document reference: 28986 |
| Study title: Taieb A; Long term management of atopic dermatitis with the emollient V0034CR. A randomised, placebo-controlled, parallel groups, double-blind study in infants and children. |
| Active substance: GLYCEROL AND LIQUID PARAFFIN |
| Study summary document link (including results): V0034CR3071B.xls |
| View full study record |
| Document reference: 28985 |
| Study title: Bettinger-J et al. Comparison of different non-invasive test methods with respect to the effect of different moisturisers on the skin. Skin Research and Technology 1999;5;(1):21-27 |
| Active substance: GLYCEROL OR GLYCEROL AND LIQUID SUGAR |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28987 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Glyoxal compositum (ampoules) [AWB-AT] |
| Active substance: Glyoxal compositum-Heel - apmpoules |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40013 |
| Study title: Safety of approved MR contrast media for intravenous injection; Runge VM; JMRI; 2000 vol.12 p.205-213Safety of approved MR contrast media for intravenous injection; Runge VM; JMRI; 2000 vol.12 p.205-213 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28857 |
| Study title: Subjective and objective image qualities: a comparison of sagittal T2-weighted spin-echo and turbo-spin-echo sequences in magnetic resonance imaging of the spine by use of a subjective ranking system;Gorres G; Rontgenpraxis; 1998 vol.51 p.258-265Subjective and objective image qualities: a comparison of sagittal T2-weighted spin-echo and turbo-spin-echo sequences in magnetic resonance imaging of the spine by use of a subjective ranking system;Gorres G; Rontgenpraxis; 1998 vol.51 p.258-265 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28853 |
| Study title: Martin D, Day J, Ward G, Carter E, Chesrown S. Effects of breathing a normoxic helium mixture on exercise tolerance of patients with cystic fibrosis. Pediatr Pulmonol 1994 Oct;18(4):206-10.Martin D, Day J, Ward G, Carter E, Chesrown S. Effects of breathing a normoxic helium mixture on exercise tolerance of patients with cystic fibrosis. Pediatr Pulmonol 1994 Oct;18(4):206-10. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29091 |
| Study title: Gentamicin : Clinical and laboratory studies in Infants and children - Nunnery AW - 1969 (J. Infect. Dis., 119, 4-5 : 460) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28904 |
| Study title: Gentamicin : Pharmacologic observations in newborns and infants. - Nunnery AW - 1969 (J. Infect. Dis., 119, 4-5 : 402) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28906 |
| Study title: Gentamicin in childhood infections - Marsden HB. & Al - 1970 - Publication in Gentamicin Registration Dossier - No author - 1977 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28907 |
| Study title: Gentamicin in Childhood infections. 6 Marsden HB. - 1970 (Curr. Ther. Res, 12 : 353) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28908 |
| Study title: Gentamicin in infections in infants with low birthweights. - Howard J. - 1971 (J. Infectious Dis. Dec. Suppl 124:232) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28909 |
| Study title: Gentamicin in Pediatric Infections caused by Gram-Negative Organisms. - Del Valle - 1969 (J. of Infectious Dis. 119, 4-5 : 453) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28913 |
| Study title: Gentamicin in Pediatrics. II. Treatment of severe urinary-tract infections caused by Gram-negative Bacilli and of Staphylococcal infections - Holt RJ. Al. - 1971 (J. of Infectious Dis. 124 Suppl.: S257) - Publication in Gentamicin Registration Dossier - N |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28916 |
| Study title: Randomised, double-blind clinical study to evaluate and compare the immunogenicity and reactogenicity of a booster dose of two formulations of SB Biologicals' Hib conjugate vaccine, when administered mixed in one syringe with SB Biologicals' DTPa vaccine to healthy children in their 2nd year of life. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41139 |
| Study title: Anderson L.T. Campbell M. et al. Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms AM J Psychiat. 1984, 141, 1195Anderson L.T. Campbell M. et al. Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms AM J Psychiat. 1984, 141, 1195 |
| Active substance: HALOPERIDOL |
| Study summary document link (including results): andersonabstract_haloperiol.pdf |
| View full study record |
| Document reference: 29065 |
| Study title: Duration of effects of inhaled formoterol versus salbutamol. |
| Active substance: FORMOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47836 |
| Study title: Asakura M, Ikegame K, Yoshihara S,Taniguchi S, Mori T, Etoh T, Takami A, Yoshida T, Fukuda T, Hatanaka K, Kanamori H, Yujiri T, Atsuta Y, Sakamaki H, Suzuki R, Ogawa H. 2010. Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor. Int J Hematol. 2010 Sep;92(2):351-9.Asakura M, Ikegame K, Yoshihara S,Taniguchi S, Mori T, Etoh T, Takami A, Yoshida T, Fukuda T, Hatanaka K, Kanamori H, Yujiri T, Atsuta Y, Sakamaki H, Suzuki R, Ogawa H. 2010. Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor. Int J Hematol. 2010 Sep;92(2):351-9. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Asakura M et al 2010.pdf |
| View full study record |
| Document reference: 39600 |
| Study title: Aschan J, Ringden O, Ljungman P, Lonnqvist B, Ohlman S. 1992. Foscarnet for treatment of cytomegalovirus infections in bone marrow transplant recipients. Scandinavian Journal of Infectious Diseases 1992; 24(2):143-150.Aschan J, Ringden O, Ljungman P, Lonnqvist B, Ohlman S. 1992. Foscarnet for treatment of cytomegalovirus infections in bone marrow transplant recipients. Scandinavian Journal of Infectious Diseases 1992; 24(2):143-150. |
| Active substance: Foscarnet |
| Study summary document link (including results): Aschan J et al 1992.pdf |
| View full study record |
| Document reference: 39625 |
| Study title: Bacigalupo A, Bregante S, Tedone E, Isaza A, Van Lint MT, Moro F. Combined foscarnet - ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation (hsct). Bone Marrow Transplantation 1996;18SUPPL:110-4 1996.Bacigalupo A, Bregante S, Tedone E, Isaza A, Van Lint MT, Moro F. Combined foscarnet - ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation (hsct). Bone Marrow Transplantation 1996;18SUPPL:110-4 1996. |
| Active substance: Foscarnet |
| Study summary document link (including results): Bacigalupo A et al 1996 supplement.pdf |
| View full study record |
| Document reference: 39665 |
| Study title: Bacigalupo A, Bregante S, Tedone E, Isaza A, Van Lint MT,Trespi G et al. Combined foscarnet-ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation. Transplantation 1996;62(3):376-380 1996;(3):376-380.Bacigalupo A, Bregante S, Tedone E, Isaza A, Van Lint MT,Trespi G et al. Combined foscarnet-ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation. Transplantation 1996;62(3):376-380 1996;(3):376-380. |
| Active substance: Foscarnet |
| Study summary document link (including results): Bacigalupo A et al 1996.pdf |
| View full study record |
| Document reference: 39664 |
| Study title: Bernstein DI, Schleupner CJ, Evans TG, Blumberg DA, Bryson Y, Grafford K et al. Effect of foscarnet cream on experimental UV radiation-induced herpes labialis. Antimicrobial Agents & Chemotherapy 1997; 41(9):1961-1964.Bernstein DI, Schleupner CJ, Evans TG, Blumberg DA, Bryson Y, Grafford K et al. Effect of foscarnet cream on experimental UV radiation-induced herpes labialis. Antimicrobial Agents & Chemotherapy 1997; 41(9):1961-1964. |
| Active substance: Foscarnet |
| Study summary document link (including results): Bernstein DI et al 1997.pdf |
| View full study record |
| Document reference: 39656 |
| Study title: Clinical efficacy of dirithromycin in pharyngitis and tonsillitis. Müller O, Wettich K. The Journal of antimicrobial chemotherapy, { Mar 1993, vol. 31 Suppl C, p. 97−102. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26472 |
| Study title: Protection against the common cold in a boys' school |
| Active substance: DICHLOROBENZYL-ALCOHOL AND LIDOCAINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25949 |
| Study title: Noncontrolled clinical trial of framycetin sulphate (sofrakay) bacterial diarrhoea and cholera in children. - Praharaj SC. - 1977 (Indian J. Pediatr. 44: 39-44) - Micromedex ref. in CES - Ohlrogge R. - 24 July 2004 - |
| Active substance: FRAMYCETIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28618 |
| Study title: Oral non-absorbed antibiotics prevent infection in acute non-lymphoblastic leukemia. - Storring RA -1977 (Lancet, 837-840) - Micromedex ref. in CES - Ohlrogge R. - 24 July 2004 - |
| Active substance: FRAMYCETIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28619 |
| Study title: Which dressing ? - Gough DCS - 1990 (Br. J. Urol. 65: 418-419) - Micromedex ref. in CES - Ohlrogge R. - 24 July 2004 - |
| Active substance: FRAMYCETIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28620 |
| Study title: Intratracheal furosemide in infants after cardiac surgery : its effects on lung mechanics and urinary output, and its levels in plasma and tracheal aspirate - Aufricht C. et AL. - 1997 ( Intensive Care Med. 23, 992-997) Publication in Clinical Expert Report - Dr. Med. Th. DOBMEYER - 27/08/2001 |
| Active substance: FUROSEMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28634 |
| Study title: Suppression of puberty with long-acting goserelin (Zoladex-LA): effect on gonadotrophin response to GnRH in the first treatment cycle.Breyer P, Haider A, Pescovitz O. Clinical Obstetrics and Gynecology 1993; 36(3):764-772.Suppression of puberty with long-acting goserelin (Zoladex-LA): effect on gonadotrophin response to GnRH in the first treatment cycle.Breyer P, Haider A, Pescovitz O. Clinical Obstetrics and Gynecology 1993; 36(3):764-772. |
| Active substance: GOSERELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29013 |
| Study title: Efficacy of rectal ibuprofen in controlling postoperative pain in children |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29518 |
| Study title: Evaluation of Ibuprofen and Paracetamol in Infective Disorders of Children. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): ibuprofen-m83081.pdf |
| View full study record |
| Document reference: 48089 |
| Study title: Evid Based Med. 2007 Oct;12(5):144. Ibuprofen was more effective than codeine or acetaminophen for musculoskeletal pain in children. Ali S, Klassen TPEvid Based Med. 2007 Oct;12(5):144. Ibuprofen was more effective than codeine or acetaminophen for musculoskeletal pain in children. Ali S, Klassen TP |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29615 |
| Study title: Brady RC, Bernstein DI. Treatment of herpes simplex virus infections. Antiviral Research~ 61(2):73-81, February 2004 2004;(2):-81, February. 2004. Brady RC, Bernstein DI. Treatment of herpes simplex virus infections. Antiviral Research~ 61(2):73-81, February 2004 2004;(2):-81, February. 2004. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Brady RC et al 2004.pdf |
| View full study record |
| Document reference: 28586 |
| Study title: Bryan CJ, Prichard MN, Daily S, Jefferson G, Hartline C, Cassady KA, Hilliard L, Shimamura M. Acyclovir-resistant chronic verrucous vaccine strain varicella in a patient with neuroblastoma.Pediatr Infect Dis J. 2008 Oct;27(10):946- 8.Bryan CJ, Prichard MN, Daily S, Jefferson G, Hartline C, Cassady KA, Hilliard L, Shimamura M. Acyclovir-resistant chronic verrucous vaccine strain varicella in a patient with neuroblastoma.Pediatr Infect Dis J. 2008 Oct;27(10):946- 8. |
| Active substance: Foscarnet |
| Study summary document link (including results): Bryan CJ et al 2008.pdf |
| View full study record |
| Document reference: 39611 |
| Study title: Bueno J, Ramil C, Green M. Current management strategies for the prevention and treatment of cytomegalovirus infection in pediatric transplant recipients. Paediatric Drugs. 2002; 4(5):279-290.Bueno J, Ramil C, Green M. Current management strategies for the prevention and treatment of cytomegalovirus infection in pediatric transplant recipients. Paediatric Drugs. 2002; 4(5):279-290. |
| Active substance: Foscarnet |
| Study summary document link (including results): Bueno J et al 2002.pdf |
| View full study record |
| Document reference: 39635 |
| Study title: Carbon C. New anti-VZV drugs: Perspectives. Medecine et Maladies Infectieuses 1998; 28(Special Issue SI):924-927.Carbon C. New anti-VZV drugs: Perspectives. Medecine et Maladies Infectieuses 1998; 28(Special Issue SI):924-927. |
| Active substance: Foscarnet |
| Study summary document link (including results): Carbon C 1998.pdf |
| View full study record |
| Document reference: 39651 |
| Study title: Caumes E, Bricaire F. Prevention of herpes simplex and varicella zoster infections in hiv infected patients. Annales de Medecine Interne 1997; 148(3):255-257.Caumes E, Bricaire F. Prevention of herpes simplex and varicella zoster infections in hiv infected patients. Annales de Medecine Interne 1997; 148(3):255-257. |
| Active substance: Foscarnet |
| Study summary document link (including results): Caumes E et al 1997.pdf |
| View full study record |
| Document reference: 39658 |
| Study title: Cesaro S, Boaro MP, Pillon M, Calore E, Cermakova I, Perruccio K, Mengoli C, Messina C. Immune reconstitution complicated by CMV retinitis in a pediatric patient who underwent haploidentical CD34+-selected hematopoietic stem cell transplant for acute lymphoblastic leukemia.Int J Hematol. 2008 Sep;88(2):145-8.Cesaro S, Boaro MP, Pillon M, Calore E, Cermakova I, Perruccio K, Mengoli C, Messina C. Immune reconstitution complicated by CMV retinitis in a pediatric patient who underwent haploidentical CD34+-selected hematopoietic stem cell transplant for acute lymphoblastic leukemia.Int J Hematol. 2008 Sep;88(2):145-8. |
| Active substance: Foscarnet |
| Study summary document link (including results): Cesaro S et al 2008.pdf |
| View full study record |
| Document reference: 39612 |
| Study title: Romagnoli C, Zecca E at al., Furosemide does not prevent indomethacin-induced renal side effects in preterm infants, Clin.Pharmacol.Ther. 62, 181-186 (1997) |
| Active substance: FUROSEMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28640 |
| Study title: Experience with Fucidin® Gel preparations in general practice |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28690 |
| Study title: Final report for a trial of Fucidin® cream using both photographic and clinical assessments (Fucidin® cream in the treatment of superficial skin sepsis) |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28673 |
| Study title: Final report for a trial of Fucidin® cream using both photographic and clinical assessments (Fucidin® cream in the treatment of superficial skin sepsis). |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28645 |
| Study title: Fucidin eye drops in acute, bacterial eye infections; Thanpaichitra, Bangkok Thailland |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28654 |
| Study title: Fucidin H Gel in acne |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28691 |
| Study title: Fucidin in various eye infections Open evaluation with fucidin eye drops and fucithalmic viscous eye drops |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28651 |
| Study title: Fucidin Ointment and Fucidin tablets in various indications |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28696 |
| Study title: Fucidin treatment of soft tissue infections in children: comparison of two dosages |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28688 |
| Study title: Fucidin versus erythromycin in skin and soft tissue infection |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28714 |
| Study title: Fucidin versus flucloxacillin in skin and soft tissue infection |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28715 |
| Study title: Fucidin® cream in the treatment of impetigo |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28682 |
| Study title: Fucidin® cream versus its vehicle and Bactroban® in the treatment of impetigo |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28675 |
| Study title: Fucidin® cream versus its vehicle in the treatment of impetigo |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28668 |
| Study title: Fucidin® cream versus its vehicle in the treatment of impetigo |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28674 |
| Study title: Fucidin® cream versus its vehicle in the treatment of impetigo |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28702 |
| Study title: Fucidin® levels in osteomyelitis. E H Chater et al. J Ir. Med. Assoc. 1972; 65: 506 -508 Note this study is included for suspension, tablets and iv reports Study includes pts from 2-72. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28712 |
| Study title: Fucidin® levels in osteomyelitis.E H Chater et al. J Ir. Med. Assoc. 1972; 65: 506 -508 |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28684 |
| Study title: Fucidin® ointment versus its vehicle and Bactroban® in the treatment of impetigo |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28703 |
| Study title: Trueman JA, Tillmann V, Cusick CF, Foster P, Patel L, Hall CM et al. Suppression of puberty with long-acting goserelin (Zoladex-LA): effect on gonadotrophin response to GnRH in the first treatment cycle. Clinical Endocrinology 2002; 57(2):223-30.Trueman JA, Tillmann V, Cusick CF, Foster P, Patel L, Hall CM et al. Suppression of puberty with long-acting goserelin (Zoladex-LA): effect on gonadotrophin response to GnRH in the first treatment cycle. Clinical Endocrinology 2002; 57(2):223-30. |
| Active substance: GOSERELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29017 |
| Study title: A SINGLE-DOSE STUDY OF NEURONTIN® (GABAPENTIN; CI-945) PHARMACOKINETICS IN HEALTHY PEDIATRIC SUBJECTS |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28755 |
| Study title: AN EXTENDED OPEN-LABEL GABAPENTIN (CI-945) PEDIATRIC MONOTHERAPY TRIAL FOLLOWING A DOUBLE-BLIND STUDY (945-094) IN PEDIATRIC PATIENTS WITH BENIGN CHILDHOOD EPILEPSY WITH CENTROTEMPORAL SPIKES (BECTS) (PROTOCOL 945-095). |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28759 |
| Study title: Khan, S. A. and Williamson, D. M. A double-blind comparison of 1% hydrocortisone plus 10% urea ('Alphaderm') and 0.1% betamethasone 17-valerate in the treatment of non-infective inflammatory dermatoses Curr.Med.Res.Opin. 1977;5:354-358. |
| Active substance: HYDROCORTIZONE AND UREA |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29189 |
| Study title: Effect on gingivitis of daily rinsing with 1.5 percent h2O2Boyd 1989 |
| Active substance: HYDROGEN PEROXIDE |
| Study summary document link (including results): Boyd_1989_effect on gingivitis of daily rinsing with 1.5 percent h2o2.pdf |
| View full study record |
| Document reference: 48175 |
| Study title: Efficacy and safety of stabilised hydrogen peroxide cream (crystacide) in mild to moderate acne vulgaris: a randomised, controlled trial versus benzoyl peroxide gel. |
| Active substance: HYDROGEN PEROXIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29191 |
| Study title: skin tolerability and efficacy of combination therapy with hydrogen peroxide stabilized cream and adapalene gel in comparasion with benzoyl peroxide cream and adapalene gel in common acne. A randomized, investigator-masked, controlled trial. |
| Active substance: HYDROGEN PEROXIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29190 |
| Study title: Succesful treatment of molluscum contagiosum skin infection with hydrogen peroxide 1% cream. in the management of patients with psoriasis.; 12th congress of the European Academy of Dermatology & venerology |
| Active substance: HYDROGEN PEROXIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29192 |
| Study title: Topical oral antiseptics, mouthwashes and throat remediesDarlington 1973 |
| Active substance: HYDROGEN PEROXIDE |
| Study summary document link (including results): Darlington_1973_Topical oral antiseptics, mouthwashes and throat remedies.pdf |
| View full study record |
| Document reference: 48176 |
| Study title: HDM9007 - Clinical observation to evaluate the patient oriented dosages of Palladon® retard with respect to circadian variations in pain intensity (0.1% of patients 10-19 years) (Germany); Protocol No.011-004: Open label, preliminary evaluation of the clinical effectiveness and steady state pharmacokinetics of a controlled release sprinkle formulation of hydromorphone in pediatric patients with chronic cancer pain. (terminated - lack of recruitment) |
| Active substance: HYDROMORPHONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29193 |
| Study title: Comparison of hydroxyzine and cyproheptadine as antipruri- tics for atopic dermatitis in children. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29370 |
| Study title: Concerning the side effects of hydroxyzine. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE96J0916-translation.pdf |
| View full study record |
| Document reference: 29314 |
| Study title: Cruzado D, Masserey-Spicher V, Roux L, Delavelle J, Picard F, Haenggeli CA. Eur J Pediatr. 2002 Aug;161(8):438-41. Early onset and rapidly progressive subacute sclerosing panencephalitis after congenital measles infection.Cruzado D, Masserey-Spicher V, Roux L, Delavelle J, Picard F, Haenggeli CA. Eur J Pediatr. 2002 Aug;161(8):438-41. Early onset and rapidly progressive subacute sclerosing panencephalitis after congenital measles infection. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30094 |
| Study title: Preoperative preparation for tonsillectomy with hydroxyzine hydrochloride in pediatric patients. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE91G2920.pdf |
| View full study record |
| Document reference: 29348 |
| Study title: Repigmentacion de vitiligo y otras leucodermias con antihistaminicos h1 (estudio prospectivo 1983-1988). |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPS91H0201.pdf |
| View full study record |
| Document reference: 29234 |
| Study title: Effect of topically applied fluorides in dental caries experiences on children residing in fluoride areas1951-Downs |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1951-Downs-Effect of topically applied fluorides in dental caries experiences on children residing in fluoride areas.pdf |
| View full study record |
| Document reference: 49131 |
| Study title: Fluoride - Ten year prospective study of deciduous and permanent dentitionFrederick J Margolis, Harold R Reames, Ernest Freshman, John C Macauley, Howard Mehaffey. Am J Dis Child - Vol 129. July 1975 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1975-margolis-Fluoride-tenyear prospective study of decidous and permanent dentition.pdf |
| View full study record |
| Document reference: 48768 |
| Study title: Carabaño−Aguado−I et al. Antipyretic effectiveness of ibuprofen and paracetamol. {An−Pediatr−Barc}, Feb 2005, vol. 62, no. 2, p. 117−22Carabaño−Aguado−I et al. Antipyretic effectiveness of ibuprofen and paracetamol. {An−Pediatr−Barc}, Feb 2005, vol. 62, no. 2, p. 117−22 |
| Active substance: IBUPROFEN AND PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29706 |
| Study title: Conscious sedation of pediatric dental patients using chloral hydrate, hydroxyzine, and nitrous oxide: a retrospective study of 382 sedations. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE96C0601.pdf |
| View full study record |
| Document reference: 29310 |
| Study title: Effect of hydroxyzine as a bronchodilator in asthmatic children |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE91B1207.pdf |
| View full study record |
| Document reference: 29260 |
| Study title: Effect of premedication with hydroxyzine on the behavior of child patients |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): DS87A301P.pdf |
| View full study record |
| Document reference: 29224 |
| Study title: Effect of tranquillizers on the end-results of operations for muscle elongation by the method of Madroszkiewicz. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): DPL78F181P.pdf |
| View full study record |
| Document reference: 29296 |
| Study title: Effectiveness of midazolam/hydroxyzine compared to chloral hydrate/hydroxyzine in sedating pedodontic patients |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE02H2305.pdf |
| View full study record |
| Document reference: 29276 |
| Study title: Sedation of children undergoing CT and MR imaging: the association of oral hydroxyzine and rectal chloral hydrate. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPF97B1206.pdf |
| View full study record |
| Document reference: 29243 |
| Study title: Symptomatic and physiologic effects of sedatives in anti- asthmatic preparations in children. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29308 |
| Study title: The antipruritic effect of placebo versus hydroxyzine versus astemizole in children with severe atopic dermatitis. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29322 |
| Study title: The effect of metoclopramide and hydroxyzine in sedation of infants undergoing dental treatment. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE99H1813.pdf |
| View full study record |
| Document reference: 29320 |
| Study title: The effect of sleep on conscious sedation: a follow-up study. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE98J3001.pdf |
| View full study record |
| Document reference: 29328 |
| Study title: The effect of sleep on conscious sedation. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE95C1702.pdf |
| View full study record |
| Document reference: 29327 |
| Study title: The effect of tranquilizers on the immediate skin wheal reaction. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29367 |
| Study title: The effectiveness of midazolam and hydroxyzine as sedative agents for young pediatric dental patients. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE97G1128.pdf |
| View full study record |
| Document reference: 29338 |
| Study title: The effects of nitrous oxide on behavior and physiological parameters during conscious sedation with a moderate dose of chloral hydrate and hydroxyzine. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE96L1315.pdf |
| View full study record |
| Document reference: 29300 |
| Study title: Überprüfung der Wirksamkeit und Verträglichkeit von Ichthocortin® Gel und Elidel® 1% Creme bei Kindern mit leichter bis mittelschwerer atopischer Dermatitis |
| Active substance: ICHTASOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29758 |
| Study title: EFFICACY AND SAFETY COMPARISON OF IDARUBICIN LOCAL PRODUCT AND IMPORT PRODUCT IN PATIENTS WITH AML AND ALL: A PROSPECTIVE, CONTROLLED, RANDOMIZED, OPEN-LABLE AND MULTI-CENTER STUDY |
| Active substance: IDARUBICIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29768 |
| Study title: A retrospective study of Atrovent nebuliser solution in wheezy infants. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30650 |
| Study title: A retrospective study of Atrovent nebuliser solution in wheezy infants. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U91-0623_synopsis.pdf |
| View full study record |
| Document reference: 30703 |
| Study title: Wahba−H. The Antipyretic Effect of Ibuprofen and Acetaminophen in Children. {PHARMACOTHERAPY}, 2004, Vol/Iss/Pg. 24/2 I (280−284) Wahba−H. The Antipyretic Effect of Ibuprofen and Acetaminophen in Children. {PHARMACOTHERAPY}, 2004, Vol/Iss/Pg. 24/2 I (280−284) |
| Active substance: IBUPROFEN AND PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29571 |
| Study title: A comparative, double-blind, randomized study to compare the immunogenicity and reactogenicity of SmithKline Beecham Biologicals' inactivated hepatitis A vaccine containing 360 EL.U injected according to a 0, 1 and 6 month schedule in healthy children. |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47329 |
| Study title: A comparative, double-blind, randomized study to compare the immunogenicity and reactogenicity of SmithKline Beecham Biologicals' inactivated hepatitis A vaccine containing 360 EL.U injected according to a 0, 1 and 6 month schedule in healthy children. |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47330 |
| Study title: A comparative, double-blind, randomized study to compare the immunogenicity and reactogenicity of SmithKline Beecham Biologicals’ inactivated hepatitis A vaccine containing 360EL.U injected according to 0, 1 and 6 month schedule in healthy children. |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47328 |
| Study title: A double-blind randomized, placebo-controlled study of the protective efficacy of SmithKline Beecham Biologicals' inactivated hepatitis A vaccine in healthy children. |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41116 |
| Study title: A double-blind randomized, placebo-controlled study of the protective efficacy of SmithKline Beecham Biologicals' inactivated hepatitis A vaccine in healthy children. |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47333 |
| Study title: A double-blind randomized, placebo-controlled study of the protective efficacy of SmithKline Beecham Biologicals' inactivated hepatitis A vaccine in healthy children. |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47334 |
| Study title: A double-blind, randomised, controlled protective efficacy study of a primary course of an inactivated hepatitis A vaccine in healthy children. |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47331 |
| Study title: A double-blind, randomized, controlled protective efficacy study of a primary course of an inactivated hepatitis A vaccine in healthy children. |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47332 |
| Study title: A preliminary report--heparin counteracts indomethacin effect on ductus arteriosus in very low birthweight infants. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29805 |
| Study title: Acute effects of indomethacin on cerebral hemodynamics and oxygenation |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29809 |
| Study title: Adverse effects of early dexamethasone in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29811 |
| Study title: A comparative study evaluating the analgesic effect of using MagnaBloc therapy, a single dose of ibuprofen 400 mg, or placebo in post-operative dental pain |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29495 |
| Study title: A comparative study evaluating the analgesic effect of using MagnaBloc therapy, a single dose of ibuprofen 400 mg, or placebo in post-operative dental pain. CSR 227. Protocol 96-614, Unpublished Report 670. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): ibuprofen 96-614.pdf |
| View full study record |
| Document reference: 47457 |
| Study title: A controlled double blind study to evaluate the analgesic efficacy of Ibuprofen following tonsillectomy in children from 5 to 13 |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29413 |
| Study title: A multi-centre assessment of acne vulgaris treated with topical isotretinoin. |
| Active substance: ISOTRETINOIN |
| Study summary document link (including results): Article 45_Ref_C0626_Final For Submission_27 Oct 2011.xls |
| View full study record |
| Document reference: 48306 |
| Study title: An Open Clinical and Photographic Evaluation of the Safety and Efficacy of Isotrex gel (0.05% isotretinoin) in the Treatment of Acne Vulgaris. |
| Active substance: ISOTRETINOIN |
| Study summary document link (including results): Article 45_Ref_C0625_Final For Submission_27 Oct 2011.xls |
| View full study record |
| Document reference: 48305 |
| Study title: Bernstein A B, Benefit Risk Summary for Accutane for Pediatric Patients |
| Active substance: ISOTRETINOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30766 |
| Study title: Frederick A*,Eberhardt D,Mcgarry C,Mclane J, Final Study Report: Efficacy and Safety of Accutane in Pediatric Patients versus Adult Patients-A Subgroup Analysis (Study NR15645) of Patients with Severe Recalcitrant Nodular Acne Treated with Accutane [Ident No: NR15645] |
| Active substance: ISOTRETINOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30771 |
| Study title: Prenatal administration of indomethacin as a tocolytic agent: effect on neonatal renal function. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29988 |
| Study title: Analgesic and antiinflammatory effects of glucamethacin (a nonsteroidal antiinflammatory analgesic) after the removal of impacted third molars. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29817 |
| Study title: Antenatal exposure to steroids and the additional prophylaxis effect of indomethacin to prevent intraventricular hemorrhage. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29819 |
| Study title: Burlo C, RotondoAggiornamento Pediatrico ; 1981. Methisoprinol in infantile viral infectionsBurlo C, RotondoAggiornamento Pediatrico ; 1981. Methisoprinol in infantile viral infections |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30079 |
| Study title: Catania S, Vittucci P, Monaceli M, et al.. Presented at the 7th International Congress of Infectious and Parasitic Diseases; June 7-11, 1982; Stockholm, Sweden; 203. Abstract 13:8. Antiviral treatment of chicken-pox and varicella-zoster in normal and compromised patientsCatania S, Vittucci P, Monaceli M, et al.. Presented at the 7th International Congress of Infectious and Parasitic Diseases; June 7-11, 1982; Stockholm, Sweden; 203. Abstract 13:8. Antiviral treatment of chicken-pox and varicella-zoster in normal and compromised patients |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30084 |
| Study title: Antman KH et al Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma J Clin Oncol. 1989 Jan;7(1):126-31. Erratum in: J Clin Oncol 1989 Sep;7(9):1369Antman KH et al Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma J Clin Oncol. 1989 Jan;7(1):126-31. Erratum in: J Clin Oncol 1989 Sep;7(9):1369 |
| Active substance: IFOSFAMIDE AND MESNA |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29776 |
| Study title: A Study of the Efficacy, Pharmaco-kinetics, Safety and Tolerability of Intravenously Administered Multiple doses of MK-787/MK-791 in Neonates, including Premature Infants. |
| Active substance: IMIPENEM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29774 |
| Study title: A multicentre, open, prospective study investigating clinical efficacy, safety, and pharmacokinetic properties of the human normal immunoglobulin for intravenous administration BT681 with intraindividual comparisons to previous standard treatment in patients with primary immunodeficiency disease (PID). |
| Active substance: IMMUNOGLOBULINS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29782 |
| Study title: Effect of indomethacin on cerebral blood flow velocities in very low birth weight neonates with a patent ductus arteriosus. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29882 |
| Study title: Effect of indomethacin phonophoresis on the relief of temporomandibular joint pain. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29883 |
| Study title: Effect of inhaled indomethacin on exercise-induced bronchoconstriction in children with asthma. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29884 |
| Study title: Effect of intravenous diclofenac or indomethacin on the emergence from anaesthesia for tonsillectomy. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29885 |
| Study title: McLane J A*, Liss C, Leach E, Eberhardt D R, Bryce G F, Khoo K-C, Final Study Report / Open label extension of Protocol NR15645 to evaluate the efficacy and safety of a second course of Accutane for severe recalcitrant nodular acne in pediatric patients experiencing recurrence between 36 and 72 weeks of previous isotretinoin treatment |
| Active substance: ISOTRETINOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30762 |
| Study title: McLane J A*, Mues B, Bryce G F, Khoo K-C, Evaluation of available post-marketing safety reports and published literature regarding epiphyseal closure in Accutane-treated pediatric patients with severe recalcitrant nodular acne |
| Active substance: ISOTRETINOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30764 |
| Study title: Ondovik M S*, Eberhardt D R, Liss C, Khoo K-C, Clinical Study Report (Protocol NR 15806): Evaluation of the pharmacokinetics and safety of Accutane in pediatric and adult patients with severe recalcitrant nodular acne |
| Active substance: ISOTRETINOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30763 |
| Study title: Ondovik M S*, Jackson K, Pentikis H S, Khoo K-C, Evaluation of the Pharmacokinetics of Isotretinoin in Pediatric and Adult Patients |
| Active substance: ISOTRETINOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30767 |
| Study title: Shah L P*, Wu E, Eberhardt D R, Ondovik M, Bryce G F, Khoo K-C, An open-label study to evaluate the effect of a single course of Accutane therapy on bone mineral density in pediatric patients with severe recalcitrant nodular acne |
| Active substance: ISOTRETINOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30765 |
| Study title: Shiomos C, Bebeau P, Smith R A, Drug Safety Report Roaccutane - Pediatric Report |
| Active substance: ISOTRETINOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30768 |
| Study title: Shiomos C, Bebeau P, Smith R A, Drug Safety Report Roaccutane (isotretinoin) - Adverse Events reported for Roaccutane during the time period 1-June-2004 to 30-June 2005 in children and adolescents under 18 years old. |
| Active substance: ISOTRETINOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30769 |
| Study title: Treatment of acne vulgaris with topical isotretinoin |
| Active substance: ISOTRETINOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30760 |
| Study title: PROPHYLAXIS OF FUNGAL INFECTION WITH DIFLUCAN IN PATIENTS WITH COLLAGEN DISEASE ON THE LONG TERM, AND LARGE-DOSAGE STEROID THERAPY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27865 |
| Study title: Prophylaxis, costs and effectiveness of gram positive therapy in neatropenic children |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27454 |
| Study title: Prophylaxis, costs and effectiveness of gram positive therapy in neatropenic children |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27818 |
| Study title: PROSPECTIVE COMPARATIVE TRIAL OF AMPHOTERICIN B VS. FCA IN NEONATAL SYSTEMIC FUNGAL INFECTIONS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27643 |
| Study title: PROSPECTIVE COMPARATIVE TRIAL OF AMPHOTERICIN B VS. FCA IN NEONATAL SYSTEMIC FUNGAL INFECTIONS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28005 |
| Study title: Serum mepivacaine concentrations after intraoral injection in young children. Chin, K.L. et al, J. Calif.Dent. Assoc. 2003Serum mepivacaine concentrations after intraoral injection in young children. Chin, K.L. et al, J. Calif.Dent. Assoc. 2003 |
| Active substance: MEPIVACAINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31606 |
| Study title: A Controlled Study on the Effect of an Absorbable Sustained Release Artificial Tear Substitute on the Dry Eye Syndrome Frequently Associated with Familial Dysautonomia. |
| Active substance: HYDROXYPROPYL CELLULOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29218 |
| Study title: Long Term Study of the Effect of a Sustained Release Artificial Tear Substitute (SR-AT) on Keratoconjunctivitis Sicca. |
| Active substance: HYDROXYPROPYL CELLULOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29217 |
| Study title: Hypereosinophilic syndrome: a multicentre, retrospective analysis of clinical characteristics and response to therapy2009 |
| Active substance: HYDROXYUREA |
| Study summary document link (including results): 19910029.pdf |
| View full study record |
| Document reference: 48369 |
| Study title: Cazzola G, Cavalieri S, Solbiati M. (1978) Presented at del Convegno Nazionale della Societa Italiana per lo Studio delle Malattie Infettive e Parassitarie; September 16-17, Ancona, Italy; 1-23. Study of the activity of Isoprinosine® in herpes virus infections.Cazzola G, Cavalieri S, Solbiati M. (1978) Presented at del Convegno Nazionale della Societa Italiana per lo Studio delle Malattie Infettive e Parassitarie; September 16-17, Ancona, Italy; 1-23. Study of the activity of Isoprinosine® in herpes virus infections. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30086 |
| Study title: Cohen AL, Antonini GM, Stefano JC La Prensa Medica Argentina. 1973; 60(8):267-278. A clinical study of various viral infections treated with methisoprinol syrup.Cohen AL, Antonini GM, Stefano JC La Prensa Medica Argentina. 1973; 60(8):267-278. A clinical study of various viral infections treated with methisoprinol syrup. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30091 |
| Study title: Effects of dextroamphetamine, chlorpromazine, and hydroxy- zine on behavior and performance in hyperactive children |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE92B1901.pdf |
| View full study record |
| Document reference: 29266 |
| Study title: Effects of hydroxyzine hydrochloride on the reaction time performance of schizophrenic children |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE92B0504.pdf |
| View full study record |
| Document reference: 29257 |
| Study title: Efficacy of hydroxyzine vs diphenhydramine in atopic dermatitis. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29345 |
| Study title: Electromyography: its potential as an adjunct to other monitored parameters during conscious sedation in children receiving dental treatment. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE91B1826.pdf |
| View full study record |
| Document reference: 29365 |
| Study title: Empleo del clorhidrato de hidroxicina en el tratamiento de la urticaria cronica. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): DS76H021P.pdf |
| View full study record |
| Document reference: 29312 |
| Study title: Evaluation of analgesic, sedative, antipyretic effects of the combination acetaminophen plus hydroxyzine in pediatrics. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPP92K0719.pdf |
| View full study record |
| Document reference: 29341 |
| Study title: Effect of prolonged indomethacin therapy on renal function and selected vasoactive hormones in very-low-birth-weight infants with symptomatic patent ductus arteriosus. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29886 |
| Study title: Effects of early indomethacin administration on oxygenation and surfactant requirement in low birth weight infants. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29887 |
| Study title: Effects of early therapy with indomethacin on the manifestation of a persistent ductus arteriosus in extremely underweight premature infants |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29888 |
| Study title: Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29889 |
| Study title: Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29890 |
| Study title: Effects of indomethacin on cerebral haemodynamics in very preterm infants. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29891 |
| Study title: Effects of indomethacin on cerebral hemodynamics at rest and during endotracheal suctioning in preterm neonates. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29892 |
| Study title: Effects of indomethacin on viral replication markers in asymptomatic carriers of hepatitis B: a randomized, placebo-controlled trial. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29893 |
| Study title: Effects of prenatal exposure to betamethasone and indomethacin on the glomerular filtration rate in the preterm infant. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29894 |
| Study title: Effects of prolonged versus acute indomethacin therapy in very low birth-weight infants with patent ductus arteriosus. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29895 |
| Study title: Effects of repeated indomethacin administration on cerebral oxygenation and haemodynamics in preterm infants: combined near infrared spectrophotometry and Doppler ultrasound study. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29896 |
| Study title: Effects on cerebral blood flow velocities of slow and rapid infusion of indomethacin. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29897 |
| Study title: Künzer Th., Retrospective investigation on children (2-12 years) concerning safety and tolerability and dosage of Echinacin Lozenges; unpublished report (1997) |
| Active substance: (HERB) Purple cone flower, pressed juice, 1.7 - 2.5 : 1 |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39726 |
| Study title: Taylor et al.JAMA December 3, 2003-Vol 290, No. 21 Efficacy and Safety of Echinacea in Treating Upper Respiratory Tract Infections in Children |
| Active substance: (HERB) Purple cone flower, pressed juice, 1.7 - 2.5 : 1 |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39728 |
| Study title: Weber et al. THE JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE Volume 11, Number 6, 2005, pp. 1021–1026 Echinacea purpurea for Prevention of Upper Respiratory Tract Infections in Children |
| Active substance: (HERB) Purple cone flower, pressed juice, 1.7 - 2.5 : 1 |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39729 |
| Study title: PROSPECTIVE OPEN PILOT COMPARATIVE STUDY OF SAFETY & EFFICACY OF FCA PARENTERAL/ORAL VS STANDARD PROPHYLACTIC REGIMEN IN PREVENTION OF FUNGAL INFECTIONS IN PTS WITH PANCYTOPENIA CAUSED BY CHEMOTHERAPY OR IN PTS SUFFERING FROM APLASTIC ANEMIA |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27396 |
| Study title: PROSPECTIVE OPEN PILOT COMPARATIVE STUDY OF SAFETY & EFFICACY OF FCA PARENTERAL/ORAL VS STANDARD PROPHYLACTIC REGIMEN IN PREVENTION OF FUNGAL INFECTIONS IN PTS WITH PANCYTOPENIA CAUSED BY CHEMOTHERAPY OR IN PTS SUFFERING FROM APLASTIC ANEMIA |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27761 |
| Study title: RANDOMIZED CONTROLLED STUDY COMPARING ORAL FLUCONAZOLE TO TOPICAL CLOTRIMAZOLE IN THE TREATMENT OF VAGINAL CANDIDIASIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27648 |
| Study title: RANDOMIZED CONTROLLED STUDY COMPARING ORAL FLUCONAZOLE TO TOPICAL CLOTRIMAZOLE IN THE TREATMENT OF VAGINAL CANDIDIASIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28010 |
| Study title: RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY OF THE EFFICACY OF FLUCONAZOLE PARENTERAL/ORAL IN THE PREVENTION OF FUNGAL INFECTIONS IN PATIENTS WITH PANCYTOPENIA CAUSED BY CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA (AML). |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27397 |
| Study title: RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY OF THE EFFICACY OF FLUCONAZOLE PARENTERAL/ORAL IN THE PREVENTION OF FUNGAL INFECTIONS IN PATIENTS WITH PANCYTOPENIA CAUSED BY CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA (AML). |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27762 |
| Study title: RETROSPECTIVE CONTROLLED ANALYSIS OF FLUCONAZOLE PROPHYLAXIS IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27619 |
| Study title: RETROSPECTIVE CONTROLLED ANALYSIS OF FLUCONAZOLE PROPHYLAXIS IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27981 |
| Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN CRYPTOCOCCAL MENINGITIS IN PATIENTS WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27677 |
| Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN CRYPTOCOCCAL MENINGITIS IN PATIENTS WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28039 |
| Study title: A comparison of the antipruritic efficacy of hydroxyzine and cyproheptadine in children with atopic dermatitis. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29282 |
| Study title: A Double-Blind Parallel Study to Compare the Efficacy and Side Effects of an Ibuprofen 400 mg/Pseudoephedrine 60 mg Combination, an Ibuprofen 200 mg/Pseudoephedrine 30 mg Combination, and Placebo in the Treatment of Sinus HeadacheA Double-Blind Parallel Study to Compare the Efficacy and Side Effects of an Ibuprofen 400 mg/Pseudoephedrine 60 mg Combination, an Ibuprofen 200 mg/Pseudoephedrine 30 mg Combination, and Placebo in the Treatment of Sinus Headache |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29669 |
| Study title: Evaluation of the effect of nitrous oxide and hydroxyzine in controlling the behavior of the pediatric dental patient. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE93B0817.pdf |
| View full study record |
| Document reference: 29337 |
| Study title: Efficacy and safety of echinacea in treating upper respoiratory tract infections in children. A randomized controlled trial.Taylor JA, Weber W, Standish L et al. JAMA 2003;290: 2824-2830Efficacy and safety of echinacea in treating upper respoiratory tract infections in children. A randomized controlled trial.Taylor JA, Weber W, Standish L et al. JAMA 2003;290: 2824-2830 |
| Active substance: (HERB) Echinacea purpurea L extract |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39702 |
| Study title: The physiological effects of supplemental oxygen versus nitrous oxide/oxygen during conscious sedation of pediatric dental patients. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE00L1003.pdf |
| View full study record |
| Document reference: 29290 |
| Study title: Assessment of the effect of 2.5 mg and 5 mg Th 1165a Linctus in school children compared with placebo. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30590 |
| Study title: Assessment of the therapeutic effect and tolerance of Th 1165a Linctus in 12 infants and 12 school children at doses of 3 x 1.25 mg and 3 x 2.5 mg. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30591 |
| Study title: Assessment of the therapeutic effect of Th 1165a-linctus with several days' administration in infants. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30601 |
| Study title: Assessment of therapeutic effect and tolerance of Th 1165a suppositories after repeated administration in infants and school children. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30597 |
| Study title: A randomized open study to investigate the boosting effect of VAQTA and AVAXIM following a single dose of AVAXIM (PM-MSD U98-XQ-003) |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41464 |
| Study title: Evaluation of the safety, immunogenicity and protective efficacy of an inactivated hepatitis A vaccine in healthy children. |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41115 |
| Study title: Letson GW et al. Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infantsJ Pediatr 2004;144:327-32Letson GW et al. Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infantsJ Pediatr 2004;144:327-32 |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41112 |
| Study title: Open study to evaluate the immunogenicity and reactogenicity of SmithKline Beecham Biologicals' inactivated hepatitis A vaccine containing 1440 EL.U of antigen per ml dose injected according to a 0, 12 month schedule in healthy adolescents. |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 21206 |
| Study title: Antipyretic effects of indomethacin in acute infectious diseases--a double blind testa |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29822 |
| Study title: Can dopamine prevent the renal side effects of indomethacin? A prospective randomized clinical study. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29827 |
| Study title: Clinical and objective assessments of naproxen through 5 years of clinical experience. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29831 |
| Study title: The spectrum of antihistamines adversely affecting pulmonary function in asthmatic children. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29330 |
| Study title: The therapeutic effectiveness of nitrous oxide and chloral hydrate administered orally, rectally, and combined with hydroxyzine for pediatric dentistry. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29305 |
| Study title: Uber die klinische bedeutung der ataraktika “tranquillanten” unter besonderer berucksichtigung ihrer anwendung in der kinderheilkunde |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29222 |
| Study title: Urticaria cronica. Caracteristicas, diagnostico y tratamiento. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPS92M2124.pdf |
| View full study record |
| Document reference: 29360 |
| Study title: Urticaria in thai children. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE92D1427.pdf |
| View full study record |
| Document reference: 29357 |
| Study title: Ketoconazole shampoo in the treatment of dandruff and/or seborrheic dermatitits: a randomized, double-blind placebo-controlled comparison of different concentrations |
| Active substance: KETOCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30831 |
| Study title: Th 1165a suppositories 7.5 mg. An assessment of the effect of Th 1165a suppositories in school children during the night on the frequency of acute attacks of bronchospasm, on chronic dyspnoea, and the necessity for adjunctive therapy. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30585 |
| Study title: The effect of administration technique on bronchodilator response to fenoterol in a metered dose inhaler. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30613 |
| Study title: Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30007 |
| Study title: Regional hemodynamic effects of dopamine in the indomethacin-treated preterm infant |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30011 |
| Study title: Retrospective economic evaluation of a controlled trial of indomethacin prophylaxis for patent ductus arteriosus in premature infants. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30016 |
| Study title: Combined treatment with a nonselective nitric oxide synthase inhibitor (l-NMMA) and indomethacin increases ductus constriction in extremely premature newborns. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29839 |
| Study title: Comparative effectiveness of voltaren and indomethacin in rheumatoid arthritis (according to the data of a double-blind study)a |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29840 |
| Study title: A Phase 1, Open-label Study Evaluating the Safety and Pharmacokinetics of a Single Intravenous Infusion of a Chimeric Monoclonal Antibody to Human TNFα (Infliximab) in Pediatric Inflammatory Bowel Disease Subjects Receiving Maintenance Treatment with Infliximab |
| Active substance: Infliximab |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47439 |
| Study title: A Randomized, Double-blind Study of Anti-TNFα Chimeric Monoclonal Antibody (Infliximab) in Combination with Methotrexate for the Treatment of Subjects with Polyarticular Juvenile Rheumatoid Arthritis |
| Active substance: Infliximab |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47436 |
| Study title: A Randomized, Double-blind Study of Anti-TNFα Chimeric Monoclonal Antibody (Infliximab) in Combination with Methotrexate for the Treatment of Subjects with Polyarticular Juvenile Rheumatoid Arthritis • OLE study report synopsis |
| Active substance: Infliximab |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47437 |
| Study title: A Randomized, Multicenter, Open-label Study to Evaluate the Safety and Efficacy of Anti-TNFα Chimeric Monoclonal Antibody (Infliximab, REMICADE®) in Pediatric Subjects with Moderate to Severe Crohn’s Disease |
| Active substance: Infliximab |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47438 |
| Study title: Double blind, controlled trial testing the immunogenicity and side effects of parenteral Vi polysaccharide typhoid vaccine in Indonesian children and adults |
| Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41210 |
| Study title: Adame G Oral itraconazole in the treatment of tinea manus and tinea pedis. Clinical summary on R51211, August 1987. (14-54 years, LMD56451)Adame G Oral itraconazole in the treatment of tinea manus and tinea pedis. Clinical summary on R51211, August 1987. (14-54 years, LMD56451) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30793 |
| Study title: Alcantara R. Treatment of dermatomycosis with 100 mg itraconazole o.d. during fifteen or thirty days. Janssen Research Foundation Products Information service. Clinical research report, February 1988. (5-90 years, LMD59929)Alcantara R. Treatment of dermatomycosis with 100 mg itraconazole o.d. during fifteen or thirty days. Janssen Research Foundation Products Information service. Clinical research report, February 1988. (5-90 years, LMD59929) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30779 |
| Study title: An open evaluation of itraconazole oral solution in paediatric patients undergoing treatment for haematological malignancy or solid tumour. Safety findings. |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): LMD129189_Interventional_Itraconazole.xls |
| View full study record |
| Document reference: 45124 |
| Study title: An open study on the pharmacokinetics and safety of itraconazole oral solution in 24 cystic fibrosis subjects |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): LMD172168_Interventional_Itraconazole.xls |
| View full study record |
| Document reference: 47581 |
| Study title: Boogaerts MA, Verhoef GE, Zachee P, Demuynck H, Verbist L, De Beulke K. Antifungal prophylaxis with itraconazole in prolonged neutropenia: Correlation with plasma levels. Proceedings of the 2nd internationa symposium on itraconazole, Antwerp, Belgium, June 22-23, 1989. Mycoses 32 (suppl.1), p.103-108, 1989. (9-78 years, LMD69411)Boogaerts MA, Verhoef GE, Zachee P, Demuynck H, Verbist L, De Beulke K. Antifungal prophylaxis with itraconazole in prolonged neutropenia: Correlation with plasma levels. Proceedings of the 2nd internationa symposium on itraconazole, Antwerp, Belgium, June 22-23, 1989. Mycoses 32 (suppl.1), p.103-108, 1989. (9-78 years, LMD69411) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30811 |
| Study title: Coninx S, et al Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea Corporis and tinea cruris. Clinical research report on R051211 no-71, May 1987. (2-78 years, LMD56442)Coninx S, et al Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea Corporis and tinea cruris. Clinical research report on R051211 no-71, May 1987. (2-78 years, LMD56442) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30784 |
| Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN LIFE THREATENING DEEP MYCOSES |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27674 |
| Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN LIFE THREATENING DEEP MYCOSES |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28036 |
| Study title: Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: a double-blind randomized trial of 100 patients with 1-year follow-up. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30020 |
| Study title: A double-blind, placebo-controlled, crossover trial of ketotifen versus hydroxyzine in the treatment of pediatric mastocytosis. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29280 |
| Study title: A prospective study of 2 sedation regimens in children: chloral hydrate, meperidine, and hydroxyzine versus midazolam, meperidine, and hydroxyzine. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE07C2107.pdf |
| View full study record |
| Document reference: 29340 |
| Study title: A retrospective study of chloral hydrate, meperidine, hydroxyzine, and midazolam regimens used to sedate children for dental care. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE01A1503.pdf |
| View full study record |
| Document reference: 29366 |
| Study title: A study of quadriceps contracture-causing factor by the analysis of muscle injection according to medical records. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): RACH90J0558P.pdf |
| View full study record |
| Document reference: 29306 |
| Study title: A study to compare the effectiveness of temazepam and a chloral hydrate/hydroxyzine combination in sedating paediatric dental patients. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE94F2815.pdf |
| View full study record |
| Document reference: 29356 |
| Study title: Acute urticaria in infancy and early childhood: a prospective study. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE99E3106.pdf |
| View full study record |
| Document reference: 29307 |
| Study title: Adverse central nervous system effects of older antihistamines in children. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE96K0715.pdf |
| View full study record |
| Document reference: 29344 |
| Study title: Hydroxyzine versus cetirizine in the treatment of atopic dermatitis in children |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): DIE90J061 - Cetirizine.pdf |
| View full study record |
| Document reference: 29220 |
| Study title: Furosemide does not prevent indomethacin-induced renal side effects in preterm infants. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29906 |
| Study title: Furosemide prevents the renal side effects of indomethacin therapy in premature infants with patent ductus arteriosus. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29907 |
| Study title: High efficacy and minor renal effects of indomethacin treatment during individualized fluid intake in premature infants with patent ductus arteriosus. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29909 |
| Study title: Improved quantification of 8-epi-prostaglandin F2 alpha and F2-isoprostanes by gas chromatography/triple-stage quadrupole mass spectrometry: partial cyclooxygenase-dependent formation of 8-epi-prostaglandin F2 alpha in humans. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29914 |
| Study title: Indomethacin and corticosteroids: an additive constrictive effect on the fetal ductus arteriosus. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29919 |
| Study title: Götte and Roschke A supportive measure in the treatment of acute infections of the respiratory tract in children with recurring infections of the upper respiratory tract; päd (7) 2001 |
| Active substance: (HERB) Purple cone flower, dried pressed juice, 31.5 - 53.6 : 1 |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39716 |
| Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN PATIENTS WITH NON-LIFE THREATENING MYCOSIS WHO CANNOT BE TREATED ADEQUATELY TREATED WITH AVAILABLE AGENTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27676 |
| Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN PATIENTS WITH NON-LIFE THREATENING MYCOSIS WHO CANNOT BE TREATED ADEQUATELY TREATED WITH AVAILABLE AGENTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28038 |
| Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN CANCER PATIENTS WITH OROPHARYNGEAL AND OESOPHAGEAL CANDIDIASIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27651 |
| Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN CANCER PATIENTS WITH OROPHARYNGEAL AND OESOPHAGEAL CANDIDIASIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28013 |
| Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH LIFE THREATENING DEEP MYCOSES. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27675 |
| Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH LIFE THREATENING DEEP MYCOSES. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28037 |
| Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH LIFE-THREATENING DEEP MYCOSES, WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27449 |
| Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH LIFE-THREATENING DEEP MYCOSES, WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27813 |
| Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27426 |
| Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27791 |
| Study title: SAFETY AND EFFICACY OF FLUCONAZOLE PO VS. AMPHOTERICIN B SUSPENSION IN PREVENTION OF CANDIDIASIS IN LEUKEMIC PATIENTS UNDERGOING CHEMOTHERAPY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27961 |
| Study title: SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FLUCONAZOLE IN PATIENTS WITH GASTRO-INTESTINAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27419 |
| Study title: Antihistamine selection in patients with allergic rhinitis. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29361 |
| Study title: A Double-Blind, Parallel Study to Compare the Efficacy and Side Effects of an Ibuprofen 400 mg/Pseudoephedrine 60 mg Combination, An Ibuprofen 200 mg/Pseudoephedrine 30 mg Combination, and Placebo in the Treatment of Sinus Headache. Protocol 86-638A, Unpublished Report TA93. |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): ibuprofen_pseudoephedrine 86-638A.pdf |
| View full study record |
| Document reference: 29645 |
| Study title: A Double-Blind, Parallel Study to Compare the Efficacy and Side Effects of an Ibuprofen 400 mg/Pseudoephedrine 60 mg Combination, An Ibuprofen 200 mg/Pseudoephedrine 30 mg Combination, and Placebo in the Treatment of Sinus Headache. Protocol 86-638B, Unpublished Report TA94. |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): ibuprofen_pseudoephedrine 86-638B.pdf |
| View full study record |
| Document reference: 29646 |
| Study title: A Double-Blind, Parallel Study to Compare the Efficacy and Side Effects of an Ibuprofen 400 mg/Pseudoephedrine 60 mg Combination, An Ibuprofen 200 mg/Pseudoephedrine 30 mg Combination, and Placebo in the Treatment of Sinus Headache. Protocol 86-638C, Unpublished Report TA95 |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): ibuprofen_pseudoephedrine 86-638C.pdf |
| View full study record |
| Document reference: 29647 |
| Study title: Hydroxyzine: pharmacokinetics and antipruritic effect in children with atopic dermatitis. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29342 |
| Study title: Intranasal midazolam better at effecting amnesia after sedation than oral hydroxyzine: a pilot study. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE96L1314.pdf |
| View full study record |
| Document reference: 29285 |
| Study title: L’hydroxyzine dans le traitement des affections allergiques. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPS92D0750.pdf |
| View full study record |
| Document reference: 29326 |
| Study title: Taylor et al. Efficacy and Safety of Echinacea in Treating Upper Respiratory Tract Infections in Children.; JAMA December 3, 2003-Vol 290, No. 21 |
| Active substance: (HERB) Purple cone flower, dried pressed juice, 31.5 - 53.6 : 1 |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39717 |
| Study title: Wber et al. Echinacea purpurea for Prevention of Upper Respiratory Tract Infections in Children; THE JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE Volume 11, Number 6, 2005, pp. 1021–1026 |
| Active substance: (HERB) Purple cone flower, dried pressed juice, 31.5 - 53.6 : 1 |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39718 |
| Study title: Künzer,Retrospective investigation on children (2-12 years) concerning safety and tolerability and dosage of Echinacin Lozenges; unpublished report (1997) |
| Active substance: (HERB) Purple cone flower, dried pressed juice, 31.5 - 53.6 : 1, 85 % |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39722 |
| Study title: Taylor et al. Efficacy and Safety of Echinacea in Treating Upper Respiratory Tract Infections in Children; JAMA December 3, 2003-Vol 290, No. 21 |
| Active substance: (HERB) Purple cone flower, dried pressed juice, 31.5 - 53.6 : 1, 85 % |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39719 |
| Study title: Weber et al. Echinacea purpurea for Prevention of Upper Respiratory Tract Infections in Children; THE JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE Volume 11, Number 6, 2005, pp. 1021–1026 |
| Active substance: (HERB) Purple cone flower, dried pressed juice, 31.5 - 53.6 : 1, 85 % |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39720 |
| Study title: Effect of valerian, Valeriana edculis, on sleep difficulties in children with intellectual deficits: randomised trial.; Francis AJ, Dempster RJ. Phytomedicine 2002 May; 9(4): 273-279 |
| Active substance: (HERB) Valeriana officinalis L. extract |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39723 |
| Study title: A combination of valerian and lemon balm is effective in the treatment of restlessness and dyssomnia in children; Article published: Mueller SF; Klement S. Phytomedicine (Jena) 2006;13(6): 383-387 |
| Active substance: (HERB) Valeriana officinalis L. extract Melissa officinalis L. extract |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39725 |
| Study title: HX181-Appréciation en ouvert de l'activité et de la tolérance héxomedine solution chez l'enfant (dossier de modification de formule du 30/10/87) -partie IVB - Paupe and Prost - 27/04/1986Kettelhut, B. V., Berkebile, C., Bradley, D., and Metcalfe, D. D. Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Disease, Bethesda, Md 20892 A double-blind, placebo-controlled, crossover trial of ketotifen versus hydroxyzine in the treatment of pediatric mastocytosis J.Allergy Clin.Immunol. 1989;83:866-870. |
| Active substance: HEXAMIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29119 |
| Study title: HX181-Open study to assess the activity and tolerance of hexomedine solution in children (french dossier-change in formulation-30/10/87)-partie IVB - Paupe and Prost - 27/04/1986Simons, F. E., Simons, K. J., Becker, A. B., and Haydey, R. P. Pharmacokinetics and antipruritic effects of hydroxyzine in children with atopic dermatitis J.Pediatr. 1984;104:123-127. |
| Active substance: HEXAMIDINE |
| Study summary document link (including results): Hexamidine STUDY 0000103117.xls |
| View full study record |
| Document reference: 29120 |
| Study title: Prevention of nosocomial infection in a pediatric intensive care unit (PICU) through the use of selective digestive decontamination. Ruza F, Alvarado F, Herruzo R, Delgado MA, García S, Dorao P, Goded F. Eur J Epidemiol. 1998 Oct;14(7):719-27.Prevention of nosocomial infection in a pediatric intensive care unit (PICU) through the use of selective digestive decontamination. Ruza F, Alvarado F, Herruzo R, Delgado MA, García S, Dorao P, Goded F. Eur J Epidemiol. 1998 Oct;14(7):719-27. |
| Active substance: HEXETIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29121 |
| Study title: Thomas JG et al. Managing the complexity of a dynamic biofilm. J Am Dent Assoc 2006; 137: 10s-15sThomas JG et al. Managing the complexity of a dynamic biofilm. J Am Dent Assoc 2006; 137: 10s-15s |
| Active substance: HEXETIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29122 |
| Study title: Comparative double-blind study of the bronchodilating effect of ipratropium bromide administered as inhalation powder with two different powder inhalators in children with bronchial asthma. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30552 |
| Study title: Comparative double-blind study of the bronchodilating effect of ipratropium bromide administered as inhalation powder with two different powder inhalators in children with bronchial asthma. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U97-0051_synopsis.pdf |
| View full study record |
| Document reference: 30713 |
| Study title: Comparison of the bronchodilatory effect of nebulised ipratropium bromide and fenoterol in children with acute crisis of asthma. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30632 |
| Study title: A double-blind, single dose parallel study to compare analgesic efficacy and side effects profile of acetaminophen 1000 mg, ibuprofen 400 mg, ibuprofen 200 mg, and placebo in the treatment of muscle contraction ('tension') headacheA double-blind, single dose parallel study to compare analgesic efficacy and side effects profile of acetaminophen 1000 mg, ibuprofen 400 mg, ibuprofen 200 mg, and placebo in the treatment of muscle contraction ('tension') headache |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29679 |
| Study title: Fluoride tablets in pre-school age - effect on primary and permanent teethRoland Andersson, Hans Grahnen. Swed Dent J69 137 - 143 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1969-anderesson-Fluoride Tablets in Preschool Age - Effect on Primary and Permanent Teeth.pdf |
| View full study record |
| Document reference: 48767 |
| Study title: Phadke−M−A et al. Ibuprofen in children with infective disorders−−antipyretic efficacy. {Br−J−Clin−Pract}, Nov−Dec 1985, vol. 39, no. 11−12, p. 437−40Phadke−M−A et al. Ibuprofen in children with infective disorders−−antipyretic efficacy. {Br−J−Clin−Pract}, Nov−Dec 1985, vol. 39, no. 11−12, p. 437−40 |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29733 |
| Study title: Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29841 |
| Study title: Comparative study of the clinical effects of ibuprofen and indomethacin in rheumatoid arthritis. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29842 |
| Study title: Commentary on the dosage of Buscopan® injection solution in children and juveniles. Boehringer Ingelheim in-house files, May 1995. |
| Active substance: HYOSCINE-N-BUTYLBROMIDE |
| Study summary document link (including results): Hyoscine Butylbromide_U96-0263_synopsis.pdf |
| View full study record |
| Document reference: 47311 |
| Study title: Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children, 2002 |
| Active substance: HYPERTONIC SOLUTIONS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29378 |
| Study title: Improved Acidosis Correction and Recovery of Mesothelial Cell Mass with Neutral-pH Bicarbonate Dialysis Solution among Children Undergoing Automated Peritoneal Dialysis, 2003 |
| Active substance: HYPERTONIC SOLUTIONS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29377 |
| Study title: Phadke−M−A et al. Ibuprofen in children with infective disorders−−antipyretic efficacy. {Br−J−Clin−Pract}, Nov−Dec 1985, vol. 39, no. 11−12, p. 437−40Phadke−M−A et al. Ibuprofen in children with infective disorders−−antipyretic efficacy. {Br−J−Clin−Pract}, Nov−Dec 1985, vol. 39, no. 11−12, p. 437−40 |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29596 |
| Study title: The effect of antenatal dexamethasone administration on the fetal and neonatal ductus arteriosus. A randomized double-blind study. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30028 |
| Study title: The effect of indomethacin on renal function in children with congenital nephrogenic diabetes insipidus |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30029 |
| Study title: The effects of indomethacin on refractoriness following exercise both with and without a bronchoconstrictor response. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30030 |
| Study title: The hemodynamic effects of antenatal indomethacin and a beta-sympathomimetic agent on the fetus and the newborn: a randomized study. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30031 |
| Study title: Continuous versus multiple rapid infusions of indomethacin: effects on cerebral blood flow velocity. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29850 |
| Study title: Controlled study of the effects of indomethacin on cerebral blood flow velocities in newborn infants. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29852 |
| Study title: Does indomethacin reduce heterotopic bone formation after operations for acetabular fractures? A prospective randomised study. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29859 |
| Study title: Anlar B, Yalaz K, Imir T, Turanli G. Eur Neurol. 1994;34(1):44-7. The effect of inosiplex in subacute sclerosing panencephalitis: a clinical and laboratory study.Anlar B, Yalaz K, Imir T, Turanli G. Eur Neurol. 1994;34(1):44-7. The effect of inosiplex in subacute sclerosing panencephalitis: a clinical and laboratory study. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30069 |
| Study title: Large scale safety study of the DTacP-IPV {acellular TETRACOQ®) vaccine, administered in combination (one injection site) or in assocation two injection sites) with Haemophilus influenzae Type b vaccine (Act-HIB®) for primary and booster immunisation |
| Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41203 |
| Study title: A Stratified, Multicenter, Randomized, Double-Blind, Parallel Group, 4-Week Comparison of Fluticasone Propionate/Salmeterol DISKUS Combination Product 100/50mcg BID versus Fluticasone Propionate DISKUS 100mcg in Pediatric and in Adolescent Subjects with Activity-Induced Bronchospasm. Report No. RM2005/00345/00 |
| Active substance: SALMETEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35593 |
| Study title: Indomethacin versus radiation therapy for prophylaxis against heterotopic ossification in acetabular fractures: a randomised, prospective study. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29943 |
| Study title: Intravenous indomethacin as postoperative analgesic in children: acute effects on blood pressure, heart rate, body temperature and bleeding. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29952 |
| Study title: Intravenous indomethacin therapy in infants with a patent ductus arteriosus complicating other congenital heart defects. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29954 |
| Study title: The response of normal and asthmatic subjects to prostaglandins E2 and F2alpha by different routes, and their significance in asthma. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30035 |
| Study title: The use of dopamine for the prevention of the renal side effects of indomethacin in premature infants with patent ductus arteriosus. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30038 |
| Study title: Assessment of the effects of 2 sedation regimens on cardiopulmonary parameters in pediatric dental patients: a retrospective study. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE06J1502.pdf |
| View full study record |
| Document reference: 29238 |
| Study title: Bullous mastocytosis : diffuse cutaneous mastocytosis with extensive blisters mimicking scalded skin syndrome or erythema multiforme |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29263 |
| Study title: Cetirizine vs hydroxyzine. Atopic dermatitis in children. Statistical report |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): 9039 - Cetirizine - MRCE91M1101.pdf |
| View full study record |
| Document reference: 29221 |
